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Abstract 
 
In the field of the development of new transition metal complexes as phosphorescent 
dopants for organic light emitting devices (OLEDs) or bio-imaging agents, new iridium(III), 
platinum(II), and palladium(II) complexes were synthesized and their luminescence properties 
studied. 
The arylation of fac-Ir(thpy)3 complexes (where thpy = N^C-cyclometallated 2-
thienylpyridine)  with various chromophores such as pyrene or naphthalimide was carried out 
using palladium-catalysed C–H activation (an approach of “chemistry on the complex”). A 
second series of iridium complexes, Ir(Me-ppy)2(tta) functionalized  with the same type of 
fluorophores via the tta unit, were synthesized and their photophysical properties studied (ppy = 
2-phenylpyridine; tta = thenoyltrifluoroacetone). 
To increase the rigidity of the square planar geometry  associated with cyclometallated 
platinum(II) and palladium(II) complexes, we have introduced new tetradentate ligands of the 
coordination type C^N^N^C. Their photophysical studies have shown that all synthesized 
platinum complexes are phosphorescent at room temperature with quantum yields from 0.12 to 
0.78. Furthermore, unusual phosphorescence at room temperature of some palladium complexes 
has been observed. 
The synthesis of new iridium complexes of the type [Ir(ppy)2(N^N)]
n+
 (where n= 1 or 0) 
is also reported,  where N^N = 1-isoquinolinebenzimidazole, 2-quinolinebenzimidazole, 3-
isoquinolinebenzimidazole or 2,2'-bisbenzimidazole. According to the protonation state of the 
azole nitrogen atoms, the charge of the iridium complex is modified. The cationic (N-protonated) 
and neutral (non-protonated) forms of the iridium complexes were obtained using two different 
synthetic methods. The introduction of isoquinolyl units leads to a red-shift in the emission 
compared to the previously studied pyridyl analogue [Ir(ppy)2(pbz)]
n+
 (pbz = 2-
pyridylbenzimidazole). Furthermore, the photophysical properties are dependent on the isomeric 
form and on the protonation state.  In the case of the 2,2'-bisbenzimidazole ligand, three different 
forms may be anticipated in principle, namely a cationic (di-protonation), a neutral (mono-
protonation) and an anionic form (no protonation). To date, the first two have been isolated and 
ii 
 
studied. A pH titration showed the presence of a third form of the iridium complex at pH  10.5, 
tentatively ascribed to the anionic form. 
Finally, new iridium(III) and platinum(II) complexes bearing phosphine-based P^N or 
sulfur-based S^S ligands, respectively, were synthesized and their photophysical properties 
studied.  
 
iii 
 
 
 
DECLARATION 
 
 
The research described herein was undertaken at the Department of Chemistry at Durham 
University between December 2011 and December 2014. All of the work is my own, except 
where specifically stated otherwise. No part of it has previously been submitted for a degree at 
this or any other university. 
 
 
 
 
 
 
 
 
 
 
 
STATEMENT OF COPYRIGHT 
 
 
The copyright of this thesis rests with the author. No quotations should be published without 
prior consent and information derived from it should be acknowledged. 
 
 
 
iv 
 
Aknowlegements 
 
Firstly, my most sincere thanks go to my supervisors, Dr Gareth Williams and Dr Véronique 
Guerchais for all the support, guidance and encouragement given throughout my PhD studies.  
 
I also acknowledge the Department of Chemistry, University of Durham, University of Rennes 1 
and the CNRS, for the financial support to undertake this research.  
 
I would like to thank the members of the jury for agreeing to review my work and have moved to 
Durham: Dr. Philip Dyer from Durham University, Dr. Valery Kozhevnikov from Northumbria 
University and Dr. Claude Lapinte from University of Rennes 1. 
  
I am grateful to Dr. Henri Doucet and Dr. Kassem Beydoun for the catalysis, Dr. Juan A. Aguilar 
Malavia, Dr. Alan Kenwright and Catherine Heffernan for NMR spectroscopy; Dr. Peter Stokes, 
Dr. David Parker and Dr Jackie A. Mosely for mass spectrometry; Dr. Dmitry S. Yufit for X-ray 
crystal structures; and to everyone else from the glassblowers to those who provide tea. 
I would also like to thank all members of the Guerchais’ group and Williams’ group, past and 
present:  
In Rennes: Muriel Escadeillas, Dr. Moussa Zaarour, Dr. Julien Boixel, Dr. Paul Savel, Dr. Yves-
Marie Hervault, He Xiaoyan, Claus Hierlinger, Pramila Selvanathan, Dr. Andrea Mulas and Dr. 
Dang Tung Thanh. 
In Durham: Dr. Victoria Whittle, Dr. Gemma Freeman and your lovely Disney’s songs, 
Raminder and your special dishes (tin can) and all of the 4
th
 year project students: Adam (and the 
thermometer), Joe, Esmee, Ruth and Marius. Thank you for your friendship, your help and 
making the lab such a fun place to work – it has been a pleasure to work with you all. 
 
Finally I would like to thank my family and friends for all the support and encouragement they 
have given. In particular, I would like to thank my parents my sister and Maxime, who have been 
brilliant throughout, and always knew how to make me smile.  
 
v 
 
Abbreviations 
 
Å Angstrom (10
- 10
 m) 
acac acetylacetonate 
AlQ3 tris(8-Hydroxyquinolate)aluminium 
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ISC Intersystem crossing 
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MLCT Metal-to-ligand charge transfer 
MMLCT Meta-metal-to-ligand charge transfer 
MS Mass spectrometry 
NIR Near Infrared 
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CHAPTER ONE: 
INTRODUCTION 
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 Introduction to luminescence 1.
 Definition 1.1.
The word luminescence refers to the emission of light by materials other than that 
which occurs through the process of incandescence (where the energy source is heat). 
Depending on the origin of the excitation energy,  luminescence can be sub-divided into 
different categories, for example, chemiluminescence when the energy comes from a 
chemical reaction, electroluminescence when emission arises as a result of the application of 
an electric field, and photoluminescence when the energy source is light (usually of higher 
energy than that emitted).
1
  
  Absorption 1.2.
When a molecule absorbs a photon of suitable wavelength, an electron is promoted 
from its ground state S0 to a higher energy orbital, producing a singlet excited electronic state 
Sn. This process is very fast, in the range of less than a femtosecond, a timescale over which 
the nuclei are effectively stationary. Thus, the Born-Oppenheimer approximation is valid 
because the nuclei remain fixed during the much faster electronic transition - transitions are 
therefore vertical in a typical diagram of potential energy surfaces, wherein the x axis refers to 
nuclear coordinates. (Figure 1)
 2
 
 
Figure 1.   Diagram showing potential energy surfaces of ground and excited states of a molecule as a 
function of some one-dimensional nuclear coordinate r (e.g. a bond length) 
The energy absorbed is defined by the difference between the energy of the ground 
state and the excited state. This energy of absorption is calculated by the Planck‟s relation:3 
3 
 
E = h
h is the Planck‟s constant and  is the frequency of the photon. In the absorption of 
light, the intensities of the incident light (I0) and transmitted light (I) at a specific wavelength 
  are related by the Beer-Lambert law:4  
A() = log I0/I 
We define absorbance A() as the capacity of the sample to absorb light. The 
absorbance is directly proportional to the the molar concentration, c, and the path length 
through the sample, l, as shown by the Beer-Lambert equation: 
A() = .l.c 
The proportionality constant in this equation,  is the extinction coefficient, the 
capacity of a molecule to absorb a specific wavelength. Extinction coefficients are related to 
the nature of the transition. In fact, if the transition is forbidden by the principles of quantum 
mechanics, the extinction coefficient results to be small (e.g. < 10
2 
dm
3
 mol
–1 
cm
–1
). On the 
other hand, if the transition is allowed, the extinction coefficient is larger (10
4–106 dm3 mol–1 
cm
–1
). Selection rules have generally been used for predicting the nature of the electronic 
transitions. According to the spin selection rule, an allowed transition could only occur 
between two states of the same spin multiplicity (S= 0).5 However, this rule could be relaxed 
by a heavy atom effect that leads to a high spin-orbit coupling due to the fast moving 
electrons around a highly positively-charged nucleus. Spin-orbit coupling results from the 
interaction of the electron magnetic moments with the magnetic field generated by their own 
orbital motion. This effect is most prominently observed in molecules containing heavy 
atom(s) such as 2
nd
 and 3
rd
 row transition metal ion(s). 
 
 Emission 1.3.
When a molecule absorbs a photon, the molecule is promoted to an excited state 
named Sn from its fundamental state S0 (Figure 2). According to Kasha‟s rule the excited 
molecule undergoes rapid relaxation via a non-radiative pathway to the lowest singlet excited 
state S1, a process which is normally much faster than radiative emission from higher Sn 
states.
6
 From this populated excited state S1, the relaxation to the fundamental ground state 
can occur through different pathways (Figure 2). Non-radiative decay is defined by transfer 
of the excess of energy into vibrational, rotational or translational energy, either within the 
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same molecule or between other molecules or solvent in the local environment. Radiative 
decay corresponds to the emission of a photon of energy corresponding to the difference 
between the energies of S1 and S0. This phenomenon is called fluorescence. This process does 
not involve a change in spin multiplicity, as the spins of the electrons in the two singly 
occupied molecular orbitals of the excited state are anti-parallel, as in the ground state. The 
fluorescence happens at lower frequencies compared to the excitation radiation because the 
emissive transition takes place after some energy is dispersed to the environment as 
vibrational energy. On the other hand, the energy can be transferred to a triplet excited state 
T1 through intersystem crossing (ISC) under the influence of spin-orbit coupling (SOC), and 
then goes back to the ground state S0.
3
 ISC occurs when the energy curve of the singlet and 
triplet excited states cross each other, therefore conversion from ↑↓ to ↑↑ of the electronic 
spins is possible and the molecule enters an excited triplet state.
7
 
The corresponding radiative transition back to the ground state, which is called 
phosphorescence, involves a change of spin.
8
 Because it is a spin-forbidden transition, 
phosphorescence is characterized by a longer lifetime; for organic molecules, it is typically in 
the millisecond to seconds range.
9
 In this case, non-radiative processes are usually much 
faster than phosphorescence at room temperature, and so phosphorescence is not usually 
observed at room temperature from organic molecules in solution. In transition metal 
complexes, luminescence is accelerated by the strong spin-orbit coupling of the metal atoms 
that promotes the triplet-to-singlet transition by introducing a mixed character of singlet and 
triplet states.
2
 In small radius metal complexes, ISC is generally much faster than either 
fluorescence or the S1 to S0 non-radiative transition, which means that only phosphorescence 
is observed at room temperature.
10
  
 
Figure 2. Jablonski diagram showing the first excited singlet and triplet states, S1 and T1, the ground 
state S0, and the processes that can occur between them. 
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The Stokes shift is the difference (in wavelength or frequency units) between positions 
of the band maxima of the absorption and emission spectra of the same electronic transition 
(Figure 3). In the case of phosphorescence, the difference between absorption and emission is 
larger than for fluorescence, because it includes the S1-T1 gap, absorption being normally to 
the singlet state.  Indeed, although often used, the term Stokes shift is perhaps erroneous in 
such cases, because the states to which absorption occurs and from emission occurs are not 
the same. 
11
 
 
Figure 3. Representation of Stokes shift principle for a phosphorescence and a fluorescence effect 
The luminescence lifetime  refers to the timescale of the luminescence observation. 
For luminescence that decays mono-exponentially with time: 
It = I0 exp(-kt) 
 the lifetime is defined as the reciprocal of the experimentally observed first-order rate 
constant of decay, k.  Here, It is the intensity at a given time t after pulsed excitation, and I0 is 
the intensity at t=0. The magnitude of k (and hence of ) is determined by the radiative decay 
constant (kr) and non-radiative decay constant (knr) of the molecule from its excited state S1 or 
T1, as follows:  
 = 1/ (kr + knr) 
The emission efficiency is defined by the luminescence quantum yield, which is the 
number of photons that are emitted relative to the number absorbed by the system 
(Figure).
12,13
 
= number of emitted photons / number of absorbed photons 
6 
 
For an excited state formed with unitary efficiency, the quantum yield is determined 
by the radiative (kr) and non-radiative (knr) rate constants through the following 
relationship:
20,21
 
 =  kr / (kr + knr) = kr
Quantum yields of metal complexes are generally highest in the green region: they fall 
off towards the blue because of the energetic proximity of higher-lying deactivating states and 
towards the red because of increased vibrational deactivation. 
 Orbital Transitions 1.4.
  Molecular orbitals (MOs) include several atomic orbitals and can be described as 
being of predominantly metal or ligand character, depending upon which atomic orbitals have 
the most similar energy to the MO of interest (Figure 4).
14,15,16
 When radiation is absorbed, an 
electronic transition between two molecular orbitals occurs and the resulting excited state can 
be characterized approximately by the molecular orbitals involved.
17
 The assignment of the 
various bands that appear in the absorption spectra of transition metal complexes is often a 
very difficult task to solve because the absorption spectra reflect the complexity of the 
electronic structure of the molecule. Charge transfer (CT) involves displacement of the 
electronic charge from the ligands to the metal or vice versa and can be itself of a number of 
types.  
In metal complexes, charge-transfer transitions are classified according to the direction 
of movement of charge in the excited state compared to the ground state (Figure 4).
18,19
 For 
example, metal-to-ligand charge transfer (MLCT) is defined as the promotion of an electron 
from a d orbital of the metal to a π* orbital of the ligand.20 Ligand-to-metal charge transfer 
(LMCT) refers to an electronic transition from an orbital of the ligand to an orbital of the 
metal.
21
 The promotion of an electron between two orbitals both localized on the ligand such 
as π-π* transitions can be define as LC, ligand-centered or intraligand transitions.22,23 
Furthermore, metal, centered transitions (MC) may be observed in which the participating 
MOs are localized predominantly on the metal centre and involve electron promotion between 
two orbitals of the metal.
24,25
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Figure 4. Representation of electronic transitions for an iridium d6 complex (right) 26 
 
 Heavy-Metal Complexes 2.
Aside from metalloporphyrins, the first luminescent heavy-metal complex to be 
discovered was [Ru(bpy)3]
2+
, reported by Paris and Brandt in 1959 (bpy = 2,2‟-bipyridine).27 
Its emission was attributed to an 
3
MLCT transition from the d orbital of the metal centre to the 
* of the 2,2´-bipyridine ligand (Figure 5).  
 
Figure 5.  Structure of [Ru(bpy)3]
2+ 
 
 
The complex [Ru(bpy)3]
2+
 has been one of the most extensively studied heavy-metal 
complexes, and has  been applied as a sensor for O2, as a photosensitizer or photocatalyst, for 
example.
28,29,30 
However, its poor solubility in organic solvents, due to the dicationic charge, 
is a limitation for some applications. Other d
6
 metal ions can be used to prepare 
phosphorescent complexes, for instance, iridium(III) and rhodium(III) from group 9 of the 
periodic table, osmium(II), and rhenium(I) (Figure 6). 
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Figure 6. Representation of frontier molecular orbitals of a d6 iridium complex  
 
Just as d
6
 complexes are generally pseudo-octahedral, d
8
 complexes tend to be square-
planar, particularly those from the 2
nd
 and 3
rd
 row transition metal series where the ligand 
field is strong, such as Pt(II), Pd(II), Ir(I) and Au(III) (Figure 7). This geometry involves 
three stabilized d orbitals, namely dxz, dyz and dz2, one slightly destabilized, dxy, and the final 
dx
2
-y
2 very strongly destabilized, hence accounting for the predominance of this geometry for 
d
8
 ions. 
 
Figure 7. Representation of frontier molecular orbitals of an octahedral (low spin) d8 platinum(II) 
complex 
 
The population of the anti-bonding dx
2
-y
2
 orbital by absorption of light involves an 
increase of the metal-ligand bond lengths and hence a deformation of the molecule in its 
excited state. The introduction of conjugated or electron-rich ligands, such as those 
incorporating aromatic rings, leads to new transitions: ligand-centered (–* or n-*), MLCT 
and/or LMCT. Often, the energy of these excited states is lower than the lowest d-d excited 
state. However a higher-lying, but thermally accessible d-d excited state can quench the 
luminescence of the complexes. The emission properties are then closely related to the 
energetic gap (E) between the d-d state and the other excited states (e.g. LC or MLCT). In 
fact, cyclometallated ligands like phenylpyridine (ppy) typically ensure a large E thanks to 
the C–M bond (strong -donor) working synergistically with the M–N bond (strong -
acceptor) to generate a very strong ligand field. 
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 Luminescence tuning of heavy-metal complexes 2.1.
2.1.1. Effect of cyclometallation 
Martin et al. reported the first synthesis of [Ir(bpy)3]
3+
in 1958 (Figure 8). The reaction 
between K3IrCl6 and bpy at 272 °C gave the final product in 20 minutes.
31
 At 77K, 
[Ir(bpy)3]
3+
 has highly structured ligand-centered emission at em = 440 nm and a lifetime of  
= 80 s.32 In degassed acetonitrile at 293 K, however, the lifetime is much shorter,  = 1.2 s, 
with a quantum yield of  = 0.025 (Table 1). This is indicative of an emissive state that is 
primarily ligand-centred with a relatively small element of MLCT character, unlike 
[Ru(bpy)3]
2+
, which exhibits emission from an MLCT excited state.
 33
  
Orthometallated Ir(ppy)3 was first synthesised by Watts et al. in 1985 (Figure 8).
34
 
The reaction between 2,2'-phenylpyridine (ppy) and IrCl3.H2O led to the formation of a dimer, 
which reacted again with 2-phenylpyridine to give the final product. The cyclometallated 
carbons induce a strong ligand field, which increases the energy of the metal-centred d-d* 
states and so attenuates their potentially deactivating ability.
35,36,37
 In degassed DCM at 298 
K, Ir(ppy)3 shows an emission  maximum at em = 510 nm, red-shifted compared to 
[Ir(bpy)3]
3+
, and a luminescence lifetime,  = 1.9 s, with a quantum yield originally 
measured to be  = 0.40 (Table 1).38 More recent works suggests that this value was 
substantially underestimated, and latest work reports a value of 0.97.
39
  The strong donor 
effect due to the cyclometallation of the phenyl ring involves a red-shift of the emission 
wavelength compared to [Ir(bpy)3]
3+
.  The much higher quantum yield is attributed to more 
efficient participation of the metal in the excited state (i.e. MLCT rather than -*), which is 
necessary to ensure a high kr value through relaxation of the spin-selection rule.
40
 
 
               
Figure 8. Representation of [Ir(bpy)3]
3+
 and fac-Ir(ppy)3 
The complex Ir(dpyx)(dppy) is identified as the bis-tridentate isomer of the archetypal 
Ir(ppy)3 (Figure 9). The comparison of these two systems showed that the bis-tridentate 
system displays a set of strong absorption bands in the visible region around abs = 500 nm 
10 
 
characteristic of MLCT transitions, but they emit at significantly lower energy than fac- and 
mer-Ir(ppy)3. This stabilisation is reasonable in that a lowering in energy of the acceptor 
ligand * orbitals (LUMO) would be expected upon increased delocalization across the three 
aromatic rings of the N^C^N ligand. Furthermore, it has been shown that in iridium(III) 
complexes containing terdentate cyclometallating ligands, low-energy emission is achieved in 
cases of more extended π systems.41,42,43 
    
Figure 9. Representation of Ir(dpyx)(dppy) and fac-Ir(ppy)3 
 
Table 1. Photophysical data for [Ir(bpy)3]
3+
, Ir(dpyx)(dppy) and fac-Ir(ppy)3 in degassed DCM solution 
at 298K  
36,37,38
 
 em / nm PL  / s kr / 10
5
 s
-1
 knr / 10
5
 s
-1
 
 
[Ir(bpy)3]
3+
 440 0.025 1.2 0.21 8.1 
Ir(dpyx)(dppy) 585 0.21 3.8 0.55 2.1 
fac-Ir(ppy)3 510 0.40 1.9 2.1 3.2 
 
2.1.2. Modulation of the HOMO-LUMO gap by functionalization  
Chemical modiﬁcation of the chromophoric cyclometallating ligand enables tuning of 
the emitting properties in a manner that can be readily understood in terms of the inﬂuence of 
electron-donating and -withdrawing substituents on the energies of the frontier orbitals. In 
fact, the level of the HOMO and / or the LUMO states can be modulated by introducing 
electron-rich or electron-deficient ligands (Figure 10). As an example, fac-Ir(ppy)3 displays 
an emission maximum of em = 508 nm in 2-MeTHF, but for the derivative incorporating two 
fluorine atoms in the phenyl ring (positions 4 and 6), em = 466 nm. The F atoms destabilize 
the level of the HOMO and thus increase the HOMO-LUMO energy gap. In contrast, the 
introduction of an electron-rich aryl unit will increase the energy of HOMO level, thus  
reducing the gap. For example, the emission of fac-Ir(thpy)3 is red-shifted compared to fac-
Ir(ppy)3:  em = 545 nm in DCM.
43,44,45
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Figure 10. Modulation of the HOMO / LUMO level by functionalization of the C^N ligand.43,44,45 
 
2.1.3. Effect of Symmetry 
The photophysical properties of a complex depend on the metal, the ligand, its 
geometry and also its symmetry. For example, facial and meridional isomers may have 
different properties.  In the case of a tris-phenylpyridine complex, the fac isomer is that in 
which the three pyridyl rings lie on one face of the octahedron (and the metallated carbons 
necessarily therefore on the other), whereas in the mer, they lie on a meridian. 
The meridional isomers of tris-cyclometallated metal complexes exhibit photophysical 
characteristics different from those of their facial analogues.
44,44,45
 For example, the emission 
in mer-Ir(tpy)3 occurs as a single intense band at 550 nm whereas fac-Ir(tpy)3 shows an 
emission at 510 nm (Table 2). Relative to their facial isomers, mer-iridium complexes are 
easier to oxidize and show a broader red-shifted emission.
45
 The broad emission spectra are 
indicative of a large geometric distortion in the excited state. This may include an increase in 
length of the already long mutually trans Ir–C bonds, consistent with the observation of 
photolytic cleavage of one of these bonds and subsequent isomerisation to the facial isomer.
43
 
At room temperature, the mer-isomers of the phenylpyridyl derivatives also have much lower 
luminescent quantum yields and shorter emission decay lifetimes than their facial 
counterparts. The poor luminescence efficiency is attributed to the high non-radiative decay 
rates associated with the occurrence of the photoisomerisation process.
46
 To conclude, facial 
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complexes are more studied in the literature because of their better luminescence properties 
and higher photochemical and thermal stabilities compared to the meridional complexes. 
 
 
Facial (fac) 
   
 
fac-Ir(ppy)3                        mer-Ir(ppy)3 
 
 
Meridional (mer) 
Figure 11. Representation of fac-Ir(ppy)3 (left) and mer-Ir(ppy)3 
 
Table 2. Photophysical data of facial and meridional Ir(ppy)3, Ir(tpy)3 and Ir(4,6dfppy) in degassed DCM 
solution at 298K  
43,44,45
 
 em / nm 
fac-    mer-
PL 
fac-      mer- 
 / s 
  fac-     mer- 
kr / 10
5
 s
-1
 
  fac      mer- 
knr / 10
5
 s
-1
 
  fac-      mer- 
Ir(ppy)3 510     512 0.40 0.036 1.9 0.15 2.1 2.4 3.2 64 
Ir(tpy)3 510     550 0.50 0.051 2.0 0.26 2.5 2.0 2.5 36 
Ir(4,6dfppy) 468     482 0.43 0.053 1.6 0.21 2.7 2.5 3.6 45 
 
 Applications 2.2.
2.2.1.   OLEDs 
One of the main applications of phosphorescent complexes is as emitters for organic 
light-emitting diodes (OLEDs). In order to be usefully applied in OLEDs, heavy-metal 
complexes must show good phototophysical and thermal stabilities, a high phosphorescence 
quantum efficiency, relatively short phosphorescence lifetimes, and the potential for facile 
colour tuning through ligand structure control. The first example of OLEDs operating at 
practicable voltages was reported by Tang and VanSlyke in 1987.
47
 In 1998, Baldo et al. and 
Ma et al. independently reported the use of phosphorescent transition metal complexes in the 
emissive layer of OLEDs.
48,49
 A typical OLED device with multilayer structure is depicted in 
Figure 12.
50
 The device is composed of layers of organic materials stacked between an anode, 
such as indium tin oxide (ITO), and a metallic cathode, such as Al/LiF or Ag/Mg/Ag. The 
devices are typically comprised of the following layers: 
(1) Electron-transporting layer (HTL), such as tris(8-hydroxyquinolate) aluminum 
(Alq3).  
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(2) Emissive layer (EML), in which an emissive dopant is doped into the host material. 
The singlet and triplet levels of the host should be higher than those of the dopant in order to 
prevent undesired reverse energy transfer from the dopant to the host and to confine the triplet 
excitons in the emissive layer. In this regard, carbazole compounds, such as N,N‟-
dicarbazolyl-4-4'-biphenyl (CBP), are commonly used as host materials. 
(3) Exciton blocking layer, such as 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline 
(BCP), which confines excitons within the organic emissive layer for improving the 
electroluminescence quantum efficiency. 
(4) Hole-transporting layer (HTL), such as N,N‟-bis(naphthalene-1-yl)-N,N‟-
bis(phenyl)-benzidine (NBP). 
Devices that incorporate phosphorescent – as opposed to fluorescent – dopants show a 
great increase in the performance in terms of efficiency.
51,52
 The formation ratio of singlet and 
triplet states in electroluminescence is 1:3. Fluorescence is the emission of a photon from a 
singlet excited state. In contrast, phosphorescence involves radiative relaxation from triplet 
states. Then phosphorescent OLED internal efficiency can, in principle, be increased as high 
as 100% whereas fluorescent OLEDS can only reach 25%. 
 
 
Figure 12. Schematic of a multilayer OLED including a hole injection/transport layer (HIL/HTL), an 
emissive layer (host/guest), a hole blocker layer (HBL) and finally transporter/injection layers 
(ETL/EIL)
51
 
Iridium complexes of cyclometallated arylpyridine ligands have attracted a great deal 
of interest as OLED phophors, for example, Ir(ppy)3, Ir(dFppy)2(pic), and Ir(piq)2(acac) as 
green, blue, and red emitters, respectively (ppyH = 2-phenylpyridine, F2ppyH = 2-(2,4-
14 
 
diﬂuorophenyl)pyridine; piqH = 1 phenylisoquinoline; picH = picolinic acid; acacH = 2,4-
pentanedione).
53,54,55,56,57
  
2.2.2. Bio-imaging and bio-sensors 
Heavy metal-complexes have interesting behaviour for application in bio-imaging.  
Compared to fluorescent organic molecules, which have a luminescence lifetime on the 
nanosecond scale, heavy-metal complexes show phosphorescence emission with a lifetime in 
the range of microseconds. This long lifetime allows an easy discrimination of 
phosphorescence from the fluorescent background of the cell or tissue sample on the basis of 
the timescale. 
Organic or biological dyes (e.g. green fluorescent protein, GFP) are mostly used in 
confocal microscopy at present, but there are still disadvantages such as a short fluorescence 
lifetime, self-quenching effects, high photobleaching rate, and strong pH dependence in some 
cases.
58
 Lanthanide(III) complexes show a long luminescence lifetime (s to milliseconds) in 
the visible (e.g. Eu and Tb) or NIR (e.g. Yb, Nd) regions of the spectrum.
59
 However, free 
lanthanides are highly toxic, and so suitable complexes must show a high stability with 
respect to metal ion dissociation, which demands the use of macrocyclic or highly polydentate 
ligands. Direct excitation of many lanthanide ions is problematic due to low  values, and 
instead an additional chromophore must be incorporated into the complex to absorb and 
subsequently transfer energy to the lanthanide. 
In order to be usefully applied in life sciences, luminescent heavy-metal complexes 
require certain attributes such as good stability and solubility in water, good photophysical 
properties and a low toxicity in cells. In the field of bio-imaging, a large Stokes shift has two-
fold importance: to prevent self-quenching (i.e. the re-absorption of emitted light by 
neighbouring fluorophores), and to distinguish the emission of the fluorophore from 
autofluorescence (i.e. emission from endogenous fluorophores such as DNA, NADPH, 
aromatic amino acids), which, while itself useful in imaging, can interfere with desired 
fluorophore emission. Typically, autofluorescence Stokes shifts are small (tens of nm) and 
large Stokes shift fluorophores allow autofluorescence to be filtered out without losing signal 
intensity. Due to their MLCT transition, inorganic complexes show large Stokes shifts (as 
discussed earlier subject to the caveat about the strict definition of Stokes shift), and are thus 
potentially very attractive probes for bio-imaging. 
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Heavy-metal complexes show good photophysical properties in degassed solution, 
with notable quantum yields and lifetimes in the range of µs.
60,61
 In the presence of oxygen, 
quantum yields and lifetimes can decrease by a factor of 60 compared to the values in 
degassed solutions.
62
 This phenomenon occurs by an efficient energy transfer from the triplet 
excited stated of the molecule T1 to the triplet ground state of the oxygen.  The luminescence 
of the complex is quenched and a singlet state oxygen(
1Δg) is formed.(Figure 13).
63
 Oxygen 
concentration is then quantified according to the changes in the luminescence intensity and in 
the lifetime of the complex.
64
 
 
 
Figure 13. Effect of the triplet oxygen on the emission 
  Tobita et al. developed a small-molecule oxygen sensor (C343-Pro4-BTP) that uses 
coumarin 343 as an oxygen-insensitive fluorophore and the iridium complex BTP as an 
oxygen-sensitive phosphor (Figure 14).
65
 The blue fluorescence of the coumarin is insensitive 
to O2, having a short lifetime, whereas the red phosphorescence of the Ir(III) complex is 
quenched by O2, as it has a long excited state lifetime. The ratio of the fluorescence  to the 
phosphorescence of the C343-Pro4-BTP showed a quantitative dependence on the oxygen 
concentrations in a DMPC membrane as well as in solution. Oxygen quenching experiments 
on C343-Pro4-BTP in HeLa cells demonstrated the potential of the molecular probe for 
quantitative mapping of local oxygen levels in living cells and tissues.   
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Figure 14. Iridium complex bearing a coumarin unit used for imaging O2 in cells 
62
  
A chemosensor is generally defined as a combination of two units: a receptor unit and 
a signaling unit.
66,67
 The receptor unit can selectively bind the analytes. The signaling units 
can record the interaction between receptors and analytes by modification of the luminescence 
properties. Phosphorescent heavy-metal complexes can act as signaling units, emitting light 
that is modulated in response to the analyte-binding process.  
To date, several approaches have been reported for linking the receptor to the 
phosphorescent signaling unit. One approach involves linking the receptor to the ligand of a 
complex through a spacer (Figure 15). It is defined as „„receptor–-signaling unit approachs‟‟ 
which involves switchable phosphorescent chemosensors.
62,63
 
 
Figure 15. “receptor–-signaling unit approach to the analyte‟‟ 63 
Furthermore, the receptor can be conjugated to a ligand without a spacer. This 
approach is called the „„receptor–conjugated signaling unit approach‟‟ (Figure 16). By 
comparison with „„receptor–conjugated signaling unit approach‟‟, phosphorescence can be 
modulated by its intensity and also by its emission wavelength. To date many ratiometric 
phosphorescent chemosensors have been developed by this route. Finally, an irreversible 
Mechanism I 
Mechanism II 
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chemical reaction between a heavy-metal complex and analytes is possible. This approach is 
called „„chemodosimeter approach‟‟. Ratiometric phosphorescence probes could be easily 
developed by this approach.  
 
 
 
Figure 16. “receptor–conjugated signaling unit approach‟‟ 62 
Secondly, the excited state properties of phosphorescent heavy-metal complexes are 
very rich and different excited states can lead to different emission properties. If the receptor 
is connected to the ligand by a spacer, or if a specific recognition site is incorporated into the 
ligand, the interaction of the receptor with the analyte will perturb the energy levels of the 
excited states. This will induce interconversion among the different charge-transfer states, 
thereby producing a change in phosphorescent signal and realizing the detection (mechanism 
II). This mechanism II of phosphorescent chemosensors is usually achieved by the „„receptor–
conjugated signaling unit approach‟‟ for linking receptor and signaling unit. The third kind of 
mechanism is based on fluorescence resonance energy transfer (FRET) (mechanism III), 
which is dependent on a change in the energy transfer between energy donor and acceptor 
after binding with analyte. 
For the d
8
 and d
10
 heavy-metal complexes, there exists intermolecular metal–metal 
interactions (such as Pt···Pt and Au···Au), which can significantly influence the excited state 
properties of complexes, such as the formation of 
3
MMLCT or 
3
LMMCT excited states.
68
 If 
the binding of complexes with analytes influences the metal-metal interaction, the emission 
properties can be changed. Utilizing this mechanism (mechanism IV), some novel 
Mechanism III 
Mechanism IV 
Mechanism V 
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phosphorescent chemosensors can be designed. The phosphorescent emission of heavy-metal 
complexes is sensitive to the local environment. If binding of heavy-metal complexes with 
analyte changes local surroundings and leads to a change in phosphorescent emission, the 
detection can be realized (mechanism V). This mechanism is often utilized to design 
phosphorescent probes for biomolecules. 
In 2012, Lee et al. synthesized and studied a new iridium complex bearing a 4-
(dimesitylboryl)benzoate as chemosensor.
69
 At room temperature, the complex emits a weak 
emission at max = 615 nm. The quenching of the luminescence of the complex was attributed 
to a photoinduced electron transfer (PET). By addition of fluorine, the phosphorescence of the 
iridium complex turns “on” as the emission intensity increases by a factor of 10.  The binding 
of receptor with analyte (F
-
) can inhibit the PET and restore the emission. Other examples 
showing the opposite effect (the addition of analyte inducing PET and quenching the emission 
of the complex) have already been developed. The „„receptors-signaling unit approach‟‟ for 
linking receptor and signaling unit is usually used for designing PET-based phosphorescent 
chemosensors. 
 
Figure 17. Representation of an OFF /ON Iridium complex66  
 
In 2014, Wong et al. synthesized and studied an iridium complex bearing a tris-(2-
pyridylmethyl)amine ligand as a Zn
2+
 receptor.
70
 The interaction between the Zn
2+
 ion and the 
iridium complex will modify the emission properties of the complex. In fact, the free iridium 
complex emits blue light (em= 495 nm), whereas the binding of a metal ion will produce a 
green light at around em = 555 nm. Zn
2+
 ions involve a suppression of the photoinduced 
electron transfer by binding the complex. 
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Figure 18. Iridium complex used as Zn2+ receptor 67 
 
 
 Thesis objectives: 3.
The objectives of this PhD were to synthesize new luminescent heavy-metal complexes 
for applications in OLEDs or bio-imaging. The manuscript is composed of four chapters, with 
a bibliographic section for each chapter.  
Chapter 2 will describe the synthesis of new tris-cyclometallated and bis-
cyclometallated iridium complexes incorporating more extended chromophoric units. The 
synthesis was performed by functionalization of thiophene-containing iridium complexes by a 
palladium-catalyzed C–H activation on the cyclometallated thienyl ring. This project was 
done in collaboration with Dr. Henri Doucet (University of Rennes 1). The absorption and 
emission properties of the resulting complexes were studied to observe the influence of the 
chromophore on the properties. 
In order to obtain better emitters, new rigid heavy-metal complexes with tetradentate 
ligands will then be described in Chapter 3. The synthesis of tetradentate platinum(II) 
complexes incorporating a C^N^N^C ligand will be first developed and their photophysical 
properties studied. An investigation of luminescent tetradentate palladium complexes and a 
brief exploration into gold complexes with the same ligands will then be discussed. 
Chapter 4 will be devoted to the synthesis and the study of new iridium(III) complexes 
incorporating (iso)-quinolylbenzimidazole and 2,2´-bisbenzimidazole ligands.  Owing to the 
presence of azole rings, the excited-state propertie of these compounds are pH-sensitive, 
which may render them of potential interest in future sensory applications.   
Finally, Chapter 5 presents the synthesis and the photophysical studies of new 
cyclometallated iridium(III) and platinum(II) complexes bearing new ancillary ligands, 
including those with phosphorus or sulfur ligating atoms in place of the nitrogen or oxygen 
atoms more commonly used in other studies to date. 
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 Arylated facial tris-cyclometallated thienylpyridine iridium 1.
complexes fac-Ir(thpy-Ar)3 
In the following section, the different procedures used for the preparation of the 
complex fac-Ir(thpy)3 and its functionalized derivatives reported in the literature will be 
presented. The absorption and luminescence properties of these complexes will be discussed 
together with the effects of functionalization on these properties. 
1.1. Synthesis of the precursor complex fac-Ir(thpy)3 
1.1.1. Classical method, first example of complex fac-Ir(thpy)3 
In 1994, Colombo et al. reported the first example of tris-cyclometallated   2-2′-
thienylpyridine iridium complex fac-Ir(thpy)3, 1 (Scheme 1).
1 
This complex was obtained in 
58 % yield by reacting the chloro-bridged dimer [Ir(thpy)2(-Cl)]2  with an excess of 2-2′-
thienylpyridine ligand in the presence of AgCF3SO3.
2
 
 
Scheme 1. Synthetic route for the formation of fac-Ir(thpy)3 
2  
The 
l
H NMR spectrum of complex 1 shows a set of six signals corresponding to one 
thienylpyridine environment indicating that the three ligands are magnetically equivalent due 
to a C3-fold symmetry axis of the molecule, which is consistent with a facial arrangement of 
the ligands.  
 
1.1.2. Synthesis of the complex fac-Ir(thpy)3 using alternative methods 
In 2007, McGee et al. reported the preparation of fac-Ir(thpy)3 at 90-115 °C using a 
multi-step procedure with longer reaction time starting from the chloro-bridged dimer 
(Scheme 2).
3
 Dissolving the chloro-bridged dimer in acetonitrile produces the mono-
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acetonitrile-mono-chloro complex 2. The resulting complex was heated in acetonitrile in the 
presence of AgPF6 to form the cationic bis-acetonitrile complex 3. Starting from complex 3, it 
was possible to prepare complex 1 in one or two steps depending on the solvent and the 
temperature used. 
 
Scheme 2. McGee’s synthetic route for the formation of fac-Ir(thpy)3 
3 
 
Heating 3 with thienylpyridine at 100 
o
C in o-dichlorobenzene for five days led to the 
formation of complex 1. On the other hand, stirring complex 3 with an excess of 2-2′-
thienylpyridine in acetone at room temperature for 72 h allowed the coordination of 
thienylpyridine through the lone pair of the sulfur atom to give the complex [Ir(C^N-
thpy)2(S^N-thpy)]PF6, 4. Heating 4 at 90-100 
o
C in o-dichlorobenzene for six days allowed the 
cyclometallation process to occur to give a mixture of complexes 1 and 4 in 2:1 ratio.  
In our laboratory, the fac-Ir(thpy)3 complex 1 was prepared with a slight modification of 
the two-step procedure reported by Colombo et al.
1
 The metallic precursor IrCl3.nH2O was 
reacted with an excess of 2,2′-thienylpyridine ligand in 2-ethoxyethanol to obtain the chloro-
bridged dimer in 76 % yield. The dimer was then reacted with a slight excess of 2,2′-
thienylpyridine (2.5 equivalents were used instead of 15 equivalents reported) in the presence 
of a base (K2CO3 instead of AgCF3SO3) in glycerol at reflux (200 
o
C). Complex 1 was 
isolated as an orange powder in 67 %.  
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1.2. Photophysical properties of complex fac-Ir(thpy)3, 1 
The absorption spectrum of complex 1 shows an intense band in the UV region at 
300 nm corresponding to the π-π* transitions of the thienylpyridine ligand (Figure 1). A 
broad and moderately intense band is observed at 385 nm corresponding to the spin-allowed 
Metal-to-Ligand-Charge-Transfer 
1
MLCT accompanied  by a shoulder extending into the 
visible region corresponding to the spin-forbidden 
3
MLCT.
1 
Complex 1 presents a structured 
emission at 550 nm arising from a primarily LC 
3
(π-π*) excited state. It has a 
photoluminescence quantum yield (φ) of 17 % and lifetime (τ) of 2.4 μs.  
 
 
 
λem = 545 nm, φ = 17 %, τ = 2.4 μs.           
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Figure 1. Absorption and emission spectra of 1 in CH2Cl2 at 298 K and in EPA solution at 77 K. 
 
The luminescence properties of the complex fac-Ir(thpy)3 (1) can be compared with that 
of the complex fac-Ir(ppy)3, (5) having three cyclometallated phenylpyridine ligands. At 298 
K, complex 5 presents a green emission originating from an MLCT excited state (Figure 2). 
The emission spectrum shows a featureless band at λmax = 508 nm. In degassed DCM solution, 
complex 5 has a quantum yield of 100 % and lifetime τ = 1.6 µs.4 Replacing the phenyl by the 
thienyl ring changes the emission color from green to orange. Complex 1 has a quantum yield 
which is much lower than that of complex 5 whereas it shows a longer lifetime (τ = 2.4 µs). 
Structural modification on the C^N ligand induces a change in the phosphorescence properties 
(emission wavelength, quantum yield and lifetime) as a result of changing the nature of the 
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excited state: the metal character in the excited-state decreases compared to 5 and becomes 
more ligand-centred with a concomitant reduction in kr.  
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Figure 2. Emission spectra of complexes fac-Ir(thpy)3, 1 and fac-Ir(ppy)3, 5 in CH2Cl2 at 298K.  
 
1.3. Synthesis and photophysical properties of functionalized fac-Ir(thpy)3 
complexes 
1.3.1. Functionalization on the proligand 
Few examples of functionalized fac-Ir(thpy)3 derivatives have been reported. In 2003, 
Tsuboyama et al. showed that the substituted derivatives of fac-Ir(thpy)3, 6, 9 and 10 are 
accessible in a one-step procedure starting from Ir(acac)3 and an excess of ligand in glycerol 
at reflux (Figure 3).
5
 A new series of luminescent derivatives having yellow, orange and red 
colours have been prepared for application in OLEDs. The ligands were first prepared using 
Suzuki cross-coupling reaction between thienyl, 5-methylthienyl or benzothienyl boronic 
acids and the appropriate chloropyridine derivative.  
In 2013, Lin et al. described the synthesis and the photophysical properties of the boryl-
thienylpyridine iridium complexes 7 and 8, for OLEDs applications (Figure 3).
6
 The 
corresponding ligands were prepared using Stille palladium cross-coupling. 
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Figure 3. Functionalised Ir(thpy)3 complexes 6-10. 
6 
 
The complexes were substituted by electron-donor or -acceptor groups introduced at the 
thienyl or the pyridine rings, or via extended π-conjugated systems. Complex 6 is 
functionalized by the weak electron-donating methyl group on the C5 position of the thienyl 
ring, while complexes 7 and 8 bear strong electron-acceptor groups. Complexes 9 and 10 have 
extended π-conjugated systems due to the replacement of the thienyl ring by benzothienyl and 
the pyridine ring by isoquinoline. 
Functionalization of the thpy ligand involves a modification  of the photophysical 
properties. Introducing the methyl group on the C5 position of the thienyl ring of complex 6 
results in a bathochromic shift of 8 nm in the emission wavelength compared to complex 1. 
The photoluminescence quantum yield and lifetime are strongly influenced by this structural 
modification, the quantum yield decreased to 8 % and the lifetime decreased to 0.99 µs.
4 
 
The boryl group attached on the C5 position of the thiophene ring revealed a 
bathochromic-shift of 98 nm for complex 7 (λem = 643 nm) and 196 nm for complex 8 (λem = 
741 nm), with respect to 1. This substitution has also an influence on the photoluminescence 
quantum yield and lifetime of the resulting complexes (φ = 39.6 %, τ = 6.9 µs for complex 7 
and φ = 5.7 %, τ = 6.2 µs for complex 8).  
Extending the π-conjugated system, by introducing aromatic rings to either the thienyl 
or the pyridyl part of the C^N ligand, also has an influence on the photophysical properties. 
Replacing the thienyl ring by a benzothienyl in complex 9 induces a bathochromic shift of 46 
nm compared to complex 1, while replacing the pyridyl ring by isoquinoline in complex 10 
induces a bathochromic shift of 99 nm.
4
 Extending the π-conjugated system changes the 
emission color from yellow-orange (compex 1) to orange-red (complex: 9 em = 596 nm and 
10: em = 644 nm). The luminescence lifetime for complex 9 is increased to 4 µs while a 
decrease of the luminescence lifetime to 0.74 µs is observed for complex 10. Interestingly, the 
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photoluminescence quantum yield is only weakly influenced by these structural modifications 
(φ (8) = 12 %, φ (10) = 12 %). 
 
1.3.2. Functionalization using “Catalysis- on-the-complex”  
Thiophene-containing fac-Ir(thpy)3 complexes form an attractive class of 
luminophores.
7
 They possess interesting phosphorescence properties that can be tuned by a 
simple modification of the thienylpyridine ligand. Developing a new synthetic strategy for the 
functionalization of this ligand would open the door for better modulation of the optical 
properties of the resulting complex. 
An efficient and direct method to functionalize the cyclometallated ligands is the 
"Chemistry-on the-complex" strategy. This method was used in Rennes to prepare tris-styryl-
phenylpyridine substituted Ir(III) complexes (Scheme 3). But the scope of the organic 
reactions that can be used is rather limited. Moreover, it is not always possible to control the 
selective mono-, bis- or tris-substitution in the presence of more than one reactive site on the 
complex such as in tris-cyclometallated Ir(III) complexes.
8a
 
 
Scheme 3. Synthesis of tris-styryl-phenylpyridine iridium complexes8a 
Catalytic reactions can be also a useful tool for the access to new luminophores that 
cannot be prepared using the classical organic reactions. The well-known cross coupling 
reactions (Suzuki, Negishi...) can lead to the functionalization of the complex by introducing 
different substituents. In addition, a C-C cross-coupling reaction between two organometallic 
species allows access to multi-nuclear complexes. 
In 2009, Williams et al. reported the palladium-catalyzed Suzuki cross-coupling 
reaction between two cyclometallated iridium complexes to form a dinuclear complex with 
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interesting photophysical properties (Scheme 4).
9
 This example shows that catalytic reactions 
can be applied directly on metallated ligands. 
The two building blocks that are necessary for a Suzuki reaction were first prepared, the 
bromo-substituted bis-terdentate (N^N^N) iridium complex 12 and the iridium bis-terdentate 
Ir(N^N^C)(N^C^N)
+
 complex 13 incorporating a boronic acid. The two complexes were 
coupled in the presence of Pd(PPh3)4 to produce the bimetallic complex 14 in 16 % yield. This 
example opens access to new classes of dinuclear complexes through performing catalytic 
reactions on the metallated ligands.  
 
Scheme 4. Synthesis of dinuclear iridium complex 14 9 
 
In 2012, Amouri reported the palladium-catalyzed Sonogashira cross-coupling reaction 
for the preparation of an iridium-polyoxometalate hybrid complex (Scheme 5).
8b 
 In this 
example, the heteroleptic iridium complex 15 incorporating two phenylpyridine ligands and 
picolinate ancillary ligand incorporating a terminal alkynyl group was prepared. The 
organotin polyoxometalate compound 16, featuring a PW11O39 moiety connected via the tin 
center to 4-iodobenzene group, was synthesized. The Sonogashira cross-coupling between the 
two components 15 and 16 produced the hybrid iridium-polyoxometalate complex 17.  
These two examples show that performing catalysis directly on the metallated ligands is 
an efficient way to build up new multi-metallic species. 
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Scheme 5. Synthesis of of iridium-polyoxometalate hybrid complex 17 8b 
 
1.3.3. Palladium-catalyzed arylation/CH bond activation 
As demonstrated above, Pd-catalysed cross-coupling reactions can be readily used, but 
more interestingly Pd-catalyzed arylation/CH bond activation is also an efficient tool to 
functionalize Ir complexes.  
 Palladium-catalyzed C-H bond activation of free thiophenes 
Pd-catalyzed arylation/C–H bond activation can be applied to various heterocycles such 
as furans, thiophenes, pyrroles. In Rennes, H. Doucet and co-workers developed the direct 
arylation of α-substituted thiophenes using palladium-catalyzed C–H bond activation 
(Scheme 6).
10 
 They also showed that the C
5–H bond of thiophene can be activated by a 
ligand-free palladium catalyst.
10b 
Blocking the α-position of the heterocycle restrains the 
possible side-reaction that would give the symmetrical bis-arylated product. Using this 
method, different aryls or heteroaryls (phenyl, pyridyl, naphthalenyl) substituted by a wide 
range of electron-donating (CH3, NH2) or electron-accepting groups (CN, COMe, COOMe, 
Cl, CF3…) were introduced into the thiophene in very good yields (52 % to 84 %). 
 
 
Scheme 6. Direct arylation of α-substituted thiophenes using palladium-catalyzed C-H bond activation 10 
 
 Palladium-catalyzed C-H bond activation of fac-Ir(thpy)3 complex: access to 
mono-, bis- and tris-arylated complexes 
The group in Rennes, in collaboration with H. Doucet, has developed the palladium-
catalyzed C–H bond activation/arylation of fac-Ir(thpy)3, 1.
11
 This method opens the door for 
the access to new class of functionalized complexes through the C–H bond activation of the 
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metallated thiophene rings. It provides the easy access to substituted complexes without the 
preparation of intermediates or metallic precursors. Furthermore, it allows the selective mono, 
bis, or tris-functionalization with various aryl or heteroaryl rings incorporating electron-
acceptor-end groups. 
1.3.4. Synthesis of mono-, bis- and tris-benzonitrile fac-Ir(thpy)3 derivatives 
For example, the coupling of complex 1 with 4-bromobenzonitrile has been performed 
in DMAc at 130 
o
C, using Pd(OAc)2 as the catalyst and KOAc as the base (Scheme 7).
11
 
These conditions were previously optimized for the palladium-catalyzed direct arylation of α-
substituted thiophenes. The phosphine-free palladium catalyst was selected in order to avoid a 
possible decomposition of the iridium complexes due to ligand exchange reaction with 
phosphines.  
 
Scheme 7. Synthesis of mono-, bis- and tris-benzonitrile fac-Ir(thpy)3 
11
 
 
The distribution of the product ratio appeared to be strongly dependent on reaction time. 
Upon heating the reaction up to 8 h, the ratio increases towards more arylated complexes: a 
mixture of 1a:1b and 1c was produced in 0:2:8. Further increase of the reaction times (48 h) 
produced selectively the tris-arylated complex 1c (64 % isolated yield). This method has been 
extended to the preparation of complexes fac-Ir(thpy-Ar)3 containing various aryl rings 
(phenyl, naphthalenyl) or heteroaryl rings (pyridyl, pyrimidyl) incorporating different 
substituents (Figure 4). 
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  Yield                           48 %                      63 %                       52 % 
Figure 4. fac-Ir(thpy-Ar)3 derivatives 
11
 
However, this method cannot be used for the preparation of tris-cyclometallated iridium 
thienylpyridine complexes with aryl rings incorporating donor-end groups. A possible 
explanation could be that the high electron density on the arylbromide incorporating donor 
end-group prevents their oxidative addition to the palladium catalyst. 
 
1.4. Photophysical characterization of arylated fac-Ir(thpy-Ar)3 complexes 
The incorporation of an aryl substituent has a direct effect on the absorption properties 
of the resulting complexes. The absorption wavelengths as well as their molar extinction 
coefficients increase upon introducing stronger electron-accepting groups onto the complex. 
The emission spectra of complexes 1, 1c, 1d, 1e and 1f are presented in Figure 5 and 
their characteristic emission data are summarized in Table 1.
11
 The functionalized complexes 
1c, 1d, 1e and 1f are luminescent at room temperature with emission spectra that have similar 
shape as that of complex 1, indicating that their lowest energy excited states have the same 
nature. The arylated fac-Ir(thpy-Ar)3 complexes show interesting photophysical properties, 
they present phosphorescence both at 298 K and 77 K originating primarily from the LC
3(π-
π*) excited state that resides on the functionalized ligand. These complexes show a fine 
tuning of emission wavelength depending on the type of the aryl or heteroaryl and on the 
acceptor-end-group used. The presence of stronger acceptor end-groups induces a stronger 
red-shift of emission wavelength; on the other hand, it results in a decrease of 
photoluminescence quantum yield and lifetime 
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Figure 5. Emission spectra of complexes 1, 1a, 1b, 1c in CH2Cl2 at 298 K. 
11
 
The phosphorescence quantum yields and lifetimes of the arylated complexes were 
found to decrease together with a red shift of the emission wavelength. An estimation of the 
radiative (kr) and non-radiative (Σknr) decay constants from the quantum yield and the lifetime 
suggests that there is an increase in Σknr and decrease in kr upon arylation. This effect can be 
attributed to the more extended π-conjugated system; it is likely that the influence of the metal 
in promoting intersystem crossing through spin-orbit coupling is reduced. 
 
Table 1. Emission data for the complexes 1, 1c, 1d, 1e and 1f in CH2Cl2 at 298 K. 
 λmax / nm 
φ lum 
(%) 
τ / ns  degassed 
[aerated] 
kr ×10
3 a 
/ s
–1
 
Σknr ×10
4 a
 
/ s
-1 
1 548, 592, 643(sh) 40 7100 [87] 56 8.5 
1c 673, 738 1.1 1500 [420] 7.3 66 
1d 652, 712, 795(sh) 2.0 2400 [370] 8.3 41 
1e 654, 714, 798(sh) 1.7 2100 [350] 8.1 47 
1f 645, 703, 784(sh) 1.9 2800 [390] 6.8 35 
(a) kr and Σknr are the estimated radiative and non-radiative rate constants estimated from the Φlum and τ 
values, assuming that formation of the emitting state occurs with unitary efficiency.  
 
Our objective in the present work was to extend the Pd catalyst synthesis method to 
more extended  systems as the chromophores (pyrene, naphthalimide, perylene…). They 
have  large Stokes shifts and high extinction coefficients. The results will be useful for the 
design of visible-light-harvesting transition-metal complexes that show long-lived triplet 
excited states and for their applications as triplet sensitizers for various photophysical 
processes, such as triplet-triplet annihilation upconversion, photovoltaics, photocatalysis… 
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1.5. Iridium complexes functionalized with polycyclic aromatic dyes 
1.5.1. Neutral iridium complexes 
In order to produce tris-cyclometallated Ir complexes that show strong absorption in the 
visible region along with long-lived triplet excited states, Zhao et al. prepared the neutral 
Ir(III) complex 22 featuring a ppy ligand connected to a naphthalimide (NI) group through an 
acetylide bond (Scheme 8).
12
 
Complex 22 was synthesized in two steps: the N-alkyl NI moiety was first attached to 2-
(4-ethynylphenyl)pyridine by using a Pd-catalyzed Sonogashira coupling reaction to produce 
the pro-ligand 21. The heteroleptic Ir complex 22 was then obtained in 58% yield by reacting 
the chloro-bridged dimer [Ir(-Cl)(thpy)2]2 with 21 in the presence of silver triflate. Compared 
to the parent complex Ir(ppy)3 5 which weakly absorbs in the visible region and is highly 
luminescent at 510 nm, complex 22 shows an intense absorption in the visible light range ( = 
39 600 L mol
–1
cm
–1
 at 402 nm), a room temperature red emission at 640 nm with a weak 
luminescence quantum yield  (φ = 1.4 %), and a long-lived T1 excited state ( = 9.30 s) 
which was identified as mainly an intraligand triplet excited state (
3
IL). This complex was 
used as triplet photosensitizer for triplet-triplet annihilation (TTA) upconversion. 
 
Scheme 8. Synthesis of the neutral Ir(III) complex 21 12 
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1.5.2. Cationic iridium complexes 
In the same way, the synthesis and photophysical behavior of a series of cationic bis-
cyclometallated Ir(III) complexes incorporating 2,2'-bipyridine ligands connected via a CC- 
bond to different dyes such as Bodipy, coumarin or naphthalenediimide (NDI) were recently 
reported.
13,14, 15, 16 
 Some representative complexes 23-27 are shown in Figure 6.  
 
Figure 6. Cationic bis-cyclometallated Ir(III) complexes 23-27 13-16 
 
Their preparations were quite similar to that of the parent iridium complex 28, and the first 
step also involved the preparation of the bipyridyl ligand by a Sonogashira coupling reaction 
between the 5-ethynyl-2,2'-bpy and the dye (Figure 7). The photophysical properties of these 
complexes are summarized in Table 2 and are compared to those of the parent complex 
[(ppy)2Ir(bpy)]PF6  28. 
 
Figure 7. Cationic iridium complex 28 
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 In contrast to 28, all the dye-containing iridium complexes display strong absorption in 
the visible region: for example, complexes 23 and 24 tethered to a Bodipy moiety show broad 
absorption bands at 499 and 527 nm, respectively, similar to the correspondingly 
functionalized bpy-Bodipy ligands.
17
 By contrast, these two complexes show different 
luminescence properties: whereas only room-temperature fluorescence of the Bodipy ligand is 
observed for 23 at 514 nm with a luminescence lifetime of 0.9 ns, both weak fluorescence and 
phosphorescence (assigned to a Bodipy-localized 
3
IL state) can be seen  for 24 at 553 and 742 
nm, respectively. This different behavior can be explained by the structure of the two Bodipy-
bpy ligands: in 23 there is no π-conjugation between the Bodipy and the coordination centre, 
whereas in 24 the Bodipy unit is directly π-conjugated to the bpy ligand via a CC triple 
bond.  
 The two diethylamino coumarin-containing Ir(III) complexes 25 and 26 (which only 
differ from 25 by the presence of an extra phenyl unit between the coumarin moiety and the 
CC triple bond) also show room temperature phosphorescence emission at  640 nm.15 
However the lifetime of 25 (s) was found to be much longer than that of 26 
(s), showing that a subtle variation of the molecular structure of the dye may affect 
the photophysical properties. The Ir(III) complex 27 featuring a naphthalenediimide dye 
exhibits the most red-shifted absorption band at 542 nm attributed to the NDI moiety. Like 
complex 24, the RT emission spectrum of 27 shows two emission bands at 572 nm and 732 
nm, respectively.
16
 The first band is fluorescence with a short luminescence lifetime of 5.0 ns, 
whereas the near IR emission is phosphorescence with a very long lifetime up to 130 s which 
is due to the NDI-localized intraligand triplet excited state. Finally, it is noteworthy that all 
these complexes were used as triplet photosensitizers for triplet-triplet annihilation (TTA), 
and upconversion quantum yields ranging from 1.2% (for 23) to up to 22.8 % (for 25) were 
observed.  
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Table 2. Photophysical data for the complexes 23-28 in CH2Cl2 at 298 K. 
13-16
 
Complex abs/nm / L mol
-1
 cm
-1
 em / nm  / s φ
 
23 
 
24 
 
 499 (7.14 ×10
4
) 
 
 527 (8.30×10
4
) 
 
514 
 
553, 742 
 
0.009 
 
0.026, -
a
 
 
0.018 
 
0.00003/0.003 
 
25 
 
26 
 
 487 (4.20 ×10
4
) 
 
        437 (4.58×10
4
)   
 
645 
 
640 
 
36.7        
 
7.3 
 
0.065 
 
       0.011 
 
27 
 
28 
 
 542 (1.71 ×10
4
) 
 
405 (0.5 ×10
4
) 
 
572, 732 
 
578 
 
0.005, 
220.3 
0.3 
 
0.001 
 
0.04 
a
too weak to be measured accurately 
 
1.5.3. Iridium complexes incorporating cyclometalated aromatic dyes  
 In 2012, Pope et al. described the synthesis and photophysical properties of new 
iridium(III) complexes incorporating cyclometalated pyrene units (Scheme 9).
18
 The synthesis 
of the pro-ligands 30 was achieved in two steps: condensation of 1-pyrenecarboxaldehyde 
with 1,2-diaminobenzene gave the benzimidazole intermediates and subsequent N-alkylation 
(using phase transfer conditions) afforded a variety of pyrene-benzimidazole derivatives 29. 
The mixed-ligand cationic iridium(III) species 31 were classically prepared in two steps from 
IrCl3.xH2O. An X-ray diffraction study of 31 (R = Bz) revealed a highly unusual coordination 
mode for the pyrenyl ligand with a metalation at position C10 (instead of C2) resulting in the 
formation of a six-membered ring. Compared to the parent complex [(ppy)2Ir(bpy)]PF6 (28), 
these complexes display enhanced absorption features in the visible region which are 
attributed to the presence of cyclometalated pyrenyl chromophores (
1
IL and 
1
MLCT 
transitions). The emission properties show emission profiles between 407 and 446 nm with 
short lifetimes (<5 ns) suggestive of a fluorescent emitting state localized on the pyrene 
moieties. Interestingly, these complexes appeared to be extremely effective 
1
O2 
photosensitizers. 
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Scheme 9. Preparation of cationic iridium(III) complex 3118 
 
A series of neutral and cationic Ir(III) complexes comprising two cyclometallating 3-
(2-benzothiazolyl)-7-(diethylamino)coumarin ligands and either one acac or diimine (2,2'-
bipyridine, 1,10-phenanthroline) ancillary ligand were prepared and their photophysical 
properties were reported (Figure 8).
19, 20
 Again, the UV-vis absorption spectra show intense 
bands in the visible region, at ca. 480 nm. The molar absorptivity of the cationic complexes 
32b,c was much larger than that of the neutral complex 32a, and this enhancement is 
presumably due to the combined effects of the ILCT transition of the coumarin ligand and the 
MLCT/LLCT transitions related to the diimine ligands. At room temperature all these 
complexes exhibit a strong emission band at 565-589 nm. Again, their relatively long 
emission lifetimes (between 6.2 and 7 µs) as compared to that of complex 27, as well as the 
vibronic fine structures observed in the emission spectra, indicate that the excited states of 
these complexes possess 
3
IL nature rather than 
3
MLCT character. Interestingly, these 
complexes were used as efficient photosensitizers for visible-light driven hydrogen 
generation.
20
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                                                         32a                                 32b                                            32c 
Figure 8. Neutral and cationic iridium complexes 32a 32b and 32c 19, 20 
 
Table 3. Photophysical data of complexes 30a-c in CH2Cl2/MeOH at 298 K.
 19, 20
 
Compounds Absorption 
max / nm, / L mol
-1
 cm
-1
 
Emission 
max / nm 
Lifetime 
 / s 
Quantum yield 
φ 
32a 472 (83200) 565 6.57 0.60 
32b 483 (129000) 589 6.21 0.26 
32c 485 (126000) 589 7.06 0.18 
 
 Results and discussion 2.
Initially, the synthesis of the following bromo aromatic chromophores, NI-Br, Per-Br, 
Pyr-Br, Coum-Br (Figure 9) will be presented. Subsequently, the Pd-catalyzed arylation 
reactions, on methylthiophene and directly on the complex fac-Ir(thpy)3 , 1   with these bromo 
derivatives will be describe. In the last part, I will describe the photophysical properties, 
absorption and emission studies, of the arylated methylthiophene and the arylated fac-
Ir(thpy)3 will be discussed.  
 
Figure 9. Bromo aromatic chromophores, NI-Br, Per-Br, Pyr-Br and Coum-Br 
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2.1. Synthesis of the bromoaryl derivatives 
 N-butyl-4-bromonaphthalimide, NI-Br 
The 4-bromonaphthalene anhydride was used as starting material for the synthesis of 
naphthalimide (Scheme 10).
21
 The reaction with N-butylamine in ethanol at 60 °C gave the 
corresponding imide in 70 % yield. The N-butyl-4-bromonaphthalimide, NI-Br was isolated 
as a pale brown powder. The 
1
H NMR spectrum of NI-Br shows the signals of the alkyl 
protons ( = 0.98, 1.45, 1.71 and 4.17 ppm). In the aromatic region, three doublets and one 
triplet are attributed to the naphthalene protons. 
 
Scheme 10. Synthesis of NI-Br 21 
 1-Bromoperylene, Per-Br  
The bromination of perylene was achieved by the addition of N-bromosuccinimide 
(NBS), the bromination occurs at the C1 position of perylene (Scheme 11).
22
 The reaction 
was performed in DMF at room temperature for 24 h.  After purification, the 1-
bromoperylene, Per-Br was obtained as a white powder in 78 % yield. 
 
Scheme 11. Synthesis of Per-Br 22 
 1-bromopyrene, Pyr-Br  
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The bromination of pyrene was achieved by the reaction between pyrene and bromine 
generated in situ by the action of hydrogen peroxide on hydrogen bromide (Scheme 12).
23
 
The compound 1-bromopyrene, Pyr-Br was isolated as a white powder in 90 % yield.  
 
Scheme 12. Synthesis of Pyr-Br 23 
 Bromo-coumarin, Coum-Br  
The synthesis of bromo-coumarin, Coum-Br was performed in three steps (Scheme 
13).
24,25
 The first step is an aldol condensation of salicylaldehyde with diethylmalonate in 
basic conditions. After purification by column chromatography, the desired product 34 was 
obtained in 70 % yield. The treatment of 33 with HCl led to the lactone 34 in 80 % yield. 
Finally, the bromination proceeds by the addition of Br2 in acid solution over 3 h. The 
collected white solid was dried under vacuum and then recrystallized in acetonitrile to afford 
the bromo-diethylamino coumarin, Coum-Br, in 78 % yield. The 
1
H NMR spectrum shows 
two singlets at = 7.67 and 8.18 ppm corresponding to the proton in the  position to 
bromine and the singlet proton adjacent to the amino group, respectively. In addition, a triplet 
observed at  = 1.29 ppm (J = 7.1 Hz) was assigned to the CH3- and a quartet at  = 3.37 ppm 
was assigned to the CH2- of the coumarin. 
 
Scheme 13. Synthesis of Coum-Br 24,25 
 
 
2.2. Pd-Catalyzed arylation of 2-methylthiophene 
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We have investigated the Pd-catalyzed arylation of methylthiophene with the 
following bromo aromatic chromophores, previously prepared: N-butyl-4-bromonaphtalimide, 
3-bromoperylene, 1-bromopyrene, 3-bromo-7-(diethylamino)chromen-2-one (Scheme 14). 
Generally the C
2
 and C
5
 positions of the thiophene are susceptible to palladium-catalyzed 
activation. However, in the present instance, the C
2
-position is blocked by a methyl group (or, 
in subsequent sections, a pyridyl ring), and hence the C
5
-position is the only available site for 
arylation.  
 
 
 
Scheme 14. Pd-Catalyzed arylation of 2-methylthiophene 
 
The reactions were performed in the presence of 0.1 mol % of Pd(OAc)2 in DMAc 
with KOAc for 24 h at 150 °C. The C
5
-arylated methylthiophene derivatives 35-38 were 
isolated in 63 to 65 % yields after purification by column chromatography on silica gel using 
a gradient of Et2O/ pentane or dichloromethane. All products were characterized by 
1
H and 
13
C {
1
H} NMR spectroscopy using CD2Cl2 as the solvent. In general, the 
1
H NMR spectra 
show two characteristic doublets around  = 6.90-7.00 ppm and 7.10-7.20 ppm corresponding 
to the H
4
 and H
3
 of the thiophene ring. In addition, the signal at  = 6.77 ppm corresponding 
to H
2
 of the thiophene ring disappears. As an example, the 
1
H NMR of the 38 shows the 
characteristic singlet of H
1coum
 at  = 7.62 ppm. 
 
2.3. Catalytic arylation of the complex fac-Ir(thpy)3 
The advantage of doing the direct arylation on the iridium complex is the selectivity of 
the on-metal approach which can lead to the formation of the mono and or the bis-arylated 
iridium complex. Moreover, this reaction allows keeping the geometry (facial or meridional) 
of the complex.  
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2.3.1. Synthesis 
The synthetic procedure used to prepare these arylated complexes involved the use of 
6 equivalents of the aryl bromide (35, 36, 37, 38) relative to the iridium complex fac-Ir(thpy)3 
7, 5 % of Pd(OAc)2 as the catalyst and a large excess of base (KOAc) in DMAc as the solvent 
(Scheme 15). The mixture was heated at 130-150 °C for 48 h. Compared to the off-metal 
reaction (see section 2.2)  the catalytic reaction on the complex required more palladium 
catalyst. In fact, with less than 5 % of Pd(OAc)2, there is no formation of the tris-arylated 
iridium complex. 
 
 
Scheme 15. Catalytic arylation of fac-Ir(thpy)3 
 
The purification was performed by column chromatography on silica gel. All 
compounds were characterized by 
1
H and 
13
C{
1
H} NMR spectroscopy in CD2Cl2. It was 
noticed that the capacity to obtain the mono- bis- and tris-arylated products depends on the 
reactivity of the aryl bromide, the temperature and the reaction time.  
 fac-Ir(thpy)3 complex bearing naphthalimide or pyrene units 
The treatment of the fac-Ir(thpy)3 complex with N-butyl-4-bromonaphthalimide leads 
to a mixture of bis- and tris-arylated compounds which were separated by column 
chromatography on silica (Eluent = pentane / Et2O (4:6)). The bis-arylated complex was 
isolated in 40 % yield whilst only a small amount of the tris-arylated complex was collected 
(Figure 10).  
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Figure 10. Arylated fac-Ir(thpy)3 complexes 39a-b and 40a-b 
The two products were characterized by 
1
H and 
13
C{
1
H} NMR in CD2Cl2. The tris-
cyclometallated complex was identified due to the presence of the C
3
-axis of symmetry: as a 
result, one set of signals corresponding to one ligand was observed. However, the bis-arylated 
complex fac-Ir(thpy)(thpy-NI)2 (39a), featuring no axis of symmetry, showed three different 
sets of signals corresponding to the three non-magnetically equivalent ligands. Indeed, the bis-
arylated complex shows two doublets at  = 6.69 and 6.74 ppm (J = 6.7 Hz) corresponding to 
H
4
 and H
5
 protons of non-arylated thienyl ring. The tris-arylation of the iridium complex 
(39b) presents a singlet at  = 8.59 ppm corresponding to the H4 proton of the thienyl ring. 
The same case was observed with the arylation between fac-Ir(thpy)3 and the bromopyrene. 
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However, due to a difficult separation of the mixture of bis- and tris-arylated iridium 
complexes, it was impossible to isolate either one of the species in suffcient purity to allow 
photophysical studies to be performed. 
 fac-Ir(thpy)3 complex bearing a coumarin unit 
Upon treating fac-Ir(thpy)3 with the bromo-coumarin for 48 h, the apparence of one new spot 
on TLC was observed, while the spots corresponding to the starting materials stayed 
unchanged (Figure 11). After workup, the new spot was isolated and identified using 
1
H and 
13
C{
1
H} NMR spectroscopy to be the mono-arylated complex 41. 
 
Figure 11. mono-Arylated complex 41 
  Two characteristic doublets of the thienyl ring at  6.43 ppm and 6.53 ppm were 
observed and a singlet at  = 6.86 ppm corresponding to the proton of the arylated thienyl 
ring. The singlet at  = 7.88 ppm is attributed to the proton of the coumarin. In addition, a 
triplet observed at  = 1.26 ppm (J = 7.1 Hz) was assigned to the CH3- and a quartet at  = 
3.46 ppm (J = 7.1 Hz) was assigned to the CH2- of the coumarin. We assume that the presence 
of strong donating amino group used has decreased the efficiency of the reaction.  A similar 
observation has been made in previous work done in the laboratory, where introducing aryl 
groups incorporating donor ends to the fac-Ir(thpy)3 complex was not possible.
11
 
 
2.3.2. Photophysical studies 
 Absorption studies 
 Methylthiophene derivatives 
The absorption spectra of the different organic compounds have been registered at 
room temperature in CH2Cl2 solution (Figure 12). The ligand 37 has a main absorption band 
at 268 nm and a second at 327 nm (Table). The ligand 36 presents a red-shifted absorption at 
447 nm. It is interesting to note that the molar extinction coefficient (absorption table) 
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increases from the pyrene (37) to the perylene (36) group. It can be attributed to the extension 
of the system. The ligands 38 and 35 absorb in the blue region with maxima at 399 nm and 
378 nm, respectively. 
 
Figure 12. UV-visible absorption spectra of 35 (dashed), 36 (plain), 37 (dashed/dotted), 38 (dotted) in CH2Cl2 
solution at 298 K.  
 
Table 4. Absorption data of 35-38 in CH2Cl2 solution at 298 K. 
Compound Absorption max / nm (/ 10
3
 L mol
-1
 cm
-1
) 
35 329 (5.40), 345 (8.07), 378 (11.3) 
36 254 (34.4), 435 (25.4), 447 (26.9) 
37 268 (17.0), 280 (15.7), 327 (23.0), 337 (21.4) 
38 260 (8.25), 399 (25.2) 
 
 Iridium complexes 
Figure 28 presents the superposition of the absorption spectra of the non-functionalized 
complex 2 and complexes with two or three ligands bearing a naphthalimide group (fac-
Ir(thpy)(thpy-NI)2 (39a), fac-Ir(thpy-NI)3 (39b), respectively). 
The bis- and tris-arylated complexes fac-Ir(thpy)(thpy-NI)2 (39a), fac-Ir(thpy-NI)3 
(39b), respectively show different absorption profiles in the UV region and similar profiles in 
the visible region, with molar extinction coefficients that increase with the increasing number 
of arylated ligands. There is an influence of the number of arylated ligands. The bis-arylated 
complex fac-Ir(thpy)(thpy-NI)2 (39a) shows three bands in the UV region at 306 nm (24.2 L 
0
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mol
-1
 cm
-1
), 351 nm (27.8 L mol
-1
 cm
-1
) and 373 (26.4 L mol
-1
 cm
-1
). The tris-arylated 
complex shows one band in the UV region at 354 nm (45.1 L mol
-1
 cm
-1
). 
 
Figure 13. UV-Visible absorption spectra of 1 (plain), 39a (dashed) and 39b (dotted) in CH2Cl2 solution at 298 K. 
The absorption spectra of different iridium complexes have been recorded at room 
temperature in CH2Cl2 solution (Figure 13). 
 
Figure 14. UV-visible absorption spectra of 40a (dotted) and 41 (plain) in CH2Cl2 solution at 298 K. 
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Table 5. Molar extinction coefficients (L mol-1 cm-1) of iridium complexes 
Complex Absorption max / nm (/ 10
3
 L mol
-1
 cm
-1
) 
 
39a 298 (24.3), 306 (24.1), 351 (27.7), 373 (26.4), 394 (12.5), 445 
(12.5), 522 (5.12) 
 
39b 296 (35.4), 305 (36.1), 354 (45.1), 443 (27.7), 520 (11.9) 
 
40a 260 (49.5), 400 (28.7) 
 
40b 262 (49.2), 394 (29.7) 
 
41 400 (14.1), 453 (25.6), 513 (15.6) 
 
 Emission studies 
 Methylthiophene derivatives 
The emission spectra of the aryl-substituted methylthiophenes have been recorded at 
room temperature in CH2Cl2 solution (Figure 15). Complexes 37 and 36 emit at 447 nm and 
505 nm, respectively. A red-shift can be observed in the case of perylene. Compared to these, 
35 presents an emission band at 482 nm. This compound has a larger Stokes shift than 38 
which displays an emission band at 468 nm (Table 6). 
35 
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Figure 15.  Emission spectra of methylthiophenes derivatives 35 (dashed), 36 (plain), 37 (dashed/dotted), 38 
(dotted) in CH2Cl2 solution at 298 K 
 
 
Table 6. Emission wavelengths of complexes 35-38 in CH2Cl2 at 298 K. 
Complexes Emission max / nm  ∆λ / nm 
35 482 104 
36 505 58 
37 447 110 
38 468 69 
 
 Iridium complex derivatives 
Unfortunately, none of the complexes are emissive at room temperature. At 77 K the 
emission of these species is weak. This particular behavior can be attributed a quenching 
effect induced by the presence of the aromatic substituents. Indeed if the substituent possesses 
a lower triplet state than the one of the complex, the emission process goes from the complex 
to the ligand triplet state. This thermodynamic transfer leads to a phosphorescence quenching 
as this ligand triplet state is non-emissive at room temperature. 
2.4. Catalytic arylation of the complex Ir(Meppy)2(tta) 
As an extension of this work, it was decided to investigate the access to arylated 
Ir(C^N-Meppy)2(O^O-tta-Ar) complexes where the incorporated aryl group is an aromatic 
chromophore such as naphthalene, pyrene, naphthalimide, and coumarine, and to study the 
0
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photophysical properties of the resulting complexes. There are several reports of the 
combination of organic dyes with bis-cyclometallated complexes [Ir(C^N)2(N^N-bpy)]
+
. 
Various designs have been reported where the 2,2'-bipyridine ligand is connected via a CC–
bond to different dyes such as Bodipy, coumarin or naphthalenediimide (NDI), leading to 
intriguing triplet-triplet annihilation (TTA) based upconversions.
26
  Direct cyclometallation of 
the fluorophore has also been reported such as complexes incorporating cyclometalated 
pyrene units which resulted in enhanced absorption in the visible as compared to benchmark 
complexes like [Ir(C^N-ppy)2(bpy)]
+
 and [Ir(ppy)2(acac)].
27
 The synthesis and photophysical 
properties of a series of neutral and cationic Ir(III) complexes comprising two 
cyclometallating 3-(2-benzothiazolyl)-7-(diethylamino)coumarin ligands and either one acac 
or diimine ancillary ligands have also been recently described and their use as efficient 
photosensitizers for visible-light driven hydrogen generation demonstrated.
28,29
  In addition, 
the fluorescent coumarin 343 has been connected to the O^O-ancillary ligand of a 
phosphorescent bis-cyclometallated iridium complex for monitoring oxygen levels in living 
cells and tissues, using a tetraproline linker to separate the phosphor from the fluorophore.
30
 
In contrast, to our knowledge the molecular engineering of heteroleptic cyclometallated Ir(III) 
complexes featuring functionalized "acac-type" ligands directly conjugated with the aromatic 
dyes has never been investigated.  
2.4.1. Synthesis 
  We found two routes to the naphthalimide-based complex Ir(C^N-Meppy)2(O^O-tta-
NI), Ir-NI: (i) Pd-catalysed direct arylation of the coordinated tta ligand of Ir(C^N-
Meppy)2(O^O-tta) Ir-1, (MeppyH = 4-methyl-2-phenylpyridine), and (ii) the synthesis of the 
proligand ttaH-NI involving a Pd-catalysed arylation step. The desired complex Ir-NI was 
formed from Ir-1 via the route (i), in the presence of a 6-bromonaphthalimide using the Pd-
catalysed direct arylation reaction conditions previously operative for aryl bromides 
(Pd(OAc)2, K2CO3 in DMA). Complex Ir-NI, where the naphthalimide group is incorporated 
onto the C
5
-position of the thiophene ring of the coordinated ligand tta, was isolated as a red 
powder in 16 % yield (Scheme 16). The 
1
H NMR of Ir-NI exhibits the typical signals in the 
aromatic region of the NI group at  8.63 8.54 and 8.47 ppm. The protons of the thiophene 
ring appear at  7.73 and 7.20 ppm. It should be mentioned that the purification of Ir-NI was 
very tedious, as several chromatography columns were needed in order to get a pure 
compound. Moreover, some degradation occurred due to a long reaction time at 100 °C. As a 
consequence, we decided to investigate the route (ii) i.e. to perform the catalytic arylation on 
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thiophene derivatives, precursors of the ttaH proligand. 
 
Scheme 16. Synthesis of Ir-NI via Pd-arylation of Ir-1 
  The arylated complexes Ir-Ar were synthesized upon treatment of the chloro-bridged 
dimer [Ir(µ-Cl2)(C^N-Meppy)2]2 with the appropriate diketone ttaH-Ar in the presence of 
Na2CO3 (Scheme 17). The reaction was performed under mild conditions (t = 80 °C) as there 
is no need to obtain the facial geometry (required for the formation of the fac-Ir(thpy)3 
complex). All complexes were isolated in low to moderate yields due to their high solubility 
and were characterized by standard techniques. The formation of the tta-Ar-based complexes 
was verified by the appearance of the aryl-thiophene protons and the formation of two sets of 
signals for the magnetically non-equivalent 4-methyl-2-phenylpyridine ligands in the 
1
H 
NMR spectra (see Experimental part). 
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Scheme 17. Synthesis of the complexes Ir-Ar. 
 
2.4.2. Photophysical properties of arylated thiopheneketones th-Ar and their Ir(III) 
complexes. 
 The electronic absorption spectra of the newly prepared arylated thienylketones th-Ar 
have been performed in dichloromethane solution at room temperature (Figure 16, Table 7). 
The thiophene derivatives th-NI and th-Pyr exhibit an intense absorption band at 365 nm 
(32100) and 367 nm (33700), respectively, whereas the absorption band of th-Napht appears 
at higher energy at 344 nm. Compounds th-Per and th-Coum show maxima at ~450 nm, their 
absorption being more into the visible. Note that the absorption band of th-PhCF3 (max = 322 
nm) is blue-shifted compared to those of the other arylated compounds of the series, due to 
the absence of a -conjugated system. All compounds are fluorescent in fluid CH2Cl2 solution 
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under excitation with UV or visible light. The corresponding emission spectra are broad and 
featureless (Figure 16). Interestingly, changing the nature of the appended aryl group allows a 
fine modulation of the emission wavelength (from 360 to 514 nm). The emission from the 
coumarine- and perylene-based compounds (em = ~515 nm) are the most red-shifted, as they 
absorb more into the visible.  
  
Figure 16. Absorption spectra (left) and Emission spectra (right) of th-PhCF3, th-Napht, th-NI, th-Pyr, th-Per 
and th-Coum in CH2Cl2 solution at 298 K. 
 
Table 7. Photophysical data of th-PhCF3, th-Napht, th-NI, th-Pyr, th-Per and th-Coum in (a) degassed DCM and 
(b) in EPA solution. 
Compound abs / nm 
(10
3
. / L mol-1 cm-1)a 
em / nm 
298 K
a 
em / nm 
77 K
b 
th-PhCF3  322 (6.1) - 374 
th-Napht 344 (32.1) 349 393,414 
th-Pyr 367 (33.7) 470 450 
th-Per 425 (23.4), 450 (28.4) 518 490,518 
th-NI 365 (32.1) 445 440 
th-Coum 450 (34.0) 514 511,532 
 
  The electronic absorption spectra of the arylated Ir(III) complexes in dichloromethane 
solution at room temperature are displayed Figure 17, and the characteristic data are listed in 
Table 8. All complexes present similar absorption profiles to one another. In the UV region 
the spectra are dominated by an intense absorption band at around  = 270 nm, attributed to 
ligand-centered transitions (
1
LC). In the lower energy region (λ > 320 nm), absorption spectra 
are characteristic of Ir(III) complexes with a moderately-intense and broad band (320 to 450 
nm) tailing up to 500 nm. This broad band could be assigned as 
1
MLCT transition 
(d(Ir)→π*(C^N)). 
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Figure 17. Absorption spectra of Ir-PhCF3, Ir-Napht, Ir-Pyr, Ir-NI and Ir-Coum in CH2Cl2 solution at 298 K. 
 
All the arylated complexes Ir-Ar display fluorescence in fluid solution at room 
temperature upon photoirradiation, the phosphorescence emission being quenched (Figure 
18). This feature was previously observed for the tta-arylated complexes containing electron-
donating substituents  in the aryl group attached to the thiophene ring (C6H4-pOMe, C6H4-p-
NH2, 3-Cl-5-NH2-C6H3).
31
 All the emissions are insensitive to O2, due to short-lived spin-
allowed fluorescence from the singlet state. These results show the dramatic effect of 
incorporating an aromatic chromophore into the ancillary ligand. It is believed that extension 
of the -conjugation of the ancillary ligand leads to a decrease of the spin-orbit coupling 
influence of the metal ion. Compared to the free ligands ttaH-Ar, the emission bands are red 
shifted ( = 86-124 nm), except for the NI-based derivatives for which the emission bands are 
located at the same energy. The quantum yields are very low in all cases (φ  0.01), except for 
the Ir-Coum complex which is strongly emissive (φ = 0.49). In order to detect emission from 
the triplet excited states, we performed luminescence studies at 77 K (EPA). Hovewer, no 
emission data could be obtained.  
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Figure 18. Normalized fluorescence spectra in CH2Cl2 at 298 K: Ir-PhCF3 (exc = 350 nm) (purple), Ir-Napht 
(exc = 400 nm) (Blue), Ir-Pyr (exc = 410 nm) (orange), Ir-NI (exc = 350 nm) (green), Ir-Coum (exc = 475 
nm) (red). 
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Normalized absorption spectra (black) and fluorescence spectra (in colour) in CH2Cl2 at 298 K  Left (a) th-
PhCF3 (b) th-Napht (exc = 320 nm) (Blue) (c) th-NI (exc = 365 nm) (green) (d) th-Pyr (exc = 360 nm) (orange) 
(e) th-Coum (exc = 460 nm) (red). Middle (a) Ir-PhCF3 (exc = 350 nm) (purple) (b) Ir-Napht (exc = 400 nm) 
(Blue) (c) Ir-NI (exc = 350 nm) (green) (d) Ir-Pyr (exc = 410 nm) (orange) (e) Ir-Coum (exc = 475 nm)  (red) 
Right Comparison of the  normalized emission spectra of the ligands (plain) and the complexes (dotted) (b) th-
Napht and Ir-Napht (c) th-NI and Ir-NI (d) th-Pyr and Ir-Pyr (e) th-Coum and Ir-Coum. 
(a) 
 
(a) 
 
 
(b)
 
(b) 
 
(b)
 
(c) 
 
(c) 
 
(c)
 
(d) 
 
(d) 
 
(d) 
 
(e) 
 
(e)  
 
(e) 
 
 = 0.001 
 = 0.01 
 = 0.49 
 = 0.01 
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  The emission spectrum of Ir-PhCF3 in EPA solution (ether/isopentane/ethanol (2:2:1 
v/v)) at 77 K is displayed in Figure 19. The spectrum displays two sets of bands: a structured 
band around 500 nm and bands at 650 nm showing a vibrational structure. By comparison 
with the behaviour of the precursor complex Ir(C^N-Meppy)2(O^O-tta), the high-energy band 
is likely to be due to the usual mixed d-* / -* excited state associated with this core unit. 
The vibrational structure within the low-energy band is not clearly resolved and could be 
attributed to the triplet IL(  *) state of state of the tta-PhCF3 ligand. 
 
Figure 19. Emission spectrum at 77 K of Ir-PhCF3 in EPA solution 
 
Table 8. Photophysical data of Ir-tta-Ar complexes 
Complex abs / nm 
(10
3
. / L mol-1 cm-1)a 
 em / nm 
298 K
b 
Ir-PhCF3  275 (61.4), 359 (42.8), 394 (33.8) 0.001 440 
Ir-Napht 275 (39.1), 364 (21.4), 400 (27.7) 0.01 473 
Ir-Pyr 277 (87.1), 337 (42.0), 408 (52.2) - 563 
Ir-NI 270 (55.2), 400 (31.2) 0.01 440 
Ir-Coum 260 (31.4), 482 (38.6) 0.49 600 
 
 Concluding Remarks 3.
  The direct approach of the arylation of chromophores on fac-I(thpy)3 complex shows 
the selective formation of mono bis and tris- arylated iridium complexes (formation of bis and 
tris cyclometallated iridium complexes containing a naphthalimide or a pyrene unit and the 
unique mono arylated fac-Ir(thpy)3 containing a coumarine unit). A yield of 40 % was 
observed for the preparation of the 39a. Two different routes for the formation of the arylated 
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Ir(C^N-Meppy)2(O^O-tta) were studied. The direct arylation of the naphthalimide on the 
metal complex requires mild conditions to avoid the degradation of the complex. Ir-NI was 
obtained in 16 % yields. The catalytic reaction on the organic compound was then used 
because of the better catalytic reaction yield. 
  The aromatic chromophore possesses a lower triplet state than the one of the complex 
fac-Ir(thpy)3, leading to a phosphorescence quenching as this ligand triplet state is non-
emissive at room temperature. The combination of these two – organic and organometallic – 
chromophores, leads to fluorescence at room temperature. The quantum yield of triplet 
formation is reduced in these systems, owing to the extension of the -conjugation of the tta 
ligand, minimizing the heavy atom effect, whilst the efficency of triplet emission will be 
reduced for the same reason.   
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 Introduction 1.
1.1. Cyclometallated Platinum Complexes of a Bidentate Ligands  
The first cyclometallated Pt(II) complexes studied involved bidentate N^C type 
ligands (Figure 1).
1,2
 These complexes can be divided into two classes: homoleptic 
complexes, which contain two identical N^C ligands simultaneously bound to platinum, i.e. 
Pt(N^C)2,
1
 and heteroleptic complexes,
2,3,4
 which contain one N^C ligand and either a second 
bidentate ligand, L^L or L^X (examples include bipyridine or acetylacetonate, respectively), 
or two monodentate ligands L and X (e.g. CO and Cl).  There are only a few examples of 
homoleptic complexes, probably due – at least in part – to the fact that their synthesis 
typically requires the use of lithiated ligands, a route that is intolerable to many functional 
groups. Such homoleptic complexes are always formed as the cis isomer, i.e. with the 
metallated carbon trans to the coordinated nitrogen of the other ligand, due to the large trans 
effect of cyclometallating carbon atoms which disfavours their disposition trans to one 
another.
5,6
 Pt(thpy)2 (thpy = 2-thienylpyridine) is phosphorescent at room temperature (max = 
578 nm) whereas Pt(ppy) is only emissive at 77 K (max = 491 nm).
7
 The literature contains 
more examples of heteroleptic complexes, as these are generally easier to synthesize. 
Unfortunately complexes involving these bidentate ligands are still prone to D2d distortions in 
the excited state, which provide a pathway of non-radiative decay. As a consequence, the 
photophysical properties are often far from optimum, with quantum yields no more than 0.22 
for the most luminescent of such systems.
2 
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Figure 1. Examples of bis-cyclometallated platinum(II) complexes and their luminescent properties (max 
and φ) at 298 K in acetonitrile (Pt(ppy)2 and Pt(thpy)2); DCM (FPtmND), DMF ([Pt(ppy)(bpy)]Cl) 
and 2-methyltetrahydrofuran (Pt(4,5-dfppy)(dpm), Pt(4,6-dfppy)(dpm), Pt(ppy)(acac), 
Pt(thpy)(acac) and Pt(p-tpy)(acac))
1,2,3,4,7
  
 
1.2. Cyclometallated Platinum Complexes with Terdentate Ligands 
An increase in the rigidity of the cyclometallating system may lead to enhanced 
luminescence quantum yields. Terdentate platinum complexes have been investigated to 
enhance the rigidity. Much of the work on Pt(N^N^C) systems has been developed by Che 
and co-workers, who have gone on to put the luminescence of such complexes to use in a 
number of applications.
8,9,10
 In an early study, Che reported on the cyclometallation of 2,9-
diphenyl-1,10-phenanthroline (dpp) to Pt(II) as a terdentate N^N^C-coordinating ligand, in 
which one of the two pendent phenyl rings cyclometallated, coplanar with the Pt(N^N) plane, 
whilst the other remains uncoordinated.
11
 In their synthesis, the product isolated contained a 
labile MeCN molecule in the fourth coordination site (Figure 2).  
Pt(thpy)2 
max = 578 nm 
Pt(4,5-dfppy)(acac) 
max = 484 nm 
φ = 0.22 
Pt(4,6-dfppy)(dpm) 
max = 466 nm 
φ = 0.02 
Pt(ppy)2 
non-emissive 
Pt(thpy)(acac) 
max = 575 nm 
φ = 0.11 
Pt(ppy)(acac) 
max = 486 nm 
φ = 0.15 
[Pt(ppy)(bpy)]Cl 
max = 490 nm 
φ = 0.06 
 
FPtmND 
max =550 nm 
φ = 0.13 
Pt(p-tpy)(acac) 
max = 585 nm 
φ = 0.22 
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Figure 2. Terdentate C^N^N platinum(II) complex11 
The perchlorate salt of this cationic complex proved to be highly emissive with a 
vibrationally structured spectrum,  max = 550 nm,  = 14 µs and φ = 0.21 in dilute solution in 
DCM at room temperature. At higher concentrations, the monomer emission (i.e. 
luminescence from isolated molecules behaving independently of one another) is quenched, 
accompanied by the formation of an excimer that emits at about max = 700 nm. 
        The chloride ligand in Pt(N^N^C)Cl complexes is quite labile, and can be displaced 
by other ligands. Yip et al. examined a series of four pyridyl adducts, [Pt(phbpy)(L)]ClO4 
where R = pyridine (py), 4-aminopyridine (4-ap), 2-aminopyridine (2-ap), and 2,6-
diaminopyridine (dap) (Figure 3).
12
 On the basis of absorption spectroscopy, the order of 
energy of the MLCT excited states was established as py ~ 4-ap > 2-ap > dap.  
 
Figure 3. Terdentate C^N^N platinum(II) complex12 
In emission, the py and 4-ap complexes displayed structured, high-energy emission 
spectra (λmax ~ 494 nm in MeCN at room temperature), assignable to 
3-* states. In contrast, 
the 2-ap complex emitted at substantially lower energy (λmax = 534 nm), even though the -
donating ability of 2-ap was similar to 4-ap. The results were interpreted in terms of the role 
of the ortho–NH2 groups in destabilizing the Pt d orbitals, through intramolecular 
interactions of their lone pairs with the metal centre (Figure 4).  
68 
 
 
Figure 4. Geometry effect on the C^N^N platinum(II) complex12 
The synthesis of a platinum complex with a single tetradentate ligand, offering four donor 
atoms to the metal, will simultaneously avoid the labile effect and the D2d distortions in the 
excited state. Enhanced luminescent properties can be anticipated because of both stronger 
inhibition of the D2d distortion caused by a high rigidity of the planar complex, and the 
elimination of a labile monodentate coordination site, which compromises the chemical 
stability and limits use in applications such as OLEDs or bio-imaging. Furthermore, since the 
metal is coordinated by only one ligand, the complex may also be advantageous in terms of 
thermal stability than bidentate and terdentate metal complexes. 
 
1.3. Tetradentate Cyclometallated Platinum Complexes 
1.3.1. Platinum complexes of “pseudocyclometallated” tetradentate Schiff-base ligands  
 O^N^N^O Systems 
In 2003, Wang et al. presented the synthesis of two Pt(O^N^N^O) complexes bearing 
bis(phenoxy)diimine ligands (where the diimine unit was 4,7-diphenyl-1,10-phenanthroline 1  
or 4,4'-di-t-butyl-2,2'-bipyridine 2).  They are tetradentate relatives of the 8-hydroxyquinoline 
or quinolinolato (q) ligand, as found in the famous fluorescent metal complex Alq3 for 
example (Figure 5).
13
 These neutral Pt(II) complexes exhibit moderately intense, low-energy 
UV/Vis absorptions around 400-500 nm that undergo slight negative solvatochromic shifts 
(Table 1). Both derivatives are highly luminescent in solution at 298 K with emission 
lifetimes in the s range. The functionalization on the pyridyl rings (i.e. t-butyl versus phenyl) 
does not affect the emission wavelength. However, a higher quantum yield and a longer 
luminescence lifetime was observed for 1 compared to 2, attributed to the enhanced rigidity 
associated with the phen over the bpy unit.  
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1 2 
Figure 5. Tetradentate platinum(II) complexes 1 and 2 13 
 
Table 1.  Photophysical data for platinum(II) complexes 1 and 2  in degassed DCM solutions at 298 K 13 
Complex 
 
absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
1 291 (39.2), 315 (34), 325 (32.3), 352 (25.8), 375 
(24.7), 420 (5.2), 488 (sh, 6.7), 504 (7.2) 
 
586 
 
5.3 
 
0.60 
 
2 
 
253 (41), 313 (18.4), 397 (8.4), 479 (2.94), 504 
(sh, 2.52) 
595 
 
1.9 
 
0.12 
 
 
Many platinum(II) complexes of tetradentate Schiff base ligands have been 
investigated due to their good photophysical properties and the facile synthesis and 
functionalization of the Schiff base ligand.
14,15,16,17,18
 A Schiff base is essentially a carbon-
nitrogen double bond with the nitrogen connected to an aryl or an alkyl unit. For example, the 
synthesis of the platinum complexes 3, 4 and 5 (Figure 6) consists of the reaction of K2PtCl4 
with the appropriate ligand in the presence of a weak base to deprotonate the phenol, at 70 °C 
to 90 °C giving yields of 65 % to 85 %. All complexes showed good thermal stability and 
exhibited intense absorption bands with max in the range 417–546 nm, which were assigned 
to states of metal-to-ligand charge-transfer 
1
MLCT character mixed with intra-ligand charge-
transfer 
3
ILCT character. They exhibited emission between 550 and 592 nm with relatively 
low quantum yields (0.19 (3), 0.14 (4) and 0.087 (5)). 
 
 
                                   3                           4                              5 
Figure 6. Tetradentate platinum(II) complexes 3, 4 and 5  15 
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 N^N^N^N Systems 
All-nitrogen-coordinated (N^N^N^N) systems, where the nitrogen atoms can be 
provided by a combination of Schiff bases and heterocycles such as pyrrole or pyridine, have 
been developed and used for biology and OLEDs applications.
19,20,21,22,23
 For example, in 
2003, Lai et al. described the synthesis and the application in organic optoelectronics of 
neutral tetradentate N-donor platinum complexes PtPren, 6, PtPrtmen, 7 and PtPrdmPhen, 
8 (Figure 7).
24
 These structures bear some resemblance to a porphyrinic unit, featuring two 
deprotonated pyrroles. PtPrdmphen emits at the lowest energy close to the NIR region, 
presumably due to its extended -conjugated ligand system, but the quantum efficiency  is 
very low (φ = 0.001). PtPren shows a yellow emission with a peak maximum at 566 nm and 
a shoulder at 613 nm in CH3CN at 298 K. Compared with Pt(II) porphyrins, which often 
display long-lived red emission (  80 s),  PtPren and PtPrtmen exhibit shorter 
luminescence lifetimes ( = 4.2 and 3.6 s, respectively) and reasonable quantum yields (φ = 
0.09 and 0.10 respectively). 
 
                                                      6                  7                  8 
Figure 7. Tetradentate platinum(II) complexes 6, 7 and 8  24 
 
 N^C^C^N Systems 
In 2013, Che et al. have reported a series of new platinum(II) complexes 
functionalised with two carbenes and two phenolic units (Figure 8).
25
 The photophysical  
investigation of these complexes showed that complex 14 does not emit at room temperature 
in solution whereas complex 11 shows an emission at em = 460 nm with a quantum yield of 
0.07. This difference was attributed to the higher distortion of complex 14 compared to 
complex 11, leading to a high value of knr at room temperature and hence to a lack of 
detectable emission under these conditions. Complex 13 displays a red-shift of its absorption 
and emission (em = 531 nm) compared to 11 due to the  extension. The interesting long 
lifetime ( = 47.3 s) was attributed to the  lack of geometrical change  in the molecule 
71 
 
between its ground state S0 and triplet excited state T1.This quasi-symmetry is postulated to  
lead to a low knr and a long lifetime.  
 
Figure 8. Platinum(II) complexes 9, 10, 11, 12, 13 and 14 bearing a tetradentate carbene ligand 25 
 
1.3.2. Cyclometallated Platinum Complexes  
 O^N^C^N 
Che and Li have recently investigated tetradentate O^N^C^N platinum complexes for 
application in OLEDs.
16,26,27,21 
The formation of this kind of tetradentate complex was 
described as one deprotonation of an –OH group and a C–H activation  at the position trans to 
the –OH unit. Double C–H activation in mutually trans positions is generally more difficult 
than in cis positions, as noted in Section 1.1, but the deprotonation of the relatively acidic –
OH group (pKa around 10) facilitates the formation of the Pt(II) complex, whilst leading to a 
charge-neutral product. A series of highly robust platinum(II) complexes 9-17 supported by 
tetradentate O^N^C^N ligands have been readily synthesized in high yields (≥ 80 %) and they 
have high thermal stabilities (Td >400°C).27,28   
The first series of O^N^C^N Pt(II) complexes 15-19 (Figure 9) feature one 6-
membered metallacycle and two 5-membered metallacycles. All complexes showed blue-
green emissions and good photophysical properties with high emission quantum yields (φ = 
0.72 to 0.93) and long luminescence lifetimes ( = 11 s to 28 s, see Table 2).  
 
Figure 9. Tetradentate platinum(II) complexes 15-19 28 
 
 
 
 
 
 
15 
16 
17 
18 
19 
9  10  11  12 13 14 
72 
 
Table 2. Photophysical data for platinum complexes 9-13  in degassed DCM solution at 298 K 28 
Complex absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
15 254 (4.59), 280 (3.16), 354 (1.77), 390 (1.46), 
426 (0.91) 
 
485, 517, 557  12.0 0.72 
 
16 
254 (4.24), 261 (4.18), 290 (2.51), 352 (1.71), 
388 (1.42), 429 (0.57) 
 
488, 522  28.0 0.80 
 
17 
247 (3.72), 261 (3.43), 279 (2.67), 356 (1.52), 
395 (1.15), 439 (0.70) 
 
508, 543, 594  11.0 0.89 
18 
251 (4.82), 261 (4.55), 294 (2.07), 350 (1.83), 
381 (1.40), 424 (0.86) 
 
488, 518  13.2 0.93 
19 
245 (4.58), 259 (4.45), 289 (2.65), 3.01 (1.86), 
349 (1.78), 376 (1.35), 424 (0.66) 482, 512  17.7 0.75 
 
The second series of O^N^C^N Pt(II) complexes incorporate one 5-membered 
metallacycle and two 6-membered metallacycles. Complexes 20, 21 and 22 (Figure 10) 
absorbed and emitted at lower energy (max = 553 nm and 552 nm) than complexes 23 and 24 
(max = 526 nm and 527 nm) as the  extended conjugation is better for the carbazole than the 
phenoxazine or the phenothiazine (Table 3). The introduction of a bulky –tBu group on 
complexes 21 and 22 did not significantly change the photophysical properties. 
           
 
Figure 10. Tetradentate platinum(II) complexes 20-24  27 
20 
21 
22 
23 
24 
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Table 3. Photophysical data for platinum complexes 14-18 in degassed DCM solution at 298 K 27 
Complex absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
20 277 (5.21), 298 (4.78), 334 (4.07), 358 (2.34), 
418 (0.92), 461 (0.41), 488 (0.35) 
 
553 , 587 
 
6.6, 6.8 0.86 
 
21 
278 (5.12), 298 (4.48), 336 (4.10), 358 (2.11),  
415 (0.90), 460 (0.34), 487 (0.32) 
 
553 , 590 
 
7.4, 7.2 0.67 
 
22 
278 (5.27), 296 (4.52), 337 (4.32), 360 (2.12),  
416 (1.08), 462 (0.39), 486 (0.34) 
 
552 , 590 
 
8.0, 7.6 0.82 
23 280 (5.22), 322 (3.03), 385 (1.46), 443 (sh, 0.47) 
 
526 5.9 0.47 
24 281 (4.67), 327 (2.85), 354 (1.46), 379 (1.45), 
453 (sh, 0.32) 
527 8.8 0.49 
 
 C^N^N^C, N^C^C^N and C^C^N^N Systems 
 C^N^N^C Systems 
bis-Cyclometallated platinum complexes with tetradentate C^N^N^C ligands are 
formed by the association of two bidentate N^C ligands through a linker Y (Y = CR2, NR or 
O) in the examples reported to date.
29,30,31,32,33
  Two C–H activations are necessary to form the 
final complex, whereas a simple deprotonation of oxygen, sulfur or nitrogen was involved for 
the synthesis of some of the previous tetradentate platinum complexes. Due to the linker, the 
rigidity of these complexes is expected to be higher than that of a bis-cyclometalled platinum 
complex with two bidentate ligands, and a structure forced closer to planarity might be 
anticipated. 
Different coordination geometries of these tetradentate platinum complexes are 
possible (Figure 11): two symmetrical conformations named as C^N^N^C and N^C^C^N 
systems, featuring a C2 axis through the metal and linker atom Y, and non-symmetrical named 
C^C^N^N and C^N^C^N systems. To date, examples of the first three are known, but no 
C^N^C^N tetradentate platinum complex  has yet been synthesized. 
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Figure 11. The « parent » complexes of the C^N^N^C, N^C^C^N, C^C^N^N and C^N^C^N systems   
In 2009, Weck et al. investigated the first bis-cyclometallated tetradentate platinum 
complexes for application in OLEDs.
29
 The interest was to append the platinum complexes 
onto a polymer through ring-opening metathesis co-polymerisation of norbornene-appended 
complexes with a norbornene-appended carbazole.  Such an approach is feasible owing to the 
broad tolerance of most ruthenium olefin metathesis initiators, allowing for the direct covalent 
grafting of metal complexes onto poly(norborene)s in a “chemistry-on-the-complex” 
approach. (Figure 12). Complexes 25 and 26 were synthesized as models for complexes 27 
and 28. The synthesis of the functionalized poly(norborene) ligands involved a Grignard 
reaction between bis(2-(6-bromopyridyl))ketone and (norbornenylpentyl magnesium 
bromide)   
 
Scheme 1. Synthesis of C^N^N^C platinum complex 26 
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                              25                         26                         27                         28 
Figure 12. C^N^N^C platinum complexes 25-28 
The absorption and emission spectra were recorded in dichloromethane at 298 K 
(Table 4). All complexes exhibited intense structured absorption bands between 250 nm and 
340 nm corresponding to the ILCT -* transitions and a medium-strength absorption band 
around 390 nm corresponding to the MLCT transition (Figure 13). They all emitted at max = 
492 nm, consistent with a 
3
MLCT excited state, with quantum yields between 0.54 and 0.58 
and lifetimes in the range 0.3-0.4 s. The photophysics and the electrochemical studies of the 
non-functionalized and the norborene-substituted platinum complexes 25 and 26 showed 
similar results to the functionalized platinum complexes 27 and 28. Thus, the functionalized 
polymer is a good host for the platinum complexes because of its lack of influence on the 
platinum-based properties.  
                    
Figure 13. Comparison of the absorption and emission spectra between 25 (plain) and 26 (dashed) (left), 
and 27 (plain) and 28 (dashed) (right) in DCM at 298 K  
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Table 4. Photophysical data for platinum(II) complexes 25, 26, 27 and 28 in degassed dichloromethane solution at 
298 K  
29 
Complex absnm / 10
3
 L mol
–1
cm
–1
) em / nm  / s φ
25 257 (33.2), 284 (32.3), 319 (19.0), 339 
(10.5), 368 (4.92), 390 (9.42), 478 (0.89) 
493, 525, 560 (sh) 0.38 0.54 
 
26 255 (33.8), 284 (32.4), 320 (18.4), 340 
(10.3), 369 (4.41), 394 (9.27), 478 (0.78) 
492, 520, 564 (sh) 0.32 0.58 
 
27 258 (33.3), 285 (31.6), 318 (19.3), 339 
(10.8), 369 (5.24), 390 (9.52), 477 (0.81) 
492, 520, 560 (sh) 0.39 0.56 
28 255 (33.6), 285 (33.4), 321 (18.2), 341 
(10.0), 370 (4.25), 394 (8.84), 478 (0.77) 
492, 522, 564 (sh) 0.38 0.55 
 
 
Huo et al. later showed the effect of the functionalization of tetradentate platinum 
complexes on the photophysical properties.
30
 They used an amine linker as opposed to the 
carbon of the complexes of Figure 12.  An amine linker is interesting for the high modularity 
it offers in ligand design and the simplicity of ligand synthesis. The complexes were prepared 
from the ligands using K2PtCl4 as the metal source, in the presence of a phase-transfer catalyst 
(Bu4NCl) to facilitate the solubilisation in refluxing acetic acid.
31
 DFT calculations of 
complexes 29 and 30 showed that the amine linker did not have any influence on the HOMO-
LUMO energy gap. Furthermore, the HOMO was based on the phenyl rings and the metal 
while the LUMO was localized on the pyridine rings (Figure 14). The photophysical studies 
of complexes 29 and 30 were performed in 2-methyltetrahydrofuran solution at 298 K (Table 
5). The presence of the fluorine in complex 30 had a hypsochromic effect on the absorption 
and the emission wavelengths (max = 488 nm for complex 30 andmax = 512 nm for complex 
29), but the quantum yield was not affected (φ = 0.74 and 0.75, respectively). The 
luminescence lifetime slightly increased for complex 30 ( = 11.4 s) compared to complex 
29 ( = 7.6 s). 
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Figure 14. EHO/LO comparison between C^N^N^C platinum(II) complexes 29 (left) and 30 (right) 
 
Table 5. Photophysical data for platinum(II) complexes 29 and 30 in degassed 2-methyltetrahydrofuran solution at 
298 K  
30 
Complex absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
29 324 (25229), 342 (26272), 384 (4903), 407 (5969) 512, 548 7.6 0.74 
 
30 268 (29196), 329 (18970), 387 (3891) 488, 523 11.4 0.75 
 
 N^C^C^N Systems 
In the same paper, Huo et al. also studied the influence of the relative disposition of 
the ligating atoms on the photophysical properties.
24
 They synthesized four N^C^C^N 
platinum(II) complexes 31–34 (Figure 15) based on the same procedure as that used for the 
C^N^N^C platinum(II) complexes. The DFT calculations again showed a HOMO based on 
the phenyl rings and the metal and a LUMO on the pyridyl or pyrazole rings. The 
luminescence was attributed to either MLCT, ILCT or mixed charge transfer (MMLLCT) 
transitions. The comparison between 31 and 32, 33 and 34 showed a strong bathochromic 
shift of the luminescence (139 nm between 31and 32, for which max = 613 and 474 nm 
respectively) (Table 6). As pyridine is a better acceptor than pyrazole, it will decrease the 
level of the LUMO and reduce the HOMO-LUMO gap to give a red-shift of the 
luminescence. The functionalization on the C
3
 or C
4
 position by a weak donor group such as 
methyl, does not have a significant effect on the emission wavelength. 
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                                      31                32                33               34 
Figure 15. N^C^C^N platinum(II) complexes 31-34  24 
 
Table 6. Photophysical data for platinum(II) complexes 31-34 in degassed 2-methyltetrahydrofuran solution at     298 
K 
24 
Complex absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
31 274 (28533), 324 (17411), 338 (17435), 409 (9656), 
507(1350) 
613 7.6 0.14 
32 304 (21396), 334 (10307), 348 (13294), 365 (5021), 
408 (1656), 428 (1401) 
474 3.4 0.37 
      33 302 (34401), 335 (16243), 351 (28521), 370 (8493), 
421 (3367), 442 (2880) 
484, 512 4.9 0.56 
34 307 (28076), 342 (10328), 357 (18193), 376 (4722), 
428 (1835), 451 (1560) 
486, 516 5.7 0.63 
 
Li et al. demonstrated in 2013, the synthesis and the photophysical properties of three 
related tetradentate platinum complexes for application in OLEDs that incorporate oxygen 
linkers between the two N^C-coordinating units (Figure 16).
32
 The emission of complex 37 in 
DCM was red-shifted (max = 512 nm) compared to complexes 36 and 35 (max = 430 nm and 
468 nm respectively) and gave a higher quantum yield (Table 7). The greater electron-
withdrawing ability of pyridine accounts for this shift. Pyridine is more electron-deficient than 
pyrazole or imidazole, so the LUMO level is lower in complex 37 than in complexes 35 and 
36. As a consequence, the HOMO-LUMO gap of complex 37 is lowest and its emission is red 
shifted.
24,32
 
  (Poorer acceptor) pyrazole ˂ Imidazole ˂ pyridine (Better acceptor) 
When we compare complexes 37 and 29, we can observe that the emission wavelength 
of complex 29 is similar to that for complex 37, but its lifetime and quantum yield are longer 
and higher respectively (Table 5 and 7). The presence of two 6-membered and one 5-
membered metallacycles for 31 compared to one 6-membered and two 5-membered 
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metallacycles for complex 29 may account for this difference, since 29 can be expected to be 
the more rigid system. 
Table 7. Photophysical data for platinum(II)  
complexes 35-37 in degassed DCM solution at 298 K 
32
 
 
            35                    36                  37 
Figure 16.  N^C^C^N platinum(II) complexes 29-31 32 
 
 C^C^N^N Systems 
In 2013, Huo et al. developed two platinum(II) complexes with the configuration 
C^C^N^N (Figure 17).
33
 Complexes 38 containing a pyridyl ring and 39 a pyrazole unit were 
obtained in 38 % and 22 % yields, respectively. The photophysical data for complexes 38 and 
39 in degassed DCM at 298 K (Table 8) show that the emission of complex 39 is blue-shifted 
(max = 555 nm) compared to 39 (max = 660 nm). Again, this can be rationalised in terms of 
the pyridine unit being a better acceptor than the pyrazole unit. Furthermore, the quantum 
yield of complex 39   is higher than that of 38 (φ = 0.17 and 0.001, respectively). Quantum 
yields are generally highest in the green region: they fall off towards the blue because of the 
role of higher-lying states and towards the red because of vibrational decay.  
 
                                                      38                            39 
Figure 17. C^C^N^N platinum(II) complexes 38 and 39  33 
 
 
 
 
Complex em / nm  / s φ
35 430,456 3.0 0.39  
 
36 468 9.0 0.64 
 
37 512 2.0  0.63 
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Table 8. Photophysical data for platinum(II) complexes 38 and 39 in degassed DCM solution at 298 K 33 
Complex absnm / 10
3 
L mol
–1
cm
–1
) em / nm  / s φ
38 261 (27.3), 392 (10.3), 418 (8.5), 519 (2.3) 660 0.85 0.001 
 
39 260 (26.5), 371 (12.9), 456 (2.7) 555 4.4 0.17 
 
1.4. Tetradentate Palladium Complexes 
Few palladium(II) complexes are luminescent in solution at room temperature.  The 
smaller spin-orbit coupling (SOC) compared to platinum leads to smaller radiative rate 
constants, and very rigid systems are likely to be required to ensure that non-radiative decay is 
not overly competitive.
34
  It is therefore not surprising that palladium(II) porphyrins are the 
most well-known Pd-based phosphors to date, typically emitting deep into the red region of 
the spectrum.  
Klimant et al. have worked on luminescent Pd
II
-porphyrins as oxygen sensors, and 
they recently prepared complexes of tetradentate O^N^N^O-coordinating Schiff base ligands 
for the same purpose.
35,36
 A selection of these complexes (48, 49 and 50) is shown in Figure 
18. 
Figure 18. O^N^N^O palladium(II) complexes 48, 49 and 50 35, 36 
 
The photophysical properties of these complexes were investigated in degassed 
toluene at 298 K (Table 9). All are weakly emissive in the red region (max = 762 to 792 nm, 
φ  10–2).  Due to the long radiative decay constants associated with the smaller SOC of 
Pd(II) compared to Pt(II), the luminescence lifetimes (45 to 70 s) are much longer than those 
of their platinum(II) analogues, which exhibit luminescence lifetimes of around 10 s. 
 
 
 
 
  
48 49 
 
50 
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Table 9. Photophysical data of palladium(II) complexes 48, 49 and 50 in degassed toluene solution at 298 K 35, 36 
Complex maxem / nm  / s φ  
48 763 45 0.012 
49 762 70 0.023 
50 792 57 0.016 
 
 In 2013, Che et al. synthesized and studied the first luminescent tetradentate 
O^N^C^N palladium complexes for applications in oxygen sensing, photocatalysis, or 
OLEDs (Figure 19).
37
 To synthesize these palladium(II) complexes, they proceeded by the 
reaction between Pd(OAc)2 and the corresponding ligand in acetic acid at reflux. Complexes 
40-47 were obtained in yields of 50 to 80 %.  
 
Figure 19. O^N^C^N palladium(II) complexes 40-47 37 
 
 The luminescence properties of these complexes were measured in degassed DCM at 
298 K (Table 10). They are all moderately emissive under these conditions, exhibiting a 
green-yellow luminescence with max between 517 and 540 nm. Compared to the platinum(II) 
analogue 9, complex 40 showed a bathochromic shift of 55 nm and a decrease of its 
luminescence lifetime and its quantum yield. 
 
 
 
 
 
 
 
41 42 40 
45 
46 
47 
44 
43 
82 
 
Table 10. Photophysical data of palladium(II) complexes 40-47 in degassed DCM solution at 298 K, together with 
platinum(II) complex 15 for comparison. 
28, 37
 
Complex max
em
/ nm  s φ  
40 540 0.4 0.0019 
41 543 0.2 0.002 
42 535 ˂ 0.2 0.0016 
43 527 105 0.15 
44 498 121 0.20 
45 527 122 0.17 
46 517 62 0.22 
47 
15 
536 
485 
83 
12 
0.14 
0.72 
 
The data in Table 10 refer to degassed solutions.  The luminescence of complex 44 
showed a drastic decrease in intensity and lifetime in the presence of air, demonstrating the 
potential of such compounds for oxygen sensing. Furthermore, it was possible to oxidize a 
secondary amine by oxygen under light irradiation with complexes 43-46 as catalysts. 
Complex 46 showed the highest activity and generated the products with up to about 1650 
turnovers in 2 h. Singlet oxygen sensitized by the triplet-excited Pd(II) complex is proposed to 
be the active oxidant.
38,39 
This finding reveals that Pd(II) complexes containing non-porphyrin 
ligands may also possess rich photochemical properties analogous to those displayed by their 
Pt(II) counterparts.  Notably, their smaller radiative decay constants can lead to exceptionally 
long lifetimes that may offer utility for applications to which Pt(II) analogues are less suited. 
 
1.5. Objectives 
It is clear from the overview given in the preceding sections that platinum(II) and 
palladium(II) complexes of tetradentate ligands may possess interesting photophysical 
properties, offering scope in diverse applications (e.g. OLEDs, catalysis, oxygen sensing, etc). 
Different ways to synthesize these complexes are possible. Depending on the rigidity and the 
functionalization of the tetradentate metal complex, we can observe a modulation of the 
luminescence properties.  
  In a first section of results presented in this Chapter, the synthesis, characterization 
and photophysical properties of platinum(II) and gold(III) complexes of a non-porphyrinic 
N^N^N^N-coordinating tetradentate ligand will be described (Figure 20). Their 
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photophysical data will be compared with corresponding metalloporphyrins and Pt(II) 
complexes with other tetradentate ligands. 
 
Figure 20. N^N^N^N heavy-metal complexes prepared and studied in this work 
 
Secondly, a study of new C^N^N^C tetradentate platinum(II) complexes will be 
described (Figure 21). More electron rich and delocalized aryl rings have been introduced 
compared to previously described complexes, with a view to extending the emission 
wavelength into the red. 
 
 
Figure 21. Summary of tetradentate C^N^N^C-coordinating ligands and their cyclmetallated platinum(II) 
complexes investigated in this work 
The possible metallation of a palladium atom into such C^N^N^C tetradentate ligands 
will then be discussed, and the photophysical properties of the resulting complexes described 
(Figure 22). 
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Figure 22. Summary of tetradentate C^N^N^C-coordinated palladium(II) complexes investigated in this 
work  
Finally, the results of a preliminary exploration into the synthesis of iridium(III) and 
gold(III) complexes of such ligands will be presented. 
 
 Synthesis and Characterization of  Tetradentate Heavy-Metal 2.
Complexes 
2.1.  N^N^N^N Tetradentate Heavy-Metal Complexes 
2.1.1. Background 
Porphyrin and phthalocyanine are both symmetrical macrocycles (C4 axis when 
coordinated to a metal ion) used for dyes or application in biology. Porphyrins are comprised 
of four pyrrole units linked by CH units at the so-called meso positions. Phthalocyanine, in 
contrast, is composed of four iminoisoindoline units linked via nitrogen atoms at each of the 
four meso positions (Figure 23).  Both macrocycles are dianionic and can bind metal atoms 
such as Fe, Co or Zn. The macrocycle known as MabiqH (Figure 23) is similar to porphyrin 
and phthalocyanine, but it is monoanionic (only one N–H available to deprotonate) and it 
incorporates an exocyclic N^N unit  by virtue of the presence of the bipyrimidine, which 
could potentially coordinate a second metal ion. Von Zelewsky et al. first with cobalt 
complexes, and then Hess and coworkers with iron complexes demonstrate that the redox 
non-innocence of the diketiminates is a matter for consideration in the chemistry of metal 
complexes containing such ligands. Only a few T.M. complexes of this ligand have been 
prepared, and it was of interest in our work to explore, firstly, whether Pt(II), Pd(II) and 
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Au(III) complexes of Mabiq could be synthesised and secondly, how their photophysical 
properties would compare with those of metalloporphyrins. Although the main focus of this 
chapter is the synthesis and study of palladium and platinum complexes, Au(III) is also of 
interest, as it isoelectronic with Pt(II). 
 
 
Figure 23. Representation of a porphyrin (dianionic), a phthalocyanine (dianionic) and a MabiqH 
(monoanionic) ligand 
 
 
 
2.1.2. Synthesis  
 
A sample of the proligand (H)Mabiq was provided by the group of Dr C. Hess at 
Durham. It was prepared according to the route originally devised by von Zelewsky (Scheme 
2).
40
 Two equivalents of 2-aminobenzamide reacted with acyl chloride to give an intermediate 
I which was sublimed at 350 °C to form II, and then chlorinated with PCl5 to obtain the first 
bipyrimidine moiety III of the final product. Product III was finally reacted with (bis)amidine 
to give the H(Mabiq) ligand in 55 % yield. 
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Scheme 2. Synthetic route of H(Mabiq) synthesis  40 
 
 Synthesis of the platinum(II) complex of Mabiq  
The synthetic pathway to prepare [PtMabiq]PF6 has been inspired by the work of 
Yeaman's group on platinum tetraphenylporphyrins (TPP). H(Mabiq) and PtCl2(dmso)2 were 
dissolved in benzonitrile and heated at 190°C for 3 h (Scheme 3).
41
 After cooling to room 
temperature, distilled water was added. The counterion exchange from Cl
–
 to PF6
–
 was made 
after several washings of the crude product with EtOH and Et2O. The orange-coloured 
complex was finally obtained by recrystallization from CH3CN/ Et2O, in 65 % yield.   
 
Scheme 3. Synthesis of [PtMabiq]PF6 
41
 
 
I II 
III 
H(Mabiq) 
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 Synthesis of the gold(III) complex of Mabiq  
The synthesis of [AuMabiq](PF6)2 was performed following a similar procedure to 
that used by Kadish et al. for the preparation of gold(III) porphyrin.
42
 A mixture of 
(H)Mabiq, potassium tetrachloroaurate(III) and NaOAc was heated at reflux in a mixture of 
toluene and glacial acetic acid for 10 min (Scheme 4). To exchange the chloride counterion to 
hexafluorophosphate and thus obtain a more soluble salt, the residue was dissolved in 
chloroform and stirred with a saturated solution of potassium hexaﬂuorophosphate in water 
for 18 h.  The yellow precipitate was isolated in 67 % yield. 
 
Scheme 4. Synthesis of [AuMabiq](PF6)2 
42 
 
 
 Attempted synthesis of the palladium(II) complex of Mabiq 
The synthesis of [PdMabiq]PF6 was attempted using a method  inspired by Harvey et 
al.
43
 Pd(OAc)2 (1.1 equiv.) was added slowly to a solution of H(Mabiq) in 1,2-
dichloroethane. The reaction mixture was heated at 110 °C for 12 h. The presence of the 
product was detected by an 
1
H NMR spectrum of the crude reaction (as the major product) 
and by mass spectrometry, but all attempts to purify the crude product to date have been 
unsuccessful.  
 
2.1.3. Characterization 
 NMR spectroscopy 
The 
1
H NMR spectrum of [PtMabiq]PF6 was recorded in CD3CN solution and 
[AuMabiq](PF6)2 in DMSO-d6 solution. Spectra are shown in Figures 24 and 25. The 
1
H 
NMR spectrum of [PtMabiq]PF6 showed a slight shift in the aromatic protons and of the C–
H protons of the diketiminate backbone compared with those spectra of the free ligand. The 
signal for the acidic cavity N–H proton of the free ligand, at 13.7 ppm, disappears upon 
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coordination of the metal ion. The same observation was made for the gold complex. For 
[PtMabiq]PF6, two peaks in the alkyl region corresponded to the methyl protons of the 
dihydropyrrole backbone due to the C2 symmetry axis through the Pt(II) and methane carbon 
of the molecule. [AuMabiq](PF6)2 displayed seven peaks in the aliphatic (methyl) region 
between 1.2 and 1.6 ppm, which suggests a lack of symmetry in the  Au(III) complex in 
contrast to the Pt(II) analogue. An elemental analysis will show if the molecule is five-
coordinate [AuMabiqCl]PF6 and not square-planar [AuMabiq](PF6)2 by oxidation with 
chloroform. The presence of the chloride ion on one face of the molecule would lead to the 
inequivalence of these methyl protons. 
 
 
Figure 24. 1H NMR of [PtMabiq]PF6 recorded at 700 MHz in CD3CN at 298 K 
                    
Aromatic region 
Methyl groups 
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Figure 25. Aliphatic region of the 1H NMR spectrum of [PtMabiq]PF6 (left) and [AuMabiq](PF6)2 
(right) recorded at 700 MHz in CD3CN and DMSO-d6 respectively at 298 K 
 
 Crystal structure 
Crystallisation of the platinum(II) complex was performed in MeCN by slow 
evaporation. The molecular structure of [PtMabiq]PF6 was determined by single crystal X-
ray diffraction analysis at 100 K, which confirmed the tetradentate coordination structure and 
the cationic form of the platinum complex with the presence of PF6 anions (Figure 26). The 
selected bond lengths and angles are listed in Tables 11.  
A slight asymmetry is observed in the Pt–N bonds, with a distance of 1.97 Å to the 
bipyrimidine nitrogen atoms (N1, N2) versus a 1.95 Å bond to the diketiminate N atoms (N3, 
N4). The asymmetry in metal-nitrogen bond lengths arises from differences in the basicity of 
the two types of nitrogen donors, as observed for the previously reported [Zn
II
(Mabiq)Cl] 
complex.
44
 No Pt···Pt interactions were observed but [PtMabiq]PF6 displayed a quasi 
planarity of the  PtN4 core. In fact, the bipyrimidine unit was distorted at an angle of only ∼ 
3.63° from the coordinating diketiminate N-atoms whereas [Zn
II
(Mabiq)Cl] showed a 
corresponding distortion of ∼ 11.5°. 
 
 
 
Figure 26. Molecular structure of [PtMabiq]PF6 complex 
 
Table 11. Selected bond lengths (Å) and torsion angles (°) of [PtMabiq]PF6 (structure was acquired at 100 K). Data 
for [ZnMabiqCl] are included for comparison. 
44
 
Complex [PtMabiq]PF6 [ZnMabiqCl] 
Torsion angle (°)            3.63         11.5 
Complex Bond lengths 
Pt–N1 
Bond lengths 
Pt–N2 
Bond  lengths 
PtN3 
Bond  lengths 
PtN4 
N1 
N2 
N3 
N4 
90 
 
 
 
 Photophysical characterization 
The ground state absorbance spectrum of [PtMabiq]PF6 in dichloromethane solution is 
shown in Figure 27 and photophysical data are summarized in Table 12. It showed two 
intense bands in the near UV region between 250 and 300 nm and between 300  and 400 nm 
corresponding to the 
1-* transitions of the ligands. These are accompanied by a weaker, 
lower energy feature centred at 452 nm, assigned to the 
1
MLCT bands. The emission spectra 
in DCM at 298 K and in EPA at 77 K showed structured bands with maxima at 530 nm and 
521 nm respectively. The well-defined vibronic structure that is observed even in solution at 
room temperature is typical of emission from ligand-centred excited states in rigid aromatic 
systems.  The small hypsochromic shift on cooling to 77 K is typical of the rigidochromic 
effect associated with rigidification of the environment of the molecule when in a frozen 
glass. The complex displayed a lifetime of 2.3 s and a quantum yield of 0.04. Whilst the 
quantum yield is comparable to that of, for example, PtTPP under the same conditions (TPP = 
tetraphenylporphyrin), the lifetime is much shorter (for PtTPP in DCM, t = 59 s, φ = 
0.046).
45
  
 
Figure 27. Normalized absorption spectrum of [PtMabiq]PF6 in DCM (blue line) and emission spectra in 
degassed DCM and in EPA solutions at 298 K and 77 K respectively (solid red and dashed green lines 
respectively).  
 
Table 12. Photophysical data for [PtMabiq]PF6 in degassed DCM and EPA solution at 298 K and 77 K
 
 
Complex abs nm em / nm  / s φ em / nm 
0
0.2
0.4
0.6
0.8
1
250 350 450 550 650 750
[PtMabiq]PF6 1.974(3) 1.972(2) 1.958(3) 1.957(3) 
[ZnMabiqCl] 2.090 2.090 2.030 2.030 
Wavelength /nm 
In
te
n
si
ty
 /
 a
.u
. 
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[PtMabiq]PF6 255, 335, 452 530, 574, 625 2.3 0.04 521, 563, 612 
PtTPP
(a)
 400, 508, 538 668, 734 59 0.04 655, 728 
(a) data from ref 45 
 Electrochemistry 
The cyclic voltammogram (CV) of [PtMabiq]PF6 was recorded in DCM (0.1 M 
TBAPF6 as electrolyte) at 50, 100 and 200 mV s
–1
. The CV exhibited two reversible waves 
centered at – 1.00 V and –1.85 V versus Fc+/Fc (Figure 28). No oxidation wave was observed 
up to 2 V. Both electron transfer processes are assigned as ligand-centered reductions.  The 
cyclic voltammogram (CV) of [Zn(Mabiq)Cl] showed a reversible one-electron redox wave 
centered at –1.4 V and an irreversible reductive process at –2.19 V. Both electron transfer 
processes were also assigned as ligand-centered reductions. CV of previously reported 
[Fe(Mabiq)] in THF displayed four distinct electron transfer processes, centered at 0.45 V, –
0.93 V (one-electron oxidations), -1.79 and –2.45 V (one-electron reduction processes, 0.1 V 
s
–1
, 0.2 M TBAPF6).
44 
 
                              
                                               
Figure 28. Cyclic voltammogram showing the two reversible reductions observed for [PtMabiq]PF6. The 
scans were performed in degassed DCM, in the presence of a 0.1 M tetrabutylammonium 
hexafluorophosphate background electrolyte, at scan rates of 50, 100 and 200 mV s
–1
. 
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n
t 
(A
) 
Potential vs SCE (V) 
-1.23E-05
-7.30E-06
-2.30E-06
2.70E-06
-1.2 -1.1 -1 -0.9
C
u
rr
e
n
t 
(A
) 
Potential vs SCE (V) 
E
1/2
 = – 1.00 V E
1/2
 = – 1.85 V 
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2.2. C^N^N^C Tetradentate Platinum Complexes  
2.2.1. Synthesis of the tetradentate ligands 
The method used to prepare the tetradentate ligands was based on that used by Huo et al.
30
 
The first step for most of the ligands consists of a double Buchwald-Hartwig amination of a 
primary aryl amine with two equivalents of 2,6-dibromopyridine catalysed by palladium 
(Scheme 5).
46
  In the present work, the aryl amine used was p-methoxyaniline – as opposed to 
unsubstituted aniline used by Huo – leading to bis(6-bromopyridin-2-yl)-N-(4-
methoxyphenyl)-amine (IV) which features two mutually parallel C–Br bonds.  The presence 
of the electron-donating methoxy group in the para position increases the nucleophilicity of 
the amine and facilitates the amination.  In contrast, it has been found that electron-
withdrawing groups at this position greatly retard the reaction, and indeed other side-products 
may form.
47
 
 
Scheme 5. Synthesis of precursor IV via a Buchwald-Hartwig reaction 
The subsequent step of the synthesis involves the Pd-catalysed coupling of the precursor 
either with aryl boronic acids (as used by Huo) or aryl stannanes.  In general, the former are 
preferred owing to the benign nature of the boronate side products.  The conditions are 
similar, although the Suzuki reaction requires the addition of base to convert the boronic acid 
into a boronate.   
Ligands L
1
H2-L
6
H2 (Scheme 6) were prepared by Suzuki coupling with the requisite 
boronic acid, commercially available in each case. The general procedure involved the use of 
3 equivalents of aryl boronic acid per equivalent of precursor IV, and an excess of sodium 
carbonate as the base. After prior degassing of this mixture, the palladium catalyst Pd(PPh3)4 
was added under nitrogen flow and the reaction mixture was heated for 24 h. 
Dimethoxyethane at 80˚C was used as the solvent for L1H2, L
2
H2 and L
3
H2, and toluene at 
110˚C for L4H2, L
5
H2 and L
6
H2, where a higher temperature was required in order to bring 
about the desired reaction. The crude product was obtained after addition of H2O and 
extraction with CH2Cl2, and purification was carried out by column chromatography on silica. 
IV 
93 
 
  
 
Scheme 6. Synthesis of L1H2-L
6
H2 tetradentate ligands via a Suzuki cross-coupling reaction   
 
It is known that 2-thienylboronic acid is not always a good substrate for Suzuki 
reactions, showing a tendency to undergo competitive deboronation.
48
  Ligand L
7
H2 and its 
benzothienyl analogue L
8
H2 were therefore prepared by Stille cross-coupling of precursor IV 
with the requisite aryl stannane, using bis(triphenylphosphine)palladium(II) chloride as the 
catalyst, in the presence of lithium chloride (Scheme 7). 
 
 
Scheme 7. Synthesis of L7H2 and L
8
H2 tetradentate ligands via a Stille cross-coupling reaction  
 
A different synthetic method was used for the preparation of the tetradentate ligand 
incorporating benzoquinoline units L
9
H2 (Scheme 8).  Selective iodination of benzoquinoline 
at the 2-position was achieved, following a procedure reported by Mongin et al.
49
 It consists 
L5H2 L
4H2 L
1H2 L
3H2 L
2H2 
L7H2 L
8
H2 
L6H2 
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of directed lithiation at the position   to the nitrogen by BuLi in the presence of 
ZnCl2TMEDA in hexane solution at 0 °C, followed by addition of iodine to give the precursor 
V in 78 % yield. Subsequent amination with p-methoxyaniline (0.5 equiv) under the same 
Buchwald-Hartwig conditions described earlier gave L
9
H2 in 31 % yield. 
 
 
Scheme 8. Synthesis of precursor V and L9H2 tetradentate ligand via regioselective iodination of benzoquinoline 
followed by Buchwald-Hartwig amination  
 
2.2.2. Synthesis of platinum complexes 
 Platinum(II) complexes 
Cyclometallated platinum(II) complexes of arylpyridine ligands are typically prepared by 
reaction of the pro-ligand with K2PtCl4, often either in acetic acid as the solvent or a mixture 
of an organic solvent, such as MeCN, and water.
50,51
 For the present series of compounds, the 
use of acetic acid was generally successful, after heating under reflux for 24 to 48 h under a 
nitrogen atmosphere (Scheme 9). Complexation of L
6
H2 with K2PtCl4 was not performed. 
 
 
L9H2 V 
PtL
1
 PtL
4
 PtL
7
 PtL
8
 PtL
9
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Scheme 9. Synthesis of platinum(II) complexes using K2PtCl4 as reagent 
In some cases, microwave irradiation was used instead.  For example, the reaction of 
L
4
H2 and K2PtCl4 in glacial acetic acid was performed under microwave irradiation at 160 °C 
for 30 min, giving a yield of 75 % compared to 55 % under conventional heating (Scheme 
10). However, microwave irradiation was unsuccessful for the formation of PtL
8
, leading to 
degradation of the starting materials. 
 
Scheme 10. Synthesis of platinum(II) complex via microwave reaction 
In the case of L
3H2 and L
5H2, it did not prove possible to prepare the Pt(II) 
complexes. For L
3H2, a Pt(IV) complex was uniquely isolated (see below).  Meanwhile, the 
attempted complexation of ligand L
5H2 to platinum under the same conditions as those used 
for PtL
1
 led to an unexpected product (Figure 29). On the basis of NMR spectroscopy and 
mass spectrometry, the product was identified as a pyrrolodipyridine compound VI. The 
1
H 
NMR spectrum of the product 3 in CDCl3 showed six signals in the aromatic region and one 
in the aliphatic region corresponding to the methyl of the compound. The six signals indicated 
symmetry of the molecule. In fact, there were four doublets, each integrating for two protons, 
and two singlets at 8.61 ppm and 7.92 ppm, integrating for four and two protons respectively. 
The comparison with the free ligand indicated that two protons are missing and a low 
frequency shift of all the protons. 
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Figure 29. TOP: Full 1H NMR spectrum of compound VI and BOTTOM: aromatic region of the 
overlaid 
1
H NMR spectra of VI (red) and its precursor proligand L
5
H2 (blue).  Both spectra were 
recorded at 700 MHz in CDCl3 at 298 K. 
Previously, the synthesis of such pyrrolodipyridines has been performed by irradiation 
of the corresponding 2,2'-dipyridylamine for 48 h (yield = 53 %).
52
 The generated product in 
our case was isolated in 53 % yield. There was no evidence of such a product being formed 
from the other proligands.  Presumably, the CF3 groups serve to deactivate the aryl rings to 
oxidative addition to Pt(II), and activation (metallation) of the 3 position of the pyridine 
occurs instead. 
53,54
 This leads to oxidative coupling of the two pyridyl units through the C
3
 
carbon atoms.  It is noteworthy that the same proligand also gave an unexpected product with 
palladium too, different from the other proligands, showing metallation at one of the pyridyl 
C
3
 positions (see Section 2.3.1 below). 
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Scheme 11.  Reaction between ligand L5H2 and K2PtCl4 leading to the unexpected organic product VI 
Another metallation method was tested for L
8
H2 to compare the reactivity and the 
yield of the final product obtained (Scheme 12).
55
 The lithiation of the free ligand L
8H2 with a 
solution of BuLi (1.6 M in hexane) was performed at -78 °C in a mixture of THF/Et2O. The 
lithiated precursor reacted with a platinum dimer [PtMe2(SMe2)2]2 at –10 °C to give PtL
8
 in 
12 % yield.
56
 The relative acidity of the  proton of the benzothiophene favored the 
regioselective lithiation, while a hazardous attack of the BuLi on the ligand L
1H2 or L
7H2 
may not give the expected complexes. Indeed, following Holleman rules, when the substituent 
on the aryl reagent is an electron acceptor (as pyridyl) the electrophilic addition is favored in 
meta position. Nevertheless, the yield of the reaction is comparable to the reaction at high 
temperature in acetic acid.
57
 
  
Scheme 12. Synthesis of PtL8 by dilithiation of the ligand and subsequent reaction with [Pt(SMe2)2(e)2]2   
 Platinum(IV) complexes 
PtL
4
 and PtL
8
 were oxidized to their corresponding Pt(IV) complexes PtL
4
Cl2 and 
PtL
8
Cl2 by bubbling Cl2 gas through a solution of the Pt(II) complex in chloroform (Scheme 
13). The reactions were performed in the dark to avoid the light-activated decomposition of 
the platinum(IV) complexes. The yellow colour of the initial solution was discharged within 1 
hour of reaction, which provided a visual indication of the oxidation to Pt(IV).  
VI 
PtL
8
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     PtL
4
Cl2                              PtL
8
Cl2 
Scheme 13. Oxidation reaction of PtL4 and PtL8 
The reaction between K2PtCl4 and the free ligand L
2
H2 and L
3
H2 led directly to the 
oxidized Pt(IV) forms alone PtL
2
Cl2 and PtL
3
Cl2 (Figure 30). The identity of the compound 
PtL
3
Cl2 was proved by the crystal structure showing the two chlorides in axial positions. The 
reaction was performed under the same conditions as for all the other ligands, namely in 
AcOH at reflux under a nitrogen atmosphere. The result was repeatable, ruling out the 
possibility of adventitious ingress of oxygen on one specific occasion, for example.  Thus it 
seems that in this case, the stability of the Pt(IV) complex is higher than that of its Pt(II) 
analogue. 
              
Figure 30. PtL2Cl2 (left) and PtL
3
Cl2 (right) complexes 
2.2.3. Characterization of Platinum complexes 
 NMR spectroscopy 
 Comparison of the proligand L1H2 with its  Pt(II) complex PtL
1
 
The 
1
H and 
13
C{
1
H} NMR spectra of the ligands and their square-planar platinum(II) 
complexes showed the expected C2 symmetry of the molecules along the anilino N···OMe 
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and the metal axis (Figure 31). This effect was apparent from the presence of 10 signals in 
the 
1
H NMR and 16 signals in the 
13
C {
1
H} NMR spectra. The metallation of the ligand L
1
H2 
to PtL
1
 was clearly indicated by the integral value (two protons are “missing” relative to the 
proligand) and the appearance of characteristic satellites flanking the signal of H
e 
due to 
coupling to 
195
Pt, 
3
J (
195
Pt–H) = 25 Hz. 
  
Figure 31. TOP: 1H NMR spectrum (700 MHz) of the proligand L1H2 and BOTTOM:  
1
H NMR 
spectrum (600 MHz) of the corresponding platinum complex PtL
1
. All spectra were recorded in CDCl3 
at 298 K. Notice the 
195
Pt satellites observed around the peak corresponding to H
e
 in the complex: 
3
J(
195
Pt–H) = 25 Hz.  
 
 In PtL
1
 complex, the aromatic ring current of the phenyl ring connected to the 
anisidine nitrogen atom influences the protons of the pyridyl ring. Indeed, the anisyl ring is 
expected to be essentially perpendicular to the rest of the complex (Figure 32), as confirmed 
by crystallography (see below). As a consequence, the chemical shift of H
3
 protons was 
shielded to = 6.5 ppm compared to the free ligand for which the corresponding value was 
7.0 ppm. This phenomenon was not observed for the free ligand because of its free rotation 
about the C–N (pyridyl–anilino) bond. The metallation brings more rigidity to the molecule 
compared to the free ligand. 
H
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Figure 32. Aromatic ring current of the pendent phenyl ring leading to upfield shifts of the pyridyl H3 
signals in the NMR spectrum 
Another characteristic of the platinum complexes was the deshielding of the proton in the 
metallated aryl ring that is  to the metal-carbon bond (labelled He in Figure 33). Upon 
cyclometallation with K2PtCl4, H
e
 ortho to the Pt–C bond exhibited an upfield shift of  = 
1.1 ppm reflecting an enhanced shifted effect. A valuable hypothesis was made by Selbin and 
coworkers as a through-space shielding caused by an adjacent aromatic ring defined as syn 
juxtaposition.
58
 They observed for [-(OAc)Pd(ppy)]2 that the C–H ortho to the C–Pd of the 
phenyl ring showed an upfield shift of  = 0.5 ppm. The larger upfield shift observed for 
tetradentate platinum complexes may be due to the enhanced of rigidity. 
 
Figure 33.  backbonding effect on a tetradentate platinum complex  
 
 Oxidation from platinum(II) to platinum(IV) 
It was noted above how L
3
H2 directly gave a Pt(IV) complex upon reaction with 
K2PtCl4.  In fact, we observed that such Pt(IV) complexes could also be formed with the other 
ligands, indirectly via their Pt(II) complexes, without the need for Cl2 or the presence of any 
obvious oxidant, in a process that seemed to involve the solvent and be activated by light.  
Chassot et al. showed that the orthometalated complexes Pt(ppy)2 and Pt(thpy)2 are 
photosensitive in several organic solvents, giving rise to oxidative addition reactions that lead 
to the formation of Pt(IV) complexes.
59,60
 
 = 6.5 ppm  
B0 
B0 = magnetic field 
(+) = shielding 
(+) (+) 
 = 8.4 ppm  
 = rich electron density 
 = poor electron density 
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We therefore tried to explore the reactivity of the platinum(II) complexes with solvent 
and under the influence of light.  For example, the oxidation of PtL
7
 under light irradiation 
was monitored by 
1
H NMR spectroscopy (Figure 34). A first 
1
H NMR was made at t = 0 with 
10 mg of PtL
7
 dissolved in CDCl3. We observed one set of signals corresponding to the Pt(II) 
complex. The NMR tube was placed in a bath at 25 °C for all the experiment time in order to 
maintain the same temperature during the irradiation. After 30 min of light irradiation, we 
observed an additional new set of aromatic signals, corresponding to the partial oxidation to 
Pt(IV), and the diminution of the integration for the Pt(II) complex. The oxidation of the Pt(II) 
to the Pt(IV) analogue was almost complete after 19 h. The oxidation state of the complex had 
a direct impact on the 
1
H NMR. In fact, the Pt–C bonds were stronger and the -bonding is 
more important for the Pt(II) than the Pt(IV) so the electron density is lower for the Pt(IV) 
which induced a deshielding of the protons. As an example the most shielded proton (H
d
) at 
6.40 ppm for the Pt(II) is shifted to 6.46 ppm for the Pt(IV) complex.  
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     PtL
7
                                PtL
7
Cl2 
 
  
Figure 34. Evolution of the 1H NMR spectrum (400  MHz) of PtL1 as it becomes oxidised to PtL1Cl2 in 
CDCl3 solution upon irradiation with light at 298 K  
 
The same experiment was made with PtL
8
 complex. It appeared that the oxidation to 
Pt(IV) was faster for PtL
8
 than PtL
7
. The planar PtL
8
 complex was oxidized in 2 h instead of 
19 h for PtL
7
 oxidation. The more electron-rich benzothiophene unit apparently facilitates the 
oxidation of the platinum(II). The back reduction of the oxidized complex was attempted by 
leaving the NMR tube in the dark for several weeks, but no re-formation of the Pt(II) complex 
was observed. 
 
 
t = 0  
t = 30 min 
t = 90 min 
t = 19 h Pt
IV
 
Pt
II
 
Mixture Pt
II 
+ Pt
IV
 
Mixture Pt
II 
+ Pt
IV
 
6.40 
6.46 6.40 
6.46 
6.40 
6.46 
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 Crystal structures 
 Crystal structures of Platinum(II) Complexes  
The molecular structures of PtL
1
, PtL
4
, PtL
7
 and PtL
8
 were determined by single 
crystal X-ray diffraction analysis at 120 K, which confirmed the tetradentate coordination 
structure (Figure 35 and 36). Selected bond lengths and angles are listed in Table 13.  
In all cases, the Pt–N bond lengths were slightly longer than the Pt–C bond lengths. 
For example, for PtL
7
, the Pt–N and Pt–C bond lengths are approximately 2.05 Å and 2.00 Å 
respectively (Table 13). The average of the Pt–C bond lengths of all complexes (~ 2.000 Å) is 
very close to that reported for cis-Pt(ppy)2 (1.993 Å) and cis-Pt(thpy)2 (1.986 Å), but the 
average of the Pt–N bonds (2.051 Å)  is shorter than in cis-Pt(ppy)2
61
 (2.127 Å) and cis-
Pt(thpy)2 (2.159 Å). The formation of three metallacycle rings in the tetradentate complexes – 
two five-membered and one six-membered due to the nitrogen linker between the two C^N 
units – explains the relative shorter Pt–N bond lengths. The comparison with the tetradentate 
complexes synthesized by Huo et al. (29 and 31)
30
 showed that the six-membered 
metallacycle ring formed with the two C^N units and the nitrogen as the linker, involved 
shorter bond lengths. Indeed, we observed that the distance Pt–C for 31 and Pt–N for 29 was 
shorter than Pt–N for 31 and Pt–C for 29. The Pt bonds close to the N bridge are shorter than 
the other Pt bonds.  
 
 
Figure 35. Pt(II) complexes 31 and 29 reported by Huo and co-workers 30 
 
31 29 
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Figure 36. Representation of a tetradentate cyclometallated platinum(II) complex   
 
Table 13. Selected bond lengths (Å) and angles (°) of Pt(II) complexes (All structures were acquired at 120 K). Data 
for cis-Pt(ppy)2, cis-Pt(thpy)2, 29 and 31 are included for comparison.
1,30
 
Complex Bond angles / ° 
N
1
^Pt^N
2
 
Bond angles / ° 
C
1
^Pt^C
2
 
Bond angles / ° 
N
1
^Pt^C
1
 
Bond angles / ° 
N
2
^Pt^C
2
 
PtL
1
 92.97(13) 103.51(16) 81.89(14) 81.78(14) 
PtL
4
 93.20(2) 102.10(3) 82.50(3) 83.00(2) 
PtL
7
 92.44(13) 102.56(17) 82.35(15) 82.66(15) 
PtL
8
 91.24(12) 106.27(16) 81.67(14) 82.01(14) 
cis-Pt(ppy)2 101.9(1) 99.30(2) 79.30(1) 79.30(1) 
cis-Pt(thpy)2 98.20(1) 103.30(3) 79.40(1) 79.10(1) 
 
 
The anilino nitrogen adopted a planar geometry (a sum of 360º of the three C^N^C 
angles around the nitrogen) rather than a normal trigonal pyramidal geometry, indicating the 
feature of an sp
2
 hybridized N for extended conjugation. Furthermore, the phenyl ring of the 
anisole group is clearly seen to be perpendicular to the plane of the rest of the complex (Table 
14). This observation supports the earlier analysis of the NMR spectra, where the aromatic 
ring current induced in the phenyl ring explains the shielding of the H
3
 protons of the pyridyl 
ring. 
 
Complex Bond lengths 
Pt–N1 
Bond lengths 
Pt–N2 
Bond  lengths 
Pt–C1 
Bond  lengths 
Pt–C2 
PtL
1
 2.041(3) 2.046(3) 2.001(4) 2.001(4) 
PtL
4
 2.038(6) 2.031(6) 1.966(7) 1.986(7) 
PtL
7
 2.054(3) 2.058(3) 2.006(4) 1.995(4) 
PtL
8
 2.054(3) 2.048(3) 2.000(4) 2.002(4) 
cis-Pt(ppy)2 2.127(3) 2.127(3) 1.993(4) 1.993(4) 
cis-Pt(thpy)2 2.159(3) 2.161(3) 1.986(4) 1.992(4) 
29 2.125(7) 2.130(6) 1.960(7) 1.959(8) 
31 2.051(2) 2.050(2) 2.000(3) 2.007(3) 
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Table 14. Torsion angles between plane A and B (defined as in Fig. 15) for PtL1, PtL4, PtL7 and PtL8  
Complex PtL
1
 PtL
4
 PtL
7
 PtL
8
 
Angle between anisole group 
and the C^N^N^N^C plane 
82.81  83.53 87.31 78.19 
 
The non-planarity of the platinum complexes was observed by the torsion between the 
two C^N-coordinating units of the tetradentate ligand. Torsion data are shown in Table 15. 
For complex PtL
7
, the torsion between the two thienylpyridine rings was quite small (3.23°) 
which provided a quasi-planarity of the complex. For complexes PtL
1
, PtL
4
 and PtL
8
, the 
two aromatic rings (phenyl, naphthalene and benzothiophene) were twisted probably because 
of the steric interaction of the two rings in the open end (tail) of the tetradentate complexes. 
The complexes had a twisted planar geometry around the metal center with a largest deviation 
of 24.90° for PtL
8
 between the two  N^Pt^C planes. 
 
Table 15. Torsion angles between the two C^N units in the platinum complexes PtL1, PtL4, PtL7 and PtL8. The 
torsion is measured as the angle between the planes of the two 5 membered rings (MCCCN) 
Complex PtL
1
 PtL
4
 PtL
7
 PtL
8
 
Torsion angle 
(°) 
15.79 ° 21.13 ° 3.23 ° 24.90 ° 
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Figure 37. Molecular structures of PtL1, PtL4, PtL7 and PtL8 viewed at various orientations 
 
PtL
1
 and PtL
7
 crystallised in a monoclinic system in P21/c and P21/n space groups 
respectively whereas PtL
4
 and PtL
8
 crystallised in a triclinic system in P1 space group due to 
the bulky complexes. They all adopted an antiparallel arrangement and packed in a head-to-
tail fashion. To estimate whether any significant C–C or Pt–Pt interactions exist in the crystal 
packing, centroid-to-centroid distances were analysed. There is no evidence of Pt····Pt 
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interactions  influencing the packing of any of the complexes, as distances are more than the 
threshold of 3.7 Å at which such interactions become plausible (PtL
7
 displayed the shortest 
distance with d = 3.983 Å). 
 
 
Figure 38. Crystal packing of PtL7 (left) and PtL4 (right) 
 
 Crystal structures of the Pt(IV) complexes 
 PtL
1
ClCN was obtained upon evaporation of a solution of PtL
1
 in CH3CN and DCM. 
PtL
1
ClCN and PtL
4
Cl2 crystallised in a triclinic system in P1 space group due to the 
octahedral geometry (Figure 39 and Table 16). Compared to PtL
1
, Pt–N and Pt–C distances 
of PtClCNL
1
 were longer than the corresponding distances in the Pt(II) complex. 
Furthermore, the Pt–Cl distance is the longest of the metal-ligand bonds (2.3712 Å) and Pt–
CN bond the shortest (1.884 Å). The plane formed by four coordinating atoms of the 
tetradentate ligand and the platinum ion showed N^Pt^N, C^Pt^C and C^Pt^N angles similar 
to those of the platinum(II) complexes. The C^Pt^Cl, N^Pt^Cl, C^Pt^CN and N^Pt^CN 
displayed angles closer to 90 ° than the previous angles cited. For PtL
4
Cl2, Pt–N and Pt–C 
distances are also longer than the distance of the analogous planar geometry. Pt–Cl bonds 
displayed the same distance as for PtL
1
ClCN (d = 2.3258 Å) and the angles did not really 
show any modifications. 
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Figure 39. Molecular structures of PtL1CNCl and PtL4Cl2 viewed at various orientations 
 
Table 16. Selected bond lengths (Å) and angles (°) of Pt(II) complexes PtL1CNCl and PtL4Cl2 (All structures were 
acquired at 120 K and 160 K respectively. 
 
Complex Bond angles / ° 
N
1
^Pt^N
2
 
Bond angles / ° 
C
1
^Pt^C
2
 
Bond angles / ° 
N
1
^Pt^C
1
 
Bond angles / ° 
N
2
^Pt^C
2
 
PtL
1
ClCN 92.27(10) 92.84(13) 80.76(12) 80.45(12) 
PtL
4
Cl2 92.29(16) 105.7(2) 81.1(2) 80.88(19) 
 
Complex Bond angles / ° 
N^Pt^Cl 
Bond angles / ° 
C^Pt^Cl 
Bond angles / ° 
N^Pt^R 
Bond angles / ° 
C^Pt^R 
Bond angles  / ° 
CN^Pt^Cl 
PtL
1
ClCN 
R = CN 
88.46(8), 
84.46(8) 
87.00(9), 
88.37(9) 
95.42(12), 
96.22(12) 
92.84(13), 
87.48(13) 
175.63(2) 
PtCl2L
4
 
R = Cl 
92.32(12), 
91.10(12) 
91.20(15), 
88.44(15) 
88.32(12), 
88.90(12) 
88.88(15), 
90.92(13) 
179.36(5) 
 
Complex 
Bond 
lengths 
Pt–N1 
Bond 
lengths 
Pt–N2 
Bond  
lengths 
Pt–C1 
Bond  
lengths 
Pt–C2 
Bond  
lengths 
Pt–R 
Bond  
lengths 
Pt–Cl 
PtL
1
ClCN 
R = CN 
2.092(3) 2.094(3) 2.055(3) 2.058(3) 1.884(3) 2.371(9) 
PtL
4
Cl2 2.083(4) 2.093(4) 2.024(5) 2.032(5) 2.315(13) 2.329(12) 
R = Cl       
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 Photophysical Characterization 
 Absorption Spectroscopy at Room Temperature  
 Platinum(II) Complexes 
The absorbance spectrum of the uncomplexed ligand L
1
H2 was recorded in DCM 
solution at 298 K and compared with that of PtL
1
 (Figure 40). We observed a similarity 
between the peaks occurring in the region 230 nm-280 nm, indicating that bands occurring in 
this region of the complex absorption profile are due to ligand-localised 
1-* transitions. 
Lower intensity bands in the range 300 – 480 nm are observed in the spectrum of PtL1 but are 
absent in the ligand absorption, confirming that these bands arise upon ligand coordination to 
platinum. These bands are likely to include MLCT transitions and intraligand transitions, 
induced by the formal deprotonation of the two phenyl rings of the tetradentate ligand L
1
H2 
that accompanied metallation, and combinations of such transitions. 
  
Figure 40. Normalized UV-visible absorption spectra of L1H2 and PtL
1
 in DCM solution at 298 K 
The ground-state absorbance spectra of PtL
1
, PtL
4
, PtL
7
 and PtL
8
 in dichloromethane 
solution are shown in Figure 41. (Unfortunately, it was not possible to obtain absorption data 
for PtL
9
 owing to its very low solubility in all solvents). They all showed intense bands in the 
UV region between 230 and 330 nm assigned to the 
1-* transitions of the ligands.  A 
weaker set of bands are observed at lower energy extending into the visible region, assigned 
to metal-to-ligand charge transfer (MLCT). PtL
7
 and PtL
8
 showed significantly lower-energy 
MLCT bands than PtL
1
 and PtL
4
. DFT calculations previously made by Huo et al. predict 
that atoms of the aryl ring involving the C–Pt bond make a significant contribution to the 
HOMO, and a lesser contribution to the LUMO-based orbitals. Therefore, placing electron-
withdrawing aryl rings around this ring can be expected to have a greater stabilising effect on 
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the HOMO, and lead to a blue shift. Conversely, electron-releasing rings may be expected to 
destabilise the HOMO, leading to a red shift.  
 
Figure 41. UV-visible absorption spectra of PtL1, PtL4, PtL7 and PtL8 complexes in degassed DCM at 
298 K 
 
 Platinum(IV) Complexes 
 Comparison of the absorption spectra of the tetradentate Pt
II
L1 and Pt
IV
L
1
Cl showed 
that the absorption in the UV region had similar shape for both complexes (Figure 42). 
However, the lowest-energy absorption bands corresponding to the MLCT transitions 
observed in the Pt(II) complexes do not appear in the Pt(IV) analogues. This observation is 
consistent with the increase in the oxidation state of the metal, which should increase the 
energy associated with the MLCT transition, as it involves transient oxidation of the metal.  
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Figure 42. Normalized absorption spectra of PtL1, and PtL1ClCN complexes in DCM at 298 K  
 
 Emission Spectroscopy at Room Temperature 
Luminescence data for PtL
1
, PtL
4
, PtL
7
 and PtL
8
 are shown in Table 18. For all 
complexes, the emission spectra showed structured bands corresponding to the 
phosphorescence from a 
3
MLCT state (Figure 43). The emission of PtL
7
 (max = 557 nm) 
was red-shifted compared to PtL
1
 (max = 499 nm), because the benzothiophene unit is more 
electron-rich which raises the HOMO. In emission, the highest intensity vibrational band was 
typically the one of highest energy, which corresponds to the 0–0 vibrational origin of the T1 
to S0 transition. The bands at lower energy (and lower intensity) correspond to transitions to 
higher vibrational levels of the ground state. The shape and highly structured nature of the 
spectrum suggests that little geometric rearrangement occurs between the ground and excited 
states. The luminescence lifetimes were in the microsecond range with a significantly shorter 
lifetime for PtL
4
 probably due to an excimeric effect; deeper study of this phenomenon is 
required for confirmation (see Section 2.2.3). Quantum yields of luminescence were higher 
for PtL
1
 and PtL
7
 than for PtL
4
 and PtL
8
. The extended  conjugation of PtL4 and PtL8 may 
explain the decrease in the efficiency of such complexes.  
φ and 0 are related to the radiative and non-radiative rate constants of the excited state. 
Relations between these radiative and non-radiative constants are given by equations 1 and 2. 
 Thus, the larger φ of PtL7 but comparable 0 between the two complexes means that kr is 
larger and knr is smaller for PtL
7
, and this complex is a more efficient emitter (values for kr 
and knr are given in Table 17).  
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Equations 1: φ and 0 are related to the radiative constant (kr). Equations 2: Relations between radiative and 
non-radiative constants. 
 
Platinum(IV) complexes PtL
2
Cl2 and PtL
3
Cl2 displayed undetectable luminescence at 
room temperature (see Section 2.2.3). 
 
Table 17. Radiative and non-radiative constants (kr and knr) for PtL
4
, PtL
4
, PtL
7 
and PtL
8
 complexes 
Complex kr / s
–1
 knr  / s
–1
 
PtL
1
 9.4 x 104 1.2 x 105 
PtL
4
 2.0 x 103 1.5 x 104 
PtL
7
 4.9 x 104 1.8 x 104 
PtL
8
 6.8 x 103 1.6 x 104 
 
 
Figure 43. Normalized phosphorescence emission spectra of PtL1, PtL4, PtL7 and PtL8 complexes in 
degassed DCM at 298 K 
 
 Excimeric Emission  
An excimeric emission was observed for PtL
4
 at lower energy than the monomeric 
emission. This effect can be seen in Figure 44; the emission profile of a dilute sample 
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(degassed DCM at 298 K) was compared to emission profiles of solutions of increasing 
concentration. As the concentration was increased, the broad structureless excimeric emission 
grew in at lower energy at the expense of the monomeric emission. The overall colour of light 
observed depended on the ratio of the monomeric-to-excimeric emission, hence colour can be 
controlled simply by controlling concentration.  
 
Figure 44.  Emission spectra of various concentrations of PtL4 in degassed DCM at 298 K. Note the 
increasing contribution from excimer emission with increasing concentration  
 
 Low Temperature Spectroscopy 
 Platinum(II) Complexes  
All the emission spectra at 77 K were recorded in a mixed solvent mix comprised of 
ether/isopentane/ethanol (2:2:1 v/v). This mixture forms an inert transparent glass at 77 K, 
which allows efficient and reproducible excitation of the solution and transmission of the 
signal to the detector. The emission spectra at 77 K were more structured than those obtained 
at 298 K (Figure 45).  A small blue shift of the emission was observed for PtL
1
, PtL
4
 and 
PtL
7
 at 77 K compared to 298 K (em = 7, 5 and 6 nm respectively). The larger Stokes shift 
(6522 cm
-1
) between the emission (in the glass solution at 77 K) and absorption spectra of 
PtL
7
 when compared to that (6825 cm
-1
) of the Pt(II) counterpart at 298 K is attributed to the 
more extensive excited state distortion in the former than in the latter complexes. 
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Figure 45. Normalized phosphorescence emission spectra of PtL1, PtL3Cl2, PtL
4
, PtL
7
 and PtL
8
 
complexes in EPA solution at 77 K 
 
 Platinum(IV) Complexes 
Platinum IV complexes are known to show luminescent properties at room 
temperature.
54,62,63
 However, PtL
3
Cl2 (IV) was only emissive at 77 K (there was no emission 
at 298 K),with max = 543 nm and a long lifetime ( = 319 ms). The metal-centred orbitals 
were contracted and interacted less with the ligand orbitals which involve a higher 
3
LC 
contribution and a lower MLCT contribution. Chloride is a weak-field ligand, and the ligand 
field splitting is apparently insufficient to allow emission to be observed at room temperature.  
 
 
Figure 46. Phosphorescence  spectrum of PtL3Cl2 in EPA glass at 77 K 
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Table 18. Photophysical data of Pt(II) and Pt(IV) complexes in degassed DCM and EPA solution at 298 K and 77 K. 
(a)
 data collected in DCM at 298 K. 
(b) 
data collected in EPA solution at 77 K. 
(c)
 [Ru(bpy)3]
2+
 was used as 
reference for the calculation of the quantum yield 
Complex absnm /10
3
 L mol
–1
cm
-
1
)
(a)
 
em / nm
(a)
 
 
em / nm
(b)
 
 
 / s 
(a) 
 / s 
(b) 

(a)(c) 
PtL
1
 272 (72.4), 289 (57.5), 
323 (34.6), 337 (38.9),  
363 (24.5), 399 (7.58) 
 
506, 541, 
588 (sh) 
499, 512, 
524, 541, 572 
8.3 12 0.78 
PtL
2
Cl2 260 (66.0), 347 (28.8), 
366 (20.8) 
 
- - - - - 
PtL
3
Cl2 237 (186.2), 270 (93.3), 
365 (66.0) 
 
- 543, 586, 
636, 693 
- 319 - 
PtL
4
 257 (75.9), 309 (38.9), 
349 (25.9), 397 (6.37) 
 
535, 580 530,543, 575, 
623, 678 
60 351 0.12 
PtL
7
 252 (45.7), 283 (74.1), 325 
(38.9), 359 (34.6), 378 
(40.7), 424 (6.7), 468 (3.8) 
 
579, 599, 
706 (sh) 
559, 585, 
598, 616, 
628, 651, 685 
15 17 0.74 
PtL
8
 358, 383, 443 635 623, 684, 756 5.9 12 0.04 
 
2.3. Synthesis and Characterization of Palladium Complexes 
We have shown that cyclometallated tetradentate platinum complexes have interesting 
photophysical properties. They showed long lifetimes and high quantum yields of 
luminescence. In contrast, luminescent palladium complexes are not well-known in the 
literature. Only a few examples of phosphorescent palladium(II) complexes containing non-
porphyrin ligands have been reported. Thus we sought to synthesize cyclometallated 
palladium(II) complexes of the tetradentate ligands of Section 2.2.2., with a view to obtaining 
molecular materials that are emissive at room temperature. 
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2.3.1. Synthesis of the tetradentate palladium complexes 
The palladium(II) complexes of ligands L
1
H2, L
7
H2, L
6
H2 and L
9
H2 were obtained upon 
reaction of the proligands with Pd(OAc)2 (1.2 equiv.) in refluxing acetic acid for 48 h. 
(Scheme 14). A precipitate appeared after 12 h but a reaction time of 48 h is necessary to 
have the tetradentate palladium complex (see Section 2.2.2.). Up to now, all the other ligands 
were not tested for the metallation to the palladium. 
 
 
 
 
Scheme 14. Synthesis of palladium(II) complexes, PdL7, PdL1, PdL6 and PdL9 
The same reaction was attempted using proligand L
5
H2 (Scheme 15). However, the 
final product did not appear as the expected palladium complex but as a cluster containing 
two palladium atoms.  A Pd–Pd bond is supported by acetate and chloride bridges. The 
molecule contains two ligands which were each coordinated through one pyridyl nitrogen and 
one carbon (C
3
) of the other pyridyl ring.  Apparently, the position 3 of the pyridyl ring is 
more reactive than the position f of the 3,5-bis(trifluoromethyl)benzene ring. The presence of 
the bulky and electron-withdrawing CF3 unit on the position “e” evidently decreases the 
reactivity of the position “f” of the phenyl ring.  This observation is consistent with the 
formation of the purely organic compound 3 upon reaction of the same proligand with 
K2PtCl4, where oxidative coupling of the C
3
 positions of the two pyridyl rings has occurred 
(see Section 2.2.2 above).   
 
PdL
6
 PdL
1
 PdL
7
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9
 
117 
 
 
Scheme 15. Reaction between L5H2 and Pd(OAc)2  leading to the Pd2 cluster 
2.3.2. Characterization of the Pd(II) complexes 
 NMR spectroscopy 
The 
1
H NMR spectra of the palladium(II) complexes were similar to their platinum(II) 
analogues. We shall take the case of PdL
7
 as an example. The presence of seven aromatic 
signals and the strong shielding of H
3
 due to the aromatic ring current of the phenyl ring are 
characteristic of a tetradentate metal complex. a shielding of the aromatic signals was 
observed when the metal changed from Pd  Pt. As an example, all signals in the aromatic 
region for PdL
7
 were shielded compared to its platinum analogue ( was 0.2 ppm). Szłyk et 
al. observed the same weak effect of the metal atom with the analysis of cis-Pt(ppy)2Cl2 and 
cis-Pd(ppy)2Cl2 by NMR spectroscopy.
64
  
 
Figure 47. 1H NMR spectra of PtL7 in blue (top) and of PdL7 in red (bottom), both recorded at 700 MHz 
in CD2Cl2 at 298 K 
 Crystal Structures 
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Crystal structures of PdL
1
, PdL
7
 and PdL
9
 were obtained by slow diffusion of DCM 
into a DMF solution of the complex and PdL
6
 was obtained by recrystallization in acetone. 
The molecular structures of PdL
1
, PdL
7
 and  PtL
9
 were determined by single crystal 
X-ray diffraction analysis at 120 K, which confirmed the tetradentate coordination structure 
(Figure 48). Selected bond lengths and angles are listed in Table 19.  
In all cases, the Pt–N bond lengths were slightly longer than the cyclometallated Pt–C 
bond lengths. For example, for PdL
7
, Pd–N and Pd–C bond lengths were approximatively 
2.05 and 2.00 Å respectively. Furthermore, the average of the bond lengths of all complexes 
(~ 2.00 Å) was very close to that reported for their platinum analogues PtL
1
 and PtL
7
. A 
similar observation was made for the torsion angles (Table 20): Pt(II) and Pd(II) complexes 
adopted the same torsion angle (plan MCCN) with a quasi-planarity for PdL
7
 (3.03 °, for 
PtL
7
 torsion = 3.23 °). The distortion between the two planes of PdL
1
 seemed to be similar to 
PdL
6
.  
 
All these four complexes adopt a quasi-square planar geometry with N–Pd–C angles 
around 170 - 175°. Compared to the tetradentate palladium(II) complexes synthesised by Che 
et al., where N^Pd^C angles of 160.14° to 162.09° were encountered, the current series of 
complexes are closer to planarity.  
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Table 19. Selected bond lengths (Å) and angles (°) of the Pd (II) complexes (All structures were acquired at 120 K). 
Corresponding data for PtL
1
 and PtL
7
 are listed for comparison 
Complex Bond angles 
/ ° 
N
1
^M^N
2
 
Bond angles 
/ ° 
C
1
^M^C
2
 
Bond angles 
/ ° 
N
1
^M^C
1
 
Bond angles 
/ ° 
N
1
^M^C
2
 
Bond angles 
/ ° 
N
2
^M^C
2
 
Bond angles 
/ ° 
N
2
^M^C
1
 
PdL
1
 91.85 102.33 83.06 169.86 82.91 174.72 
PdL
6
 92.62 102.50 82.47 170.51 82.59 174.63 
PdL
7
 91.85 101.33 83.96 174.68 83.67 172.82 
PdL
9
 89.00 103.33 83.77 171.92 83.85 174.93 
       
PtL
1
 92.97 103.51 81.89 170.33 81.78 174.33 
PtL
7
 92.44 102.56 82.66 174.73 82.35 175.04 
 
Complex Bond lengths 
M–N1 
Bond lengths 
M–N2 
Bond lengths 
M–C1 
Bond lengths 
M–C2 
PdL
1
 2.052 2.058 1.983 1.987 
PdL
6
 2.035 2.047 1.997 1.996 
PdL
7
 2.052 2.058 1.983 1.987 
PdL
9
 2.053 2.054 2.010 2.008 
     
PtL
1
 2.041 2.046 2.001 2.001 
PtL
7
 2.054 2.058 2.006 1.995 
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Figure 48. Molecular structures of PdL1, PdL6, PdL7 and PdL9 viewed at various orientations  
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Table 20. Torsion angles between the two C^N parts of the palladium complex for PdL1, PdL6, PdL7 and PdL9. The 
torsion is measured as the angle between the planes of the two 5 membered rings (PdCCCN) 
Complex PdL
1
 PdL
6
 PdL
7
 PdL
9
 
Torsion angle 
(°) 
16.31 15.41 3.03 7.08 
 
All palladium(II) complexes showed head-to-tail crystal packing (Figure 49). They all 
showed weak stacking or - interactions between molecules, similar to the crystal packing of 
the previous tetradentate platinum(II) complexes. 
 
 
Figure 49. Crystal packing of PdL1 (left) and PdL6 (right) 
PdCl2(L
1
H2) was obtained by the reaction of L
1
H2 and Pd(OAc)2 in acetic acid for 12 
h. The precipitate formed was then recrystallized by slow evaporation from chloroform. The 
X-ray crystal structure of PdCl2(L
1
H2) provides an indication of the mechanism of the 
reaction and how the metal initially binds to the ligand (Figure 50).  
 
                                              
Figure 50. Representation of Pd(L1H2)Cl2 and its molecular structure  
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 Photophysical Characterization 
 Absorption Spectroscopy at Room temperature  
The ground state absorbance spectra of PdL
1
, PdL
6
 and PdL
7
 in dichloromethane 
solution are shown in Figure 51 (summarized in Table 21). Each complex showed intense 
bands in the near UV region between 230 and 300 nm corresponding to the 
1-* transitions 
of the ligands. These are accompanied by a series of weaker, lower energy features extending 
to the visible region, assigned to the 
1
MLCT bands. PdL
7
 showed significantly lower energy 
1
MLCT bands than those for PdL
1
. This is attributed to the more electron rich nature of the 
thiophene compare to the phenyl ring. The MLCT transitions of the fluorinated PdL
6
 complex 
were blue-shifted with respect to the two other complexes, due to stabilization of the HOMO 
as a result of the electron-withdrawing nature of the fluorine substituents.  
The complex PdL
7
 exhibited intense absorption bands at 230-370 nm ( = 2 × 104 L 
mol
-1
 cm
-1
), and moderately intense absorption bands at 375-430 nm ( = 1 × 104 L mol-1 cm-
1
). The absorption bands at 230-375 nm resembled those of the corresponding ligand, 
attributed to -* transitions.  
 
Figure 51. Normalized UV-visible absorption spectra of PdL1, PdL6 and PdL7 complexes in DCM at 
298K 
 
The comparison between L
1
H2, PdL
1
 and PdL
1
H2Cl2 in DCM at 298 K (Figure 52) 
showed that the cyclometallation had an effect on the absorption properties. In fact, the 
palladium complex PdCl2L
1
H2 was only coordinated by the two nitrogens of the pyridine 
rings, and its absorption spectrum resembled that of the free ligand L
1
H2.  
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Figure 52. Normalized absorption spectra of L1H2, PdL
1
 and PdCl2L
1
 in DCM at 298 K  
 
 Emission Spectroscopy at room temperature 
PdL
1
, PdL
6 
and PdL
7
 are emissive at 298 K. In contrast, L
6 
is a weak field ligand in 
PdL
6 
which involved a weak emission from the complex at room temperature ( = 0.0002). 
PdL
9
 was impossible to solubilize, as was found for its platinum analogue.
65
 The emission 
was at lower energy for PdL
1
 ( = 485 nm) compared to PdL7 ( = 553 nm) due to the more 
electron rich thienyl group of PdL
7
. Furthermore, PdL
1
 was less emissive than PdL
7
 (φ = 
0.012 and 0.15 respectively) and had a shorter lifetime (1.1 s and 180 s, respectively). 
 
Figure 53. Normalized luminescent emission spectra of PdL1 and PdL7 complexes in degassed DCM at 
298 K, following excitation into the lowest energy absorption band 
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Table 21. Photophysical data for PdL1, PdL6 and PdL7 complexes in degassed DCM (a) and EPA solution (b) at 298 
K and 77 K (c) 
Complex absnm /10
3
 L mol
-1
 cm
-1
) em
(a)
 
nm 
 (a) 
 s 
(a) em 
(b)
 
 nm 
 (b) 
 s 
PdL
7
 233 (30.8), 279 (22.1), 325 
(22.1), 342 (20.1), 364 
(15.0), 386 (9.7), 407 (9.4) 
553, 572, 
600, 652 
180 [c] 0.15 547, 566, 
592, 611, 
644 
350 
PdL
1
 256 (49.2), 350 (8.0),  
451 (0.8) 
485, 
520,550 
1.1 [314] 0.012 479, 515, 
553, 596, 
653 
350 
PdL
6
 241 (5.2), 276 (3.5), 
311(1.5), 345 (1.4),  
365 (1.4) 
475, 517, 
555, 597 
76 [70] 0.0002 465, 500, 
539, 580 
640 
 
 
 Low Temperature Spectroscopy 
All the emission spectra at 77 K were recorded in an EPA glass. Data are reported in 
Table 21. All complexes emitted at 77 K and showed structured bands (Figure 54). PdL
6
 
showed an emission at em = 465 nm. This is attributed to the decrease of non-radiative effects 
(knr) at low temperature.
66
 The emission spectrum of PdL
6
 was blue shifted compared to those 
for the complexes PdL
1
 and PdL
7
. This was due to the weak field ancillary fluorinated ligand. 
The lifetimes of the PdL
1
, PdL
6 
and PdL
7
 complexes are longer at 77 K than at 298 K.  
  
Figure 54. Normalized luminescence spectra of PdL1, PdL6 and PdL7 complexes in an EPA glass at 77 K  
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 Comparison Between Platinum(II) and Palladium(II) Complexes 
Comparison of the photophysical properties of the tetradentate Pt(II) and Pd(II) 
complexes showed that a lower absorption band maximum at abs > 430 nm was observed for 
PtL
7
 (Figure 55). In fact, the 4d orbitals of palladium(II) systems are lower in energy than the 
5d orbitals of their platinum(II) analogues: the higher energy absorption maxima are 
indicative of MLCT character in the excited states.
67
 Despite similarly high molar absorption 
coeﬃcients, the absorption bands in the UV region were much broader in the case of PdL7 
complex. The emission bands had similar shapes for both complexes. Regarding the 
luminescence properties, the phosphorescence quantum yields of the PtL
7
 were signiﬁcantly 
higher and the decay lifetimes shorter than for PdL
7
.  In fact, the higher ISC and better orbital 
match occuring in platinum(II) complexes will lead to a larger radiative constant (kr) hence to 
shorter lifetime and higher quantum yield of luminescence. 
 
 
Figure 55. Normalized absorption and emission spectra for the PtL7 and PdL7 complexes in degassed 
DCM at 298 K 
 
2.4. C^N^N^C Gold, Mercury and Iridium Complexes 
2.4.1. Mercuric complex 
The formation of a cyclometallated gold complex bearing a tetradentate ligand has 
often required the synthesis of a mercuric complex as a precursor.
68,69,70,71
 Transmetallation 
from the mercuric complex to the gold is easier than the direct reaction between the ligand 
and inorganic gold salts such as KAuCl4. Wenger et al. proposed a way to synthesize a 
cyclometallated tetradentate mercuric precursor (HgL) by heating the cyclometallated 
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tridentate ligand with Hg(OAc)2 in EtOH at reflux for 3 days.
72
 Adopting these conditions for 
the present case, when only a 1:1 ratio of mercuric reagent and ligand were reacted, the 
reaction after 24 h was not complete. The 
1
H NMR spectrum of the mixture showed an 
exchange between the free ligand and the expected mercuric compound. We slightly changed 
the procedure. An excess of Hg(OAc)2 (5 eq) was added to a mixture of L
7
H2 dissolved in 
EtOH. The reaction time was reduced to 24 h (Scheme 16). A yellow precipitate was formed 
after 1 h of reaction at 78 °C. The NMR and mass spectra proved the formation of the 
mercuric complex. 
 
Scheme 16. Synthesis of HgL7 mercuric complex 
 
2.4.2. Gold Complex 
The trans-metallation between the mercuric complex and KAuCl4 gave a final impure 
product, which may correspond to the tetradentate Au(III) complex. Stoichiometric amounts 
of the mercuric precursor and KAuCl4 were stirred in acetonitrile at reflux for 12 h in the 
absence of light (Scheme 17). The 
1
H NMR in DMSO-d6 recorded at 400 MHz of the 
resulting product, did not fit with the mercuric complex or the free ligand and it showed a 
shifted proton at 6.35 ppm, which may correspond to the proton of the pyridyl ring. Further 
studies are required to provide definitive identification of the product obtained (Figure 56). 
 
Scheme 17. Attempted synthesis of [AuL7] gold (III) complex 
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Figure 56. 1H NMR spectrum of AuL7 recorded at 400 MHz in DMSO-d6 at 298 K 
 
 
 Concluding Remarks 3.
 
Huo et al. have performed DFT calculations on the parent platinum complex, PtL
1
 
(Section 3.2). The calculations predict that the HOMO-based orbitals are localised along the 
platinum centre and the ancillary ligand, and the LUMO-based orbitals are mainly localised 
on the pyridyl rings. Using this as a starting point, rational structure modification has been 
employed to prepare complexes with tuneable emission.  
On considering the tetradentate ligand, we realised that functionalisation of the phenyl ring 
should alter the energy of the HOMO-based orbitals more significantly than the LUMO-based 
orbitals. A series of Pt(II) complexes were synthesized and characterized. 
All the Pt(II) complexes were emissive from DCM solution at 298 K, with quantum yields 
reaching as high as 0.78. The quantum yields of these complexes were found to be 
significantly higher than complexes involving analogous bidentate ligands, highlighting the 
importance of the extra rigidity conferred by the tetradentate system. PtL
1
 and PtL
7
 
complexes show the best photophysical properties as they emit at low energy (PtL
1em = 506 
nm and PtL
7
 em = 579 nm) with a high quantum yield (0.78 for PtL
1
 and
 
0.74 for PtL
7
). By 
increasing the -conjugating system, (PtL4 and PtL8), we observed an emission into the lower 
energy compared to the emission of PtL
1
 and PtL
7
. On the other hand, the quantum yield of 
luminescence decreased (from 0.78 for PtL
1
 to 0.12 for PtL
4
). The deviation from planarity 
observed by X-ray diffraction for PtL
4
 may explain the decreased of the efficiency.  
Palladium(II) complexes containing a cyclometallated tetradentate C^N^N^C ligand 
systems, PdL
1
, PdL
6
, PdL
7
 and PdL
9
 complexes, have been synthesised and characterized. 
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Photophysical properties of PdL
1
, PdL
6 
and PdL
7
 display phosphorescence emission at 298 
K emission with quantum yields 0.012, 0.0002 and 0.15 respectively. Their more rigid ligand 
scaffold which avoid the excited-state distortions efficiently. The lower radiative decay rate of 
palladium(II) complexes relative to platinum(II) complexes is explained as the heavy atom 
Pd(II)/Pt(II) in promoting radiative decay of the triplet state. 
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 Introduction  1.
 Luminescent probes are crucial tools in cell biology, physiology, and related areas of 
the biomedical sciences. They can be utilised for the sensitive detection of species in vitro and 
in vivo and for the visualisation of intracellular structure, functions and tissue sections. 
To date, most imaging agents are fluorescent organic compounds due to their intense 
emission and high color tunability.
1,2
 Such compounds generally work well for conventional 
intensity-based imaging.  A newer method of imaging is based on measuring the lifetimes at 
all points in the image, known as fluorescence lifetime imaging microscopy or FLIM.  
Lifetimes can provide additional information about the local environment of fluorescent 
molecules, for example, not available through intensities alone.  However, as fluorescence has 
a lifetime typically in the range of nanoseconds, the studies of such small changes in lifetime 
involve sophisticated set-ups. Sub-nanosecond light sources and fast detectors are required. A 
further limitation of using fluorescence is that the natural fluorescence of endogenous 
biomolecules leads to interference in the image. This so-called autofluorescence becomes 
increasingly problematic as one goes from single cells to multicellular samples and 
particularly tissue sections.   
 In combating these limitations, it is of interest to incorporate a heavy metal atom (e.g. 
Ru, Rh Ir, Pt…) into the organic molecule in order to facilitate the analysis. Heavy metal 
complexes, thanks to the effect of spin-orbit coupling and fast intersystem crossing (ISC), 
may show a luminescence lifetime in the microsecond timescale.
3
 The figure below shows 
how the luminescence of a long-lived probe can be detected without interference from 
fluorescent molecules (Figure 1).
4,5
 As an example, in a cell containing a phosphorescent 
metal complex probe, the background fluorescence of the cell displays a shorter lifetime than 
the complex. The distinction between the two types of emission is facilitated as the intensity 
of the fluorescence decreases faster than that of the phosphorescent probe. A delay can be set 
between excitation and detection, during which the fluorescence decays to negligible values. 
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 Illustrating the concept of time-resolved imaging and time-gated removal of background Figure 1.
fluorescence 
5
 
Lanthanide complexes are also used as bio-imaging probes.
6,7,8,9
 They show interesting 
photophysical properties such as a large Stokes shifts and narrow emission bands, a long 
emission lifetime and a good chemical stability profile. However, lanthanide ions are toxic, so 
a high complex stability is required by the synthesis of complexes bearing macrocyclic 
ligands. Another disadvantage is that the direct excitation of the lanthanide is very inefficient 
( < 1), so the incorporation of a sensitising chromophore is needed to absorb and transfer the 
energy to the lanthanide.  
In the last decade, heavy metal complexes have been used as biosensor reagents.
10,11
 
Luminescent transition metal complexes are attractive candidates because of their intense, 
long-lived, and environment-sensitive emission with large Stokes shifts.  In fact, they have 
been utilized to determine the concentration of substances and other parameters of biological 
interest (recognition of DNA or RNA, oxygen, cations, amino acids, sugar levels in cells and 
tissues).
12,13,14,15
 Cyclometallated heavy metal complexes are often luminescent and show 
good stability; such complexes are often used in OLEDs but have only recently started to 
attract interest as luminescent sensors.
16,17,5
  
In the present chapter, I will first introduce and briefly survey different applications of 
such complexes as biosensors. In the second part, I will present and discuss the synthesis, 
photophysical and bio-imaging studies of iridium complexes whose emission is modulated by 
acid or base and which thus have potential as sensory systems for pH and, by extension, other 
species such as metal ions. 
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1.1. Sensors for Amino Acids and Sugar Molecules  
Thiols play important roles in biological systems. Cysteine (Cys) and homocysteine 
(Hcy) are mercapto biomolecules that play crucial roles in maintaining biological systems.
18
 
For example, Cys deﬁciency is involved in many syndromes including slow growth in 
children and liver damage. At elevated levels in plasma, Hcy is a risk factor for Alzheimer’s 
or cardiovascular diseases.
19
 
An off-on ruthenium complex was synthesized by Zhao et al. to detect the presence of 
sulfhydryl-containing compounds (Figure 2).
20
 On itself, the ruthenium complex is not 
emissive due to an electron transfer (ET) from the ruthenium to the 2,4-dinitro-
benzenesulfonyl (DNBS) acceptor unit via PET (photoinduced electron transfer). The 
cleavage of the DNBS unit by a thiolate compound leads to the phosphorescence of the 
ruthenium complex. 
 
 Excitation response of an off-on ruthenium complex20 Figure 2.
Sugars are one of the most important energy sources for cells and organisms. As an 
example, the main energy source of the brain is glucose. To detect these sugars in cells, a 
series of cationic iridium complexes were synthesized as phosphorescent labelling reagents 
for reducing sugars.
21,22,23
 Lo et al. have developed cyclometalated iridium(III) bipyridine 
complexes containing an N-methylamino-oxy group to allow reducing sugars to be detected. 
During this reduction process, the cationic iridium complex exhibits emission (Figure 3).
24
 
The amino-oxy group reacts with the reducing part of glucose, galactose, lactose, and maltose 
to increase the quantum yield of the luminescence. In fact, the emission of the non-conjugated 
iridium complex displays a quantum yield of 0.42. The reaction of the iridium complex with 
-galactose, -galactose,  -lactose and  -maltose will increase the quantum yield to 0.80, 
0.80, 0.81 and 0.83 respectively. 
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 Iridium complexes for detection of reducing sugars 24 Figure 3.
 
1.2. DNA / RNA sensors 
The majority of DNA/RNA sensors are metallointercalators. Intercalation was first 
proposed by L. S. Lerman and is defined as non-covalent insertion between base pairs.
25
 The 
intercalator is usually a planar unit, typically an aromatic ring or polyaromatic, which can 
bind to the DNA/RNA (Figure 4).
26
  
 
 Metallointercalator introduced in DNA 26 Figure 4.
Simple iridium(III) complexes present an essentially spherical exterior, owing to the 
six-coordinate d
6
 configuration of the metal.  A more extended ligand protruding out from the 
core of the complex will thus be required for intercalation to occur.  An example of an 
intercalating iridium complex was demonstrated by Lo and co-workers (Figure 5). Three 
cyclometallated iridium(III) dipyridoquinoxaline complexes were synthesized and studied as 
metallointercalators for DNA.
27
 Upon the addition of DNA or the protein bovine serum 
albumin (BSA) in aqueous solution, the emission of the complexes increases. The 
enhancement effect of BSA arises from the binding of the complex to hydrophobic pockets  in 
the protein, which reduces non-radiative decay processes.  
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 Metallointercalator iridium complexes 27 Figure 5.
 
1.3. Cation Sensors 
The monitoring of bio-agent concentration in biological species is an important key to 
observing and understanding biological mechanisms. Zn
2+
 and Cu
2+
 are abundant elements in 
the human body; their concentrations play an important role in many cellular processes. For 
example a high level of Zn
2+
 is cytotoxic and may lead to skin diseases, diabetes, etc. Copper 
ions are important for the regulation of the human nervous system. To monitor the 
concentration of such cations in vivo, dipicolylamine can be used as an ion recognition unit  in 
conjunction with an amine electron donor which quenches the luminescence of the free probes 
through a PET process.
28,29,30
 
 
DPA 
 Representation of DPA molecule Figure 6.
A series of cyclometallated iridium(III) complexes were synthesized as sensors for Zn
2+
 by Lo 
et al. (Figure 7).
31
 In the presence of Zn
2+
, they observed an enhancement of the 
phosphorescence emission and the luminescence lifetime of the iridium complexes thanks to 
the coordination of the metal to the DPA unit.  
 
 Zn2+ iridium complexes sensor 31 Figure 7.
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In 2014, Nam et al. studied a series of phosphorescent cyclometalated iridium(III) 
complexes containing phenanthroline ancillary ligand as biosensor.
32
 Metal-chelating 
receptors can readily be introduced into the ligand peripheries of the iridium(III) complexes to 
create phosphorescence sensors for detection of zinc, cupric, and chromium ions. Alterations 
in the structures of the C^N ligands produce varying extents of phosphorescence responses to 
metal ions. Mechanistic investigations establish that a nonradiative PET process is dominantly 
responsible for phosphorescence modulation. It is suggested that phosphorescence turn-on 
might result from the effective suppression of a non-radiative ILCT transition. The zinc probe 
based on the cyclometalated iridium(III) complex is cell-permeable when added to the culture 
media and is localized within the mitochondria of HeLa cells. The zinc-ion-sensing utility has 
been verified by carrying out phosphorescent visualization of intracellular zinc ions in 
mammalian cells.  
 
 Cationic iridium complexes used as biosensors 32 Figure 8.
  
1.4. Intracellular pH sensors 
Intracellular pH measurements provide important diagnostic information because a 
small deviation of the pH value may lead to cardiopulmonary and neurological diseases such 
as Alzheimer’s disease, or may be associated with the formation of solid tumours. Cancer 
cells tend to be hypoxic which in turn leads to a lower pH.  Luminescent pH sensors are 
attractive as pH probes due to their high sensitivity and convenience as well as the relatively 
non-invasive nature of fluorescence microscopy. 
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Excitation and emission profiles in the infrared and near infrared show better tissue 
penetration than UV, blue and green, which have a poor tissue penetration and (especially in 
the case of UV) may cause damage. 
A water-soluble alkynylplatinum(II) terpyridine complex was synthesized and studied 
by Yam and co-workers (Figure 9).
33
 They observed that the emission intensity can be 
modulated by the pH and the temperature (Figure 10). 
   
 Alkynylplatinum(II) terpyridine complex 33 Figure 9.
 
In fact, they showed a pH-dependence of the complex’s structure. For the complex in 
aqueous solution (50 mM NaCl) at 20˚C, the emission intensity in the NIR region remains 
relatively unchanged over the range from pH 3.5 to pH 5.6. The formation of aggregate 
explained the emission in the complex at lower pH. However, at pH above 5.6, the NIR 
emission shows a significant drop in intensity and becomes completely “turned-off” at or 
above pH 7.6 via PET. The decrease in the NIR emission intensity has been associated with 
the deprotonation of the phenolic protons of the complex. It is likely that the deprotonation 
leads to an increase in the hydrophilicity of the complex causing de-aggregation of the 
complex and hence a drop in its 
3
MMLCT emission intensity. A temperature dependence of 
the complex’s emission properties was also observed. At pH = 4, when the temperature was 
increased (from 10 °C to 80 °C), the emission intensity at 795 nm decreased. Below 50 °C, 
the de-aggregation of the complex and the increase of the non-radiative decay at high 
temperature gave rise to a significant decrease in the low-energy emission.  
The NIR emission of the complex will be “off” at physiological pH (7.0-7.4) but will 
be “on” upon small changes of pH below 7, for example in tumour cells. The temperature 
below 50 °C will have no effect on the NIR emission; the aggregation of the complex 
moieties is negligible. A small change in physiological temperature would not have any 
interference on the detection of pH by the NIR emission spectral responses of the complex.  
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 Left: Variation of the emission intensity of the complex shown in Figure 9, at 795 nm, as a Figure 10.
function of pH.  Right: emission spectra of the complex over the range of pH values indicated.  The 
complex was at a concentration of 200 M in 50 mM NaCl at 20 ˚C.33 
 
Another example of a pH sensor was demonstrated in the laboratory at Durham. Two 
iridium complexes based on a pyridyl-benzimidazole (pybz and pybzH) were synthesized and 
studied (Figure 11).
34
 The cationic and the neutral forms of the iridium complexes were 
obtained using two different synthetic methods. The photophysical properties of the neutral 
and the cationic complexes are different (Table 1). Indeed, the cationic complex shows a red-
shift of the emission wavelength compared to the neutral complex (max = 590 and 521 nm 
respectively). A pH titration in aqueous solution (DMSO / water 1:1) shows that a decrease of 
the intensity at 590 nm was observed after pH ≥ 5.6 (Figure 12).  The introduction of the 
complex in the ovary cell of a hamster shows its localization in the lysosome. In co-staining 
experiments with a fluorescent nuclear stain (Hoechst 33342), image acquisition with no time 
delay shows only nuclear fluorescence associated with the fluorescent stain, whereas a short 
delay (10 ns) before image acquisition gives images with strong phosphorescence from 
cytoplasmic structures instead of the nucleus.  
  
                  
 Neutral (left) and cationic (right) forms of pyridylbenzimidazole iridium complexes 34 Figure 11.
 
Ir(ppy)2(pbz) [Ir(ppy)2(pbzH)]PF6 
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Table 1. Photophysical data of Ir(ppy)2(pbz) and [Ir(ppy)2(pbzH)]
+
 in degassed DCM at 298 K 
34
 
 Ir(ppy)2(pbz) [Ir(ppy)2(pbzH)]PF6
 
 
Absorption 
max(nm) ( (L mol
-1
cm
-1
)) 
340 (33100), 433 (5140), 
476 (1270) 
320 (30100), 380 (8670), 
418 (4170), 470 (1100) 
Emission max (nm) 496, 521 590 
Quantum yield lum 0.48 0.22 
Lifetime (ns) 3200 (100) 840 (210) 
 
 
 Titration of the neutral iridium complex Ir(ppy)2(pbz) (left) and the comparison of the Figure 12.
emission from inside a CHO cell with the emission of the neutral (1) and cationic (2)  iridium complexes in 
solution.
34
 
 
1.5. Objectives 
New iridium complexes incorporating a bis-benzimidazole ligand (bbz) as potential 
phosphorescent reagents for bio-imaging will be report. In this case, three different forms may 
be anticipated in principle, namely a cationic, a neutral and an anionic form, according to the 
protonation state of the azole nitrogen atoms (Figure 13). 
144 
 
 
 Protonation and deprotonation of iridium complex Figure 13.
  A related series of isomeric complexes containing isoquinolyl-benzimidazoles (L
10
H, 
L
11
H, L
12
H) will also be describe. The introduction of iso-quinolyl units leads to a red-shift in 
the emission compared to the pyridyl analogue, although the properties are dependent on the 
isomeric form.  The complexes display pH-dependent absorption and emission properties.   
 
 (Iso)-quinoline and bromo-pyridyl neutral and cationic iridium complexes Figure 14.
 
 
 
 
 
Cationic complexes  Neutral complexes  
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  Synthesis and Characterizations 2.
2.1. Preparation of the ligands/proligands 
2.1.1. Benzimidazole derivatives 
Benzimidazol-(iso)quinolyl derivatives L
10
H, L
11
H, L
12
H and bromo-
pyridylbenzimidazole L
13
H were prepared using the Leavitt benzimidazole condensation 
(Scheme 1).
35
 The reaction between o-phenylenediamine and the appropriate carboxylic acid 
was performed at 150 °C in polyphosphoric acid (PPA). It consists of the formation of the 
amide followed by the acid catalyzed-cyclisation thanks to the PPA.
36
 Reactions gave the 
organic compounds L
10
H, L
11
H, L
12
H and L
13
H in 85 to 88 % yields. 
 
 
 
                   L
10
H                          L
11
H                         L
12
H                     L
13
H 
Scheme 1. Synthesis of benzimidazole derivatives via condensation 
2.1.2. Bis-benzimidazole derivatives 
 
 
                                                             L
14
H2 
Scheme 2. Synthesis of 2,2′- bis-benzimidazole via condensation 
The synthesis of 2,2′-bis-benzimidazole L14H2 was carried out by reaction of 1,2-
benzenediamine with hexachloropropanone in ethyleneglycol at 0 °C (Scheme 2). A 
mechanism proposed by Meakins et al. was described as the formation of the amide followed 
by the condensation between the amine and the amide.
37
 The product was dried under reduced 
pressure to give a white solid in 53 % yield.  The dimethylated derivative L
15
 was also 
prepared. The methylation of the two azole rings was performed using the same procedure as 
Huang et al. (Scheme 3),38 giving the product as a white solid in 75 % yield. 
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                                                               L
15
 
Scheme 3. Synthesis of 1,1′-dimethyl-2,2′- bis-benzimidazole from L15 
 
2.2. Preparation of the complexes 
All the complexes were synthesized by the reaction of the well-known “iridium dimer” 
[Ir(ppy)2(-Cl)]2 with the appropriate organic compound L
10
H, L
11
H, L
12
H, L
13
H, L
14
H2 or 
L
15
. The preparation of the chloride-bridged di-iridium(III) intermediate was usually 
performed with IrCl3.3H2O and an excess of the proligand ppyH in a mixture of 2-
ethoxyethanol and water at 146 °C (see Chapter 1).
39
 The interest of using these ligands is 
the ability to protonate or deprotonate the azole ring leading to the formation of either a 
positively charged or charge-neutral iridium(III) complex. Similar behaviour has been 
observed for [Ru(bpy)2(pbzH)]
2+
.
40
 The cationic and the neutral complexes, incorporating 
L
n
H and L
n
 respectively (n = 1 to 6), were synthesized separately using two different 
methods. 
 
2.2.1. Neutral Complexes  
The synthesis of the neutral complexes required the deprotonation of the azolic 
nitrogen of the benzimidazole unit. The N^N
–
-coordinating pyridyl-azolate ligand resembles a 
cyclometallated N^C-coordinating ligand. This resemblance is well-established by the 
synthesis of iridium bis-phenylpyridyl complexes bearing 2-pyridyl pyrazolate, triazolate or 
tetrazolate, for example, from the work established by Chi and Chou.
41,42 The 2,2′- bis-
benzimidazole acted as a primary amine ligand. The formation of the neutral complexes was 
realized under relatively aggressive conditions conditions in DMF at 152 °C (Scheme 4).43 
The addition of base such as K2CO3 was necessary to deprotonate the 2,2′- bis-benzimidazole 
and/or to remove the HCl liberated upon coordination of the ligand, which would protonate 
remaining ligand and inhibit further reaction. The cleavage and the coordination of the N^N 
ligand occurred within 24 h. The reaction was quenched with water and extracted with DCM. 
The final neutral complexes were obtained by recrystallization from THF in 45 % to 63 % 
yields.  
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                                         Ir(ppy)2L
10
                Ir(ppy)2L
12
                 Ir(ppy)2L
13
          
                                                       
 
Ir(ppy)2(L
14
H) 
                                                                          
Scheme 4. Synthesis of neutral iridium complexes Ir(ppy)2L
10
, Ir(ppy)2L
11
, Ir(ppy)2L
12
 and Ir(ppy)2(L
14
H) in 
DMF at 152 °C 
2.2.2. Cationic Complexes 
The cationic iridium complex is the conjugate acid of the corresponding neutral 
iridium complex. In the cationic complexes, the benzimidazole unit binds as a neutral imine-
like =N- ligand, similar to a pyridine.  The net coordination sphere is therefore comparable to 
that of [Ir(N^C–ppy)2(N^N-bpy)]
+
 for example, thus leading to the formation of a bis-
cyclometallated cationic iridium complex. The synthesis of the cationic complexes was 
achieved under milder conditions, through reaction of the dimer with the benzimidazole 
ligand in a mixture of MeOH and DCM at 52 °C (Scheme 5).
44
 The cleavage and the 
coordination of the N^N ligand was complete within 24 h. The solvent was evaporated and 
the residue was dissolved in the minimum volume of acetonitrile. At this point, the counterion 
is Cl
–
. In order to obtain a more tractable, organic-soluble salt, the chloride can be exchanged 
for a larger ion such as PF6
–
.  This was achieved by adding the acetonitrile solution dropwise 
to a saturated aqueous solution of KPF6. The precipitate that formed was separated by 
centrifugation and washed several times with EtOH and Et2O. Recrystallization in acetonitrile 
gave the iridium complexes as coloured powders in 40 to 78 % yields. 
148 
 
 
                           [Ir(ppy)2(L
10
H)]PF6   [Ir(ppy)2(L
11
H)]PF6    [Ir(ppy)2(L
12
H)]PF6 
                                   
                        
                       [Ir(ppy)2(L
13
H)]PF6     [Ir(ppy)2(L
14
H2)]PF6    [Ir(ppy)2L
15
]PF6                                  
Scheme 5. Synthesis of cationic iridium complexes [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6, 
[Ir(ppy)2(L
12
H)]PF6, [Ir(ppy)2(L
13
H)]PF6, [Ir(ppy)2(L
14
H2)]PF6 and [Ir(ppy)2L
15
]PF6 under mild 
conditions: DCM/MeOH at 52˚C 
 
2.3. Characterizations 
2.3.1. NMR spectroscopy 
The 
1
H NMR spectra of Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 displayed significant 
differences in the signals of the benzimidazole-based ligand (Figure 15) compared to the free 
ligand L
10
H. The signals for protons 11 and 12 of the quinoline ring are slightly shifted for 
the neutral complex compared to the proligand L
10
H and more shifted for the cationic iridium 
complex. On the other hand, the signal of proton 3 of the benzimidazole ring is shifted to 
lower frequency in both of the iridium complexes compared to the free ligand. The presence 
of the proton of the benzimidazole unit around 13 ppm confirmed the nature of the cationic 
iridium complex. 
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 TOP: 1H NMR of the ligand L10H, 2-(2-quinolyl)benzimidazole. MIDDLE: 1H NMR of the Figure 15.
corresponding neutral iridium complex, Ir(ppy)2L
10
 and BOTTOM: 
1
H NMR of the corresponding cationic 
iridium complex, [Ir(ppy)2(L
10
H)]PF6. All spectra were recorded in CDCl3 at 298 K (700MHz) 
 
The 
1
H NMR in CDCl3 of Ir(ppy)2(L
14
H) and [Ir(ppy)2(L
14
H2)]PF6 are shown in Figure 
16. Both iridium complexes, neutral and cationic, displayed twelve protons, despite the fact 
that Ir(ppy)2(L
14
H) would be expected to show one fewer than [Ir(ppy)2(L
14
H2)]PF6. 
[Ir(ppy)2(L
14
H2)]PF6 showed a clear C2 symmetry, with twelve signals in the aromatic 
region, consistent with the two benzimidazole units being equivalent. Ir(ppy)2(L
14
H), due to 
the deprotonation of one of the two azole rings, should not be anymore symmetrical. 
However, the 
1
H NMR still shows the two benzimidazole rings to be equivalent. The azolic 
proton is “shared” between the two azole nitrogen atoms, which confers symmetry. 
11 
11 
11 
12 
12 
12 
14 
14 
14 
Multiplets of the phenyl  
and benzimidazole rings 
Multiplets of the phenyl 
and benzimidazolerings 6Ph of the 
ppy A and B  
3 bq 
3 bq 
3 bq 
6 Ph of the 
ppy A and B  
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 1H NMR of Ir(ppy)2(L
14
H) and [Ir(ppy)2(L
14
H2)]PF6 overlayed to illustrate the observed Figure 16.
differences in NMR spectra on the protonation of the benzimidazole unit. The blue spectrum is the neutral 
form of the iridium complex and the purple spectrum is the cationic form of the iridium complex. All spectra 
were recorded in CDCl3 at 298 K (700 MHz)   
 
2.3.2. Crystal structures 
Crystals of Ir(ppy)2L
12
, [Ir(ppy)2(L
12
H)]PF6 and Ir(ppy)2L
10
 were obtained by slow 
evaporation in acetone or chloroform. The molecular structures of Ir(ppy)2L
12
, 
[Ir(ppy)2(L
12
H)]PF6 and Ir(ppy)2L
10
 were determined by single crystal X-ray diffraction 
analysis at 120 K for the cationic iridium complex [Ir(ppy)2(L
12
H)]PF6 and at 100 K for the 
neutral complexes Ir(ppy)2L
10
 and Ir(ppy)2L
12
, which confirmed the pseudo-octahedral 
coordination structure (Figure 17). The trans angles at the metal centre range between 170.29 
Å and 175.41 Å for Ir(ppy)2L
10
, 171.7 Å and 178.1 Å for complex Ir(ppy)2L
12
 and 170.7 Å 
and 174.1 Å for [Ir(ppy)2(L
12
H)]PF6. Furthermore, the presence of the PF6 as a counterion of 
[Ir(ppy)2(L
12
H)]PF6 proved the protonated form of the complex. The selected bond lengths 
and angles are listed in Table 2. 
                      
 
[Ir(ppy)2(L
12
H)]PF6 Ir(ppy)2L
12 
N1 
N2 
N2 
N1 
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 ORTEP structures of [Ir(ppy)2(L
12
H)]PF6, Ir(ppy)2L
12
 and Ir(ppy)2L
10
 Figure 17.
 
All the bond angles of the neutral and the corresponding cationic complexes are 
similar. The Ir–N2 bond was slightly shorter for the neutral complex Ir(ppy)2L
12
 than for 
complex [Ir(ppy)2(L
12
H)]PF6 (2.090 Å and 2.123 Å respectively). In fact, due to the 
deprotonation of the azolic ring, the Ir–N bond of Ir(ppy)2L
12
  is closer to that of fac-Ir(ppy)3 
(2.095 Å),whilst the Ir–N bond of [Ir(ppy)2(L
12
H)]PF6 is similar to the Ir–N(bpy) (2.135 
Å).
45,46 
However, all the metal-ppy bond distances were closer to the cationic [Ir(ppy)2(bpy)]
+
 
complex than to fac-Ir(ppy)3. Interestingly, the Ir–N
1
 bond distance was significantly longer 
than the other Ir–N bond distances of all the other complexes presented. The steric effect of 
the benzimidazole-quinoline ligand influenced its bond distances to the metal. 
 
Table 2. Selected bond lengths (Å) and angles (°) of Ir(III) complexes. [Ir(ppy)2(bpy)]PF6 and fac-Ir(ppy)3 are 
included for comparison 
44,45 
 
 
Complex 
Bond 
lengths 
Ir–N1 
Bond 
lengths 
Ir–R 
Bond  
lengths 
Ir–N 
Bond  
lengths 
Ir–N 
Bond  
lengths 
Ir–C 
Bond  
lengths 
Ir–C 
[Ir(ppy)2(L
12
H)]PF6 
R = N
2 
2.161(4) 2.123(4) 2.046(4) 2.045(4) 2.003(5) 2.017(5) 
Ir(ppy)2L
12 
R = N
2 
2.123(16) 2.090(15) 2.048(16) 2.018(18) 2.050(2) 1.985(19) 
Ir(ppy)2L
10 
R = N
2 
2.252(3) 2.117(3) 2.042(3) 2.039(3) 2.010(4) 2.017(4) 
[Ir(ppy)2(bpy)]PF6 
R = N 
2.142(5) 2.135(5) 2.042(7) 2.050(9) 2.011(5) 2.012(5) 
fac-Ir(ppy)3 
R = C 
2.095(9) 2.034(9) 2.086(8) 2.071(10) 2.032(9) 2.060(10) 
Ir(ppy)2L
10
 
N1 
N2 
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Complex Bond angles / ° 
N
1
^Ir^R 
Bond angles / ° 
C
1
^Ir^C
2
 
Bond angles / ° 
N
1
^Ir^C
1
 
[Ir(ppy)2(L
12
H)]PF6 
R = N
2 
75.09(16) 80.71(19) 80.45(18) 
Ir(ppy)2L
12 
R = N
2 
75.80(6) 80.45(8) 80.40(7) 
Ir(ppy)2L
10 
R = N
2 
76.22(11) 80.40(15) 80.21(14) 
[Ir(ppy)2(bpy)]PF6 
R = N 
76.50(6) 80.20(6) 80.40(4) 
fac-Ir(ppy)3 
R = C 
78.60(4) 79.00(4) 79.60(4) 
 
 
2.3.3. DFT calculations     
DFT and TD-DFT calculations for Ir(ppy)2L
10
, [Ir(ppy)2(L
10
H)]PF6, Ir(ppy)2L
11
, 
[Ir(ppy)2(L
11
H)]PF6, Ir(ppy)2L
12
, [Ir(ppy)2(L
12
H)]PF6 were carried out using the B3LYP 
functional, with 6-31G* as the basis set for the ligands and LanL2DZ for the iridium  
(Figures 18 and 19). According to the contour plots of the molecular orbitals of the neutral 
iridium complexes Ir(ppy)2L
10
, Ir(ppy)2L
11
 and Ir(ppy)2L
12
, the HOMO is based on the 
benzimidazole unit and the metal centre and the  LUMO essentially only on the (iso)-quinolyl 
part of the molecule. For the cationic iridium complexes, the LUMO is again based on the 
(iso)quinolyl unit, but now the HOMO is based on the phenyl rings of the ppy ligands. As a 
consequence, the functionalization of the ppy ligands by electron-withdrawing or -donating 
groups is expected to have little effect on the photophysical properties of the neutral iridium 
complexes. On the other hand, such functionalization may be anticipated to have a larger 
effect on the optical properties of the cationic iridium complexes, as it should influence the 
HOMO energy. 
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HOMO -5.29 eV 
 
LUMO -2.10 eV 
 
HOMO -5.21 eV 
 
LUMO -2.08 eV 
 
HOMO -5.32 eV 
 
LUMO -2.12 eV 
 Contour plots of the HOMO and LUMO of neutral iridium complexes Ir(ppy)2L
10
 (TOP), Figure 18.
Ir(ppy)2L
11
 (MIDDLE) and Ir(ppy)2L
12 
(BOTTOM)  
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HOMO – 7.95 eV 
 
LUMO – 5.30 eV 
 
HOMO – 7.83 eV 
 
LUMO – 5.02 eV 
 
HOMO - 7.86 eV 
 
LUMO – 5.43 eV 
  
 Contour plots of the HOMO and LUMO of cationic iridium complexes [Ir(ppy)2(L
10
H)]PF6 Figure 19.
(TOP), [Ir(ppy)2(L
11
H)]PF6 (MIDDLE) and [Ir(ppy)2(L
12
H)]PF6 (BOTTOM) 
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2.3.4. Electrochemistry 
Cyclic voltammetry was performed in DCM, with tetrabutylammonium 
hexafluorophosphate (0.1 M) as a supporting electrolyte, and the solutions were purged with 
nitrogen before each measurement. The nature of the ancillary ligands affects both the 
potentials and the reversibility of the redox processes. All compounds display at least one 
oxidation process. The formal half-wave potentials of the reversible processes and the peak 
potentials of the irreversible ones are reported in Table 3. 
The CVs of Ir(ppy)2L
10
, Ir(ppy)2L
11 
and
 
Ir(ppy)2L
12
 are shown in Figure 20. The 
CVs of
 
Ir(ppy)2L
11 
and
 
Ir(ppy)2L
12
 display two reversible anodic waves with E½ = +1.15 V 
and +1.45 V for Ir(ppy)2L
11
 and E½ = +1.03 V and +1.27 V for Ir(ppy)2L
12
. In contrast, the 
CV of Ir(ppy)2L
10 
exhibits also two anodic waves, one reversible at around +1.5 V and 
another at +1.45 V that do not display the corresponding backward wave either at 0.05 V s
–1
 
or at higher scan rates, suggesting irreversibility. The nature of the ancillary ligand of these 
complexes has an impact on the oxidation process as the neutral Ir(ppy2)(pbz) complex 
exhibits only one reversible oxidation (E½ = +1.2 V). As far as the electrochemical behaviour 
of Ir(ppy)2L
10
, Ir(ppy)2L
11 
and
 
Ir(ppy)2L
12
 is concerned, we can observe that the first 
oxidation process occurs at less anodic potentials than that of Ir(ppy2)(pbz) because the 
quinoline and isoquinoline moiety is more electron-rich than the pyridine. 
 
 Cyclic voltammogram of Ir(ppy)2L
10 
(green), Ir(ppy)2L
11 
(blue)
 
and
 
Ir(ppy)2L
12 
(red)
 
in Figure 20.
DCM/TBAPF6 (0.1 M) versus Fc/Fc
+
 at 100 mV s
−1 
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The CVs of [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6 and [Ir(ppy)2(L
12
H)]PF6 are 
shown in Figure 21. All cationic complexes display one reversible oxidation with a formal 
potential of E½ = +1.27 V, +1.06 V and +1.15 V respectively. On the cathodic side, 
[Ir(ppy)2(L
10
H)]PF6 exhibits a partially reversible reduction process around −1.4 V. The CV 
of [Ir(ppy)2(L
12
H)]PF6 displays two cathodic waves at −1.28 and −1.90 V which appear to be 
irreversible. One irreversible reduction wave was observed for [Ir(ppy)2(L
11
H)]PF6 around  
−1.8 V. 
 
 Cyclic voltammogram of [Ir(ppy)2(L
10
H)]PF6 (green), [Ir(ppy)2(L
11
H)]PF6 (blue) and Figure 21.
[Ir(ppy)2(L
12
H)]PF6 (red) in dichloromethane/TBAPF6 (0.1 M) versus Fc/Fc
+
 at 50 mV s
−1 
 
           
                                             [Ir(ppy)2(L
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H)]PF6                     Ir(ppy)2L
12                             
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 TOP: Representation of [Ir(ppy)2(L
12
H)]PF6 and Ir(ppy)2L
12
. MIDDLE: Cyclic Figure 22.
voltammogram of the first oxidation of [Ir(ppy)2(L
12
H)]PF6 (left) and Ir(ppy)2L
12
 (right) in DCM/TBAPF6 
(0.1 M) versus Fc/Fc
+
 at 50 to 400 mV s
−1
. BOTTOM: Overlay of the oxidation waves of 
[Ir(ppy)2(L
12
H)]PF6 and Ir(ppy)2L
12
 in DCM/TBAPF6 (0.1 M) versus Fc/Fc
+
 at 100 mV s
−1 
 
The first reduction of the Ir complexes usually occurs on the ancillary ligands, while 
the oxidation is centered on the Ir-aryl moiety. The redox gap of the whole series (calculated 
as the difference between the formal potentials of the cathodic and anodic systems) spans over 
a wide range, namely, ∼2.3−2.7 V (Figure 23). The onset potentials of all complexes were 
estimated by analysing the intersection of the slope drawn at the rising oxidation and 
reduction current and the baseline. The oxidation potential onset was calculated in relation to 
ESCE (-4.4 ± 0.1 eV) from the equation:
47,48 
HOMO LEVEL = ESCE – Eonset-ox 
LUMO LEVEL = ESCE – Eonset-red 
The electrochemical band gap (Eg) was defined as the difference between the onsets of 
oxidation (Eox) and reduction (Ered). The reduction of Ir(ppy)2(L
14
H) and 
[Ir(ppy)2(L
14
H2)]PF6 was not possible to observe but they both displayed reversible 
oxidation waves with E½ = 1.01 V for Ir(ppy)2(L
14
H) and 1.05 V for [Ir(ppy)2(L
14
H2)]PF6.  
Some conclusions can be made from the comparison between cationic and neutral 
complexes:  
(i) The electrochemistry of the complexes is affected by the protonation state of the azolic 
ring. In fact, we observed that neutral complexes are easier to oxidise than the cationic 
complexes. This is due to the fact that it is difficult to remove electrons from an already 
charged complex as we observed the same case for the Ir(ppy)3 and the Ir(ppy)2(bpy)
+
. 
Related to the DFT calculation (section 2.3.3), the oxidation process of the neutral 
complexes involves the removal of one electron from the electron rich benzimidazole. In 
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contrast, the oxidation of the cationic iridium complexes occurs on the ppy units as the 
benzimidazolium became electron deficient. This matches the fact that neutral complexes 
are easier to oxidise than cationic complexes. 
(ii) Cationic complexes are easier to reduce than neutral complexes. A lowering of the LUMO 
level occurs in the cationic complexes due to the proximity of the electron deficient 
benzimidazolium unit. 
(iii) The drop of the LUMO level is more important than the evolution of the HOMO level 
for the cationic complexes. This involves a diminution of the HOMO-LUMO gap for the 
cationic complexes  compared to the neutral complexes    
 
 
 HOMO-LUMO energy levels for [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6 and Figure 23.
[Ir(ppy)2(L
12
H)]PF6 complexes and Ir(ppy)2L
10
, Ir(ppy)2L
11 
and
 
Ir(ppy)2L
12 
complexes 
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Table 3.   Electrochemical data for neutral and cationic Ir(III) complexes 
Complex E1/2 ox (V) E1/2 red (V) Eonset-ox (V) ; HOMO (eV) Eonset-red (V) / LUMO (eV) Energy gap 
Eg (eV) 
Ir(ppy)2L
10
 1.10 -1.53 0.98 V ; -5.38 eV -1.42 / -2.98 eV 2.40 eV 
[Ir(ppy)2(L
10
H)]PF6 1.27 -1.43 1.09 V; -5.49 eV -1.27 / -3.13 eV 2.36 eV 
Ir(ppy)2L
11 1.15; 1.45 -1.82 0.94 V; -5.34 eV -1.77 / -2.63 eV 2.74 eV 
[Ir(ppy)2(L
11
H)]PF6 1.06 - 0.96 V; -5.36 eV -1.61 / -2.73 eV 2.63 eV 
Ir(ppy)2L
12 1.03; 1.27 -1.78 0.91 V; -5.31 eV -1.78 / -2.62 eV 2.69 eV 
[Ir(ppy)2(L
12
H)]PF6 1.15 - 0.98 V; -5.38 eV -1.30 / 3.10 eV  2.28 eV 
Ir(ppy)2(L
14
H) 1.05 - - - - 
[Ir(ppy)2(L
14
H2)]PF6 1.01 - - - - 
The values were determined from DCM solutions at 298 K (10-4 M), in the presence of a 0.1 M tetrabutylammonium hexafluorophosphate as the supporting electrolyte. A 
scan rate of 200 mV s
-1
 was employed and values are reported relative to SCE, using ferrocene as the standard (E½ = 0.42 V vs. SCE). 
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2.4. Photophysical studies 
2.4.1. Absorption in dichloromethane 
 Quinolyl and isoquinolyl iridium complexes 2.4.1.1.
The ground-state absorbance spectra of cationic ([Ir(ppy)2(L
10
H)]PF6, 
[Ir(ppy)2(L
11
H)]PF6, [Ir(ppy)2(L
12
H)]PF6 and neutral (Ir(ppy)2L
10
, Ir(ppy)2L
11
, 
Ir(ppy)2L
12
) iridium complexes in DCM solution are shown in Figures 24 and 25 
respectively. They all showed intense bands in the UV region between 230 and 330 nm 
assigned to the 
1-* transitions of the ligands.  Weaker bands at lower energy extending into 
the visible region (between 330 and 490 nm) were attributed to metal-to-ligand charge 
transfer (MLCT) transitions. Ir(ppy)2L
11 
and Ir(ppy)2L
11
 absorbed at higher energy than the 
other iridium complexes. In fact their absorption spectra were characterized by a broad band 
centered at 330 nm whereas [Ir(ppy)2(L
12
H)]PF6, which absorbed at the lowest energy, was 
characterized by a broad band centered at 389 nm.  
 
 UV-visible absorption spectra of [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6  and Figure 24.
[Ir(ppy)2(L
12
H)]PF6, complexes in DCM at 298 K   
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 Normalized UV-visible absorption spectra of Ir(ppy)2L
10
, Ir(ppy)2L
11 
and Ir(ppy)2L
12
, Figure 25.
complexes in DCM at 298 K 
The absorbance process measures the energy difference between the ground state and 
the excited state. Since there are a number of vibrational states associated with both the 
ground state and the excited state, the E00 band gap is the energy difference between the 
lowest vibrational states of the ground and excited states (Figure 26). The onset absorption 
wavelengths of all complexes were estimated by analysing the intersection of the slope drawn 
at the lowest energy and the baseline. The optical gap was calculated as the energy 
corresponding to the onset wavelength. The calculated optical and electrochemical gap values 
are similar (difference from 0 eV for Ir(ppy)2L
10
 to 0.21 eV for [Ir(ppy)2(L
12
H)]PF6, Table 
4), so we can conclude that the first transition observed in the absorption corresponds to a 
HOMO/LUMO transition. Moreover, from DFT calculation, we can see that this 
HOMO/LUMO transition corresponds to a metal-to-ligand charge-transfer (MLCT) transition. 
 
 Relation between optical gap and the transition S0-S1
  
 Figure 26.
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Table 4. Absorption and energy gap data of iridium complexes in DCM solution at 298 K. 
Complex abs / nm ( / 10
-3 
L mol
-1
 cm
-1
) Eg
opt(a) Eg
cv(b)
 
Ir(ppy)2L
10
 248, 293, 370 (2.6) 2.40 2.40 
Ir(ppy)2L
11
 264, 346 (1.2) 2.74 2.63 
Ir(ppy)2L
12
 235, 263, 290 (3.1), 395 (2.8) 2.59 2.55 
[Ir(ppy)2(L
10
H)]PF6 246, 294, 347, 360 (23) 2.36 2.35 
[Ir(ppy)2(L
11
H)]PF6 243, 317 (25), 422 (3.8) 2.58 2.63 
[Ir(ppy)2(L
12
H)]PF6 235, 294, 317, 389 (19) 2.24 2.55 
(a)
Optical gap 
(b)
Energy gap taken from the electrochemistry table 
 
2.4.2. bis-benzimidazole iridium complexes 
The ground-state absorbance spectra of cationic ([Ir(ppy)2(L
14
H2)]PF6, [Ir(ppy)2L
15
]PF6 
and neutral Ir(ppy)2(L
14
H) iridium complexes in DCM solution are shown in Figure 27. 
They all show intense bands in the UV region between 230 and 360 nm assigned to the 
1-* 
transitions of the ligands.  A weaker band at lower energy extending into the visible region 
(between 360 and 550 nm) is attributed to metal-to-ligand charge-transfer (MLCT) 
transitions. [Ir(ppy)2(L
14
H2)]PF6 and Ir(ppy)2(L
14
H) display a weak, low-energy band 
around 430 nm that is not present for [Ir(ppy)2L
15
]PF6. 
   
 Normalized absorption spectra of Ir(ppy)2(L
14
H), [Ir(ppy)2(L
14
H2)]PF6 and Figure 27.
[Ir(ppy)2(L
15
H2)]PF6 complexes in DCM at 298 K   
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2.4.3. Emission studies in degassed DCM at 298 K 
 Neutral (iso)-quinolyl iridium complexes 2.4.3.1.
Emission spectra of complexes Ir(ppy)2L
10
, Ir(ppy)2L
11
 and Ir(ppy)2L
12
 were recorded in 
degassed DCM solution at 298 K. Spectra of the neutral complexes are shown in Figure 28 
and luminescence data are collected in Table 4. All three complexes are strongly 
phosphorescent in degassed solution. The emission profiles of Ir(ppy)2L
11
 and Ir(ppy)2L
12
 
are more structured than Ir(ppy)2L
10
. Ir(ppy)2L
10
 and Ir(ppy)2L
12
 are bright ( = 0.50 and 
0.42 respectively) and showed similar luminescence properties as Ir(ppy)2(pbz) ( = 0.48 and 
 = 3.2 s). However, Ir(ppy)2L
10
 (em = 619 nm) and Ir(ppy)2L
12
 (em = 575 nm) displayed 
a bathochromic shift of their emission compared to Ir(ppy)2(pbz) due to the  extension on 
the pyridyl ring. The quantum yield of luminescence of Ir(ppy)2L
11
 was  low (= 0.15) 
compared to Ir(ppy)2L
10
 and Ir(ppy)2L
12
, but its lifetime was much longer ( = 25 s, 
compared to  = 4.4 s and 7.6 s, respectively). This specific characteristic  has also been 
observed for a cyclometallated platinum(II) complex that contains an isoquinoline linked at 
position 3 to the metallated ring: platinum[2,6-di(3-isoquinolyl)-benzene]chloride displayed a 
luminescence lifetime ( = 40 s)  much longer than its isomer in which the isoquinoline is 
linked at position 4 to the metallated ring ( = 3.5 s).49   The effect in both cases appears to 
be derived from a much smaller kr value for the 3-substituted isomer. 
 
 Normalized phosphorescence emission spectra of Ir(ppy)2L
10
, Ir(ppy)2L
11
, and Ir(ppy)2L
12
 Figure 28.
complexes in degassed DCM at 298 K 
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 Cationic (iso)-quinolyl iridium complexes 2.4.3.2.
Emission spectra of complexes [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6 and 
[Ir(ppy)2(L
12
H)]PF6 were recorded in degassed DCM solution at 298 K (Figure 29). 
Luminescence data are compiled in Table 5. All three complexes are strongly phosphorescent 
in degassed solution. The emission spectrum of [Ir(ppy)2(L
10
H)]PF6 showed a broad brand 
characterized by a maximum at 625 nm whereas [Ir(ppy)2(L
11
H)]PF6 displayed a broad 
brand with a maxima at 566 nm and two shoulders at 530 nm and 615 nm. 
[Ir(ppy)2(L
11
H)]PF6 showed the most structured emission band with two maxima at 580 and 
625 nm. However, the emission bands were less structured than for the neutral complexes. 
Emission of [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6 and [Ir(ppy)2(L
12
H)]PF6 were also 
red-shifted compared to the neutral complexes (max = 625 nm, 566 nm and 625 nm 
respectively). According to the DFT calculations, the LUMO was based on the quinolyl / 
isoquinolyl unit and the HOMO based on the phenyl rings of the cationic iridium complex. 
The luminescence lifetime of [Ir(ppy)2(L
11
H)]PF6 ( = 14 s) was higher than 
[Ir(ppy)2(L
10
H)]PF6 and [Ir(ppy)2(L
12
H)]PF6 complexes ( = 3.9 s and 7.0 s, 
respectively). The quantum yields of luminescence of the cationic complexes were similar to 
their neutral analogues. The comparison with [Ir(ppy)2(pbz)]PF6 showed that the emission 
wavelength was in the same range as [Ir(ppy)2(L
12
H)]PF6. However, the quantum yield and 
lifetime of [Ir(ppy)2(pbz)]PF6 luminescence were lower than all the other cationic 
complexes.  
 
 
 Normalized phosphorescence emission spectra of [Ir(ppy)2(L
10
H)]PF6, [Ir(ppy)2(L
11
H)]PF6 Figure 29.
and [Ir(ppy)2(L
12
H)]PF6 complexes in degassed DCM at 298 K 
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 Comparison between Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 2.4.3.3.
 
The emission of the cationic and the neutral complexes showed a single broad band 
which corresponds to phosphorescence from an MLCT triplet state (Figure 30). For example, 
the cationic [Ir(ppy)2(L
10
H)]PF6 emission (max = 625 nm) is red-shifted compared to the 
neutral Ir(ppy)2L
10
. This bathochromic shift is attributed to the protonation of the 
benzimidazole unit.  In fact, the LUMO is lower in the cationic compared to neutral complex, 
because in the cationic complex the acceptor ligand (quin-bzH) is neutral whereas it is anionic 
in the neutral complex.  It is the same as why [Ir(ppy)2(bpy)]
+
 is red-shifted compared to 
Ir(ppy)3.
50
     
   
 Normalized phosphorescence emission spectra of Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 (left), Figure 30.
Ir(ppy)2L
11
 and [Ir(ppy)2(L
11
H)]PF6 (middle) and Ir(ppy)2L
12
 and [Ir(ppy)2(L
12
H)]PF6 (right) complexes 
in degassed DCM at 298 K.  
 
 Emission of the bis-benzimidazole iridium deriatives 2.4.3.4.
The emission spectra of Ir(ppy)2(L
14
H), [Ir(ppy)2L
15
]PF6 and [Ir(ppy)2(L
14
H2)]PF6 
were recorded in degassed DCM at 298 K (Table 5). The comparison between 
Ir(ppy)2(L
14
H) and [Ir(ppy)2(L
14
H2)]PF6 showed that there was a significant difference in 
the emission properties which was not apparent from  the absorption studies (Figure 31). In 
fact, the emission wavelength of the protonated complex (max = 535 nm) was red shifted 
compared to its non-protonated analogue (max = 503 nm). Furthermore, [Ir(ppy)2L
15
]PF6 
showed a strong bathochromic shift (max = 593 nm) due to the methylation of the azole rings. 
[Ir(ppy)2(L
11H)]PF6 
[Ir(ppy)2(L
12H)]PF6 
Ir(ppy)2L
12 
Ir(ppy)2L
11 Ir(ppy)2L
10 
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 Normalized phosphorescence emission spectra of Ir(ppy)2(L
14
H), [Ir(ppy)2(L
14
H2)]PF6 and Figure 31.
[Ir(ppy)2(L
15
H2)]PF6 complexes in degassed DCM at 298 K 
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Table 5. Photophysical data of iridium complexes in degassed DCM at 298 K. Ru(bpy)3 was used as reference for the calculation of the quantum yield ϕ, Data for [Ir(ppy)2(pbz)] 
and [Ir(ppy)2(pbzH)]PF6 have been included for comparison
34
 
 abs / nm 
( / 10-3L mol-1cm-1) 
em / nm  / s  kr / s
-1
 knr / s
-1
 
Ir(ppy)2L
10
 248, 293, 370 (2.6) 579 4.4 0.50 113636 113636 
Ir(ppy)2L
11
 264, 346 (1.2) 535, 568 25 0.15 6000 34000 
Ir(ppy)2L
12
 235, 263, 290 (3.1), 395(2.8) 579, 629 7.6 0.42 52263 79316 
Ir(ppy)2(pbz) 340 (33), 433 (5.1), 476 (1.3)  496, 521 3.2 0.48 150000 162500 
[Ir(ppy)2(L
10
H)]PF6 246, 294, 347, 360 (23) 625 3.9 0.48 123711 134020 
[Ir(ppy)2(L
11
H)]PF6 243, 317 (25), 422 (3.8) 530, 566, 615 14 0.20 13870 55478 
[Ir(ppy)2(L
12
H)]PF6 235, 294, 317, 389 (18.9) 580, 625, 680 (sh) 7.0 0.38 54285 88571 
[Ir(ppy)2(pbzH)]PF6 320 (30.1), 380 (8.6), 418 (4.2), 
470 (1.1) 
590 0.84 0.22 261904 928571 
Ir(ppy)2(L
14
H) 255, 330 (13.8), 420 (1.5) 503, 520 2 0.24 120000 380000 
[Ir(ppy)2L
15
]PF6 284, 343 (19.9), 390 (7.4),  
411 (2.6) 
593 1        0.24 
 
240000 760000 
[Ir(ppy)2(L
14
H2)]PF6 255, 377 (11.6), 420 (3), 470 (0.5) 535 2 0.46 230000 270000 
[Ir(ppy)2(pbzH)]PF6
 
 
320 (30.1), 380 (8.6), 418 (4.2), 
470 (1.1) 
590 0.80 0.22 261904 928572 
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2.4.4. Emission in EPA solution at 77 K 
All the emission spectra at 77 K were recorded in an EPA solution (Figure 32). They 
show more pronounced structured than those obtained at 298 K.  
The luminescence lifetimes of all complexes were longer at 77 K than at 298 K. A 
small difference was observed between the neutral and cationic iridium complexes, 
Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 (Ir(ppy)2L
10
  = 14.6 s and [Ir(ppy)2(L
10
H)]PF6  = 
9.8 s, Table 6). 
  
 
 TOP: Normalized phosphorescence emission spectra of neutral iridium complexes (left) and Figure 32.
cationic iridium complexes (right). BOTTOM: emission spectra of Ir(ppy)2(L
14
H), [Ir(ppy)2(L
14
H2)]PF6 
and [Ir(ppy)2L
15
]PF6. All spectra were acquired in EPA solution at 77 K 
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Table 6. Photophysical data of cationic and neutral iridium complexes in EPA solution at 77 K 
 em / nm 
 
 / s 
Ir(ppy)2L
10 
 
536, 572, 632 14.6 
Ir(ppy)2L
11 450, 481, 515, 525, 556, 602, 666, 
718 
132 
Ir(ppy)2L
12 
 
564, 577, 612, 668, 736 7.8 
[Ir(ppy)2(L
10
H)]PF6 
 
555, 597, 631 9.8 
[Ir(ppy)2(L
11
H)]PF6 
 
484, 515, 525, 555, 599, 634 133 
[Ir(ppy)2(L
12
H)]PF6 
 
566, 584, 614, 632, 665, 735 8 
Ir(ppy)2(L
14
H) 
 
476, 511, 544, 599 5.3 
[Ir(ppy)2(L
14
H2)]PF6 
 
452, 476, 511, 544, 605 4.1 
[Ir(ppy)2L
15
]PF6 
 
476, 512, 542, 582, 636, 710 4.5 
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2.5. pH dependence of optical properties 
Owing to the presence of the azole ring, which can undergo deprotonation / 
protonation (e.g. compare Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 in the figure below), it was 
of interest to investigate the pH dependence of the optical properties of the iridium 
complexes.  The UV-visible absorption and emission spectra of aqueous solutions of 
complexes Ir(ppy)2L
10
, Ir(ppy)2L
11
and Ir(ppy)2L
12
 in the pH range between 12 and 2 have 
been recorded at various pH concentrations by adding H2SO4 at different concentrations to the 
buffer solution (DMSO/water, 1:1) at 298 K. Measurements were recorded with a glass pH 
electrode calibrated with standard buffer solutions. 
2.5.1. Ir(ppy)2L
10
 and [Ir(ppy)2(L
10
H)]PF6 
 
                                    Ir(ppy)2L
10
                       [Ir(ppy)2(L
10
H)]PF6 
 Representation of the neutral (left) and the cationic (right) iridium complexes Figure 33.
The absorption spectra at different pH values and the variation of the absorption 
intensity at 400 nm with pH are shown in Figure 34, and corresponding data are compiled in 
Table 7.  Over the pH range 12– 2, only one isosbestic point (namely, at 362 nm) can be 
clearly distinguished. An isosbestic point is a specific wavelength which is constant in 
intensity for all pH values in the experiment. The occurrence of isosbestic points provides a 
good indication of the presence of only two interchanging species.  In basic solution, the UV-
visible absorption spectrum was essentially composed of a broad band characterized by two 
maxima at 363 nm and 387 nm. From pH = 12 to 7, the absorption spectrum did not show any 
variations, indicating that the complex was uniquely in its neutral form over this range.  
Below pH = 7, the absorbance bands were blue-shifted, the absorbance intensity at 400 nm 
decreased with the pH, whereas the shoulder at 343 nm became more pronounced. These 
changes can be attributed to the protonation of the azolic ring. At pH around 5.0 until pH = 2, 
the spectrum shape did not change anymore and featured a single maximum at 349 nm. Over 
this range, the protonation is apparently complete and the cationic complex uniquely present. 
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The equivalence, where pH = pKa, was determined by the graphical method.
51
 A pKa of 5.87 
was found.  
 
 
 
 Variation of the absorption intensity of Ir(ppy)2L
10
 (Concentration  = 2.42  10–5 M)  in Figure 34.
DMSO / H2O (1:1, 100 mL) as a function of pH. trifluoroacetic acid and sodium hydroxide were used as 
acid and base respectively. The same profile was observed starting from the pre-formed sample of 
[Ir(ppy)2(L
10
H)]PF6 
The emission spectra during the titration of all complexes were recorded without 
degassing. The emission spectra showed a single broad band throughout (Figure 35). From 
pH = 12 to pH around 7, the spectral profile and intensity were essentially independent of pH, 
with max = 590 nm. Below pH = 7.11, the emission intensity decreased and there was a 
progressive shift in max towards longer wavelengths, until around pH 4 at which max was 
around 640 nm.  Further acidification led to no further discernible effect.  These changes are 
consistent with the protonation of the azole ring. The equivalence, where pH = pKa
*
, was 
determined by the graphical method. A pKa
*
 of 5.45 was found, a little lower than the 
corresponding value obtained from absorption data, indicating that the excited state is slightly 
less basic than the ground state.  The lifetimes were determined at the extremes, namely at pH 
12 and at pH 2, in degassed solutions, giving values of  = 2.8 and 0.2 s respectively, 
corresponding to the neutral and protonated forms respectively.   
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
250 300 350 400 450 500
A
b
so
rb
an
ce
 
Wavelength (nm) 
pH 
0.17
0.22
0.27
0.32
0.37
0.42
2 7 12
abs = 400 nm 
isobestic point 
362 nm 
A
b
so
rb
an
ce
 
pH 
172 
 
 
 Variation of the emission intensity of complex Ir(ppy)2L
10
 in DMSO / H2O (1:1) as a function Figure 35.
of pH. Trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The same profile 
was observed starting from the pre-formed sample of [Ir(ppy)2(L
10
H)]PF6. 
2.5.2. Ir(ppy)2L
11
 and [Ir(ppy)2(L
11
H)]PF6 
 
                                           Ir(ppy)2L
11
                       [Ir(ppy)2(L
11
H)]PF6 
 Representation of the neutral (left) and the cationic (right) iridium complexes Figure 36.
The absorption spectra of the titration and the variation of the absorption intensity at 
400 nm were shown in Figure 36 and Table 9. Behaviour was similar with one isosbestic 
point (namely, at 325 nm). In basic solution (from pH = 12 to pH = 7.9), the UV / Vis 
absorption spectrum of the neutral form was essentially composed of a broad band 
characterized by two maximum at 314 nm and 421 nm. The complex was in its neutral form. 
At pH around 5.0 until pH = 2, the spectrum shape of the cationic form was composed of 
maxima at  = 316 and 356 nm. A pKa of 6.55 was found. 
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 Variation of the absorption intensity of Ir(ppy)2L
11
 in DMSO / H2O (1:1) as a function of pH. Figure 37.
Trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The same profile was 
observed starting from the pre-formed sample of [Ir(ppy)2(L
11
H)]PF6 
The emission spectra always showed a single broad band (Figure 37). Emission and 
luminescence lifetime measurements at pH = 2 and pH = 14 were performed on degassed 
solutions by bubbling nitrogen for several minutes (Table 7). From pH = 12 to pH around 7.9, 
Neutral complex Ir(ppy)2L
11
 was slightly emissive with a maximum at max = 602 nm. 
After pH = 7.8 the emission intensity increased with the protonation of the azole ring until pH 
around 5.3. After this pH, the protonation of the benzimidazole unit was complete. The 
emission band was characterized by a maximum at  max = 623 nm. At pH = 12 and pH = 2 
the protonated form [Ir(ppy)2(L
11
H)]PF6 had a shorter luminescence lifetime ( = 14 s) than 
the neutral form Ir(ppy)2L
11
 ( = 52 s). A pKa* of 6.60 was found. 
 
 Variation of the emission intensity of complex Ir(ppy)2L
11
 in DMSO / H2O (1:1) as a function Figure 38.
of pH. trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The same profile 
was observed starting from the pre-formed sample of [Ir(ppy)2(L
11
H)]PF6 
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2.5.3. Ir(ppy)2L
12
 and [Ir(ppy)2(L
12
H)]PF6 
 
                                           Ir(ppy)2L
12
                           [Ir(ppy)2(L
12
H)]PF6 
 Representation of the neutral (left) and the cationic (right) iridium complexes Figure 39.
The absorption spectra of the titration and the variation of the absorption intensity at 
400 nm are shown in Figure 40 and Table 9. In the pH range 12- 2, one isosbestic point at 
376 nm was observed. In basic solution, the UV / Vis absorption spectrum was essentially 
composed of a broad band characterized by two maximum at 367 nm and 425 nm. From pH = 
12 to pH = 6 the absorbance spectrum did not show any variations. After pH = 6, the 
absorbance bands were blue-shifted, the absorbance intensity at 400 nm decreased with the 
pH, whereas the shoulder at 303 nm and 367 nm became more pronounced. The protonation 
was complete and gave the cationic complex at pH = 5. A pKa of 5.52 was calculated.  
 
 
 
 
 Variation of the absorption intensity of Ir(ppy)2L
12
 in DMSO / H2O (1:1) as a Figure 40.
function of pH. trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The 
same profile was observed starting from the pre-formed sample of [Ir(ppy)2(L
12
H)]PF6 
The emission spectra always showed a single broad band. From pH = 12 to pH around 6.5, 
the emissions of the neutral complex were highly emissive with a maximum at max = 620 
nm. After pH = 6.5 the emission intensity decreased with the protonation of the azole ring 
until pH around 4.2. After this pH, the protonation of the benzimidazole unit was complete. 
0
0.2
0.4
0.6
0.8
1
1.2
250 350 450
A
b
so
rb
an
ce
 
Wavelength (nm) 
0.19
0.21
0.23
0.25
0.27
0.29
2 4 6 8 10
abs = 400 nm 
isobestic point 
376 nm 
12≤pH≤2 
A
b
so
rb
an
ce
 
pH 
175 
 
The weaker emission band was characterized by a maximum at  max = 660 nm. At pH = 12 
and pH = 2 the protonated form [Ir(ppy)2(L
12
H)]PF6 had a shorter luminescence lifetime ( = 
1 s) than the neutral form Ir(ppy)2L
12
 ( = 4 s). A pKa* of 5.37 was found. 
 
 Variation of the emission intensity of complex Ir(ppy)2L
12 
in DMSO / H2O (1:1) as a function Figure 41.
of pH. Trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The same profile 
was observed starting from the pre-formed sample of [Ir(ppy)2(L
12
H)]PF6 
2.5.4. [Ir(ppy)2(L
14
H2)]PF6, Ir(ppy)2(L
14
H) and [Ir(ppy)2(L
14
)]Na 
                
                    [Ir(ppy)2(L
14
H2)]PF6            Ir(ppy)2(L
14
H)                [Ir(ppy)2(L
14
)]Na 
 Three different forms of the bis-benzimidazole iridium complexes Figure 42.
The absorption spectra of the titration and the variation of the absorption intensity at 
400 nm are shown in Figure 43 and Table 7.  In acid solution, the UV / Vis absorption 
spectrum was essentially composed of a broad band characterized by two maximum at 325 
nm and 335 nm. From pH = 2 to pH = 6.9 the absorbance spectrum did not show any 
variations. The complex was in its cationic form. After pH = 6.9, the absorbance intensity at 
325 and 335 nm decreased with the pH, whereas the shoulder at 360 nm became more 
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pronounced. The deprotonation of the first azolic ring started. At pH around 7 until pH = 10.5, 
the spectrum shape did not change anymore and was composed of maxima at 335 nm and a 
shoulder at 360 nm. After pH = 10.5, the absorbance intensity at 335 nm increase, which 
involves the formation of a new specie. Between pH = 10.5 until pH = 12, the spectrum shape 
did not change and was composed of a maxima at 335 nm and a shoulder at 360 nm.  By 
comparison with the shape of the neutral form, the absorbance intensity at 370 nm decreased. 
As comparison with the previous titrations of Ir(ppy)2L
10
, Ir(ppy)2L
11
and Ir(ppy)2L
12
, 
where only two forms (neutral and cationic) are possible and observed, we distinguished three 
states (Figure 44). In fact, in the case of the bis-benzimidazole ligand, three species are 
possible: cationic [Ir(ppy)2(L
14
H2)]PF6 neutral (Ir(ppy)2(L
14
H)) and anionic 
([Ir(ppy)2(L
14
)]Na). The deprotonation of the second azolic ring started to give the anionic 
form. The titration from pH = 12 to pH = 2 showed the same characteristics observed for the 
titration from pH= 2 to pH= 12.  
 
 
 
  Variation of the absorption intensity of Ir(ppy)2(L
15
H) in DMSO / H2O (1:1)  as a function of Figure 43.
pH. trifluoroacetic acid and sodium hydroxide were used as acid and base respectively 
The emission spectra always showed a single broad band (Figure 43 and 44). From pH = 
12 to pH around 10.5, the emission intensity of the neutral complex decreased and was 
characterized with a maximum at max = 508 nm. After pH = 10.5 the emission intensity 
increased with the protonation of the azole ring until pH around 6.9 and a maxima emission 
wavelength at  max = 515 nm. At pH = 6.9 and pH = 2 the protonation of the second azolic 
ring was performed to give the cationic form [Ir(ppy)2(L
10
H)]PF6. The protonation was 
characterized by a decrease of the emission intensity and a maximum at max = 555 nm. 
Surprisingly, the luminescence lifetime was constant for all the titration. Two pKa
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calculated at 5.65 and 8.9.  During the titration, the lifetime of degassed solution at pH 2, 6, 
10 and 12 did not show any variation ( = 1 s). 
 
 
 Variation of the emission intensity of complex [Ir(ppy)2(L
14
H2)]PF6 in DMSO / H2O (1:1) as a Figure 44.
function of pH. trifluoroacetic acid and sodium hydroxide were used as acid and base respectively. The 
same profile was observed starting from the pre-formed sample of Ir(ppy)2(L
14
H) 
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 Variation of the absorption intensity of Ir(ppy)2(L
14
H) in DMSO / H2O (1:1) as a function of Figure 45.
pH. trifluoroacetic acid and sodium hydroxide were used as acid and base respectively 
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Table 7. Photophysical data of cationic and neutral iridium complexes in a solution of DMSO /  H2O (1:1) at 298 K  
 Complex abs / nm em / nm  / s 
 
 pKa 
[Ir(ppy)2(L
10
H)]PF6 250, 290, 355, 418 646 0.2 
5.45 
Ir(ppy)2L
10
 250, 294, 361, 396, 446 590 2.8 
[Ir(ppy)2(L
11
H)]PF6 314, 421 530, 556, 602 14 
6.68 
Ir(ppy)2L
11
 316, 356 528, 568, 623 52 
[Ir(ppy)2(L
12
H)]PF6 301, 366, 425 660 1 
5.37 
Ir(ppy)2L
12
 301, 387, 367 585, 620 4 
[Ir(ppy)2(L
14
H2)]PF6
 320, 334, 420, 469 555 1 
5.7; 8.8 Ir(ppy)2(L
14
H) 309, 324, 340, 357, 449 489, 515 1 
[Ir(ppy)2L
14
]Na 309, 336, 357 508 1 
 
 Concluding Remarks 3.
 
We presented the synthesis of new pH sensitive iridium complexes containing iso-
(quinolyl) or 2,2'- bis-benzimidazole unit. Two different routes were used to synthesize the 
neutral or the cationic complex. The deprotonation of the proligand L
n
H (n = 10, 11, 12 and 
14) leads to the neutral form as the ligand acted as a N^N cyclometallated ligand. This 
difference was shown with the NMR spectroscopy and a shift of the aromatic proton signals 
of the (iso)-quinolyl unit. DFT calculations made on the neutral complexes Ir(ppy)2L
n
 and 
cationic complexes [Ir(ppy)2(L
n
H)](PF6) (n = 10 to 12) showed that the HOMO was based 
on the ppy unit for the cationic iridium complexes and on the benzimidazole for the neutral 
complexes. Furthermore, the oxidation of neutral complexes is easier than the cationic 
complexes. Photophysical differences were observed between the three isomers Ir(ppy)2L
10
, 
Ir(ppy)2L
11
, Ir(ppy)2L
12
: the emission wavelength and the luminescence quantum yield of 
Ir(ppy)2L
10 
and Ir(ppy)2L
12 
are similar (em = 579 nm and  = 0.50 and 0.42, respectively) 
and red-shifted compared to Ir(ppy)2L
11
(em = 535 nm and  = 0.15). In contrast, Ir(ppy)2L
11
 
showed a longer lifetime ( = 25 s) than Ir(ppy)2L
10 
and Ir(ppy)2L
12
 ( = 4.4 s and 7.6 s). 
The photophysical properties showed a red shift of the emission for the cationic 
complexes compared to the neutral iridium complexes. The titration made on the (iso)-
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quinoline iridium complexes Ir(ppy)2L
10
, Ir(ppy)2L
11
 and Ir(ppy)2L
12 displayed pKa* of 
5.45, 6.60 and 5.37 respectively. Furthermore, As the isomer iridium complexes Ir(ppy)2L
11 
and [Ir(ppy)2L
11
H](PF6) displayed a longer lifetime than the other complexes, it will be 
interesting to substitute the position 4 of the pyridyl ring by a phenyl or a biphenyl rings. The 
synthetic route was already choose and started (Scheme 6).  
 
Scheme 6. Synthetic route of the formation of [Ir(ppy)2(pbzH-bph)]PF6 
New iridium complexes incorporating a bis-benzimidazole ligand (bbz) were also 
synthesized and studied. In this case, three different forms may be anticipated in principle, 
namely a cationic, a neutral and an anionic form, according to the protonation state of the 
azole nitrogen atoms.  The titration of the bis-benzimidazole iridium complexes displays  of 
three different species: neutral, cationic and anionic forms. Their lifetime did not change for 
all the experiment in a mixture of DMSO / H2O (1:1). 
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 Introduction 1.
Homoleptic and heteroleptic cyclometallated Ir(III) complexes are well known to emit 
phosphorescence at ambient temperature with high quantum yield.
1,2
 Numerous examples of 
cationic complexes incorporating a combination of two cyclometallated ligands and one 
diimine (e.g. bipyridine, phenanthroline or their derivatives) have been reported and the 
influence of the substitution of the diimine ligand on the electronic excited states described.
3
 
The emission energy of such heteroleptic complexes is readily fine-tuned by changing the 
nature of the C^N cyclometallated ligand and/or the N^N diimine ligand. For example, blue 
and green–blue phosphorescent Ir(III) complexes have been reported. The commonly used 
approaches to widen the HOMO–LUMO gap and shift emission further to the blue are either 
the use of electron-withdrawing substituents such as F or CF3 in the metallated aryl ring, 
which lowers the HOMO, or the use of electron-donating substituents such as tert-butyl in the 
bipyridine rings which raise the LUMO (Figure 1).
4,5,6,7
  
 
Figure 1. Example of tuning the emission of an heteroleptic iridium(III) complex. Left to right: [Ir(ppy)2(bpy)]PF6, 
[Ir(ppy)2(
t
Bu-bpy)]PF6, [Ir(2,6F2ppy)2(bpy)]PF6 with their emission wavelengths in degassed DCM at 
298 K 
4,5,6  
 
Another way to increase the energy gap is through the use of non-conjugated ancillary 
diarylphosphine chelates in place of the diimine.
8
 Indeed, the -accepting character of the 
PAr2 group is expected to increase the metal to-ligand charge-transfer (MLCT) by increasing 
the LUMO energy level resulting in blue-shifted emission. Thus, blue shifts of the emission 
maxima have been obtained using neutral
9,10
 or cationic
11
 heteroleptic Ir(III) complexes 
combining C^N ligands with either P^C or P^N chelates.  
Sulfur-based ligands have also been used in the generation of luminescent metal 
complexes. In a landmark study, Cummings and Eisenberg explored two series of 
Pt(diimine)(dithiolate) complexes in which the chelating ligands were systematically varied 
(Figure 2).
12
 These complexes were obtained by replacement of the chloride ligands in 
complexes of the well-known form PtCl2(N^N-diimine), which are normally not luminescent 
em = 595 nm em = 570 nm em = 535 nm 
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in solution at room temperature.  The first series consists of Pt(dbbpy)(dithiolate) complexes, 
with six different 1,1- or 1,2-dithiolates (S^S) of varying electron demand (dbbpy = 4,4'-di-
tert-butyl-2,2'-bipyridine).
13,14,15,16,17,18
 In the second series, electron-donating or withdrawing 
substituents were introduced into the N^N ligands, whilst the dithiolate was held constant as 
toluene-3,4-dithiolate (tdt).
19,20,21,22,23
 These two series of complexes offer dramatic support 
for  a charge-transfer-to-diimine formulation of the lowest-energy excited state. Thus, the 
lowest energy absorption band red-shifts in absorption by > 4000 cm
–1
 in Series II, on-going 
from the platinum(3,4,7,8-tetramethyl-1,10-phenanthroline) (toluene-3,4-dithiolate) 
(Pt(tmphen)(tdt)) through to the platinum(4,4'-bis(ethoxycarbonyl)-2,2'-bipyridine)(toluene-
3,4-dithiolate) (Pt(4,4-(EtCO2)2-bpy)(tdt)), as the electron accepting nature of the diimine 
increases. A good correlation with Hammett constants is observed for the substituted 
bipyridine ligands. There is a similar range of energies for Series I. The quantum yields of the 
complexes are of the order 10
–3
-10
–4
, and lifetimes are in the range 1–1000 ns in DCM at 
298K.  
 
 
Figure 2. Platinum(II) diimine complexes (Series I and II) bearing S^S ligands11  
Series I 
Series II 
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In this Chapter, new platinum(II) and iridium(III) complexes are reported, 
incorporating one (Pt) or two (Ir) N^C-cyclometallating ligands, and with either an S^S or 
P^N-coordinating co-ligand to complete the coordination sphere of the metal ion. P^N ligands 
such as 8-(diphenylphosphino)quinoline (Ph2Pqn), 2-(diphenylphosphino-amino)-pyridine 
(Ph2PNHpy) and 8-(diphenylphosphinoamino)-pyrimidine (Ph2PNHpym) represent an 
interesting class of heterobidentate ligands that had been applied previously at Université de 
Rennes for the palladium-catalyzed methoxy-carbonylation of olefins.
24
 Having in hand these 
chelating ligands, we sought to use them for the preparation of luminescent cationic Ir(III) 
complexes.  Meanwhile, an “inorganic analogue of acac” – well-established in the literature 
but never previously investigated in the context of luminescent metal complexes – has also 
been explored as an S^S-coordinating co-ligand.   
 Heteroleptic Iridium(III) and Platinum(II) Complexes bearing sulfur-2.
based ligands 
2.1. Synthesis  
2.1.1. Ligand Synthesis 
The transition metal chemistry of tetraphenyldithioimidodiphosphinic acid, 
Ph2P(S)NHP(S)Ph2 (SPNHPS) has been studied over recent years as its complexes have many 
applications as selective extraction agent for metals, as lanthanide NMR shift reagents and in 
catalysis.
25,26,27,28
 The synthesis of the SPNHPS ligand consists of the reaction of N-
(diphenylphosphino)-P,P-diphenyl-N-[(1S)-1-phenylethyl] with sulfur in THF at reflux for 8 
h (Scheme 1).
29
 
 
Scheme 1. Synthesis of the pro-ligand SPNHPS 
2.1.2. Synthesis of metal complexes of the SPNPS ligand 
The reaction of SPNHPS with metal ions usually involves the deprotonation of the 
NH group, which leads to the formation of the anionic tetraphenyldithioimidodiphosphinate 
ligand. The produced negative charge is delocalised throughout the SPNPS skeleton, just as in 
the deprotonation of 2,4-pentanedione to give the well-known acac
–
 ligand. 
 
2.1.2.1. Iridium complex 
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Ir(ppy)2(SPNPS) was synthesized under mild conditions.
30
 The iridium dimer 
complex [Ir(-Cl)(ppy)2]2 was reacted with the tetraphenyldithioimidodiphosphinic acid pro-
ligand in a mixture of MeOH and DCM (1:1) at 52 °C for 24 h. After several washings with 
Et2O, the product was obtained in 65 % yield (Scheme 2).   
 
Scheme 2. Synthesis of Ir(ppy)2(SPNPS)
29
 
2.1.2.2. Platinum complexes 
The synthesis of the platinum complexes showed that the temperature had a major 
impact on the reactivity and the formation of the complex. In the first instance, 1 equivalent of 
[Pt(ppy)(µ-Cl)]2 and 3 equivalents of phosphinothioic amide (i.e., Pt : SPNPS ratio = 1:1.5) 
were reacted in 2-ethoxyethanol at 90 °C for 24 h, without addition of base. After purification 
by several washings with Et2O, the homoleptic bis-phosphinothioic amide platinum complex 
Pt(SPNPS)2 was obtained in 46 % yield. There was no evidence for the anticipated 
heteroleptic product.  Apparently, the platinum(II) centre is so thiophilic that the S^S ligand 
can displace the N^C ligand from the coordination sphere of platinum.  When the reaction 
was performed at room temperature with the same stoichiometry, however, in a mixture of 
DCM and methanol (1:1), the heteroleptic Pt(ppy)(SPNPS) complex was isolated in 54 % 
yield (Scheme 3).  
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Scheme 3. Synthetic routes for the formation of Pt(ppy)(SPNPS) and Pt(SPNPS)2 
 
2.2. Characterisation 
2.2.1. NMR spectroscopy 
The NMR spectra of Ir(ppy)2(SPNPS),  Pt(ppy)(SPNPS) and Pt(SPNPS)2 complexes 
were recorded in CDCl3 at 700 MHz. The 
1
H NMR of Pt(SPNPS)2  showed only one set of 
three signals (o, m, p protons of the aromatic rings) due to its symmetry (Figure 3). On the 
other hand, the 
1
H NMR spectrum of Pt(ppy)(SPNPS) displayed two characteristic signals at 
9.4 ppm and 8.1 ppm corresponding to H
py-6 
and H
3´
 of the ppy ligand. Their localisation, 
close to the platinum metal centre, led to a clearly observable 3-bond 
195
Pt–1H coupling for 
both signals. 
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Figure 3. TOP: 1H NMR spectrum of Pt(ppy)(SPNPS) complex and BOTTOM: 1H NMR spectrum of Pt(SPNPS)2.  
Both spectra were recorded in CDCl3 at 298 K. Note the 
195
Pt satellites around the peaks corresponding to 
H
py-6 
and H
3´ 
in the Pt(ppy)(SPNPS) complex 
The 
31
P NMR spectrum of Pt(SPNPS)2  showed only one phophorus signal at 32.6 
ppm due to the equivalence of all four phosphorus atoms  (Figure 4). Coupling to 
195
Pt is 
evident from poorly-defined satellites on either side of the signal. By comparison, the 
31
P 
signal of the free ligand is found at 57.6 ppm.
31
 Furthermore, the 
31
P NMR spectrum of 
Pt(ppy)(SPNPS) displayed two characteristic signals at 33.4 ppm and 36.7 ppm, the latter 
showing well-defined 
195
Pt-coupling satellites.  
 
 
Figure 4. TOP: 31P NMR of Pt(ppy)(SPNPS) complex and BOTTOM: 31P NMR of Pt(SPNPS)2. All spectra were 
recorded in CDCl3 at 298 K. Note the 
195
Pt satellites around peaks
 
in Pt(SPNPS)2 and Pt(ppy)(SPNPS) 
complexes  A third signal appeared, attributed to the 
31
P of the free ligand.  
 
 
H2, 6 
H4 
H4 + H3, 5 H2, 6 
H3, 5 
HPy-6 H
3´ 
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2.2.2. Crystallography 
The structures of the three complexes were confirmed by X-ray crystal structure 
analyses, as shown in Figures 5 and 6. Selected bond length and bond angle data are listed in 
Table 1. Ir(ppy)2(SPNPS) crystallised in a mixture of DCM and hexane solution. The 
complex shows a distorted octahedral geometry around iridium, consisting of two 
cyclometallated C^N ligands and one S^S ligand. The ligand arrangement, where the two Ir–
C bonds are in mutually cis positions, is similar to that of the parent phenylpyridine ligands in 
many heteroleptic Ir(III) complexes such as the diketonate complex Ir(ppy)2(acac) and the 
cationic bipyridine derivatives. The N–Ir and C–Ir bond distances involving the 
cyclometallated ligand are in the same range as those reported for related Ir complexes.
14
 The 
Ir–S bond distances of about 2.48 Å are significantly longer than those to the coordinated ppy 
ligand. 
 
Figure 5. Molecular structure of Ir(ppy)2(SPNPS) 
Pt(ppy)(SPNPS) crystallised by slow evaporation  from a chloroform solution 
(Figure 9). The molecule adopts a slightly distorted square-planar geometry: the angles trans 
S
1
^Pt^N (174.9°) and S
2
^Pt^C (172.2°) showed a deviation from the 180° of a pure square 
planar geometry. Furthermore, in this case, the Pt–S bond lengths (2.038 Å and 2.031 Å) are 
similar to those of Pt–C and Pt–N (2.010 Å and 2.048 Å respectively). Similar bond lengths 
were observed for cis-Pt(ppy)2. 
Pt(SPNPS)2 was crystallised in DMSO solution (Figure 6). The crystal structure of 
this compound was previously reported.
32
 The complex adopts a square planar geometry with 
angles trans S
1
^Pt^S
1*
 and S
2
^Pt^S
2*
 of 180°, angle cis S
1
^Pt^S
2
* and S
1*
^Pt^S
2
 of 86.8° and 
angle S
1
^Pt^S
2
 and S
1*
^Pt^S
2*
 of 93.1°. These measurements are comparable with literature 
review. The differences between S^Pt^S are due to the six-membered metallo rings. The four 
Pt–S bond lengths are identical (Pt–S = 2.33 Å) and shorter than observed for 
S1 
S2 
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Pt(ppy)(SPNPS). The bond length P–S2 and P–S1 (2.0243 Å and 2.0309 Å respectively) are 
closer to single bond than double bond lengths. An angle of 60.6° was observed between the 
square planar S1^S2^Pt^S1*^S2* plane and the plane formed by the ligand S1^P1^P2^S2.  
 
Figure 6. Molecular structure of Pt(ppy)(SPNPS) (left) and Pt(SPNPS)2 (right) (T = 120 K) 
Table 1. Selected bond lengths (Å) and angles (°) of Pt(II) and Ir(III) complexes incorporating the SPNPS ligand. 
(All structures were acquired at 120 K). Data for the cis-Pt(ppy)2 and fac-Ir(ppy)3 are included for 
comparison.
33
 
Complex Bond angles / ° 
trans X^Pt^Y 
Bond angles / ° 
cis X^Pt^Y 
Bond angles / ° 
cis X^Pt^X and 
cis Y^Pt^Y  
Pt(ppy)(SPNPS) 
(X = S
1,2
, Y = N, C) 
 
174.9(6), 
172.2(6) 
94.5(6), 94.9(6) 89.7(18), 
81.0(8) 
Pt(SPNPS)2 
(X = S
1,2
, Y = S
1*,2*
)
 
180 86.8(3) 93.18(3) 
cis-Pt(ppy)2 
(X = C, Y = N) 
176.4(3), 
176.8(3) 
103.3(3), 
101.9(3) 
79.3(1), 79.3(1) 
 
  
Complex Bond lengths 
M–S1 
Bond lengths 
M–S2 
Bond  lengths 
M–X 
Bond  lengths 
M–Y 
Ir(ppy)2(SPNPS) 
(X = C, Y = N) 
2.492(14) 2.479(14) 2.030(6), 2.035(6) 2.059(5), 2.053(5) 
fac-Ir(ppy)3 
(X = C, Y = N) 
˗ ˗ 2.032, 2.034, 2.060 2.096, 2.095, 2.01 
Pt(ppy)(SPNPS) 
(X = C, Y = N) 
2.33(5) 2.41(5) 2.010(2) 2.048(19) 
Pt(SPNPS)2 
(X = S, Y = S) 
2.336(7) 2.337(7) 2.336(7) 2.337(7) 
cis-Pt(ppy)2 
(X = C, Y = N) 
˗ ˗ 1.993(4), 1.993(4) 2.127(3), 2.127(3) 
S2 
S1 
S1 
S2 
C 
N 
S1* 
S2* 
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2.2.3. Electrochemistry 
Cyclic voltammetry was performed in DCM, with tetrabutylammonium 
hexafluorophosphate (0.1 M) as a supporting electrolyte, and the solutions were purged with 
nitrogen before each measurement. All data were measured at multiple scan rates (0.05, 0.1, 
0.2, 0.3, 0.4 and 0.5 V.s-1) and are shown in Table 2.   Pt(ppy)(SPNPS) displayed one 
irreversible oxidation wave with an oxidation potential of Ep
ox
 = 0.81 V, but no reduction 
waves within the investigated range. Pt(SPNPS)2 showed one irreversible oxidation wave at 
1.00 V (Ep
ox
 = 0.94 V) and one irreversible reduction wave at  Ep
red 
=  –1.9 V. The cyclic 
voltammogram of Ir(ppy)2(SPNPS) (Figure 7) displayed a reversible first oxidation wave 
(E1/2 = 0.60 V) and  a second, irreversible, second oxidation wave at around 1.1 V. No 
reduction was observable within the accessible window. 
 
 
Figure 7. Cyclic voltammogram of Ir(ppy)2(SPNPS) in 0.1 M NBu4PF6 at a glassy carbon electrode. Scan rate = 0.05  
V s
–1
.  
Table 2. Electrochemical data of Ir(ppy)2(SPNPS),  Pt(ppy)(SPNPS) and Pt(SPNPS)2 in DCM solution (0.1 M 
NBu4PF6) 
Complex 
 
Ep
ox
 / V Ep
red
 / V E1/2 / V 
Ir(ppy)2(SPNPS) 
 
 0.47 - 0.60 
Pt(ppy)(SPNPS) 
 
 0.81 - - 
Pt(SPNPS)2 
 
0.94  –1.9 - 
 
2.2.4. Photophysics 
The ground-state absorbance spectra of Ir(ppy)2(SPNPS), Pt(ppy)(SPNPS) and 
Pt(SPNPS)2 in dichloromethane solution are shown in Figure 8. They all showed intense 
bands in the UV region between 250 and 310 nm assigned to the 
1-* transitions of the 
-5.00E-06
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ligands.  A weaker band at lower energy, extending into the visible region, is assigned to 
metal-to-ligand charge transfer transitions in each case. Ir(ppy)2(SPNPS) shows lower energy 
MLCT band than Pt(ppy)(SPNPS) and Pt(SPNPS)2.  It is common for iridium complexes of 
a given N^C ligand to absorb at lower-energy than platinum complexes. As an example, 
Ir(ppy)2(acac) absorbs at 476 nm whereas Pt(ppy)(acac) absorbs at 392 nm.
34,35
 
 
Figure 8. UV-visible absorption spectra of Ir(ppy)2(SPNPS), Pt(ppy)(SPNPS) and Pt(SPNPS)2 in DCM at 298 K  
Table 3.  Photophysical data of iridium(III) and platinum(II) complexes in degassed DCM at 298K and EPA solution 
at 77 K 
Complex abs nm (
L mol-1 cm-1) em / nm 
298 K 
 em / nm 
77 K 
Ir(ppy)2(SPNPS) 300 (35.3), 355 (6.07),  
397 (4.58) 
- - - 
Pt(ppy)(SPNPS) 280 (18.5), 328 (6.37),  
373 (6.19) 
515, 546, 
605 (sh) 
0.001 475, 486, 500, 
511, 538, 551, 
592 
Pt(SPNPS)2 274 (30.2), 332 (44.1),  
368 (3.96), 400 (1.67) 
- - - 
Luminescence data for Ir(ppy)2(SPNPS), Pt(ppy)(SPNPS) and Pt(SPNPS)2 are 
shown in Table 3. Pt(ppy)(SPNPS) was weakly emissive at room temperature, showing a 
broad band with a maximum at 515 nm (Figure 9). At 77 K, the emission spectrum shows 
pronounced vibrational structure, typical of Pt(N^C) complexes, with a maximum at 475 nm.  
Similar emission was observed for Pt(ppy)(acac) (em = 481 nm).
35
 The formation of an 
aggregate may be the cause of the broad, red shifted emission at 298 K. Neither Pt(SPNPS)2 
nor Ir(ppy)2(SPNPS) displayed detectable emission at room temperature or at 77 K.  
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Figure 9. Emission spectra of Pt(ppy)(SPNPS) in degassed DCM at 298 K (red) and in EPA solution at 77 K (blue) 
 Heteroleptic iridium(III) complexes bearing phosphine-based ligands 3.
P^N ligands such as 8-(diphenylphosphino)quinoline (Ph2Pqn, L
16
), 2 
(diphenylphosphinoamino)pyridine (Ph2PNHpy, L
17
) and 8-(diphenylphosphinoamino)-
pyrimidine (Ph2PNHpym, L
18
) represent an interesting class of heterobidentate ligands that 
have been applied for the palladium catalyzed methoxy-carbonylation of olefins.
24
 Having in 
hand these chelating ligands, we sought to use them for the preparation of luminescent 
cationic Ir(III) complexes (Figure 10). The three P^N ligands were prepared following 
previously reported procedures.
36,37
 The cationic complexes [Ir(ppyMe)2L
n
]PF6 (L
n
 = L
16
, L
17
 
and L
18
) in which L
16
 = 8-(diphenylphosphino)quinoline, L
17
  = 2-
(diphenylphosphinoamino)pyridine and L
18
 = 8-(diphenylphosphinoamino)pyrimidine were 
readily accessible by treatment of the chloro-bridged dimer [Ir(C^N-ppyMe)2(-Cl)]2 with 2 
equivalents of the appropriate P^N ligand in the presence of excess AgPF6 to facilitate the 
removal of the chloride ligands. The AgPF6 also ensures that the complexes are isolated as 
their hexafluorophosphate salts, which offer better solubility over the chloride salts. All 
complexes were isolated in good yield after recrystallization from DCM/Et2O. They were 
fully characterized by standard spectroscopic methods (
1
H and 
31
P NMR) and gave 
satisfactory analysis.  
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Figure 10. Representation of iridium complexes [Ir(ppyMe)2L
16
]PF6, [Ir(ppyMe)2L
17
]PF6 and [Ir(ppyMe)2L
18
]PF6. 
[Ir(ppy)2(dppmp)]PF6, investigated in a study by another research group, has been included  for 
comparison.
9
 
3.1. Electrochemistry 
Cyclic voltammetry was performed in DCM, with tetrabutylammonium 
hexafluorophosphate (0.1 M) as a supporting electrolyte, and the solutions were purged with 
nitrogen before each measurement. All data were shown in Table 4. 
All complexes showed an irreversible oxidation and reduction. Determination of Eonsets 
was previously explained (Chapter 3, Section. 2.3.4). We can observe similar energy gap 
(2.71 eV) and optical gap (2.75 eV) for complex [Ir(ppyMe)2L
16
]PF6. Furthermore, no 
significant difference of the electrochemical properties was observed for complexes 
[Ir(ppyMe)2L
17
]PF6 and [Ir(ppyMe)2L
18
]PF6 as we noticed before. 
Table 4. Electrochemical data of 1, 2 and 3 in DCM solution (0.1 M NBu4PF6) 
Complex Eonset-ox (V);  
HOMO (eV) 
Eonset-red (V);  
LUMO (eV) 
Energy 
gap Eg  
(eV) 
Optical 
gap  
(eV) 
[Ir(ppyMe)2L
16
]PF6 0.77 ; -5.17 -1.94 ; -2.46 2.71 2.75 
[Ir(ppyMe)2L
17
]PF6 1.11 ; -5.51 -1.77 ; -2.63 2.88 3.02 
[Ir(ppyMe)2L
17
]PF6 1.22 ; -5.62 -1.61 ; -2.79 2.83 3.02 
 
3.2. Photophysics 
3.2.1. Absorption 
The UV–Vis absorption data of complexes [Ir(ppyMe)2L
16
]PF6,  
[Ir(ppyMe)2L
17
]PF6  and [Ir(ppyMe)2L
18
]PF6 in DCM are summarized in Table 5, and the 
corresponding spectra are shown in Figure 11. The spectra show intense absorption bands in 
the higher energy region (< 340 nm) which are dominated by intra-ligand 1IL (*) 
[Ir(ppyMe)2L
16
]PF6  [Ir(ppyMe)2L
17
]PF6  [Ir(ppyMe)2L
18
]PF6  [Ir(ppy)2(dppmp)]PF6  
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transitions of the C^N and P^N ligands, and a moderately intense lower-energy absorption 
band at longer wavelength (around 360 nm) assigned to the tail of the IL transitions 
overlapping with MLCT d(Ir) * (C^N and P^N) transitions. The spectrum of complex 
[Ir(ppyMe)2L
16
]PF6 has a weak shoulder extending to longer wavelengths than for 
[Ir(ppyMe)2L
17
]PF6 and [Ir(ppyMe)2L
18
]PF6, possibly reflecting the more extended -
conjugation of the chelated quinolylphosphine ligand. The spectra of [Ir(ppyMe)2L
17
]PF6 
and [Ir(ppyMe)2L
18
]PF6 are very similar to those reported for the related complex 
[Ir(ppy)(dppmp)]PF6 having a P^N-coordinated 2-diphenylphosphinomethylpyridine 
(dppmp) ligand, which contains a saturated  CH2 bridge instead of NH.
9 
 
Figure 11. UV-visible absorption spectra of complexes [Ir(ppyMe)2L
16
]PF6, [Ir(ppyMe)2L
17
]PF6 and 
[Ir(ppyMe)2L
18
]PF6 in DCM at 298 K 
3.2.2. Emission 
Upon irradiation, complexes [Ir(ppyMe)2L
16
](PF6), [Ir(ppyMe)2L
17
](PF6) and 
[Ir(ppyMe)2L
18
](PF6) are photoluminescent in DCM solution at 298 K but they display very 
different emission characteristics depending on the nature of the P^N ligand. The 
luminescence data are listed in Table 5 and the emission spectra are shown in Figure 12. 
Complex [Ir(ppyMe)2L
16
](PF6) displays a broad emission band centered in the orange region 
of the spectrum at em590 nm with a lifetime of  = 1800 ns. The emission is red-shifted 
compared to related well-known complexes such as Ir(C^N-ppy)2(O^O-acac), which may be a 
reflection of a lower-lying LUMO, localized on the quinolyl group of the P^N ligand as 
opposed to the pyridyl of the C^N ligands. Complexes [Ir(ppyMe)2L
17
](PF6)  and 
[Ir(ppyMe)2L
18
](PF6), on the other hand, emit in the blue spectral region, and the spectra 
display well-resolved structure. The breaking of the conjugation of the P^N bridge has an 
essential impact in determining the nature of the emissive state. The blue emission could be 
[Ir(ppyMe)2L
17
]PF6   
[Ir(ppyMe)2L
16
]PF6   
[Ir(ppyMe)2L
18
]PF6   
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attributed to the -accepting properties of the phosphorus, lowering the energy of the metal-
based orbitals that contribute to the HOMO, whilst the LUMO remains localized on the 
pyridyl rings of the C^N ligands. As has frequently been found in other studies aimed at blue 
emitters, the quantum yield falls off and the lifetimes shorten on moving to the blue region, 
possibly due to quenching of the emissive state through close-lying d-d states. Replacement of 
a pyridine by a pyrimidine ring in [Ir(ppyMe)2L
18
]PF6 has little influence on the emission 
maxima, but it is striking that the lifetime decreases by an order of magnitude. This could be 
due to a greater degree of distortion in the excited state of [Ir(ppyMe)2L
18
]PF6. Indeed, close 
inspection of the spectra of [Ir(ppyMe)2L
17
]PF6  and [Ir(ppyMe)2L
18
]PF6 reveals that, although 
the wavelengths of the emission maxima coincide, the relative intensity of the 0–0 vibrational 
band in the spectrum of [Ir(ppyMe)2L
18
]PF6  is substantially smaller than for 
[Ir(ppyMe)2L
17
]PF6, consistent with a larger degree of excited state distortion in the former.  
 
Figure 12. Normalized phosphorescence emission spectra of complexes [Ir(ppyMe)2L
16
]PF6,  [Ir(ppyMe)2L
17
]PF6  
and [Ir(ppyMe)2L
18
]PF6 in degassed DCM solution at 298 K 
At 77 K, on the other hand, such distortion will be impeded, and indeed the spectra of 
[Ir(ppyMe)2L
17
]PF6  and [Ir(ppyMe)2L
18
]PF6 under these conditions are essentially identical 
(Figure 13). The significant variation of emission wavelength between the use of 
„„conjugated‟‟ and „„non-conjugated‟‟ P^N ligands has been previously reported. For instance, 
when diphenylnaphthyl-phosphine (dpn) is used as ancillary ligand in Ir(III) complexes 
[(C^N-Fppy)2Ir(dpn)],
38
 a broad emission in the orange region is observed em580–630 
nm (FppyH = 2-(2,4-difluoro-phenyl)pyridine) whereas the diphenylbenzyl phosphine 
analogue gives rise to blue-emitting species.
4a,b  
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Figure 13. Normalized phosphorescence emission spectra of [Ir(ppyMe)2L
16
]PF6, [Ir(ppyMe)2L
17
]PF6 and 
[Ir(ppyMe)2L
18
]PF6 complexes in EPA solution at 77 K 
  
Table 5. Photophysical data of [Ir(ppyMe)2L
16
]PF6 (1),  [Ir(ppyMe)2L
17
]PF6 (2) and [Ir(ppyMe)2L
18
]PF6 (3) 
complexes in degassed DCM at 298 K and in EPA solution at 77 K 
Complex abs / nm 
( / 103 L mol-1 cm-1) 
em / nm 
at 298K 
 / ns em / nm 
at 77K 

at 
1 293sh (22.3), 359 (7.1) 580 1800 500, 530, 567 0.075 
2 296 (20.1), 361 (5.9) 461, 491, 522 270 458, 481, 512 0.0068 
3 306sh (16.8), 362 (6.3) 460, 493, 526 30 458, 481, 512 0.0004 
 
 Concluding Remarks 4.
Two neutral cyclometallated platinum complexes, Pt(SPNPS)2 and Pt(ppy)(SPNPS) 
and one iridium complex Ir(ppy)2(SPNPS) were prepared in moderate to good yields (46% 
54% and 65%, respectively). The analysis of their properties was carried out by X-ray 
crystallography and by photoluminescence. Pt(SPNPS)2 and Ir(ppy)2(SPNPS) did not show 
any emission at room  temperature and at 77 K, while Pt(ppy)(SPNPS) is weakly emissive at 
room temperature (em = 515 nm and  = 0.001). Furthermore, we showed that the use of 
„„non-conjugated‟‟ and  accepting phosphorus-based species as ancillary ligands allows the 
emission of cationic heteroleptic Ir(III) complexes (1, 2 and 3) from yellow (complex 1) to the 
blue region (complexes 2 and 3). 
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 Materials and Methods 1.
All solvents used were Analar® quality (with the exception of acetonitrile which was HPLC 
grade) and were used without further purification. Dry, oxygen-free solvents were obtained by 
passing the HPLC grade solvent through a Pure Solv 400 solvent purification system. Water 
was purified using the PuriteSTILL Plus
TM
 system and had a conductivity of ≤ 0.04 μS cm-1. 
Unless stated otherwise, all reagents were used as supplied from commercial sources. 
Reactions requiring an inert atmosphere were carried out using Schlenk line techniques under 
an atmosphere of dry nitrogen. 
Thin layer chromatography (TLC) was carried out on silica plates (Merck Art 5554) which 
are fluorescent upon irradiation at 254 nm. Column chromatography was carried out using 
silica (Merck Silica Gel 60, 230-400 mesh). 
 Characterization Techniques 2.
1
H NMR spectra were recorded in the appropriate solvents on Mercury-400, Varian-200, 
Varian-500 or VNMRS-700 MHz instruments. 
13
C NMR spectra were recorded at 126 MHz 
on the Varian Inova-500 or at 176 MHz on the VNMRS-700 MHz. Chemical shifts are 
quoted relative to the appropriate protio-solvent resonances, and all J values are given in Hz. 
Low-resolution electrospray mass spectra (ES) were recorded using a Thermo Finnigan LTQ 
FT mass spectrometer, with methanol or acetonitrile as the carrier solvent. Accurate ES mass 
spectra were obtained using either a LCT Premier XE mass spectrometer (Waters Ltd, UK) or 
a LTQ FT mass spectrometer (Thermo-Finnigan Corporation). Solid state mass spectroscopy 
was performed on a Waters Xevo quadrupole time-of-flight (QToF) machine fitted with an 
atmospheric solids analysis probe (ASAP). High resolution mass spectrometry was 
performed on a Waters Xevo QToF (ASAP) spectrometer. 
 
Elemental analysis was performed using an Exeter Analytical E-440 elemental analyser. 
Melting points were determined on a Gallenkamp 8893 39 capillary melting point apparatus. 
 
206 
 
X-Ray diffractions were collected by Dr Dmitry S. Yufit at Durham University. 
Crystallographic data for all reported structures were collected at 120 K. X-Ray diffraction 
data for all complexes were collected on an Oxford Diffraction Gemini S Ultra diffractometer 
using graphite monochromated Mo K radiation ( = 0.71073 Å). The data were collected 
and integrated using Oxford Diffraction CrysAlis software.
1
 X-ray diffraction data for PtL
11
Cl 
were collected at 120 K on a Nonius Kappa CCD diffractometer using graphite 
monochromated Mo K radiation ( = 0.71073 Å); data were collected using the strategy 
calculated by the COLLECT software (Nonius, 1999)
2
 and integrated using HKL Scalepack.
3
 
The remaining X-ray diffraction  data were collected at 120 K on a Bruker APEX CCD 
diffractometer. These data were collected using the SMART software, with subsequent data 
processing carried out in SAINT.
4
 All of the structures were solved by direct methods in 
SHELXS-97 and refined by full matrix least squares on F2 in SHELXL-97.5 
 
 Photophysical Characterization 3.
UV/Vis absorption spectra were measured using a Biotek Instruments UVIKON XS 
spectrometer operating with LabPower software. The sample was held in a quartz cuvette of 1 
cm path length, and spectra were recorded against a reference of pure solvent held in a 
matched cuvette. Extinction coefficients were determined using a dilution method, and 
graphical application of the Beer-Lambert law: 
A = ε l c 
Equation 1: where A is absorbance, ε is molar absorptivity, l is the path length and c is the 
concentration. 
Solution-based emission and excitation spectra were acquired on a Jobin-Yvon Spex 
Fluoromax-2 spectrometer. All samples were contained within quartz cuvettes of 1 cm path 
length. Samples that were to be measured in the absence of air were placed in quartz cuvettes 
that were modified with appropriate glassware to allow connection to a high vacuum line. To 
remove air prior to the measurement, the sample was degassed within the cuvette by three 
freeze-pump-thaw cycles. Emission was recorded at 90  to the excitation source, and 
appropriate filters were used when required to remove second order peaks. All emission 
spectra were corrected after acquisition for dark count and for the spectral response of the 
detector. Excitation spectra were automatically corrected upon measurement for lamp output, 
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through use of a beam splitter which directs 8% of the excitation light to a reference 
photodiode. 
The quantum yields were determined relative to a reference solution containing [Ru(bpy)3]Cl2. 
The quantum yield of this complex is well established in air-equilibrated H2O to be 0.028.
11
 To 
measure the quantum yield, a sample of the complex in DCM was prepared so that the 
absorbance at the chosen excitation wavelength was below 0.1, to minimize inner filter 
effects. A solution containing [Ru(bpy)3]Cl2 with similar absorbance was prepared, and the 
emission spectra of the complex and reference were measured under identical conditions (i.e. 
same excitation wavelength, same slit size). The quantum yield was determined from the 
absorbance and emission data by use of equation 1: 
 = ST [I / IST] [AST / A] [n
2
 / nST
2
] 
Equation 2: where Φ is the quantum yield of the sample, ΦST is the quantum yield of the 
standard, I and IST are the overall intensities of the sample and standard respectively 
(obtained from integration of the respective emission spectrum), A and AST are the 
absorbance of the sample and standard at the chosen excitation wavelength, and n and nST 
are the refractive indices of the solvents. 
Lifetimes were determined using an Edinburgh Instruments OB 920 fluorimeter. 
Luminescence lifetimes of the complexes up to approximately 10 µs were measured by time-
correlated single-photon counting (TCSPC), using an EPL-375 pulsed-diode laser as the 
excitation source (374 nm excitation pulse length of 60 ps). The laser repetition rate was 
selected such that the pulse period was at least 5-10 times longer than the luminescence 
lifetime being measured. The emission was detected at 90  to the excitation source, after 
passage through a monochromator using a Peltier-cooled R928. Lifetimes in excess of 10 µs 
were measured by multichannel scaling, and a xenon flash lamp was used as the excitation 
source (excitation wavelength matched to a suitable absorption band of the complex, pulse 
length of approximately 2 µs). 
The lifetimes were obtained by least-squares fitting to a mono-exponential decay and 
goodness-of-fit was assessed from the residuals. Low temperature (77 K) experiments were 
performed using a glass vacuum cold finger apparatus built in-house. A small amount of 
sample was dissolved in a mixture of ether/isopentane/ethanol (2:2:1 by volume and referred 
to in this thesis as EPA), and placed into a glass tube. The cold finger was filled with liquid 
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nitrogen and the tube containing the sample was inserted (see right). EPA forms an 
amorphous glass upon freezing, which has a very low propensity for cracking. 
 Electrochemical Measurements 4.
Cyclic voltammetry was carried out in a background electrolyte of tetrabutylammonium 
tetrafluoroborate (0.1 M) in CH2Cl2. A Autolab type III potentiostat was used with computer 
control and data storage via GPES Manager. A three-electrode assembly was employed, 
consisting of a platinum wire counter electrode, platinum flag reference electrode and a 
platinum working electrode. The measurements were carried out in a glass cell charged with 2 
mg of complex in 2 mL of electectrolyte and purged with nitrogen. 
 General Procedures 5.
5.1. General Procedures for Chapter Three 
5.1.1. Synthesis of Tetradentate Ligands 
General Stille Cross Coupling Procedure 
 
Precursor 1, a stannane derivative and LiCl were placed into a Schlenk tube. Toluene was 
added and a condenser was fitted. The mixture was degassed by three freeze-pump-thaw 
cycles, and bis(triphenylphosphine) palladium dichloride PdCl2(PPh3)2 was added to the 
mixture. The reaction was heated at 110 °C for 48 h under nitrogen. After cooling to room 
temperature, water (5 mL) was poured into the reaction mixture. The organic phase was 
extracted with dichloromethane (2 × 10 mL), and washed with water (2 × 10 mL). The 
organic layer was dried with MgSO4, filtered, and the solvent was removed under reduced 
pressure. The crude product was purified by column chromatography on silica gel. 
 
General Suzuki-Miyaura Cross Coupling Procedure 
 
Precursor IV, a boronic acid derivative and sodium carbonate were suspended in a mixture of 
DME and water (5:1) or in toluene. The reaction mixture was degassed by three freeze-pump-
thaw cycles and put under a nitrogen atmosphere. The catalyst, tetrakis(triphenylphosphine) 
palladium, Pd(PPh3)4 was added to the solution, and the mixture was heated at 80 °C for 24 h. 
After cooling to room temperature, the solution was poured into water, and the organic layer 
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was extracted with DCM (2 × 10 mL) and washed with water (2 × 10 mL). The organic layer 
was dried with MgSO4, filtered, and the solvent was removed in vacuo. The crude product 
was purified by column chromatography on silica gel. 
5.1.2. Synthesis of tetradentate complexes 
General platinum complexation procedure 1 
 
Ligand L
n
H2 (0.66 mmol), K2PtCl4 (0.30 g, 0.72 mmol), and acetic acid (3 mL) were 
introduced into a Schlenk. The reaction mixture was degassed with three freeze-pump-thaw 
cycles, and heated at 90 °C for 24 to 48 h. The reaction was quenched with water (5 mL), and 
the precipitate was collected by centrifugation and washed with EtOH (1 × 5 mL) and Et2O (5 
× 5 mL). 
 
General palladium complexation procedure 2 
 
Ligand L
n
H2 (0.20 mmol), Pd(OAc)2 (0.05 g, 0.22 mmol), and acetic acid (3 mL) were 
introduced into a Schlenk. The reaction mixture was degassed with three freeze-pump-thaw 
cycles, and heated at 90 °C for 24 h. The reaction was quenched with water (5 mL), and the 
precipitate was collected by centrifugation and washed with EtOH (1 × 5 mL) and Et2O (5 × 5 
mL). The product was dissolved in a minimum of DMF and crystallized by slow diffusion of 
DCM into the DMF.  
 
General mercuric complexation procedure 3 
 
Ligand L
n
H2 (0.062 mmol), Hg(OAc)2 (0.31 mmol, 5 equiv.), and EtOH (3 mL) were 
introduced into a Schlenk. The reaction mixture was heated at 78 °C for 24 h. The reaction 
was quenched with water (5 mL), and the precipitate was collected by Büchner filtration and 
washed with EtOH (1 × 5 mL) and Et2O (5 × 5 mL)  
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5.2. General Procedures for Chapter Four 
5.2.1. Ligands Synthesis 
Method A: General procedure for the synthesis of benzimidazol-(iso)-
quinolines: 
 
Under an atmosphere of nitrogen, the heterocyclic carboxylic acid derivative (1 eq), 1,2-
benzenediamine (1 eq) and an excess of polyphosphoric acid (PPA) were heated to 150 °C for 
2 h. After cooling  to room temperature, the solution was poured into cold water with stirring. 
The pH was adjusted to 7-8 by addition of 1 M NaOH aqueous solution and the resulting 
beige precipitate was filtered, washed with water, and dried under vacuum. 
 
5.2.2. Complexes Synthesis 
Method B: General procedure for the synthesis of cationic, bis-cyclometallated 
iridium complexes:  
 
A suspension of [Ir(µ-Cl)(ppy)2]2 (1 eq) and ligand (2.2 eq) in a mixture of MeOH and DCM 
(1:1) was heated at 52 °C for 24 h under a positive pressure of N2. After cooling to room 
temperature, the solvent was removed under reduced pressure and the resulting solid was 
dissolved in a mixture of water and acetonitrile (1:1). The solution was added dropwise to an 
aqueous solution of KPF6, and the resulting precipitate was collected by centrifuge and 
washed with water. The product was dried under vacuum to give a red, yellow or orange 
solid.   
 
Method C: General procedure for the synthesis of neutral iridium complexes:  
 
A mixture of ligand (2 eq), [Ir(µ-Cl)(ppy)2]2 (1 eq), and potassium carbonate (10 eq) in DMF 
(3 mL) was degassed prior to being refluxed under an atmosphere of nitrogen for 24 h. After 
allowing to cool to ambient temperature, water (10 mL) was added, and the resulting 
precipitate was separated by centrifugation, and washed with water (3 x 5 mL). The yellow 
solid was dissolved in CH2Cl2, the solution dried over MgSO4, filtered, and the solvent 
removed under reduced pressure. Recrystallisation from THF gave the title complex. 
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 Experimental Details for Chapter Two 6.
[Ir(C^N-thpy)2(-Cl)]2 
 
 
 
In a Schlenk tube, under argon atmosphere, 2,2'-thienylpyridine (0.94 g, 5.81 mmol) and 
iridium chloride (0.5 mg, 1.67 mmol) were dissolved in a mixture of 2-ethoxyethanol (12 mL) 
and water (4 mL). The reaction mixture was stirred for 24 h at 135 °C, quenched by addition 
of distilled water (15 mL) and the precipitate was decanted by centrifugation. The product 
was washed with ethanol and diethyl ether. An orange powder was obtained in 80 % yield 
(0.73 g).
 1
H NMR (400 MHz, CD2Cl2): 9.04 (ddd, J = 5.8 Hz, J = 1.5 Hz, J = 0.8 Hz, 1H, H
6
-
py), 7.71 (ddd, J = 8.1 Hz, J = 7.4 Hz, J = 1.6 Hz, 1H, H
4
-py), 7.60 (ddd, J = 8.1 Hz, J = 1.5 
Hz, J = 0.8 Hz, 1H, H
3
-py), 7.16 (d, J = 4.8 Hz, 1H, H
5
-thio), 6.71 (ddd, J = 7.4 Hz, J = 5.8 
Hz, J = 1.5 Hz, 1H, H
5
-py), 5.93 (d, J = 4.8 Hz, 1H, H
4
-thio).
13
C {
1
H} NMR (101 MHz, 
CD2Cl2):  164.6 (C
2
-py), 151.5 (C
6
-py), 145.0 (C
3
-thio), 137.2 (C
4
-py), 135.4 (C
2
-thio), 129.2 
(C
4
-thio), 127.6 (C
5
-thio), 119.5 (C
5
-py), 117.4 (C
3
-py). 
 
fac-Ir(C^N-thpy)3 
 
 
 
 
The [Ir(C^N-thpy)2(-Cl)]2 (0.73 g, 0.66 mmol) was added to a mixture of 2,2'-
thienylpyridine (0.27 g, 1.65 mmol) and K2CO3 (0.91 g, 6.62 mmol) in 20 mL of glycerol. 
The solution was stirred for 48 h at 200 °C, quenched by addition of 20 mL of distilled water 
and the resulting precipitate separated by centrifugation. The product was washed with 
ethanol and diethyl ether. An orange powder was obtained after purification by column 
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chromatography on silica gel (eluant = CH2Cl2, Rf = 0.61). (0.51 g, 58 %). 
1
H NMR (400 
MHz, CD2Cl2): 7.58 (d, J = 5.4 Hz, 1 H), 7.54 (d, J = 7.5 Hz, 1 H), 7.49 (d, J = 7.5 Hz, 1 
H),7.21 (d, J = 4.6 Hz, 1 H), 6.79 (t, J = 5.6 Hz, 1 H) ,6.35 (d, J = 4.7 Hz, 1 H). 
13
C {
1
H} 
NMR (100 MHz, CD2Cl2): 162.4, 159.2, 147.9, 136.7, 135.3, 134.8, 127.4, 119.2, 117.4. 
 
N-butyl-4-bromonaphtalimide, NI-Br 
1
 
 
 
 
In a round bottom flask, 4-bromonaphthalene (2 g, 7.2 mmol) and n-butylamine (0.64 g, 8.6 
mmol) were dissolved in EtOH (150 mL). After 18 h of stirring at 60 °C, the solution was 
hydrolysed with water (20 mL), and the compound was extracted with DCM (40 mL). The 
organic phase was dried with MgSO4. A light brown powder was obtained. Yield 1.5 g (64%). 
1
H NMR (400 MHz, CDCl3): 8.68 (d, J = 7.2 Hz, 1 H) 8.57 (d, J = 8.5 Hz, 1 H), 8.41 (d, J = 
7.9 Hz, 1 H), 8.02 (d, J = 7.9 Hz, 1 H), 7.84 (t, J = 7.9 Hz, 1 H), 4.17 (t, J = 7.5 Hz, 2 H), 1.71 
(m, 2 H), 1.45 (m, 2 H), 0.98 (t, J = 7.3 Hz, 3 H). 
13
C {
1
H} NMR (100 MHz, CDCl3): 163.5, 
163.4, 133.1, 131.9, 131.1, 131.0, 130.5, 130.1, 128.9, 128.0, 123.1, 122.2, 40.4, 30.1, 20.4, 
13.9. 
1-Bromopyrene, Pyr-Br 
2
 
 
 
 
In a round bottom flask, pyrene (2 g, 10 mmol) and HBr (1.7 mL, 11 mmol) were added to  a 
mixture of MeOH and Et2O (20 mL : 20 mL). An excess of H2O2 was added dropwise to the 
reaction mixture. After 24 h of stirring at room temperature, the precipitate was washed with 
Et2O (20 mL) followed by acetone (20 mL). 1-Bromopyrene was obtained without further 
purification in 98 % yield. 
1
H NMR (400 MHz, CDCl3): 8.45 (d, J = 8.2 Hz, 1H), 8.21 (m, 4 
H), 8.05 (m, 4 H). 
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3-bromoperylene, Per-Br 
3
 
 
 
In a round bottom flask, perylene (0.20 g, 0.79 mmol) was dissolved in distilled DMF (36 
mL). NBS (0.14 g, 0.79 mmol) was added dropwise to the solution. After 24 h of stirring at 
room temperature, the reaction was quenched with 50 mL of water. The precipitate formed 
was extracted into CH2Cl2 (3 × 50 mL) of and the solution was washed with distilled water 
(10 mL). The yellow powder was obtained in 78 % yield. 
1
H NMR (400 MHz, CDCl3): 8.22 
(d, J = 7.5 Hz, 1 H), 8.19 (m, 1 H), 8.15 (d, J = 7.4 Hz, 1 H), 8.08 (d, J = 8.3 Hz, 1 H), 7.98 
(d, J = 8.0 Hz, 1 H), 7.76 (d, J = 8.1 Hz, 1 H), 7.70 (m, 2 H), 7.58 (t, J = 8.0 Hz, 1 H), 7.48 
(m, 2 H). 
 
7-diethylamino-2-oxo-chromene-3-carboxylic acid ethyl ester 
4
 
 
4-Diethylaminosalicylaldehyde (1.93 g, 10 mmol), diethylmalonate (3.2 g, 20 mmol) and 
piperidine (1 mL) were combined inabsolute ethanol (40 mL). The reaction mixture was 
heated at 78 °C for 6 h. The solvent was evaporated and the product was extracted with 
CH2Cl2 (30 mL) and purified by chromatography on silica gel (petroleum ether / ethyl acetate, 
3:1). A yellow crystalline solid was isolated in 70 % yield. 
1
H NMR (400 MHz, CD2Cl2): 8.39 
(s, 1 H), 7.37 (d, J = 8.9 Hz, 1 H), 6.63 (dd, J = 8.9 Hz, J = 2.4 Hz, 1 H), 6.45 (d, J = 2.2 Hz, 1 
H), 4.30 (q, J = Hz, 2 H), 3.45 (q, J = 7.1 Hz, 4H), 1.36 (t, J = Hz, 3 H), 1.22 (t, J = 7.1 Hz, 
6H). 
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7-(diethylamino)chromen-2-one 
4
 
 
 
  
7-Diethylamino-2-oxo-chromene-3-carboxylic acid ethyl ester (1 g, 3.46 mmol) was added to 
a solution of HCl (60 mL). The reaction mixture was heated at 110 °C for 5 h. After cooling, 
saturated sodium acetate solution (30 mL) was added and the pH was adjusted to 4-5 with a 
saturated solution of sodium hydroxide. The precipitate was filtered and dried under vacuum 
at 50 °C. The white solid was obtained with 80 % yield. 
1
H NMR (400 MHz, CD2Cl2): 7.54 
(d, J = 9.3 Hz, 1 H), 7.26 (d, J = 8.9 Hz, 1 H), 6.58 (dd, J = 8.7 Hz, J = 2.4 Hz, 1 H), 6.48 (d, 
J = 2.2 Hz, 1 H), 5.96 (d, J = 9.3 Hz, 1 H), 3.42 (q, J = 7.1 Hz, 4 H), 1.20 (t, J = 7.1 Hz, 6 H). 
 
3-bromo-7-(diethylamino)chromen-2-one 
4
 
 
In a round bottom flask, Br2 (0.89 g, 5.57 mmol) was added dropwise to a solution of 7-
diethylaminocoumarin (1.21 g, 5.57 mmol) in acetic acid (30 mL). The reaction mixture was 
stirred for 2 h 30 at room temperature. The white precipitate was washed with distilled water 
(3  20 mL) and extracted with CH2Cl2 (40 mL). After evaporation, the solid was 
recrystallized from acetonitrile in 78 % yield. 
1
H NMR (400 MHz, CD2Cl2): 8.18 (s, 1 H), 
7.92 (d, J = 8.9 Hz, 1 H), 7.67 (s, 1 H), 7.67 (d, 1 H), 3.37 (d large, 4H), 1.29 (t, J = 7.1 Hz, 
6H). 
 
2-methyl-5-(N-butylnaphatalenyl)thiophene 
 
 
In a Schlenk tube, N-butyl-4-bromonaphthalimide (0.166 g, 0.5 mmol ), 2-methylthiophene 
(0.075 g, 0.75 mmol), and KOAc (0.098 g, 1 mmol) were mixed with Pd(OAc)2 (0.001 mg, 
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0.005 mmol) in DMAc (5mL) at 150 °C. After 48 h of stirring, the 2-methyl-5-(N-
butylnaphthalenyl)thiophene was purified by chromatographic silica gel (pentane). A yellow 
powder was obtained in 65 % yield. 
1
H NMR (400 MHz, CD2Cl2): 8.67 (dd, J = 8.5 Hz, J = 
1.12 Hz), 8.58 (d, J = 7.3 Hz, J = 1.12 Hz), 8.52 (d, J = 7.6 Hz), 7.83 (d, J = 7.6 Hz), 7.81 (t, J 
= 7.9 Hz), 7.16 (d, J = 3.7 Hz), 6.91 (d, J = 6.7 Hz), 4.13 (t, J = 12 Hz), 1.68 (m), 1.43 (m), 
0.96 (t, J = 10 Hz). 
13
C {
1
H} NMR (100 MHz, CD2Cl2): 164.1, 163.8, 142.8, 139.3, 137.4, 
132.2, 130.9, 130.4, 129.8, 129.0, 128.2, 127.0, 126.3, 123.1, 121.7, 40.1, 30.2, 20.4, 15.11, 
13.6. HRMS [M
 
+ H
+
] for C21H19N2O2S m/z theoretical: 349.45. Found: 350.01. 
 
2-methyl-5-(pyrene)thiophene 
 
 
 
In a Schlenk tube, 1-bromopyrene (0.141 g, 0.5 mmol), 2-methylthiophene (0.075 g, 0.75 
mmol), and KOAc (0.098 g, 1 mmol) were mixed with Pd(OAc)2 (0.001 mg, 0.005 mmol) in 
DMAc (5mL) at 150 °C for 48 h. After evaporation of the solvent, the 2-methyl-5-
(pyrene)thiophene was purified by column chromatography on silica gel (pentane). 
1
H NMR 
(400 MHz, CD2Cl2): 8.56 (d, J = 9.3, 1 H), 8.17 (m, 3 H), 8.05 (m, 5H), 7.19 (d, J = 3.4 Hz, 
1H), 6.94 (m, 1H), 2.64 (s, 1H). HRMS [M
 
+ H
+
] for C21H14S m/z theoretical: 298.08. Found: 
299.97. 
 
 
2-methyl-5-(perylene)thiophene 
 
 
In a Schlenk tube, 3-bromoperylene (0.166 g, 0.5 mmol), 2-methylthiophene (0.075 g, 0.75 
mmol), and KOAc (0.098 g, 1 mmol) were mixed with Pd(OAc)2 (0.001 mg, 0.005 mmol) in 
DMAc (5mL) at 150 °C. After 48 h of stirring, the 2-methyl-5-(perylene)thiophene was 
purified by column  chromatography on silica gel (pentane). 
1
H NMR (400 MHz, CD2Cl2): 
8.22 (m, 1 H), 7.71 (m, 3 H), 7.50 (m, 5H), 7.08 (d, J = 3.4 Hz, 1H), 6.87 (d, J = 3.5 Hz, 1H), 
216 
 
2.64 (s, 3H). 
13
C {
1
H} NMR (100 MHz, CD2Cl2):140.5, 139.3, 134.6, 133.0, 132.5, 131.2, 
131.1, 130.9, 130.7, 128.6, 128.6, 128.4, 127.8, 127.7, 127.4, 126.8, 126.8, 126.6, 125.8, 
125.6, 120.6, 120.5, 120.4, 120.3, 119.8, 29.6. HRMS [M
 
+ H
+
] for C25H16S m/z theoretical: 
348.10. Found: 349.76. 
 
 
2-methyl-5-(7-(diethylamino)chromen-2-one)thiophene 
 
 
In a Schlenk tube, 3-bromo-7-(diethylamino)chromen-2-one (0.166 g, 0.5 mmol), 2-
methylthiophene (0.075 g, 0.75 mmol), and KOAc (0.098 g, 1 mmol) were mixed with 
Pd(OAc)2 (0.001 mg, 0.005 mmol) in DMAc (5 mL) at 150 °C. After 48 h of stirring, the 2-
methyl-5-(N-butylnaphatlenyl)thiophene was purified by column chromatography on silica 
gel (CH2Cl2). A yellow powder was obtained in 15 % yield. 
1
H NMR (400 MHz, CDCl3): 
7.62 (s, 1 H), 7.29 (d, J = 8.8 Hz, 1 H), 7.26 (d, J = 6.1 Hz, 1 H), 6.91 (d, J = 5.11 Hz, 1 H), 
6.61 (dd, J = 8.8 Hz, J = 2.4 Hz, 1 H), 6.54 (d, J = 2.2 Hz, 1 H), 3.44 (q, 4H), 2.30 (s, 3H), 
1.22 (t, 6H). HRMS [M
 
+ H
+
] for C18H19N2O2S m/z theoretical: 313.11. Found: 314.23. 
 
 
4-methyl-2-phenylpyridine 
 
Preparation of the phenyllithium 
An excess of lithium (2.89 g, 430 mmol) was ground, activated in ethanol, deactivated in n-
heptane and suspended in 70 mL of diethyl ether. The suspension was cooled to 0 
o
C and 
bromobenzene (22.6 mL, 215 mmol) in diethyl ether (70 mL) was added dropwise during 20 
min. The reaction mixture was stirred for six hours at room temperature. 
Preparation of 4-methyl-2-phenylpyridine 
The freshly-prepared phenyllithium was added dropwise to a solution of 4-picoline (5 g, 53.8 
mmol) in 70 mL toluene at 0 
o
C. The reaction was stirred for 24 h at room temperature, 
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cooled down to 0 
o
C and
 
distilled water was added dropwise to hydrolyze the excess 
phenyllithium. The residue was extracted in dichloromethane, washed with water and dried 
over MgSO4. The product was purified by column chromatography on silica gel (100% n-
heptane to n-heptane/ethylacetate 8:2) to afford an orange powder (m = 5 g, 55%). 
1
H NMR 
(200 MHz, CDCl3): 8.55 (d, J = 4.8 Hz, 1H, H
6
-py), 7.98 (m, 2H, H-ortho), 7.55 (s, 1H, H
3
-
py), 7.43 (m, 3H, H-meta, H-para), 7.05 (dd, J = 4.8 Hz, J = 1 Hz, 1H, H
5
-py), 2.41 (s, 3H, 
CH3). 
13
C{
1
H} NMR (75 MHz, CDCl3)  = 157.2 (C
4
-py), 149.4 (C
6
-py), 147.7 (C
2
-py), 
139.5 (C-ipso Ph), 128.8 (C-para), 128.7 (C-meta), 126.9 (C-ortho), 123.1 (C
5
py), 121.1 (C
3
-
py), 21.1 (CH3). 
 
Ir(C^N-thpy-NI)3, 39a and Ir(C^N-thpy )(C^N-thpy-NI)2, 39b 
 
 
 
N-butyl-4-bromonaphthalimide (498 mg, 1.50 mmol), fac-Ir(thpy)3 (168 mg, 0.25 mmol), and 
KOAc (147 mg, 1.5 mmol) with Pd(OAc)2 (2.80 mg, 0.0125 mmol) were combined in DMAc 
(5mL) at 150 °C during 48 h. The solvent was evaporated and the reaction mixture was 
purified by column chromatography on silica gel (pentane/Et2O, 6:4). Two products were 
collected, 39a in 40 % yield and 39b in less than 5 % yield. HRMS [M
 
+ H
+
] for 
C75H57IrN6O6S3 m/z theoretical: 1426.70. Found: 1427.87. 
Characterisations for 39a: 
1
H NMR (400 MHz, CD2Cl2): 9.18 (d, J = 8.2 Hz, 1 H), 8.77 (t, J = 6.9 Hz, 1 H), 8.71 (d, J = 
7.2 Hz, 1 H), 8.65 (d, J = 8.5 Hz, 1 H), 8.61 (d, J = 7.3 Hz, 1 H), 8.57 (m, 1 H), 8.59 (s, 1 H), 
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8.48 (m, 2 H), 8.11 (t, J = 8.0 Hz, 1 H), 7.93 (d, J = 7.6 Hz, 1 H), 7.89 (d, J = 7.9 Hz, 1 H), 
7.86 (t, J = 7.5 Hz, 1 H), 7.82 (m, 1 H),  7.67 (m, 6 H), 7.31 (d, J = 4.6 Hz, 1 H), 7.24 (d, J = 
8.2 Hz, 1 H),  7.00 (t, J = 6.5 Hz, 1 H), 6.93 (m, 1 H), 6.74 (d, J = 6.7 Hz, 1 H),  6.69 (d, J = 
6.7 Hz, 1 H), 4.12 (t, J = 7.4 Hz, 2H), 1.42 (m, 2H), 1.67 (m, 2H), 0.96 (t, J = 4.6 Hz, 3H). 
HRMS [M
 
+ H
+
] for C59H44IrN5O4S3 m/z theoretical: 1175.42. Found: 1176.56. 
Characterisations for 39b:  
1
H NMR (400 MHz, CD2Cl2): 9.47 (d, J = 5.3 Hz, 1 H), 8.53 (dd, J = 7.3 Hz, J = 1.1 Hz, 1 
H), 8.46 (dt, J = 7.7 Hz, J = 1.7 Hz, 1 H), 8.42 (dd, J = 8.6 Hz, J = 1.1 Hz, 1 H), 7.64-7.79 (m, 
4 H), 6.85 (t, J = 6.6 Hz, J = 1.4 Hz), 6.28 (t, J = 13.6 Hz), 4.12 (t, J = 7.4 Hz, 2H), 1.42 (m, 
2H), 1.67 (m, 2H), 0.96 (t, J = 4.6 Hz, 3H). 
13
C {
1
H} NMR (100 MHz, CD2Cl2): 163.8, 163.8, 
163.6, 153.4, 147.1, 142.6, 138.7, 138.4, 137.7, 131.9, 131.1, 130.9, 130.1, 129.68 128.7, 
127.9, 127.0, 123.0, 122.0, 120.7, 118.1, 0.74, 13.6, 15.0, 20.3, 40.0. HRMS [M
 
+ H
+
] for 
C40H31IrN4O2S3 m/z theoretical: 888.11. Found: 889.16. 
 
Ir(C^N-thpy-pyr)3, 40a and Ir(C^N-thpy )(C^N-thpy-pyr)2, 40b 
 
1-Bromopyrene (336 mg, 1.19 mmol), fac-Ir(thpy)3 (115 mg, 0.17 mmol), KOAc (117.4 mg, 
1.19 mmol)  and Pd(OAc)2 (1.92 mg, 0.0085 mmol) were combined in DMAc (5 mL) and the 
mixture heated at 150 °C  for 48 h. The solvent was evaporated and the reaction mixture was 
purified by column chromatography on silica gel (pentane/Et2O, 6:4). Two products were 
collected, 40a in 23 % yield and 40b in less than 5 % yield. 
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Due to the poor solubility of 40a and 40b, analysis by 
1
H NMR spectroscopy was possible.  
40a: HRMS [M
 
+ H
+
] for C75H49IrN3S3 m/z theoretical: 1273.22. Found: 1274.78. 
40b: HRMS [M
 
+ H
+
] for C59H34IrN3S3 m/z theoretical: 1073.33. Found: 1074.09. 
 
 
Synthesis of Complex 41 
 
                                     
            
3-Bromo-7-(diethylamino)chromen-2-one (296.06 mg, 0.90 mmol), fac-Ir(thpy)3 (100 mg, 
0.15 mmol), and KOAc (87.5 mg, 0.9 mmol) with Pd(OAc)2 (1.70 mg, 0.0075 mmol) were 
combined in DMAc (5mL) at 150 °C during 48 h. The solvent was evaporated and the 
reaction mixture was purified by column chromatography on silica gel (CH2Cl2)  An orange 
powder was collected. 
1
H NMR (400 MHz, CD2Cl2): 7.88 (s, 1 H), 7.65 (m, 1 H), 7.58 (m, 8 
H),  7.33 (d, J = 8.9 Hz, 1 H), 7.31 (d, J = 4.6 Hz, 1 H), 7.27 (d, J = 4.7 Hz, 1 H),  6.86 (s, 1 
H), 6.83 (d, J = 5.4 Hz, 1 H), 6.83 (m, 2 H), 6.64 (dd, J = 8.9 Hz, J = 2.5 Hz, 1 H),  6.54 (d, J 
= 3.3 Hz, 1 H), 6.53 (d, J = 4.7 Hz, 1H), 6.43 (d, J = 4.6 Hz, 1H), 3.46 (q, J = 7.1 Hz, 4H), 
1.26 (t, J = 7.1 Hz, 6H). HRMS [M
 
+ H
+
] for C40H31IrN4O2S3 m/z theoretical: 888.11. Found: 
889.16. 
 
Ir(C^N-ppy)2(tta) 
 
In a Schlenk  tube, under argon atmosphere, the chloro-bridged dimer Ir(C^N-2-ppy)2(μ-Cl)]2 
(289 mg, 0.27 mmol), 1-(2-thienyl)-3,3,3-trifluoroacetone (155 mg, 0.70 mmol), and K2CO3 
(386 mg, 2.80 mmol) were introduced into 10 mL of 2-ethoxyethanol. The reaction mixture 
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was heated at 80 °C for 24 h, quenched by 10 mL of distilled water and the precipitate was 
decanted by centrifugation. The product was then washed with water, ethanol, and diethyl 
ether to afford an orange powder (m = 301 mg, 72 %).
1
H NMR (400 MHz, CD2Cl2)  = 8.55 
(ddd, J = 5.8 Hz, J = 1.6 Hz, J = 0.8 Hz, 1H, H
6 
or H
6’
-py), 8.52 (ddd, J = 5.7 Hz, J = 1.6 Hz, 
J = 0.8 Hz, 1H, H
6
-py or H
6’
-py), 7.95 (s, 2H, H
3
-py, 
 
H
3’
-py), 7.71 (dd, J = 3.9 Hz, J = 1.2 
Hz, 1H, H
5
-thio), 7.68–7.66 (m, 1H, H3-Ph or H3’-Ph), 7.66–7.64 (m, 1H, H3-Ph or H3’-Ph), 
7.59 (dd, J = 5.0 Hz, J = 1.1 Hz, 1H, H
3
-thio), 7.25 (ddd, J = 7.3 Hz, J = 5.8 Hz, J = 1.4 Hz, 
1H, H
5
-py
 
or H
5’
-py), 7.20 (ddd, J = 7.3 Hz, J = 5.8 Hz, J = 1.4 Hz, 1H, H
5
-py
 
or H
5’
-py), 7.08 
(dd, J = 5.0 Hz, J = 3.8 Hz, 1H, H
4
-thio), 6.94 (m, 2H, H
4
-Ph, H
4’
-Ph ), 6.82 – 6.74 (m, 2H, 
H
5
-Ph,
 
H
5’
-Ph), 6.32 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H, H
6
-Ph or H
6’
-Ph), 6.29 (s, 1H, H-metine), 
6.27 (ddd, J = 7.7, 1.2, 0.5 Hz, 1H, H
6
-Ph or H
6’
-Ph), 2.61 (s, H
-CH3
) 
13
C{
1
H} NMR (101 
MHz, CD2Cl2  = 176.37 (O=C), 168.0 (C
2
-py or C
2’
-py), 167.91(C
2
-py or C
2’
-py), 147.92 
(C
6
-py , C
6’
-py), 145.7 (C
2
-thio), 144.98 (C
2
-Ph, C
2’
Ph), 144.48(C
1
-Ph, C
1’
Ph) , 143.90 (C
2
-Ph 
or C
2’
-Ph), 137.73 (C
4
-py, C
4’
-py), 133.10 (C
6
-Ph, C
6’
-Ph), 131.6 (C
3
-thio), 128.97 (C
5
-thio), 
128.89(C
5
-Ph, C
5’
-Ph), 128.4 (C
4
-thio), 123.98 (C
3
-Ph or C
3’
-Ph), 123.83 (C
3
-Ph or C
3’
-Ph), 
122.15 (C
5
-py or C
5’
-py), 122.11 (C
5
-py or C
5’
-py),  121.39 (C
4
-Ph or C
4’
-Ph), 121.29 (C
4
-Ph 
or C
4’
-Ph), 118.85 (C
3
-py or C
3’
-py), 118.72 (C
3
-Ph or C
3’
-Ph), 92.69 (C-methine). HRMS 
[M
+
] for C30H22F3N2O2F3SIr m/z theoretical: 722.08215. Found: 722.0809. 
 
Ir(ppy-Me)2(tta-NI) 
 
 
 
 
 
 
 
DMAc (4 mL) was added to a Schlenk charged with N-butyl-4-bromonaphthalimide (26 mg, 
0.080 mmol), Ir(ppy-Me2)2(tta) (50 mg, 0.067 mmol), KOAc (10 mg, 0.1 mmol) and 
Pd(OAc)2 (0.2 mg, 0.0066 mmol). Then the mixture was heated at 100 °C for 72 h. After 
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cooling at room temperature, 10 mL of water was added and the resulting precipitate was 
washed several times with ethanol and diethyl ether. The resulting mixture was purified by 
column chromatography on silica gel (Eluent: hexane / diethyl ether, 9:1 and then 7:3). The 
solvent was removed under reduced pressure to afford a red solid (11 mg, 16.5 %). 1H NMR 
(600 MHz, CDCl3) δ 8.65 (d, 1 H, J = 7.64 Hz,  H
NI-3
), 8.56 (d, 1 H, J = 8.50 Hz, H
NI-9
), 8.50 
(d, 1 H, J = 7.64 Hz, H
NI-5
), 8.37 (d, 1 H, J = 5.85 Hz, H
py-6 or py-6'
), 8.34 (d, 1 H, J = 5.85 Hz, 
H
py-6 or py-6'
), 7.75 (d, 1 H, J = 8.50 Hz, H
NI-10
), 7.74 (s, 1 H, H
py-3 or py-3'
), 7.73 (d, 1 H, J = 4.23 
Hz, H
th-5
), 7.72 (s, 1 H, H
py-3 or py-3'
), 7.69 (t, 1 H, J = 7.64 Hz, H
NI-4
), 7.56  (d, 2 H, J = 7.60 
Hz, H
ph-3 and ph-3'
), 7.24 (d, 1 H, J = 4.23 Hz, H
th-4
), 7.03 (d, 1 H, J = 5.85 Hz, H
py-5 or py-5'
), 7.00 
(d, 1 H, J = 5.85 Hz, H
py-5 or py-5'
), 6.85 (t, 2 H, J = 7.60 Hz, H
ph-4 and ph-4'
), 6.72 (t, 2 H, J = 7.60 
Hz, H
ph-5 and ph-5'
), 6.31 (d, 1 H, J = 7.60 Hz, H
ph-6 or ph-6'
), 6.25(d, 1 H, J = 7.60 Hz, H
ph-6 or ph-6'
), 
6.21 (s, 1 H, -CH), 4.21 (t, 2 H, -CH2), 2.62 (s, 3 H, -CH3), 2.60 (s, 3 H, -CH3), 1.74 (m, 2 H, 
-CH2), 1.47 (m, 2 H, -CH2), 1.00 (t, 3 H, -CH3). 
13
C{
1
H} (101 MHz, CDCl3) δ 174.9, 167.9, 
164.2, 163.9, 149.2, 148.0, 147.4, 147.3, 145.1, 145.0, 144.9, 144.9, 144.3, 138.4, 133.5, 
133.4, 131.9, 131.6, 130.5, 129.9, 129.6, 128.9, 128.9, 128.8, 128.6, 127.6, 123.7, 123.5, 
123.2, 123.1, 122.9, 122.7, 121.2, 121.1, 119.6, 119.4, 40.5, 30.5, 30.3, 21.6, 21.6, 20.5. 
HRMS: m/z = 999.2083 (M + 2 H
+
) calcd for C17H13Br2N3O m/z = 999.2063. 
 
 
 Experimental details for Chapter Three 7.
[Pt(Mabiq)]PF6 
 
MabiqH (28 mg, 0.0516 mmol) and PtCl2(dmso)2 (21.7 mg, 0.0516 mmol) were placed in a 
schlenk tube. Benzonitrile (2 mL) was added. After degasing using freeze and pump thaw 
method (3 times), the solution was heated at 190 °C for 3 h. After cooling to room 
temperature, 3 mL of distilled water was added. The orange precipitate was washed with 
EtOH (3 × 5 mL) and Et2O (3 × 5 mL) by centrifugation. The crude solid was recrystallized in 
CH3CN/ Et2O. 
1
H NMR (700 MHz, CD3CN) δ = 9.26 (d, J = 8.0 Hz, 2H, H
d
), 8.39 (d, J = 8.0 
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Hz, 2H, H
a
), 8.30 (t, J = 8.0 Hz, 2H, H
b
), 8.05 (t, J = 8.0 Hz, 2H, H
c
), 7.13 (s, 1H, H
n
), 1.60 (s, 
6H, H
j
), 1.59 (s, 6H, H
l
). 
13
C{
1
H} NMR (176 MHz, CD3CN) δ = 180.5 (C
m
), 175.5 (C
h
), 155.1 
(C
g
), 150.4 (C
e
), 137.4 (C
b
), 132.2 (C
c
), 130.3 (C
a
), 127.6 (C
d
), 123.8 (C
f
), 98.9 (C
n
), 53.2 
(C
i+k
), 52.7 (C
i+k
), 24.8 (C
j
), 24.3 (C
l
). HRMS (ES+) m/z = 735.2471 (M) calcd for 
C33H33N8Pt m/z = 735.2455. 
 
[Au(Mabiq)]PF6 
 
(H)Mabiq (20.0 mg, 0.0316 mmol), potassium tetrachloroaurate(III) (37.0 mg, 0.0979 mmol), 
and sodium acetate (61.0 mg, 0.744 mmol) were dissolved in a solution of toluene (12 mL) 
and glacial acetic acid (12 mL). The reaction mixture was heated at reﬂux for 10 min. The 
mixture was then diluted in dichloromethane (30 mL) and washed with water (2 × 100 mL). 
After evaporation of the organic layer, the residue was dissolved in chloroform (12 mL) and 
stirred with a saturated solution of potassium hexaﬂuorophosphate (0.600 g, 0.326 mmol) in 
water (12 mL) for 18 h. The solution was evaporated and the yellow solid was washed with 
Et2O (3 × 5 mL) using centrifugation method. A yellow solid was obtained in 67 % yield. 
1
H 
NMR (700 MHz, dmso-d6) δ = 9.02 (d, J = 7.8 Hz, 2H, H
d
), 8.30 (m, 4H, H
a,b
), 8.03 (m, 2H, 
H
c
), 6.99 (s, 3H), 1.57 (s, 3H), 1.40 (s, 3H), 1.36 (s, 6H), 1.28 (s, 3H), 1.15 (s, 3H), 1.01 (s, 
3H). 
13
C{
1
H} NMR (176 MHz, DMSO-d6) δ = 181.3, 180.7, 170.0, 168.9, 151.5, 151.3, 
148.8, 148.7, 148.2, 147.7, 147.5, 136.9, 136.6, 131.1, 131.0, 129.0, 128.9, 126.9, 122.4, 
122.1, 107.8, 90.3, 62.4, 51.7, 51.3, 50.8, 49.1, 47.8. 
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6-bromo-N-(6-bromopyridin-2-yl)-N-(4-methoxyphenyl)pyridin-2-amine, 
IV 5 
 
A mixture of p-Anisidine (0.49 g, 4 mmol), 2,6-dibromopyridine (2,37 g, 10 mmol), sodium 
tert-butoxide (0.96 g, 10 mmol), Pd(dba)2 (0.05 g, 0.08 mmol) and dppf (0.09 g, 0.16 mmol) 
were poured in dry toluene (40 mL). The reaction mixture was heated at 110 °C for 48 h 
under a nitrogen atmosphere. After cooling to room temperature, water (10 mL) was added to 
the reaction mixture. The organic phase was extracted with ethyl acetate (3 × 20 mL), and 
washed with water (3 × 20 mL). The organic layer was dried with MgSO4, and the solvent 
was reduced under vacuum. The crude oil was purified with column chromatography on silica 
gel (hexane / ethyl acetate, 100:0 and then 80:20), to give a white powder (1.04 g, 60 %). Rf = 
0.66 (silica, 100 % DCM). 
1
H NMR (700 MHz, CDCl3)  = 7.36 (t, J = 7.8 Hz, 2 H, H
4
), 7.13 
(d, J = 8.9, 2 H, H
3′, 5′
), 7.06 (d, J = 7.8 Hz, 2 H, H
3
), 6.94 (d, J = 8.9 Hz, 2 H, H
2′, 6′
), 6.92 (d, 
J = 7.8 Hz, 2 H, H
5
), 3.84 (s, 3 H, H
-Me
). 
13
C {
1
H} NMR (175 MHz, CDCl3)  = 157.5 (C
4′
), 
156.3 (C
2
), 138.6 (C
6
), 138.4 (C
4
), 135.1 (C
1′
), 128.8 (C
3′, 5′
), 120.7 (C
3
), 114.3 (C
2′, 6′
), 113.4 
(C
5
), 54.6 (C
-Me
). HRMS (ES+) m/z = 433.9509 (M+H
+
) calcd for C17H14Br2N3O m/z = 
433.9504. Mp  125 °C. 
 
2-iodobenzoquinoline V 
6
 
 
A solution of BuLi (1.6 M in hexanes solution, 6.0 mmol) was added to a solution of 2,2,6,6-
tetramethylpiperidine (0.85 g, 6.0 mmol) in THF (5 mL) at 0 °C.  After 5 min, ZnCl2.TMEDA 
(0.51 g, 2.0 mmol) was added to the solution. The mixture was stirred for 15 min at 0 °C 
before introduction of the benzoquinoline (0.72 g, 4.0 mmol). After 2 h at 25 °C, a solution of 
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I2 (1.52 g, 6.0 mmol) in THF (10 mL) was added. The mixture was stirred overnight before 
addition of an aqueous saturated solution of Na2S2O3 (4 mL) and extraction with EtOAc (3 × 
20 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated 
under reduced pressure. The crude product was purified by column chromatography on silica 
gel (hexane/ ethyl acetate, 70:30) to give a white powder (0.96 g, 79 %). Rf = 0.59 (silica, 30 
% Et2O, 70 % hexane). 
1
H NMR (600 MHz, CDCl3) δ = 9.21 (d, J = 7.4 Hz, 1 H, H
3
), 7.90 (d, 
J = 7.6 Hz, 1 H, H
12
), 7.87 (d, J = 8.2, 1 H, H
9
), 7.84 (d, J = 8.6 Hz, 1 H, H
7
), 7.79 – 7.69 (m, 
3 H, H
4+10+11
), 7.63 (d, J = 8.8, 1 H, H
6
). 
13
C{
1
H} NMR (175 MHz, CDCl3) δ = 148.2 (C
14
), 
137.0 (C
4
), 133.7 (C
5
), 132.7 (C
9
), 130.7 (C
13
), 128.9 (C
11
) 128.5 (C
7
), 127.8 (C
12
), 127.5 
(C
10
), 125.5 (C
8
), 124.9 (C
3
), 124.8 (C
6
), 117.5 (C
2
). HRMS (ES+) m/z = 305.978 (M+H
+
) 
calcd for C13H8IN m/z = 305.980. Mp  121 °C. 
 
N-(4-methoxyphenyl)-6-phenyl-N-(6-phenylpyridin-2-yl)pyridin-2-amine, 
L
1
H2 
 
 
Ligand L
1
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology using 
precursor 1 (0.41 g, 0.931 mmol), phenyl boronic acid (0.34 g, 2.79 mmol), sodium carbonate 
(0.99 g, 9.31 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 (0.08 g, 0.07 
mmol). The crude product was purified with column chromatography on silica gel (hexane/ 
ethyle acetate 7:3) to give a white powder (0.12 g, 30 %). Rf = 0.37 (silica, 100 % DCM). 
1
H 
NMR (700 MHz, CDCl3) δ = 7.88 (d, J = 7.1 Hz, 4 H, H
b, f
), 7.61 (t, J = 7.9 Hz, 2 H, H
4
), 7.41 
– 7.30 (m, 8 H, H5, c, d, e), 7.28 (d, J = 8.8 Hz, 2 H, H2′, 6′), 7.04 (d, J = 8.2 Hz, 2 H, H3), 6.98 
(d, J = 8.8 Hz, 2 H, H
3′, 5′
), 3.87 (s, 3 H, H
-Me
). 
13
C{
1
H} NMR (175 MHz, CDCl3) δ = 
157.8(C
2
), 157.7 (C
6
), 155.3 (C
a
), 139.4 (C
1′
), 137.9 (C
4
), 129.9 (C
2′, 6′
), 128.8 (C
d
), 128.7 (C
c, 
e
), 126.8 (C
b, f
), 114.9 (C
3′, 5′
), 114.7 (C
3
), 113.7 (C
5
), 55.7 (C
-Me
). HRMS (ES+) m/z = 
430.1907 (M+H
+
) calcd for C29H24N3O m/z = 430.1919. Mp  188 °C.  
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N,6-bis(4-methoxyphenyl)-N-(6-(4-methoxyphenyl)pyridin-2-yl)pyridin-2-
amine, L
2
H2 
 
Ligand L
2
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology from 
precursor 1 (0.54 g, 1.25 mmol) 2-naphthaleneboronic acid (0.57 g, 3.75 mmol) sodium 
carbonate (1.32, 12.5 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 (0.12 g, 
0.1 mmol). The crude product was purified with column chromatography on silica gel 
(hexane/ ethyl acetate 7:3) to give a white powder (0.48 g, 79 %). Rf = 0.81 (silica, 100 % 
DCM). 
1
H NMR (700 MHz, CDCl3) δ = 7.84 (d, J = 8.8 Hz, 4H, H
b, f
), 7.57 (t, J = 7.9 Hz, 2H, 
H
4
), 7.31 (d, J = 7.9 Hz, 2H, H
5
), 7.28 (d, J = 7.9 Hz, 2H, H
2′,6′
), 6.98 (d, J = 7.9 Hz, 4H, 
H
3′,5′,3
), 6.90 (d, J = 8.8 Hz, 4H, H
c,e
), 3.88 (s, 3H, H
-Me
), 3.83 (s, 6H, H
-Me
). 
13
C{
1
H} NMR 
(176 MHz, CDCl3) δ = 160.3, 157.7, 154.9, 138.0, 137.7, 132.1, 129.9, 128.0, 114.8, 114.0, 
113.9, 112.8, 55.6, 55.4. HRMS (ES+) m/z = 490.2136 (M+H
+
) calcd for C31H28N3O3 m/z = 
490.2131. Mp  162 °C. 
 
N-(4-methoxyphenyl)-6-(naphthalen-1-yl)-N-(6-(naphthalen-1-yl)pyridin-2 
yl)pyridin-2-amine, L
3
H2 
 
Ligand L
3
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology. Precursor 1 
(0.23 g, 0.535 mmol) 1-naphthaleneboronic acid (0.28 g, 1.60 mmol), sodium carbonate (0.57 
g, 5.35 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 (0.05, 0.043 mmol). 
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The crude product was purified with column chromatography on silica gel (hexane/ DCM, 
5:5) to give a white powder (0.13 g, 47 %). Rf = 0.28 (silica, 100 % DCM). 
1
H NMR (700 
MHz, CDCl3) δ = 8.13 (d, J = 8.6 Hz, 2H, H
c
), 7.83 (d, J = 8.2 Hz, 4H, H
f,h
), 7.65 (t, J = 8.2 
Hz, 2H, H
4
), 7.58 (d, J = 7.2 Hz, 2H, H
j
), 7.46 (t, J = 7.2 Hz, 2H, H
i
), 7.37 (t, J = 8.6 Hz, 2H, 
H
e
), 7.33 (d, J = 8.8 Hz, 2H, H
2′
), 7.22 – 7.17 (m, 4H, H5,d), 7.14 (d, J = 8.3 Hz, 2H, H3), 6.98 
(d, J = 8.6 Hz, 2H, H
3′
), 3.86 (s, 3H, H
-Me
). 
13
C{
1
H} NMR (175 MHz, CDCl3) δ = 157.8, 
157.8, 157.7, 138.4, 138.1, 137.7, 134.0, 131.2, 129.9, 128.8, 128.1, 127.7, 126.3, 126.0, 
125.7, 125.3, 118.9, 115.1, 114.7, 55.6. HRMS (ES+) m/z = 530.2226 (M+H
+
) calcd for 
C37H28N3O m/z = 530.2232. Mp  113 °C. 
 
N-(4-methoxyphenyl)-6-(naphthalen-2-yl)-N-(6-(naphthalen-2-yl)pyridin-2 
yl)pyridin-2-amine, L
4
H2 
 
 
Ligand L
4
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology. Precursor 1 
(0.23 g, 0.535 mmol) 2-naphthaleneboronic acid (0.28 g, 1.60 mmol), sodium carbonate (0.57 
g, 5.35 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 (0.05 g, 0.043 mmol). 
The crude product was purified with column chromatography on silica gel (hexane/ ethyle 
acetate 7:3) to give a white powder (0.16 g, 55 %). Rf = 0.81 (silica, 100 % DCM). 
1
H NMR 
(700 MHz, CDCl3)  = 8.40 (s, 2H, H
b
), 8.04 (d, J = 8.5 Hz, 2H, H
j
), 7.81 (m, 6H, H
d,g,i
), 7.68 
(t, J = 7.9 Hz, 2H, H
4
), 7.55 (d, J = 7.9 Hz, 2H, H
5
), 7.45 (m, 4H, H
e,f
), 7.35 (d, J = 9.1 Hz, 
2H, H
2′
), 7.10 (d, J = 8.0 Hz, 2H, H
3
), 7.02 (d, J = 9.1 Hz, 2H, H
3′
), 3.90 (s, 3H, H
-Me
). 
13
C{
1
H} NMR (175 MHz, CDCl3)  = 132.7, 132.5, 129.1, 127.7, 127.3, 126.7, 125.2, 123.6, 
113.6, 54.7. HRMS (ES+) m/z = 530.2238 (M+H
+
) calcd for C37H28N3O m/z = 530.2232. Mp 
 151 °C. 
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6-(3,5-bis(trifluoromethyl)phenyl)-N-(6-(3,5-bis(trifluoromethyl) 
phenyl)pyridin-2-yl)-N-(4-methoxyphenyl)pyridin-2-amine, L
5
H2 
 
 
Ligand L
5
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology. Precursor 1 
(0.23 g, 0.535 mmol), 3,5-bis(trifluoromethyl)phenylboronic acid (0.41 g, 1.60 mmol), 
sodium carbonate (0.57 g, 5.35 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 
(0.05 g, 0.043 mmol). The crude product was purified with column chromatography on silica 
gel (hexane/ DCM 7:2) to give a white powder (0.19 g, 51 %). Rf = 0.66 (silica, 50 % DCM, 
50 % hexane). 
1
H NMR (700 MHz, CDCl3) δ = 8.32 (s, 4 H, H
f, b
), 7.82 (s, 2 H, H
d
), 7.68 (m, 
2 H, H
4
), 7.48 (d, J = 8.3 Hz, 2 H, H
5
), 7.30 (d, J = 8.9 Hz, 2 H, H
2′,6′
), 7.22 (d, J = 8.3 Hz, 2 
H, H
3
), 7.05 (d, J = 8.9 Hz, 2 H, H
3′,5′
), 3.89 (s, 3 H, H
-Me
). 
13
C{
1
H} NMR (175 MHz, CDCl3) 
δ = 158.8 (C4′), 157.4 (C2), 151.5 (Ca), 141.1, 138.4 (C4), 136.5, 132.0 (CCF3), 131.9 (CCF3), 
130.4 (C
2′,
 
6′
), 126.7 (C
f,b
), 124.3 (C
e
), 122.7 (C
c
), 122.2 (C
d
), 115.9 (C
5
), 115.3 (C
3′,5′
)
, 
113.9 
(C
3
), 55.7 (C
-Me
). HRMS (ES+) m/z = 702.1414 (M+H
+
) calcd for C33H20F12N3O m/z = 
702.1415. Mp  198 °C. 
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6-(2,4-difluorophenyl)-N-(6-(2,4-difluorophenyl)pyridin-2-yl)-N-(4-
methoxyphenyl)pyridin-2-amine, L
6
H2 
 
 
 
Ligand L
6
H2 was prepared via the Suzuki-Miyaura cross-coupling methodology. Precursor 1 
(0.35 g, 0.795 mmol) 3,5-bis(trifluoromethyl)phenylboronic acid (0.38 g, 2.38 mmol), sodium 
carbonate (0.84 g, 7.95 mmol) and tetrakis(triphenylphosphine) palladium, Pd(PPh3)4 (0.07 g, 
0.06 mmol). The crude product was purified with column chromatography on silica gel 
(dichloromethane) to give a yellow powder (0.30 g, 75 %). Rf = 0.5 (silica, 100 % DCM). 
1
H 
NMR (400 MHz, CDCl3) δ = 7.79 (td, J = 9.1, 6.8 Hz, 1H), 7.66 – 7.58 (m, 1H), 7.47 – 7.41 
(m, 1H), 7.27 – 7.22 (m, 1H), 7.02 (dd, J = 8.2, 0.5 Hz, 1H), 7.00 – 6.94 (m, 1H), 6.90 – 6.80 
(m, 2H).
 13
C{
1
H} NMR (101 MHz, CDCl3) δ = 157.8, 157.5, 150.1, 137.7, 137.4, 132.1, 
132.0, 129.6, 117.8, 117.7, 114.9, 114.8, 111.7, 111.5, 104.4, 104.2, 103.9. HRMS (ES+) m/z 
= 502.1530 (M+H
+
) calcd for C29H19F4N3O m/z = 502.1543. Mp  127 °C. 
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N-(4-methoxyphenyl)-6-(thiophen-2-yl)-N-(6-(thiophen-2-yl)pyridin-2-
yl)pyridin-2-amine, L
7
H2 
 
 
 
Ligand L
7
H2 was prepared via the Stille cross-coupling methodology. Reagents: Precursor 1 
(0.25 g, 0.57 mmol), 2-tri-n-butylstannylthiophene (0.54 g, 1.44 mmol) and 
bis(triphenylphosphine)palladium dichloride {Pd(PPh3)2Cl2} (0.03 g, 0.04 mmol). 
Purification: The crude product was purified with column chromatography on silica gel 
(hexane/ ethyl acetate, 70:30) to give a white powder (0.16 g, 63 %). Rf = 0.59 (silica, 100 % 
DCM). 
1
H NMR (700 MHz, CDCl3) δ = 7.54 (t, J = 7.9 Hz, 2H, H
4
), 7.47 (d, J = 3.4 Hz, 2H, 
H
b
), 7.27 (m, 4H, H
2′,6′,d
),
 
7.23 (d, J = 7.9 Hz, 2H, H
5
), 7.03 (m, 4H, H
3,c
), 6.99 (d, J = 8.7 Hz, 
2H, H
3′,5′
), 3.87 (s, 3H, H
-Me
). 
13
C{
1
H} NMR (175 MHz, CDCl3) δ = 158.1 (C
4′
), 157.0 (C
6
), 
150.5 (C
2
), 145.7 (C
a
), 137.7 (C
4
), 137.1 (C
1′
), 130.5 (C
d
), 127.9 (C
3
), 127.2 (C
2′,6′
), 124.2 
(C
b
), 114.8 (C
3′,5′
), 114.1 (C
c
), 111.9 (C
5
), 55.6 (C
-Me
). HRMS (ES+) m/z = 442.1033 (M+H
+
) 
calcd for C25H19N3OS2 m/z = 442.1040.1920 Mp  137 °C. 
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6-(benzo[b]thiophen-2-yl)-N-(6-(benzo[b]thiophen-2-yl)pyridin-2-yl)-N-(4 
methoxyphenyl)pyridin-2-amine, L
8
H2 
 
 
 
Ligand L
8
H2 was prepared via the Stille cross-coupling methodology. Reagents: Precursor 1 
(0.25 g, 0.57 mmol), 2-tri-n-butylstannylbenzothiophene (0.61 g, 1.44 mmol) and 
bis(triphenylphosphine)palladium dichloride {Pd(PPh3)2Cl2} (0.03 g, 0.04 mmol). 
Purification: The crude product was purified with column chromatography on silica gel 
(hexane/ ethyl acetate, 70:30) to give a white powder (0.24 g, 79 %). Rf = 0.34 (silica, 50 % 
DCM, 50 % hexane). 
1
H NMR (700 MHz, CDCl3)  = 7.78 (d, J = 8.3 Hz, 2H, H
d
), 7.74 (m, 
4H, H
b,g
), 7.63 (t, J = 7.9 Hz, 2H, H
4
), 7.41 (d, J = 7.9 Hz, 2 H, H
5
), 7.33-7.28 (m, 6H, 
H
e,f,2′,6′
), 7.13 (d, J = 7.9 Hz, 2 H, H
3
), 7.04 (d, J = 8.7 Hz, 2 H, H
3′,5′
), 3.91 (s, 3 H, H
-Me
). 
13
C 
{
1
H} NMR (175 MHz, CDCl3)  = 158.3, 157.0, 150.4, 145.6, 140.9, 140.7, 137.8, 136.8, 
130.6, 124.8, 124.4, 124.1, 122.6, 120.8, 115.0, 114.9, 113.0, 55.7 (C
-Me
). HRMS (ES+) m/z = 
542.1361 (M+H
+
) calcd for C33H24N3OS2 m/z = 542.1354. Mp  201 °C.  
 N-(benzo[h]quinolin-2-yl)-N-(4-methoxyphenyl)benzo[h]quinolin-2-amine, 
L
9
H2 
 
 
Ligand L
9
H2 was prepared via the Buchwald-Hartwig Amination methodology. Reagents: p-
anisidine (0.07 g, 0.584 mmol), 2-iodobenzoquinolone (0.39 g, 1.28 mmol), sodium tert-
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butoxide (0.13 g, 1.35 mmol), and Pd(dppf)Cl2 (0.02 g, 0.0292 mmol). Purification: The 
crude oil was purified with column chromatography on silica gel (hexane / dichloromethane, 
5:5), to give a white powder (0.09 g, 31 %). Rf = 0.62 (silica, 100 % DCM).
1
H NMR (700 
MHz, CDCl3) δ = 8.83 (d, J = 8.3 Hz, 2 H, H
12
), 8.07 (d, J = 8.6 Hz, 2 H, H
4
), 7.86 (d, J = 8.3 
Hz, 2 H, H
9
), 7.71 (d, J = 8.7 Hz, 2 H, H
6
), 7.67 (d, J = 8.7 Hz, 2 H, H
7
), 7.60 (t, J = 8.3 Hz, 2 
H, H
10
), 7.50 (m, 4 H, H
11,3
), 7.41 (d, J = 8.9 Hz, 2 H, H
2′, 6′
), 7.07 (d, J = 8.9 Hz, 2 H, C
3′, 5′
), 
3.93 (s, 3 H, C
-Me
). 
13
C {
1
H} NMR (175 MHz, CDCl3) δ = 158.3, 156.0, 144.9, 137.0, 134.0, 
131.0, 130.4, 127.9, 127.6, 126.6, 125.5, 125.0, 124.7, 122.6, 116.5, 115.0, 55.7. HRMS 
(ES+) m/z = 478.1930 (M+H
+
) calcd for C33H24N3O m/z = 478.1920. Mp ≥ 250 °C. 
 
SYNTHESIS OF TETRADENTATE PLATINUM COMPLEXES 
 
PtL
1
 
 
 
The complex was prepared via procedure 1. L
1
H2 (0.28 g) (Crystallization was performed by 
slow diffusion of DCM into DMF. (0.14 g, 33 %). 
1
H NMR (600 MHz, CDCl3) δ = 8.42 (d, J 
= 7.4 Hz, 2H, H
e
), 7.80 (d, J = 7.4 Hz, 2H, H
b
), 7.71 (t, J = 8.7 Hz, 2H, H
4
), 7.61 (d, J = 8.7 
Hz, 2H, H
5
), 7.46 (t, J = 7.4 Hz, 2H, H
d
), 7.31 (d, J = 8.7 Hz, 2H, H
2′
), 7.23 (t, J = 7.4 Hz, 2H, 
H
c
), 7.18 (d, J = 8.7 Hz, 2H, H
3′
), 6.53 (d, J = 8.7 Hz, 2H, H
3
), 3.96 (s, 3H, H
-Me
). 
13
C {
1
H} 
NMR (151 MHz, CDCl3) δ = 164.3 (C
2
), 160.2 (C
4’
), 149.1 (C
6
), 148.8 (C
f
), 147.0 (C
a
), 136.9 
(H
4
), 136.1 (H
e
), 136.0 (C
1’
), 131.5 (H
2’
), 129.5 (H
d
), 123.9 (H
b
), 123.4 (H
c
), 116.7 (H
3′
), 
113.9 (H
3
), 111.8 (H
5
), 55.8 (C
-Me
). HRMS (AP+) m/z = 622.100 (M) calcd for C29H21N3OPt 
m/z = 622.130. Mp ≥ 250 °C. 
 
 
 
 
232 
 
PtL
1
ClCN 
 
 
 
The complex was prepared via procedure 1. L
1
H2 (0.28 g) Crystallization was performed by 
slow diffusion of hexane into DCM unexpectedly yielding the Pt(IV) complex (0.056 g, 20 
%). 
1
H NMR (700 MHz, DMSO-d6) δ = 8.29 (d, J = 7.9 Hz, 2H, He), 8.12 (d, J = 7.9 Hz, 2H, 
H
b
), 8.11 (d, J = 8.6 Hz, 4H, H
5
), 7.98 (t, J = 7.9 Hz, 2H, H
d
), 7.62 (d, J = 8.5 Hz, 2H, H
2′
), 
7.44 (t, J =, 2H, H
5
), 7.33 – 7.23 (m, 4H, Hc), 6.86 (d, J = 8.6 Hz, 2H, H3), 3.89 (s, 3H, H-Me). 
13
C{
1
H} NMR (176 MHz, DMSO-d6) δ = 163.4, 159.6, 151.4, 146.4, 139.9, 138.7, 135.7, 
135.3, 131.7, 129.6, 125.5, 124.1, 116.4, 114.9, 114.1, 55.6. 
 
PtL
2
Cl2 
 
 
 
The complex was prepared via procedure 1. L
2
H2 (0.32 g) The product was dissolved in DCM 
for crystallization by slow diffusion of hexane into DCM (0.11 g, 22 %). 1H NMR (700 MHz, 
CDCl3) δ = 7.79 (d, J = 8.7 Hz, 2H, H
b
), 7.71 (d, J = 2.4 Hz, 2H, H
e
), 7.69 – 7.62 (m, 4H, 
H
4,5
), 7.42 (d, J = 8.8 Hz, 2H, H
2′
), 7.19 (d, J = 8.8 Hz, 2H, H
3′
), 6.89 – 6.85 (dd, J = 8.7, 2.4, 
2H, H
c
), 6.57 (d, J = 8.0 Hz, 2H), 4.03 (s, 6H), 3.95 (s, 3H, H
3
). HRMS (AP+) m/z = 751.0910 
(M) calcd for C31H25Cl2N3O3Pt m/z = 751.0900. Mp ≥ 250 °C. 
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Attempted complexation of Pt(II) to L
5
H2, VI 
 
 
The attempted complexation of platinum(II) to L
5
H2 (0.46 g) using procedure 1 led to the 
unexpected organic product shown above, as a green solid (0.39 g, 85 %).
1
H NMR (700 MHz, 
CDCl3) δ = 8.61 (s, 4H, H
f,b
), 8.54 (d, J = 8.0 Hz, 2H, H
5
), 7.94 (d, J = 8.9 Hz , 2H, H
2′
), 7.87 
(m, 4H, H
d,4
), 7.21 (d, J = 8.9 Hz, 2H, H
3′
), 3.98 (s, 3H, H
-Me
). 
13
C {
1
H} NMR (176 MHz, 
CDCl3) δ = 158.8, 152.0, 151.8, 141.4, 132.5, 132.3, 132.1, 131.9, 130.3, 128.3, 128.1, 127.5, 
127.2, 125.8, 124.3, 122.7, 122.5, 121.2, 115.7, 114.2, 114.1, 114.1, 55.7. HRMS (ES+) m/z = 
700.1239 (M+H
+
) calcd for C33H18N3OF12 m/z = 700.1258. 
 
PtL
3
Cl2  
 
 
 
The complex was prepared via procedure 1. L
3
H2 (0.35 g) The yellow solid was dried under 
reduced pressure. Crystallization was performed by slow diffusion of hexane into DCM (0.16 
g, 31 %). 
1
H NMR (700 MHz, CDCl3) δ = 8.57 (d, J = 8.7 Hz, 2H, H
c
), 8.48 (d, J = 8.5 Hz, 
2H, H
i
), 8.22 (d, J = 8.1 Hz, 2H, H
5
), 8.06 – 7.99 (m, 4H, Hf, h), 7.80 (t, J = 8.1 Hz, 2H, H4), 
7.59 (t, J = 7.2 Hz, 2H, H
d
), 7.49-7.44 (m, 4H, H
2′, e
), 7.23 (d, J = 8.8 Hz, 2H, H
3′
), 6.73 (d, J 
= 8.6 Hz, 2H, H
3
), 3.98 (s, 3H, H
-Me
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 162.3 (C
2
), 160.5 
(C
4′
), 152.4 (C
6
), 139.8 (C
4
), 137.9 (C
a
), 137.4 (C
j
), 136.1 (C
1′
), 133.4 (C
i
), 131.5(C
2′
), 131.2 
(C
h
), 130.5 (C
b
), 129.6 (C
f
), 127.1 (C
g
), 126.2 (C
d
), 124.9 (C
e
), 123.7 (C
c
), 119.8 (C
5
), 116.9 
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(C
3′
), 114.6 (C
3
), 55.9 (C
-Me
). HRMS (AP+) m/z = 722.1702 (M-2Cl
-
) calcd for C37H26N3OPt 
m/z = 722.1703. Mp ≥ 250 °C. 
 
PtL
4
 
 
 
 
Ligand L
4
H2 (0.35 g, 0.66 mmol), K2PtCl4 (0.30 g, 0.72 mmol), and acetic acid (3 mL) were 
introduced to a microwave cell. The reaction mixture was degassed with three freeze-pump-
thraw, and heated at 160 °C for 30 min in a microwave. The reaction was quenched with 
water (5 mL), and the precipitate was collected and washed with Et2O (5 × 5 mL) by 
centrifugation. The red solid was dried under reduced pressure and crystallized by slow 
diffusion of hexane into DCM (0.36 g, 75 %). NMR (700 MHz, CDCl3)  = 8.78 (s, 2H, H
i
), 
8.21 (s, 2H, H
b
), 8.02 (d, J = 7.9 Hz, 2H, H
d
), 7.88 (d, J = 7.9 Hz, 2H, H
g
), 7.72 (d, J = 7.7 
Hz, 2H, H
5
), 7.64 (t, J = 7.7 Hz, 2H, H
4
), 7.52 (t, J = 7.5 Hz, 2H, H
e
), 7.40 (t, J = 7.5 Hz, 2H, 
H
f
), 7.24 (d, J = 8.6, 2H, H
2′
), 7.09 (d, J = 8.6, 2H, H
3′
), 6.43 (d, J = 7.7 Hz, 2H, H
3
), 3.92 (s, 
3H, H
-Me
). 
13
C {
1
H} NMR (175 MHz, CDCl3)  = 163.6, 149.5, 146.9, 143.3, 135.2, 133.9, 
133.8, 131.2, 130.0, 127.0, 127.4, 122.9, 122.8, 116.8, 116.3, 114.3, 114.0, 55.6. HRMS 
(AP+) m/z 722.1701 (M+H
+
) calcd for C37H26N3OPt m/z = 722.1703. Mp ≥ 250 °C. 
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 PtL
7
 
 
 
The complex was prepared via procedure 1. L
7
H2 (0.29 g) Crystallization was performed by 
slow diffusion of hexane into DCM. (0.22 g, 52 %). NMR (700 MHz, CD2Cl2)  = 7.72 (m, 
4H, H
4,d
), 7.60 (d, J = 4.6 Hz, 2H, H
c
), 7.35 (m, 4H, H
2′, 5
), 7.21 (d, J = 8.7 Hz, 2H, H
3′
), 6.46 
(d, J = 8.5 Hz, 2H, H
3
), 3.95 (s, 3H, H
-Me
). 
13
C {
1
H} NMR (176 MHz, CD2Cl2) δ = 160.7 
(C
4′
), 158.9 (C
2
), 152.8 (C
a
), 148.6 (C
6
), 142.3 (C
e
), 137.6 (C
d
), 135.7 (C
4
), 135.6 (C
1′
), 131.7 
(C
2′
), 128.5 (C
c
), 116.8 (C
3′
), 112.7 (C
3
), 111.1 (C
5
), 56.1 (C
-Me
). HRMS (AP+) m/z= 
634.0526 (M+H
+
) calcd for C25H18N3OPtS2 m/z = 634.0518. Mp ≥ 250 °C. 
 
PtL
7
Cl2 
 
 
 
PtL
7
Cl2 was obtained by irradiation of PtL
7 
with light at 298 K in CDCl3. 
1
H NMR (400 
MHz, CDCl3) δ = 7.75 – 7.57 (m, 6H, H
c,d,4
), 7.44 (m, 4H, H
2′,5
), 7.21 (d, J = 9.0 Hz, 2H, H
3′
), 
6.45 (d, 2H, H
3
), 3.97 (s, 3H, H
-Me
). 
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PtL
8
 
 
 
A mixture of dry Et2O and THF (2 mL of each) was added to a mixture of L
8
H2 (0.03 g, 
0.0564 mmol) and [Pt(µ-Cl)(SMe2)2]2 (0.02 g, 0.0282 mmol). The reaction was cooled to –10 
°C under nitrogen pressure. BuLi (1.6 M in hexane, 4 eq) was added dropwise to the solution 
and the reaction was allowed to warm to room temperature after 30 min at -10 °C. The 
reaction mixture was quenched with water (5 mL), and the precipitate was collected by 
centrifugation. Crystallization was performed by slow diffusion of hexane into DCM. (0.01 g, 
20 %). 
1
H NMR (700 MHz, CDCl3)  = 8.10 (d, J = Hz, 2H), 7.89 (d, J = Hz, 2H), 7.74 (t, J = 
Hz, 2H), 7.41 (d, J = Hz, 2H), 7.29 (m, J = 8.0 Hz, 4H, H-ph), 7.19 (t, J = Hz, 2H), 7.09 (t, J 
=  Hz, 2H), 7.44 (d, 2H), 3.96 (s, 2H, -CH3). 
13
C{
1
H} NMR (175 MHz, CDCl3)  = 158.3, 
156.9, 150.4, 145.4, 140.9, 140.7, 137.8, 136.8, 130.6, 124.8, 124.4, 124.1, 122.6, 120.8, 
115.0, 114.9, 113.0, 55.7 (C
-Me
). HRMS (ES+) m/z = 542.1361 (M+H
+
) calcd for 
C33H24N3OS2 m/z = 542.1354. Mp ≥ 250 °C. 
PtL
8
Cl2 
 
 
Irradiation of PtL
8
 with light at 298 K in CDCl3. 
1
H NMR (700 MHz, CDCl3)  = 7.68 (d, J = 
Hz, 2 H, H-), 7.61-7.66 (m, 2 H, H-), 7.42 (m, 2 H, H-), 7.20 (d, J = Hz, 2 H, H-), 6.44 (d, J = 
8.0 Hz, 4 H, H-ph), 3.96 (s, 3H, H
-Me
). Mp ≥ 250 °C. 
237 
 
PtL
9
 
 
 
 
Ligand L
9
H2 (0.32 g, 0.66 mmol), K2PtCl4 (0.30 g, 0.72 mmol), and acetic acid (3 mL) were 
introduced to a microwave cell. The reaction mixture was degassed with three freeze-pump-
thaw cycles, and heated at 160 °C for 30 min in a microwave. The reaction was quenched 
with water (5 mL), and the precipitate was collected and washed with Et2O (5 x 5 mL) by 
centrifugation. The brown solid was dried under reduced pressure. Crystallization was 
performed by slow diffusion of DCM into DMF. (0.13 g, 30 %). HRMS (AP+) m/z= 668.1363 
(M+H
+
) calcd for C33H22N3OPt m/z = 668.1373. Mp ≥ 250 °C. The product was too insoluble 
to have correct NMR spectroscopies. 
 
SYNTHESIS OF TETRADENTATE PALLADIUM 
COMPLEXES 
 
PdL
1
 
 
 
 
The complex was prepared via procedure 2. L
1
H2 (0.09 g) Crystallization was performed by 
slow diffusion of DCM into DMF. (0.06 g, 60 %). 
1
H NMR (400 MHz, CDCl3) δ = 8.26 (d, J 
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= 7.6 Hz, 2H, H
e
), 7.75 (d, J = 7.6 Hz, 2H, H
b
), 7.60 – 7.55 (m, 4H, H4, 5), 7.41 (td, J = 7.6, 
1.1 Hz, 2H, H
d
), 7.27 (m, 2H, H
2′
), 7.21 (t, J = 7.6 Hz, 2H, H
c
), 7.15 (d, J = 8.7 Hz, 2H, H
3′
), 
6.36 (d, J = 7.5 Hz, 2H, H
3
), 3.93 (s, 3H, H
-Me
).
13
C{
1
H} NMR (101 MHz, CDCl3) δ = 163.3 
(C
2
), 160.6 (C
4′
), 160.1 (C
6
), 151.6 (C
f
), 147.8 (C
a
), 138.0 (C
4
), 136.3 (C
e
), 135.9 (C
1′
), 131.5 
(C
2′
), 129.3 (C
d
), 123.9 (C
b
), 123.9 (C
c
), 116.6 (C
3′
), 113.6 (C
3
), 111.7 (C
5
), 55.84 (C
-Me
). 
HRMS (AP+) m/z =532.0803 (M+H
+
) calcd for C29H21N3OPd m/z = 532.0803. Mp ≥ 250 °C. 
 
PdL
6
 
 
 
 
The complex was prepared via procedure 2. L
6
H2 (0.10 g) Crystallization was performed by 
slow diffusion of DCM into DMF. (0.08 g, 67 %). 
1
H NMR (700 MHz, CD2Cl2) δ = 7.91 (d, J 
= 8.5 Hz, 2 H, H
5
), 7.68 (t, J = 8.5 Hz, 2 H, H
4
), 7.55 (dd, J = 8.2, 2.4 Hz, 2 H, H
e
), 7.29 (d, J 
= 8.7 Hz, 2 H, H
2′
), 7.19 (d, J = 8.7 Hz 2 H, H
3′
), 6.71 – 6.62 (m, 2 H, Hc), 6.50 (d, J = 8.5 Hz, 
2 H, H
3
), 3.94 (s, 3 H, H
Me
). 
13
C{
1
H} NMR (176 MHz, CD2Cl2) δ = 166.9 (C
f
), 160.7 (C
4′
), 
159.5 (C
6
), 151.8 (C
2
), 139.1 (C
4
), 135.9 (C
1′
), 131.6 (C
2′
), 130.5 (C
a
), 117.8 (d, J = 16.2 Hz, 
C
e
), 117.0 (C
3′
), 116.1 (d, J = 21.8 Hz, C
5
), 114.6 (C
3
), 100.4 (t, J = 27.2 Hz, C
c
), 56.1 (C
-Me
). 
HRMS (AP+) m/z = 603.0366 (M) calcd for C29H17F4N3OPd m/z = 603.0348. Mp ≥ 250 °C. 
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PdL
7
 
 
 
 
The complex was prepared via procedure 2. L
7
H2 (0.09 g) Crystallization was performed by 
slow diffusion of DCM into DMF. (0.06 g, 52 %). 
1
H NMR (700 MHz, CD2Cl2) δ = 7.64 (d, J 
= 4.7 Hz, 2H, H
d
), 7.59 (td, J = 8.7, 7.6 Hz, 2H, H
4
), 7.53 (d, J = 4.7 Hz, 2 H, H
c
), 7.32 (d, J = 
8.7 Hz, 2 H, H
2′
), 7.28 (d, J = 7.6 Hz, 2 H, H
5
), 7.19 (d, J = 8.7 Hz, 2 H, H
3′
), 6.29 (d, J = 8.7 
Hz, 2 H, H
3
), 3.94 (s, 3 H, H
-Me
). 
13
C{
1
H} NMR (176 MHz, CD2Cl2) δ = 162.9 (C
e
), 160.6 
(C
4′
), 158.4 (C
6
), 151.2 (C
2
), 141.6 (C
a
), 138.7 (C
4
), 135.4 (C
d
), 135.3 (C
1′
), 131.7 (C
2′
), 127.0 
(C
c
), 116.8 (C
3′
), 112.2 (C
3
), 111.1 (C
5
), 56.1 (C
-Me
). HRMS (ES+) m/z = 541.9947 (M+H
+
) 
calcd for C25H18N3OS2Pd m/z = 541.9968. Mp ≥ 250 °C. 
 
PdL
9
 
 
 
The complex was prepared via procedure 2. L
9
H2 (0.10 g) Crystallization was performed by 
slow diffusion of DCM into DMF. (0.02 g, 15 %). HRMS (AP+) m/z = 580.0820 (M+H
+
) 
calcd for C33H22N3OPd m/z = 580.0803. Mp ≥ 250 °C. 
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SYNTHESIS OF TETRADENTATE MERCURIC COMPLEXES 
HgL
7
 
 
 
The complex was prepared via procedure 3. Yellow powder (Yield = 45 %). 
1
H NMR (400 
MHz, DMSO) δ = 7.81 (d, J = 3.6 Hz, 2 H), 7.69 (t, J = 7.9 Hz, 2 H), 7.43 (d, J = 7.6 Hz, 2 
H), 7.21 (d, J = 8.9 Hz, 2 H), 7.04 (dd, J = 10.7, 6.3 Hz, 4 H), 6.89 (d, J = 8.2 Hz, 2 H), 3.81 
(s, 3 H). 
13
C{
1
H} NMR (176 MHz, dmso-d6) δ = 157.3, 156.7, 156.6, 150.8, 150.4, 147.7, 
138.3, 136.6, 136.5, 135.5, 129.6, 124.6, 114.7, 113.8, 112.2, 55.2. HRMS (AP+) m/z = 
637(M) calcd for C29H17F4N3OPd m/z = 603.0348. Mp ≥ 250 °C. 
 
 Experimental details for Chapter Four 8.
[Ir(µ-Cl)(ppy)2]2 
 
 
 
In a Schlenk tube, a suspension of 2-phenylpyridine (0.65 g, 4.18 mmol) and iridium 
trichloride hydrate (0.50 g, 1.67 mmol) in a mixture of 2-ethoxyethanol (12 mL) and water (4 
mL) was heated for 24 h at 146 °C. After cooling to room temperature, the precipitate was 
collected via centrifugation and washed with EtOH (2 × 10 mL) and Et2O (2 × 10 mL). The 
product was dried under vacuum to give a yellow powder (0.71 g, 79 %). 
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[Pt(µ-Cl)(ppy)]2 
 
 
 
In a Schlenk tube, a suspension of 2-phenylpyridine (0.65 g, 4.18 mmol) and potassium 
tetrachloroplatinate (0.50 g, 1.67 mmol) in a mixture of 2-ethoxyethanol (12 mL) and water (4 
mL) was heated for 24 h at 146 °C. After cooling to room temperature, the precipitate was 
collected via centrifugation and washed with EtOH (2 × 10 mL) and Et2O (2 × 10 mL). The 
product was dried under vacuum to give a yellow powder (0.71 g, 79 %). 
 
2-(2-quinolyl)benzimidazole, L
10
H 
 
 
 
L
10
H was prepared following method A, starting from  1,2-phenylenediamine (156 mg, 1.02 
mmol) and quinoline-2-carboxylic acid (250 mg, 1.44 mmol), giving the product as a white 
powder (205 mg, 58 %). 
1
H NMR (700 MHz, CDCl3) δ = 8.59 (d, J = 8.5 Hz, 1 H, H
9
), 8.33 
(d, J = 8.6 Hz, 1 H, H
10
), 8.12 (d, J = 8.5 Hz, 1 H, H
12
), 7.88 (d, J = 8.0 Hz, 1 H, H
15
), 7.76 (t, 
J = 7.6 Hz, 1 H, H
14
), 7.71 (s, 2 H, H
2+5
), 7.59 (t, J = 7.4 Hz, 1 H, H
13
), 7.36 – 7.30 (m, 2 H, 
H
3+4
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 150.8 (C
7
), 148.0 (C
8
), 147.6 (C
18
), 137.6 (C
10
), 
130.4 (C
14
), 129.2 (C
15
), 128.7 (C
11
), 128.0 (C
12
), 127.5 (C
13
), 123.8 (C
3,4,2,5
), 119.3 (C
9
). 
HRMS (ES+) m/z = 246.1034 (M+H
+
) calcd for C16H12N3 m/z = 246.1031. Mp  223 °C. 
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2-(3-isoquinolyl)benzimidazole, L
11
H 
 
 
 
L
11
H was prepared following method A, from 1,2-phenylenediamine (62.5 mg, 0.58 mmol), 
and isoquinoline-3-carboxylic acid (100 mg, 0.58 mmol), giving the product as a white 
powder (142 mg, 47 %). 
1
H NMR (700 MHz, CDCl3) δ = 8.59 (d, J = 8.5 Hz, 1 H, H
16
), 8.32 
(d, J = 8.6 Hz, 1 H, H
9
), 8.12 (d, J = 8.5 Hz, 1 H), 7.88 (d, J = 8.0 Hz, 1 H), 7.75 (t, J = 7.6 
Hz, 2 H), 7.71 (s, 1 H), 7.59 (t, J = 7.4 Hz, 1 H), 7.35 – 7.30 (m, 2 H). 13C{1H} NMR (176 
MHz, CDCl3) δ = 152.3, 151.5, 141.9, 136.4, 134.8, 131.3, 129.1, 128.4, 127.8, 127.7, 120.4, 
118.7, 116.8. HRMS (ES+) m/z = 246.1027 (M+H
+
) calcd for C16H12N3 m/z = 246.1031. Mp = 
152 °C. 
 
2-(1-isoquinolyl)benzimidazole, L
12
H 
 
 
 
Ligand L
12
H was prepared following method A from 1,2-phenylenediamine (156 mg, 1.02 
mmol) and 4-isoquinoline-1-carboxylic acid (250 mg, 1.44 mmol), giving the product as a 
white powder (216 mg, 61 %). 
1
H NMR (700 MHz, CDCl3) δ = 10.92 (s, 1 H, N-H), 10.22 (d, 
J = 8.6 Hz, 1 H, H
16
), 8.58 (d, J = 5.5 Hz, 1 H, H
10
), 7.97 (d, J = 7.7 Hz, 1 H, H
2
), 7.89 (d, J = 
8.1 Hz, 1 H, H
13
), 7.78 (m, 3 H, H
11+12+15
), 7.55 (d, J = 7.7 Hz, 1 H, H
5
), 7.34 (m, 2 H, H
3+4
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 151.6 (C
8
), 146.7 (C
9
), 145.1 (C
7
), 141.5 (C
10
), 137.3 
(C
14
), 133.1 (C
1
), 130.7 (C
15
), 128.9 (C
12
), 128.6 (C
16
), 126.9 (C
13
), 126.8 (C
6
), 124.4 (C
3
), 
122.7 (C
11
), 122.6 (C
4
), 120.8 (C
2
), 111.2 (C
5
). HRMS (ES+) m/z = 246.1053 (M+H) calcd for 
C16H12N3 m/z = 246.1031. Mp  211 °C. 
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2-(4-bromopyrid-2-yl)benzimidazole, L
13
H 
 
 
 
L
13
H was prepared following method A from 1,2-phenylenediamine (268 mg, 2.47 mmol) 
and 4-bromopicolinic acid (500 mg, 2.47 mmol), giving the product as a white powder (0.34 
mg, 51 %). 
1
H NMR (700 MHz, (CD3)2CO) δ = 8.56 (d, J = 2.6 Hz, 1 H, H
12
), 8.55 (s, 1 H, 
H
9
), 7.70 (dd, J = 5.3, 1.8 Hz, 3 H, H
2,5,11
), 7.28 (dd, J = 6.0, 3.1 Hz, 2 H, H
3,4
). 
13
C {
1
H} 
NMR (176 MHz (CD3)2CO) δ = 232.6 (C
7
), 150.4 (C
12
), 150.2 (C
1,6
), 149.3 (C
8
), 132.9 (C
10
), 
127.3 (C
2,5,11
), 124.1 (C
9
), 122.9 (C
3,4
). HRMS (ES+) m/z = 273.9988 (M+H
+
) calcd for 
C12H8BrN3 m/z = 273.9980. Mp  185 °C. 
 
2,2'-Bisbenzimidazole, L
14
H2  
7
 
 
 
 
A solution of hexachloropropanone (1.06 g, 0.002 mol) was added dropwise to 1,2-
benzenediamine (5.32 g, 0.02 mol) in ethylene glycol (5 mL) at 0 °C. The reaction mixture 
was sonicated for 1 h at 0 °C. The gray-white precipitates were isolated from the solution by 
filtration on a Büchner funnel. The solid was washed with Et2O (3 × 20 mL) and acetone (2 x 
10 mL), and dried under reduced pressure to give a white solid (2.5 g, 53 %). 
1
H NMR (600 
MHz, (CD3)2SO) δ = 13.52 (s, 2 H, -NH), 7.75 (d, J = 8.0 Hz, 2 H, H
8
), 7.55 (d, J = 7.8 Hz, 2 
H, H
5
), 7.44 (m, 4 H, H
6, 7
). 
13
C{
1
H} NMR (150 MHz, (CD3)2SO) δ = 143.9 (C
2
), 134.6 (C
4
), 
134.9 (C
9
), 123.7 (C
6
), 122.3 (C
7
), 119.3 (C
8
), 112.2 (C
5
). HRMS (ES+) m/z = 235.1017 
(M+H) calcd for C14H10N4 m/z = 235.0984. Mp ≥ 250 °C. 
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1,1'-Dimethyl-2,2'-bisbenzimidazole, L
15
  
9
 
 
 
 
2,2'-Bisbenzimidazole (50 mg, 0.213 mmol) and potassium carbonate (74 mg, 0.533 mmol) 
were dissolved in DMF (5 mL) at 298 K. After 30 min, iodomethane (181 mg, 1.28 mmol) 
was added dropwise to the solution. The reaction mixture was stirred for 12 h at 298 K. The 
beige precipitate formed was centrifuged and washed with Et2O (3 × 10 mL) and acetone (2 × 
10 mL). The product was dried under reduced pressure to give a white solid. (42 mg, 75 
%).
1
H NMR (600 MHz, (CD3)2SO) δ = 7.81 (d, J = 8.1 Hz, 2 H, H
8
), 7.72 (d, J = 8.1 Hz, 2 H, 
H
5
), 7.41 (t, J = 8.1 Hz, 2 H, H
7
), 7.34 (t, J = 8.1 Hz, 2 H, H
6
), 4.27 (s, 6 H, H
-CH
3).
 13C{
1
H} 
NMR (151 MHz, (CD3)2SO) δ = 142.9, 141.8, 135.9, 123.7, 122.6, 119.6, 110.9, 54.3. HRMS 
(ES+) m/z = 263.1303 (M+H
+
) calcd for C16H14N4 m/z = 263.1297. Mp ≥ 250 °C. 
 
[Ir(ppy)2(L
10
H)]PF6 
 
 
[Ir(ppy)2(L
10
H)]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and L
10
H (25 mg, 0.103 mmol), leading to the product as a red powder (54 mg, 78 
%). 
1
H NMR (600 MHz, CDCl3) δ = 12.19 (s, 1 H, NH), 8.74 (1 H, d, J = Hz, ), 8.61 (1 H, d, 
J = Hz, ), 8.12 (1 H, d, J = Hz, ), 7.91 (3 H, d, J = Hz, ), 7.84 (1 H, d, J = Hz, ), 7.74-7.63 (5 
H, m, ), 7.55 (1 H, t, J = Hz, ), 7.48 (1 H, d, J = Hz), 7.35 (1 H, t, J = Hz, ), 7.27 (1 H, t, J = 
Hz, ), 7.13 (1 H, t, = Hz, ), 7.06 (1 H, t, J = Hz), 7.02-6.86 (5 H, m, ), 6.46 (1 H, d, J = Hz, ), 
6.24 (1 H, d, J = Hz, ), 5.96 (1 H, d, J = Hz, ). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 168.1, 
167.9, 152.4, 149.5, 148.5, 143.9, 143.8, 141.9, 137.6, 137.5, 136.5, 133.2, 132.3, 131.6, 
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130.8, 130.1, 128.0, 127.7, 126.6, 126.1, 125.4, 124.8, 124.5, 123.9, 123.2, 122.8, 122.5, 
122.4, 119.7, 119.2, 118.5, 117.3, 115.0. HRMS (ES+) m/z = 743.1788 (M) calcd for 
C38H26IrN5 m/z = 743.1794. Mp ≥ 250 °C. 
 
Ir(ppy)2L
10
 
 
 
 
Ir(ppy)2L
10
 was prepared following method C from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 mmol), 
and L
10
H (25 mg, 0.103 mmol), giving the product as an orange powder (44 mg, 63 %). 
1
H 
NMR (700 MHz, CDCl3) δ = 8.78 (d, J = 8.6 Hz, 1 H, ), 8.38 (d, J = 8.6 Hz, 1H), 8.11 (d, J = 
8.9 Hz, 1H), 7.84 (ddd, J = 4.0, 2.8, 2.2 Hz, 2H), 7.81 (d, J = 8.2 Hz, 1H), 7.79 (dd, J = 8.1, 
1.3 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.67 (dd, J = 7.9, 1.1 Hz, 1H), 7.64 (dd, J = 7.7, 1.1 Hz, 
1H), 7.63 – 7.58 (m, 1H), 7.54 (td, J = 8.2, 1.6 Hz, 1H), 7.42 (td, J = 6.9, 1.3 Hz, 2H), 7.19 – 
7.13 (m, 2H), 7.09 – 7.05 (m, 1H), 7.00 (td, J = 7.5, 1.3 Hz, 1H), 6.96 (td, J = 7.4, 1.4 Hz, 
1H), 6.87 (td, J = 7.5, 1.3 Hz, 1H), 6.82 – 6.74 (m, 3H), 6.52 (dd, J = 7.5, 0.9 Hz, 1H), 6.25 
(dd, J = 7.7, 0.7 Hz, 1H), 5.90 (d, J = 8.3 Hz, 1H). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 
168.7, 167.9, 158.9, 155.4, 150.2, 149.1, 148.0, 145.3, 144.2, 143.9, 143.5, 139.8, 137.0, 
136.8, 132.2, 131.8, 131.1, 130.5, 130.0, 129.3, 128.5, 128.3, 127.5, 124.7, 124.2, 122.9, 
122.7, 122.4, 122.2, 121.7, 120.7, 119.2, 118.9, 117.6, 116.8. HRMS (AP+) m/z = 743.1783 
(M) calcd for C38H26N5Ir m/z = 743.1794. Mp ≥ 250 °C. Anal. Calcd for C38H26IrN5: C 61.27, 
H 3.52, N 9.4; found C 61.25, H 3.51, N 9.45. 
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[Ir(ppy)2(L
11
H)]PF6 
 
 
[Ir(ppy)2(L
11
H)]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and L
11
H (25 mg, 0.103 mmol), as an orange powder (39 mg, 56 %). 
1
H NMR (700 
MHz, CDCl3) δ = 9.27 (s, 1H), 8.44 (s, 1H), 8.30 (d, J = 7.6 Hz, 1H), 7.94 – 7.85 (m, 3H), 
7.82 (d, J = 8.2 Hz, 1H), 7.77 (m, 2H), 7.70 (m, 5H), 7.51 (d, J = 5.3 Hz, 1H), 7.33 (t, J = 7.3 
Hz, 1H), 7.10 (m, 2H), 6.98 (t, 7.6 Hz, 2H), 6.96 (t, J = 7.3 Hz, 1 H), 6.93 (t, J = 6.6 Hz, 1 H), 
6.89 (t, J = 6.8 Hz, 1 H), 6.46 (d, J = 7.6 Hz, 2H), 6.43 (d, J = 7.6 Hz, 2H), 6.23 (d, J = 8.1 
Hz, 1H). 
13
C{
1
H} NMR (175 MHz, CDCl3)  = 168.3, 167.9, 154.3, 149.5, 148.2, 144.1, 
137.7, 137.5, 133.7, 132.6, 132.4, 131.8, 131.4, 130.8, 130.1, 130.0, 129.5, 129.2, 128.0, 
125.7, 124.8, 124.5, 123.2, 122.8, 122.5, 122.3, 119.5, 119.2, 117.1, 114.1. HRMS (ES+) m/z 
= 744.1837 (M+H) calcd for C38H27IrN5 m/z = 744.1872. Mp ≥ 250 °C. 
 
Ir(ppy)2L
11
 
 
 
 
Ir(ppy)2L
11
  was prepared following method C from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 mmol), 
and L
11
H (25 mg, 0.103 mmol), which gave the product as a yellow powder (31 mg, 45 %). 
1
H NMR (700 MHz, CDCl3) δ = 8.40 (s, 1H), 7.99 (d, J = 7.7 Hz, 1H), 7.84 – 7.75 (m, 4H), 
7.72 (t, J = 7.5 Hz, 1H), 7.68 (t, J = 8.4 Hz, 3H), 7.61 – 7.49 (m, 4H), 7.07 (t, J = 7.6 Hz, 1H), 
7.05 – 7.00 (m, 2H), 6.95 (td, J = 7.4, 1.3 Hz, 1H), 6.90 (td, J = 7.5, 1.3 Hz, 1H), 6.75 (dt, J = 
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17.3, 6.1 Hz, 3H), 6.53 – 6.45 (m, 2H), 6.16 (d, J = 8.1 Hz, 1H). 13C{1H} NMR (176 MHz, 
CDCl3) δ = 168.7, 168.5, 153.5, 150.2, 148.5, 144.8, 144.3, 137.0, 136.7, 136.4, 132.6, 132.5, 
132.4, 130.5, 129.8, 129.0, 128.1, 124.6, 124.3, 122.7, 122.2, 121.8, 121.6, 118.9, 118.8, 
115.8. HRMS (AP+) m/z = 743.1790 (M) calcd for C38H26N5Ir m/z = 743.1794. Mp ≥ 250 °C. 
Anal. Calcd for C38H26IrN5: C 61.27, H 3.52, N 9.4; found C 61.25, H 3.51, N 9.45. 
 
[Ir(ppy)2(L
12
H)]PF6 
 
 
[Ir(ppy)2(L
12
H)]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and L
12
H (25 mg, 0.103 mmol), yielding the product as a red powder (53 mg, 77 %). 
1
H NMR (400 MHz, CDCl3) δ = 13.43 (s, 1 H, NH), 9.17 (d, J = 9.15 Hz, 1 H), 8.14 (m, 1 
H), 8.03 (d, J = 8.90 Hz, 1 H), 7.95-7.87 (m, 5 H), 7.73-7.66 (m, 5 H), 7.44 (d, J = 6.25 Hz, 1 
H, ), 7.39 (t, J = 7.70 Hz, 1 H), 7.12-7.07 (m, 3 H), 7.02 (t, J = 7.70 Hz, 2 H, ), 6.98 (m, 2 H), 
6.91 (t, J = 6.40 Hz, ), 6.87 (t, J = 6.90 Hz, ), 6.44 (d, J = 7.30 Hz, 1 H, ), 6.39 (d, J = 7.60 
Hz, 1 H, ), 6.32 (d, J = 8.70 Hz, 1 H, ). 
13
C{
1
H} NMR (150 MHz, (CDCl3)) δ = 167.4, 167.1, 
151.6, 148.7, 147.7, 143.2, 143.0, 141.2, 136.9, 136.7, 135.7, 132.5, 131.5, 130.8, 130.0, 
129.3, 127.2, 126.9, 125.9, 125.3, 124.6, 124.0, 123.7, 122.4, 122.1, 121.7, 121.6.  HRMS 
(ES+) m/z = 744.1870 (M) calcd for C38H27IrN5 m/z = 744.1849. Mp ≥ 250 °C.  
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Ir(ppy)2L
12
 
 
 
Ir(ppy)2L
12
  was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 mmol), 
and L
12
H (25 mg, 0.103 mmol), giving the product as anorange powder (43 mg ,62 %). 
1
H 
NMR (600 MHz, CDCl3) δ = 8.80 (d, J = Hz, 1 H), 8.27(d, J = Hz, 1 H), 8.12 (d, J = Hz, 1 
H), 7.91 (d, J = Hz, 1 H), 7.85 (d, J = Hz, 1 H), 7.79 (d, J = Hz, 1 H), 7.74 (d, J = Hz, 1 H), 
7.67 (d, J = Hz, 1 H), 7.63 (d, J = Hz, 1 H), 7.58 (t, J = Hz, 1 H), 7.51 (t, J = Hz, 1 H), 7.40 
(d, J = Hz, 1 H), 7.37 (t, J = Hz, 1 H), 7.14 (t), 7.08 (t, J = Hz, 1 H), 6.98 (m, 1 H), 6.86 (t, J 
= Hz, 1 H), 6.72 (t, J = Hz, 1 H),  6.57 (d, J = Hz, 1 H), 6.26 (d, J = Hz, 1 H), 5.87 (d, J = 
Hz, 1 H). HRMS (AP+) m/z = 743.1791 (M) calcd for C38H26N5Ir m/z = 743.1794. Mp ≥ 250 
°C. Anal. Calcd for C38H26IrN5: C 61.27, H 3.52, N 9.40; found C 61.26, H 3.51, N 9.45. 
 
[Ir(ppy)2L
13
H]PF6 
 
[Ir(ppy)2L
13
H]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and 2-(4-bromo-pyrid-2-yl)benzimidazole (28 mg, 0.103 mmol), leading to the 
product as a brown powder (71 mg, 40 %). 
1
H NMR (700 MHz, CDCl3) δ = 11.92 (s, 1 H), 
8.79 (s, 1 H), 7.91 (d, J = 8.5 Hz, 1 H), 7.87 (d, J = 8.5 Hz, 1 H), 7.82 (d, J = 8.3 Hz, 1 H), 
7.76 (t, J = 8.0 Hz, 1 H), 7.74 – 7.67 (m, 4 H), 7.62 (d, J = 5.8 Hz, 1 H), 7.54 – 7.49 (m, 2 H), 
7.35 (t, J = 8.0 Hz, 1H), 7.10 (t, J = 7.4 Hz, 1 H), 7.06 (t, J = 7.3 Hz, 1 H), 7.01 (t, J = 7.6 Hz, 
2 H), 6.95 (m, 3 H), 6.41 (d, J = 7.9 Hz, 1 H), 6.35 (d, J = 7.4 Hz, 1 H), 6.23 (d, J = 8.0 Hz, 1 
H). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 168.3, 167.9, 150.9, 150.4, 149.6, 148.7, 148.5, 
146.2, 144.1, 144.0, 140.3, 138.1, 137.9, 137.1, 134.6, 132.4, 131.9, 131.3, 131.0, 130.4, 
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127.9, 126.9, 125.6, 124.9, 124.7, 123.6, 123.2, 122.8, 122.7, 119.6, 119.5, 117.7, 114.8 . 
HRMS (ES+) m/z = 772.0830 (M) calcd for C34H24BrIrN5 m/z = 772.0821. Mp ≥ 250 °C. 
 
[Ir(ppy)2L
14
H2]PF6  
 
 
[Ir(ppy)2L
14
H2]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol) and 2,2'-bisbenzimidazole (25 mg , 0.103 mmol), which gave the product as ayellow 
solid (128 mg, 75 %). 
1
H NMR (700 MHz, CDCl3) δ = 12.10 (s, 2 H, NH), 7.84 (d, J = 8.20 
Hz, 2 H), 7.69 (m, 6 H), 7.65 (t, J = 6.80 Hz, 2 H), 7.32 (t, J = 7.7 Hz, 2 H), 7.10 (t, J = 7.6 
Hz, 2 H), 7.01 (t, J = 7.7 Hz, 2 H), 6.96 (t, J = 7.6 Hz, 2 H), 6.88 (t, J = 6.80 Hz, 2 H), 6.52 
(d, J = 7.60 Hz, 2 H), 6.20 (d, J = 8.30 Hz, 2 H). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ =  
168.2, 149.4, 147.7, 144.7, 140.5, 137.2, 134.4, 132.5, 129.9, 125.5, 124.7, 124.3, 122.7, 
122.1, 118.9, 117.5, 114.1. HRMS (ES+): m/z = 733.1846 (M) calcd for C36H26IrN6 m/z = 
733.1825. Mp ≥ 250 °C. 
 
Ir(ppy)2(L
14
H) 
 
 
Ir(ppy)2(L
14
H) was prepared following method C from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and 2,2'-bisbenzimidazole (25 mg , 0.103 mmol), giving a yellow powder (90 mg, 53 
%). 
1
H NMR (700 MHz, CDCl3) δ = 7.84 (d, J = 8.20 Hz, 2 H), 7.69 (m, 6 H), 7.65 (t, J = 
6.80 Hz, 2 H), 7.32 (t, J = 7.7 Hz, 2 H), 7.10 (t, J = 7.6 Hz, 2 H), 7.01 (t, J = 7.7 Hz, 2 H), 
6.96 (t, J = 7.6 Hz, 2 H), 6.88 (t, J = 6.80 Hz, 2 H), 6.52 (d, J = 7.60 Hz, 2 H), 6.20 (d, J = 
8.30 Hz, 2 H).  
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 168.2, 149.4, 147.7, 144.7, 140.5, 137.2 
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, 134.4, 132.5, 129.9, 125.5, 124.7, 124.3, 122.7, 122.1, 118.9 (C
3
-Py), 117.5, 114.1. HRMS 
(AP+) m/z = 732.1757 (M) calcd for C36H25N6Ir m/z = 732.1747. Mp ≥ 250 °C. 
 
[Ir(ppy)2L
15
]PF6 
 
[Ir(ppy)2L
15
]PF6 was prepared following method B from [Ir(-Cl)(ppy)2]2 (50 mg, 0.046 
mmol), and 1,1'-dimethyl-2,2'-bisbenzimidazole (25 mg, 0.103 mmol), giving a yellow 
powder (63 %). 
1
H NMR (700 MHz, CDCl3) δ = 8.04 (d, J = 5.6 Hz, 1H), 7.79 (d, J = 7.6 Hz, 
1H), 7.69 – 7.61 (m, 2H), 7.57 (d, J = 8.3 Hz, 1H), 7.39 (t, J = 7.7 Hz, 1H), 7.07 (t, J = 7.4 
Hz, 1H), 7.01 (dd, J = 16.2, 7.8 Hz, 2H), 6.93 (t, J = 7.5 Hz, 1H), 4.67 (s, 3H).
 13
C{
1
H} NMR 
(176 MHz, CDCl3) δ = 150.5, 140.5, 137.4, 132.4, 130.1, 126.4, 125.6, 124.5, 123.5, 122.3, 
118.9, 118.5, 37.6. HRMS (ES+) m/z = 761.2109 (M) calcd for C36H26IrN6 m/z = 761.2138. 
 
 Experimental details for Chapter Five 9.
 [Ir(ppy)2(SPNPS)] 
 
 
A suspension of [Ir(µ-Cl)(ppy)2]2 (0.050 g, 0.046 mmol) and phosphinothioic amide (0.046 g, 
0.10 mmol) in a mixture of MeOH (5 mL) and DCM (5 mL) was heated for 24 h at 52 °C. 
After cooling to room temperature, the solvent was removed and the crude residue was 
washed with Et2O (3 × 10 mL). The product was dried under vacuum to give a yellow powder 
(0.057 g, 65 %). 
1
H NMR (700 MHz, CDCl3) δ = 9.27 (d, J = 7.7 Hz, 1 H, H
py-6
), 7.97 (m, 
2H, H
2,6
), 7.69 (d, J = 8.0 Hz, 1 H, H
py-3
), 7.62 (m, 2 H, H
b,f
), 7.53 (d, J = 7.7 Hz, 1 H, H
6′
), 
7.39 (d, J = 8.0 Hz, 1 H, H
py-4
), 7.35 (m, 3 H, H
3,4,5
), 7.21 (t, J = 7.4 Hz, 1 H, H
4
), 7.01 (m, 2 
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H, H
3,5
), 6.84 – 6.79 (m, 1H, H5′), 6.66 (t, J = 7.7 Hz, 1H, H4′), 6.34 – 6.27 (m, 1 H, Hpy-5), 
5.99 (d, J = 7.7 Hz, 1 H, H
3′
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 167.9, 152.3, 151.0, 
143.6, 141.2, 140.6, 140.0, 135.7, 131.0, 130.9, 130.2, 130.2, 130.0, 129.9, 129.8, 129.4, 
128.2, 128.1, 128.0, 127.9, 123.7, 121.3, 121.1, 117.9. 
31
P NMR (283 MHz, CDCl3) δ = 
29.20. HRMS (AP+) m/z = 948.1501 (M+) calcd for C46H37IrN3P2S2 m/z = 948.1510. 
 
[Pt(ppy)(SPNPS)]  
 
 
A suspension of [Pt(ppy)(µ-Cl)]2 (0.050 g, 0.065 mmol) and phosphinothioic amide (0.088 g, 
0.19 mmol) in a mixture of MeOH (5 mL) and DCM (5 mL) was stirred for 24 h at 25 °C. 
After cooling to room temperature, the solvent was removed and the crude residue was 
washed with Et2O (3 × 10 mL). The product was dried under vacuum to give a yellow powder 
(0.056 g, 54 %). 1H NMR (700 MHz, CDCl3) δ = 9.40 (d, J = 6.7 Hz, 1 H, H
py-6
), 8.07 (d, J = 
7.7 Hz, 1 H, H
3′
), 8.00 – 7.85 (m, 8 H, H2,6), 7.74 (t, J = 7.7 Hz, 1 H, Hpy-4), 7.63 (d, J = 7.7 
Hz, 1 H, H
py-3
), 7.44 (d, J = 7.7, 1.2 Hz, 1 H, H
6′
), 7.41 – 7.34 (m, 4 H, H4), 7.34 – 7.26 (m, 8 
H, H
3,5
), 7.16 (t, J = 7.7 Hz, 1 H, H
4′
), 7.08 (t, J = 7.7 Hz, 1.1 Hz, 1 H, H
5′
), 7.01 (t, J = 6.7 
Hz, 1 H, H
py-5
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 167.5, 148.1, 147.1, 145.0, 138.7, 
138.6, 138.1, 138.0, 137.9, 137.5, 137.5, 136.9, 136.9, 132.2, 131.4, 131.4, 131.2, 131.1, 
131.0, 131.0, 130.8, 130.8, 130.0, 128.2, 128.2, 128.1, 128.1, 123.8, 123.6, 121.9, 118.7. 
31
P 
NMR (283 MHz, CDCl3) δ = 36.68 (d, J = 4.6 Hz), 33.4 (d, J = 4.6 Hz). HRMS (AP+) m/z = 
796.0790 (M) calcd for C35H28N2P2PtS2 m/z = 796.0796. 
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[Pt(SPNPS)2] 
  
  
 
A suspension of [Pt(µ-Cl)(ppy)]2 (0.050 g, 0.065 mmol) and phosphinothioic amide (0.088 g, 
0.019 mmol) in 2-ethoxyethanol was heated for 24 h at 90 °C. After cooling to room 
temperature, the reaction was quenched with water and the precipitate was collected by 
centrifugation. The crude product was washed with EtOH (1 × 10 mL) and Et2O (3 × 10 mL). 
The product was dried under vacuum to give a yellow powder. (0.065 g, 46 %). 
1
H NMR (700 
MHz, CDCl3) δ = 7.89 – 7.83 (m, 16 H, H
2,6
), 7.40 (t, J  = 7.4 Hz, 8 H, H
4
), 7.30 (m, 16 H, 
H
3,5
). 
13
C{
1
H} NMR (176 MHz, CDCl3) δ = 131.5, 131.4, 131.1 (C
4
), 128.2, 128.1. 
31
P NMR 
(283 MHz, CDCl3) δ = 34.26. HRMS (AP+) m/z = 1090.0648 (M) calcd for C48H40N2P4PtS4 
m/z = 1090.0652. 
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A1. Crystallographic Data 
 
Crystal data and structure refinement for [PtMabiq]PF6 
Empirical formula  C33H33N8Pt  x PF6 x CH3CN 
Formula weight  922.79 
Temperature/K  100.0 
Crystal system  triclinic 
Space group  P-1 
a/Å , b/Å, c/Å  9.9204(19), 11.790(2), 16.146(3) 
α/°, β/°, γ/°    109.1410(19), 94.126(2), 104.617(2) 
Volume/Å
3
  1701.4(6) 
Z  2 
ρcalcmg/mm
3
  1.801 
m/mm
-1
  3.910 
F(000)  912.0 
Crystal size/mm
3
  0.2 × 0.04 × 0.01 
Radiation  synchrotron (λ = 0.68890 Å) 
2Θ range for data collection  3.7 to 58° 
Index ranges  -8 ≤ h ≤ 12, -16 ≤ k ≤ 16, -22 ≤ l ≤ 22 
Reflections collected  19717 
Independent reflections  9156 [Rint = 0.0242, Rsigma = 0.0333] 
Data/restraints/parameters  9156/28/460 
Goodness-of-fit on F
2
  1.067 
Final R indexes [I>=2σ (I)]  R1 = 0.0286, wR2 = 0.0731 
Final R indexes [all data]  R1 = 0.0317, wR2 = 0.0749 
Largest diff. peak/hole / e Å
-3
  1.64/-1.88 
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Crystal data and structure refinement for PtL
8
 
Empirical formula  C33H21N3OPtS2 x CH2Cl2 
Formula weight  819.66 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 10.9257(3), 11.5129(3), 12.7088(3) 
α/°, β/°, γ/° 81.4610(10), 69.8240(10), 72.7010(10) 
Volume/Å
3
  1430.75(6) 
Z  2 
ρcalcmg/mm
3
  1.903 
m/mm
-1
  5.272 
F(000)  800.0 
Crystal size/mm
3
  0.28 × 0.06 × 0.03 
2Θ range for data collection  3.72 to 58° 
Index ranges  -14 ≤ h ≤ 14, -15 ≤ k ≤ 15, -17 ≤ l ≤ 17 
Reflections collected  23429 
Independent reflections  7609[R(int) = 0.0424] 
Data/restraints/parameters  7609/0/389 
Goodness-of-fit on F
2
  1.082 
Final R indexes [I>=2σ (I)]  R1 = 0.0320, wR2 = 0.0697 
Final R indexes [all data]  R1 = 0.0398, wR2 = 0.0737 
Largest diff. peak/hole / e Å
-3
  4.26/-1.71 
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Crystal data and structure refinement for 180K Pt L
3
Cl2 
Empirical formula  C37H25Cl2N3OPt x CH2Cl2 
Formula weight  878.52 
Temperature/K  180 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 11.1199(5), 12.6052(6), 12.6121(5) 
α/°, β/°, γ/° 99.0680(10), 98.3320(10), 
105.9410(10) 
Volume/Å
3
  1645.29(13) 
Z  2 
ρcalcmg/mm
3
  1.773 
m/mm
-1
  4.626 
F(000)  860.0 
Crystal size/mm
3
  0.40 × 0.12 × 0.04 
2Θ range for data collection  3.34 to 56° 
Index ranges  -14 ≤ h ≤ 14, -16 ≤ k ≤ 16, -16 ≤ l ≤ 16 
Reflections collected  17108 
Independent reflections  7933[R(int) = 0.0418] 
Data/restraints/parameters  7933/0/425 
Goodness-of-fit on F
2
  1.029 
Final R indexes [I>=2σ (I)]  R1 = 0.0423, wR2 = 0.1010 
Final R indexes [all data]  R1 = 0.0547, wR2 = 0.1076 
Largest diff. peak/hole / e Å
-3
  3.29/-2.14 
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Crystal data and structure refinement for PdL
7
 
Empirical formula  C25H17N3OS2Pd 
Formula weight  545.94 
Temperature/K  120 
Crystal system  monoclinic 
Space group  P21/c 
a/Å, b/Å, c/Å 11.8429(5), 16.9154(8), 11.7698(5) 
α/°, β/°, γ/° 90.00, 119.3810(10), 90.00 
Volume/Å
3
  2054.54(16) 
Z  4 
ρcalcmg/mm
3
  1.765 
m/mm
-1
  1.132 
F(000)  1096.0 
Crystal size/mm
3
  0.42 × 0.06 × 0.05 
2Θ range for data collection  3.94 to 57° 
Index ranges  -15 ≤ h ≤ 15, -22 ≤ k ≤ 22, -15 ≤ l ≤ 15 
Reflections collected  32335 
Independent reflections  5190[R(int) = 0.0505] 
Data/restraints/parameters  5190/0/357 
Goodness-of-fit on F
2
  1.106 
Final R indexes [I>=2σ (I)]  R1 = 0.0384, wR2 = 0.0898 
Final R indexes [all data]  R1 = 0.0528, wR2 = 0.1004 
Largest diff. peak/hole / e Å
-3
  1.77/-0.99 
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Crystal data and structure refinement for PtL
7
  
Identification code  13srv293 
Empirical formula  C25H17N3OPtS2 
Formula weight  634.63 
Temperature/K  120 
Crystal system  monoclinic 
Space group  P21/c 
a/Å, b/Å, c/Å 11.8455(6), 16.9073(9), 11.7422(6) 
α/°, β/°, γ/° 90.00, 119.0990(10), 90.00 
Volume/Å
3
  2054.85(18) 
Z  4 
ρcalcmg/mm
3
  2.051 
m/mm
-1
  7.057 
F(000)  1224.0 
Crystal size/mm
3
  0.36 × 0.1 × 0.02 
2Θ range for data collection  3.94 to 55° 
Index ranges  -15 ≤ h ≤ 15, -21 ≤ k ≤ 21, -15 ≤ l ≤ 15 
Reflections collected  29491 
Independent reflections  4721 [Rint = 0.0522, Rsigma = 0.0360] 
Data/restraints/parameters  4721/0/290 
Goodness-of-fit on F
2
  1.077 
Final R indexes [I>=2σ (I)]  R1 = 0.0250, wR2 = 0.0556 
Final R indexes [all data]  R1 = 0.0368, wR2 = 0.0610 
Largest diff. peak/hole / e Å
-3
  2.08/-1.74 
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Crystal data and structure refinement for PtL
1
  
Empirical formula  C29H21N3OPd 
Formula weight  533.89 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å, b/Å, c/Å  10.2400(2), 13.9674(3), 15.3870(3) 
α/°, β/°, γ/°  90.00, 102.119(2), 90.00 
Volume/Å
3
  2151.72(8) 
Z  4 
ρcalcmg/mm
3
  1.648 
m/mm
-1
  0.892 
F(000)  1080.0 
Crystal size/mm
3
  0.45 × 0.08 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.38 to 57.98° 
Index ranges  -13 ≤ h ≤ 13, -19 ≤ k ≤ 19, -20 ≤ l ≤ 20 
Reflections collected  39737 
Independent reflections  5714 [Rint = 0.0725, Rsigma = 0.0466] 
Data/restraints/parameters  5714/0/308 
Goodness-of-fit on F
2
  1.026 
Final R indexes [I>=2σ (I)]  R1 = 0.0322, wR2 = 0.0684 
Final R indexes [all data]  R1 = 0.0476, wR2 = 0.0750 
Largest diff. peak/hole / e Å
-3
  0.59/-0.62 
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Table 1 Crystal data and structure refinement for L
1
H2  
Empirical formula  C29H23N3O 
Formula weight  429.50 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  C2 
a/Å, b/Å, c/Å  22.398(3), 5.5178(8), 17.919(3) 
α/°, β/°; γ/°  90.00, 104.119(5), 90.00 
Volume/Å
3
  2147.6(5) 
Z  4 
ρcalcmg/mm
3
  1.328 
m/mm
-1
  0.082 
F(000)  904.0 
Crystal size/mm
3
  0.27 × 0.18 × 0.13 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.68 to 60° 
Index ranges  -31 ≤ h ≤ 31, -7 ≤ k ≤ 7, -25 ≤ l ≤ 25 
Reflections collected  15073 
Independent reflections  6161 [Rint = 0.0777, Rsigma = 0.1001] 
Data/restraints/parameters  6161/1/390 
Goodness-of-fit on F
2
  1.002 
Final R indexes [I>=2σ (I)]  R1 = 0.0674, wR2 = 0.1609 
Final R indexes [all data]  R1 = 0.0959, wR2 = 0.1795 
Largest diff. peak/hole / e Å
-3
  0.35/-0.28 
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Crystal data and structure refinement for PdL
9
  
Empirical formula  C33H21N3OPd 
Formula weight  581.93 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å , b/Å, c/Å 14.0765(8), 10.5865(6), 16.5111(10) 
α/°, β/°, γ/°   90.00, 104.9793(17), 90.00 
Volume/Å
3
  2376.9(2) 
Z  4 
ρcalcmg/mm
3
  1.626 
m/mm
-1
  0.815 
F(000)  1176.0 
Crystal size/mm
3
  0.41 × 0.24 × 0.14 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.62 to 58° 
Index ranges  -19 ≤ h ≤ 19, -14 ≤ k ≤ 14, -22 ≤ l ≤ 22 
Reflections collected  34079 
Independent reflections  6324 [Rint = 0.0908, Rsigma = 0.0660] 
Data/restraints/parameters  6324/0/344 
Goodness-of-fit on F
2
  1.027 
Final R indexes [I>=2σ (I)]  R1 = 0.0425, wR2 = 0.0987 
Final R indexes [all data]  R1 = 0.0597, wR2 = 0.1061 
Largest diff. peak/hole / e Å
-3
  0.94/-0.74 
 
 261 
 
 
Crystal data and structure refinement for L
9
  
Empirical formula  C33H23N3O 
Formula weight  477.54 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å  5.5915(3), 12.4353(7), 17.4649(8) 
α/°, β/°, γ/° 90.294(4), 94.368(4), 100.667(4) 
Volume/Å
3
  1189.68(10) 
Z  2 
ρcalcmg/mm
3
  1.333 
m/mm
-1
  0.082 
F(000)  500.0 
Crystal size/mm
3
  0.3007 × 0.1857 × 0.1608 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  5.8 to 60° 
Index ranges  -7 ≤ h ≤ 7, -17 ≤ k ≤ 17, -24 ≤ l ≤ 24 
Reflections collected  14103 
Independent reflections  6930 [Rint = 0.0351, Rsigma = 0.0639] 
Data/restraints/parameters  6930/0/426 
Goodness-of-fit on F
2
  1.041 
Final R indexes [I>=2σ (I)]  R1 = 0.0555, wR2 = 0.1083 
Final R indexes [all data]  R1 = 0.0896, wR2 = 0.1292 
Largest diff. peak/hole / e Å
-3
  0.31/-0.26 
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Crystal data and structure refinement for PtL
4
 
Empirical formula  C37H25N3OPt 
Formula weight  722.69 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 8.6552(6), 9.9973(7), 15.9145(13) 
α/°, β/°, γ/° 78.658(6), 84.855(6), 84.322(6) 
Volume/Å
3
  1340.05(17) 
Z  2 
ρcalcmg/mm
3
  1.791 
m/mm
-1
  5.273 
F(000)  708.0 
Crystal size/mm
3
  0.2907 × 0.0779 × 0.0197 
2Θ range for data collection  5.24 to 56° 
Index ranges  -8 ≤ h ≤ 11, -13 ≤ k ≤ 13, -21 ≤ l ≤ 20 
Reflections collected  13121 
Independent reflections  6465[R(int) = 0.0685] 
Data/restraints/parameters  6465/0/380 
Goodness-of-fit on F
2
  1.003 
Final R indexes [I>=2σ (I)]  R1 = 0.0514, wR2 = 0.1033 
Final R indexes [all data]  R1 = 0.0702, wR2 = 0.1133 
Largest diff. peak/hole / e Å
-3
  2.64/-1.77 
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Crystal data and structure refinement for PdL
1
  
Empirical formula  C29H21N3OPd 
Formula weight  533.89 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å, b/Å, c/Å  10.2400(2), 13.9674(3), 15.3870(3) 
α/°, β/°, γ/°  90.00, 102.119(2), 90.00 
Volume/Å
3
  2151.72(8) 
Z  4 
ρcalcmg/mm
3
  1.648 
m/mm
-1
  0.892 
F(000)  1080.0 
Crystal size/mm
3
  0.45 × 0.08 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.38 to 57.98° 
Index ranges  -13 ≤ h ≤ 13, -19 ≤ k ≤ 19, -20 ≤ l ≤ 20 
Reflections collected  39737 
Independent reflections  5714 [Rint = 0.0725, Rsigma = 0.0466] 
Data/restraints/parameters  5714/0/308 
Goodness-of-fit on F
2
  1.026 
Final R indexes [I>=2σ (I)]  R1 = 0.0322, wR2 = 0.0684 
Final R indexes [all data]  R1 = 0.0476, wR2 = 0.0750 
Largest diff. peak/hole / e Å
-3
  0.59/-0.62 
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Crystal data and structure refinement for PdL
6 
 
Empirical formula  C29H17F4N3OPd 
Formula weight  605.86 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å, b/Å, c/Å  13.0656(12), 13.3619(12), 51.709(5) 
α/°, β/°, γ/°    90.00, 94.561(2), 90.00 
Volume/Å
3
  8998.9(14) 
Z  16 
ρcalcg/cm
3
  1.789 
μ/mm-1  0.889 
F(000)  4832.0 
Crystal size/mm
3
  0.242 × 0.233 × 0.079 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.36 to 56 
Index ranges  -17 ≤ h ≤ 17, -17 ≤ k ≤ 17, -68 ≤ l ≤ 68 
Reflections collected  135988 
Independent reflections  21718 [Rint = 0.1023, Rsigma = 0.0673] 
Data/restraints/parameters  21718/0/1373 
Goodness-of-fit on F
2
  1.122 
Final R indexes [I>=2σ (I)]  R1 = 0.0811, wR2 = 0.1826 
Final R indexes [all data]  R1 = 0.0997, wR2 = 0.1928 
Largest diff. peak/hole / e Å
-3
  2.32/-1.19 
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Crystal data and structure refinement for PtL
1
ClCN  
Empirical formula  C30H21ClN4OPt 
Formula weight  684.05 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 8.8886(7), 11.8297(9), 12.3324(10) 
α/°, β/°, γ/° 71.188(2), 74.189(2), 83.033(2) 
Volume/Å
3
  1180.24(16) 
Z  2 
ρcalcmg/mm
3
  1.925 
m/mm
-1
  6.091 
F(000)  664.0 
Crystal size/mm
3
  0.197 × 0.077 × 0.06 
Radiation  MoKα (λ = 0.71000) 
2Θ range for data collection  5.2 to 60° 
Index ranges  -12 ≤ h ≤ 12, -16 ≤ k ≤ 16, -17 ≤ l ≤ 17 
Reflections collected  19246 
Independent reflections  6863 [Rint = 0.0345, Rsigma = 0.0448] 
Data/restraints/parameters  6863/6/336 
Goodness-of-fit on F
2
  1.096 
Final R indexes [I>=2σ (I)]  R1 = 0.0296, wR2 = 0.0600 
Final R indexes [all data]  R1 = 0.0371, wR2 = 0.0621 
Largest diff. peak/hole / e Å
-3
  3.01/-1.66 
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Crystal data and structure refinement for 14srv051 
Empirical formula  C68H37Cl1F24N6O4Pd2 x 3 CHCl3 
Formula weight  2064.39 
Temperature/K  120.0(2) 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 14.9235(6), 15.8217(7), 18.1312(7) 
α/°, β/°, γ/° 97.389(3), 105.093(3), 107.245(4) 
Volume/Å
3
  3848.0(3) 
Z  2 
ρcalcmg/mm
3
  1.782 
m/mm
-1
  0.926 
F(000)  2036.0 
Crystal size/mm
3
  0.2535 × 0.1186 × 0.027 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  3.88 to 56° 
Index ranges  -19 ≤ h ≤ 19, -20 ≤ k ≤ 20, -23 ≤ l ≤ 23 
Reflections collected  50243 
Independent reflections  18554 [Rint = 0.0790, Rsigma = 0.1146] 
Goodness-of-fit on F
2
  1.023 
Final R indexes [I>=2σ (I)]  R1 = 0.0711, wR2 = 0.1361 
Final R indexes [all data]  R1 = 0.1215, wR2 = 0.1599 
Largest diff. peak/hole / e Å
-3
  2.08/-1.48 
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Crystal data and structure refinement for 13srv306  
Identification code  13srv306 
Empirical formula  C13H8IN 
Formula weight  305.10 
Temperature/K  120 
Crystal system  triclinic 
Space group  P-1 
a/Å, b/Å, c/Å 7.4453(5), 7.5245(5), 9.8877(6) 
α/°, β/°, γ/° 100.6280(10), 93.5190(10), 107.7040(10) 
Volume/Å
3
  514.55(6) 
Z  2 
ρcalcmg/mm
3
  1.969 
m/mm
-1
  3.072 
F(000)  292.0 
Crystal size/mm
3
  0.3 × 0.18 × 0.11 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  4.22 to 58° 
Index ranges  -10 ≤ h ≤ 10, -10 ≤ k ≤ 10, -13 ≤ l ≤ 13 
Reflections collected  6347 
Independent reflections  2730 [Rint = 0.0190, Rsigma = 0.0235] 
Data/restraints/parameters  2730/0/168 
Goodness-of-fit on F
2
  1.079 
Final R indexes [I>=2σ (I)]  R1 = 0.0237, wR2 = 0.0566 
Final R indexes [all data]  R1 = 0.0257, wR2 = 0.0578 
Largest diff. peak/hole / e Å
-3
  1.89/-1.03 
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Crystal data and structure refinement for [Ir(ppy)2L
12
H]PF6 
Empirical formula  C38H27IrN5 x PF6 x 2(C3H6O) 
Formula weight  1006.97 
Temperature/K  120 
Crystal system  monoclinic 
Space group  C2/c 
a/Å, b/Å, c/Å 27.3787(14), 13.7434(7), 22.1437(11) 
α/°, β/°, γ/° 90.00, 110.0600(10), 90.00 
Volume/Å
3
  7826.7(7) 
Z  8 
ρcalcmg/mm
3
  1.709 
m/mm
-1
  3.528 
F(000)  4000.0 
Crystal size/mm
3
  0.51 × 0.22 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  3.16 to 55° 
Index ranges  -35 ≤ h ≤ 35, -17 ≤ k ≤ 17, -28 ≤ l ≤ 28 
Reflections collected  55912 
Independent reflections  8983[R(int) = 0.0678] 
Data/restraints/parameters  8983/5/533 
Goodness-of-fit on F
2
  1.036 
Final R indexes [I>=2σ (I)]  R1 = 0.0380, wR2 = 0.0885 
Final R indexes [all data]  R1 = 0.0593, wR2 = 0.1011 
Largest diff. peak/hole / e Å
-3
  1.71/-1.28 
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Crystal data and structure refinement for Ir(ppy)2L
10
 
Empirical formula  C38H26N5Ir 
Formula weight  744.84 
Temperature/K  100 
Crystal system  monoclinic 
Space group  P21/n 
a/Å, b/Å, c/Å 10.3173(3), 17.8089(6), 15.8935(5) 
α/°, β/°, γ/° 90.00, 93.672(3), 90.00 
Volume/Å
3
  2914.27(16) 
Z  4 
ρcalcmg/mm
3
  1.698 
m/mm
-1
  4.217 
F(000)  1464.0 
Crystal size/mm
3
  0.10 × 0.05 × 0.001 
Radiation  Synchrotron (λ = 0.688900) 
2Θ range for data collection  3.34 to 54° 
Index ranges  -13 ≤ h ≤ 13, -23 ≤ k ≤ 23, -20 ≤ l ≤ 17 
Reflections collected  27454 
Independent reflections  6753[R(int) = 0.0556] 
Data/restraints/parameters  6753/0/398 
Goodness-of-fit on F
2
  1.091 
Final R indexes [I>=2σ (I)]  R1 = 0.0310, wR2 = 0.0743 
Final R indexes [all data]  R1 = 0.0383, wR2 = 0.0795 
Largest diff. peak/hole / e Å
-3
  0.95/-1.14 
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Crystal data and structure refinement for  Ir(ppy)2L
12
 
Empirical formula  C38H26IrN5 x C3H6O 
Formula weight  802.92 
Temperature/K  100.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å, b/Å, c/Å 22.501(12), 8.487(5), 17.122(9) 
α/°, β/°, γ/° 90.00, 102.036(5), 90.00 
Volume/Å
3
  3198(3) 
Z  4 
ρcalcmg/mm
3
  1.668 
m/mm
-1
  3.878 
F(000)  1592.0 
Crystal size/mm
3
  0.1 × 0.05 × 0.01 
Radiation  ? (λ = 0.68890) 
2Θ range for data collection  5.88 to 46° 
Index ranges  -25 ≤ h ≤ 23, -7 ≤ k ≤ 9, -12 ≤ l ≤ 18 
Reflections collected  7812 
Independent reflections  4120 [Rint = 0.0537, Rsigma = 0.0743] 
Data/restraints/parameters  4120/288/435 
Goodness-of-fit on F
2
  1.308 
Final R indexes [I>=2σ (I)]  R1 = 0.0956, wR2 = 0.2093 
Final R indexes [all data]  R1 = 0.1134, wR2 = 0.2176 
Largest diff. peak/hole / e Å
-3
  2.68/-2.92 
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Crystal data and structure refinement for L
10
H 
Identification code  13srv246 
Empirical formula  C16H11N3 x H2O 
Formula weight  263.29 
Temperature/K  120 
Crystal system  monoclinic 
Space group  Cc 
a/Å, b/Å, c/Å  12.8724(8), 7.7651(5), 25.8262(15) 
α/°, β/°, γ/°    90.00, 103.327(2), 90.00 
Volume/Å
3
  2512.0(3) 
Z  8 
ρcalcmg/mm
3
  1.392 
m/mm
-1
  0.090 
F(000)  1104.0 
Crystal size/mm
3
  0.40 × 0.21 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  3.24 to 56° 
Index ranges  -16 ≤ h ≤ 16, -10 ≤ k ≤ 10, -34 ≤ l ≤ 34 
Reflections collected  18656 
Independent reflections  6051[R(int) = 0.0699] 
Data/restraints/parameters  6051/2/367 
Goodness-of-fit on F
2
  0.944 
Final R indexes [I>=2σ (I)]  R1 = 0.0679, wR2 = 0.1603 
Final R indexes [all data]  R1 = 0.0960, wR2 = 0.1781 
Largest diff. peak/hole / e Å
-3
  0.80/-0.29 
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Crystal data and structure refinement for L
11
H 
Identification code  13srv247 
Empirical formula  C16H11N3 x C6H8N2 
Formula weight  353.42 
Temperature/K  120 
Crystal system  monoclinic 
Space group  C2/c 
a/Å, b/Å, c/Å  10.0514(9), 14.3896(13), 24.673(2) 
α/°, β/°, γ/°  90.00, 99.011(2), 90.00 
Volume/Å
3
  3524.6(5) 
Z  8 
ρcalcmg/mm
3
  1.332 
m/mm
-1
  0.082 
F(000)  1488.0 
Crystal size/mm
3
  0.34 × 0.18 × 0.12 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection  3.34 to 58° 
Index ranges  -13 ≤ h ≤ 13, -19 ≤ k ≤ 19, -33 ≤ l ≤ 33 
Reflections collected  18462 
Independent reflections  4677[R(int) = 0.0502] 
Data/restraints/parameters  4677/0/320 
Goodness-of-fit on F
2
  1.006 
Final R indexes [I>=2σ (I)]  R1 = 0.0541, wR2 = 0.1295 
Final R indexes [all data]  R1 = 0.0831, wR2 = 0.1544 
Largest diff. peak/hole / e Å
-3
  0.34/-0.26 
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Crystal data and structure refinement for [Pt(ppy)(SPNPS)] 
Empirical formula C35H28N2P2PtS2 
Formula weight 797.74 
Temperature/K 120.0 
 Crystal system monoclinic 
Space group P21/n 
a/Å, b/Å, c/Å 9.5289(6), 13.6212(8), 22.9936(14) 
α/°, β/°, γ/° 90.00, 96.765(2), 90.00 
Volume/Å
3
 2963.7(3) 
Z 4 
ρcalcmg/mm
3
 1.788 
m/mm
-1
 5.013 
F(000) 1568.0 
Crystal size/mm
3
 0.351 × 0.196 × 0.115 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection 4.46 to 60° 
Index ranges -13 ≤ h ≤ 13, -19 ≤ k ≤ 19, -32 ≤ l ≤ 32 
Reflections collected 46564 
Independent reflections 8660 [Rint = 0.0300, Rsigma = 0.0197] 
Data/restraints/parameters 8660/0/379 
Goodness-of-fit on F
2
 1.067 
Final R indexes [I>=2σ (I)] R1 = 0.0223, wR2 = 0.0541 
Final R indexes [all data] R1 = 0.0245, wR2 = 0.0551 
Largest diff. peak/hole / e Å
-3
 1.44/-0.64 
 
 274 
 
 
Crystal data and structure refinement for [Ir(ppy)2(SPNPS)] 
Identification code IrSPNPS 
Empirical formula C47H38Cl2IrN3P2S2 x CH2Cl2 
Formula weight 1033.96 
Temperature/K 120 
Crystal system orthorhombic 
Space group Pbca 
a/Å, b/Å, c/Å 21.1512(17), 16.5056(13), 27.014(2) 
α/°, β/°, γ/° 90.00, 90.00, 90.00 
Volume/Å
3
 9430.9(13) 
Z 8 
ρcalcmg/mm
3
 1.456 
m/mm
-1
 3.135 
F(000) 4112.0 
Crystal size/mm
3
 0.05 × 0.1 × 0.46 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection 1.5 to 62.08° 
Index ranges -30 ≤ h ≤ 30, -23 ≤ k ≤ 23, -39 ≤ l ≤ 39 
Reflections collected 134186 
Independent reflections 11380 [Rint = 0.1156, Rsigma = 0.0694] 
Data/restraints/parameters 11380/6/512 
Goodness-of-fit on F
2
 1.082 
Final R indexes [I>=2σ (I)] R1 = 0.0486, wR2 = 0.1204 
Final R indexes [all data] R1 = 0.0834, wR2 = 0.1367 
Largest diff. peak/hole / e Å
-3
 2.45/-1.34 
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Crystal data and structure refinement for Pt(SPNPS)2 
Identification code 13srv303 
Empirical formula C48H40N2P4PtS4 
Formula weight 1092.03 
Temperature/K 120.0 
Crystal system triclinic 
Space group P-1 
a/Å, b/Å, c/Å 9.5936(6), 12.9454(8), 13.4912(9) 
α/°, β/°, γ/° 113.792(2), 94.410(2), 102.155(2) 
Volume/Å
3
 1474.02(16) 
Z 1 
ρcalcmg/mm
3
 1.230 
m/mm
-1
 2.658 
F(000) 544.0 
Crystal size/mm
3
 0.22 × 0.2 × 0.04 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection 4.88 to 58° 
Index ranges -13 ≤ h ≤ 13, -18 ≤ k ≤ 18, -19 ≤ l ≤ 19 
Reflections collected 23585 
Independent reflections 7787 [Rint = 0.0285, Rsigma = 0.0393] 
Data/restraints/parameters 7787/0/268 
Goodness-of-fit on F
2
 1.096 
Final R indexes [I>=2σ (I)] R1 = 0.0304, wR2 = 0.0762 
Final R indexes [all data] R1 = 0.0334, wR2 = 0.0803 
Largest diff. peak/hole / e Å
-3
 2.42/-0.86 
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